Case,Sentrix ID (.idat),Tissue source,Pathological Diagnosis (WHO 2016),WHO Grade,Mode of Histological Review (central or local),Age (years at operation),Sex,Tumour Location,Disease Stage,Reference Group abbreviation,Reference Group (Classifier version V11),Estimated tumour purity according to TCGA / Ceccarelli et al. 2016,Pan Glioma DNA Methylation Class according to TCGA / Ceccarelli et al. 2016,Material type,Array processing date / batch,Array ID
A_IDH_01,9611519028_R03C02,University Hospital of Tuebingen,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,16,male,"supratentorial, hemispheric, temporal;  right;",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",62%,LGm2,DNA_FFPE,3月10日,9611519028
A_IDH_02,3998909027_R02C01,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,20,male,"supratentorial, hemispheric, frontal; ",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",61%,LGm2,DNA_FFPE,5月1日,3998909027
A_IDH_03,9968646113_R05C02,German Glioma Network ,"Diffuse astrocytoma, IDH-mutant",II,Central review Duesseldorf,23,male,"supratentorial, hemispheric, temporal; ",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",57%,LGm2,DNA_FFPE,7月8日,9968646113
A_IDH_04,9444374134_R01C01,University Hospital of Tuebingen,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,23,male,"supratentorial, hemispheric, frontal; ",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",69%,LGm2,DNA_FFPE,1月27日,9444374134
A_IDH_05,8622007118_R03C02,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,24,male,"supratentorial, hemispheric, temporal;  left;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",64%,LGm2,DNA_FFPE,1月16日,8622007118
A_IDH_06,3999834094_R05C01,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,24,female,"supratentorial, hemispheric, frontal;  right;",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",63%,LGm2,DNA_FFPE,2月20日,3999834094
A_IDH_07,9969477123_R01C01,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,25,male,"supratentorial, hemispheric, frontal, parietal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",64%,LGm2,DNA_FFPE,9月6日,9969477123
A_IDH_08,9741950087_R02C02,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,26,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",70%,LGm2,DNA_FFPE,4月7日,9741950087
A_IDH_09,9283265153_R05C02,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,26,female,"supratentorial, hemispheric, frontal;  left;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",65%,LGm2,DNA_FFPE,4月29日,9283265153
A_IDH_10,9878827229_R01C01,German Glioma Network ,"Anaplastic astrocytoma, IDH-mutant",III,Central review Duesseldorf,27,female,supratentorial;  right;,not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",69%,LGm2,DNA_KRYO,12月2日,9878827229
A_IDH_11,9855358018_R02C02,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,27,female,"supratentorial, hemispheric, parietal, occipital; ",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",70%,LGm2,DNA_KRYO,9月12日,9855358018
A_IDH_12,9553932002_R05C02,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,27,female,"supratentorial, hemispheric, frontal;  right;",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",67%,LGm2,DNA_FFPE,2月14日,9553932002
A_IDH_13,9370847061_R02C02,University Hospital of Tuebingen,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,27,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",62%,LGm2,DNA_FFPE,9月19日,9370847061
A_IDH_14,9406921070_R06C01,University Hospital of Tuebingen,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,27,male,"supratentorial, hemispheric, frontal;  left;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",61%,LGm2,DNA_FFPE,10月11日,9406921070
A_IDH_15,9769100008_R01C02,German Glioma Network ,"Anaplastic astrocytoma, IDH-mutant",III,Central review Duesseldorf,29,female,"supratentorial, hemispheric, temporal, parietal;  left;",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",69%,LGm2,DNA_KRYO,5月23日,9769100008
A_IDH_16,9878820107_R04C01,University Hospital of Tuebingen,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,29,male,"supratentorial, hemispheric, occipital;  right;",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",68%,LGm2,DNA_KRYO,10月27日,9878820107
A_IDH_17,9878827225_R04C02,University Hospital of Bern,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,30,female,"supratentorial, hemispheric, temporal; ",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",67%,LGm2,DNA_FFPE,11月28日,9878827225
A_IDH_18,9533774084_R06C02,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,30,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",63%,LGm2,DNA_FFPE,6月16日,9533774084
A_IDH_19,9370847061_R03C01,University Hospital of Tuebingen,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,30,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",67%,LGm2,DNA_FFPE,9月19日,9370847061
A_IDH_20,9769100024_R04C01,German Glioma Network ,"Diffuse astrocytoma, IDH-mutant",II,Central review Duesseldorf,31,male,not available,not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",69%,LGm2,DNA_KRYO,5月23日,9769100024
A_IDH_21,9769100024_R06C01,German Glioma Network ,"Diffuse astrocytoma, IDH-mutant",II,Central review Duesseldorf,31,male,"supratentorial, hemispheric, frontal; ",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",62%,LGm2,DNA_KRYO,5月23日,9769100024
A_IDH_22,8622007091_R02C02,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,31,male,"supratentorial, hemispheric, frontal; ",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",63%,LGm2,DNA_FFPE,12月21日,8622007091
A_IDH_23,9741950087_R03C02,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,31,female,"supratentorial, hemispheric, frontal;  left;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",65%,LGm2,DNA_FFPE,4月7日,9741950087
A_IDH_24,9969477079_R04C02,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,31,female,"supratentorial, hemispheric, temporal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",68%,LGm2,DNA_FFPE,8月15日,9969477079
A_IDH_25,9969477108_R02C02,University Hospital of Goettingen,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,32,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",66%,LGm2,DNA_FFPE,9月4日,9969477108
A_IDH_26,8622007097_R02C02,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,32,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",67%,LGm2,DNA_FFPE,12月21日,8622007097
A_IDH_27,9829119119_R03C02,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,32,male,"supratentorial, hemispheric, frontal;  right;",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",64%,LGm2,DNA_FFPE,5月23日,9829119119
A_IDH_28,3999547092_R06C02,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,32,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",79%,LGm2,DNA_FFPE,4月17日,3999547092
A_IDH_29,9379082092_R02C01,University Hospital of Frankfurt am Main,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,33,female,supratentorial; ,recurrence ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",66%,LGm2,DNA_FFPE,11月8日,9379082092
A_IDH_30,3999875056_R04C01,University Hospital of Frankfurt am Main,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,33,male,"supratentorial, hemispheric, frontal;  left;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",55%,LGm1,DNA_FFPE,1月16日,3999875056
A_IDH_31,9020331028_R06C01,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,33,male,"supratentorial, hemispheric, temporal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",73%,LGm2,DNA_FFPE,3月28日,9020331028
A_IDH_32,9855358056_R04C02,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,33,female,"supratentorial, hemispheric, frontal, temporal;  left;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",66%,LGm2,DNA_FFPE,10月6日,9855358056
A_IDH_33,9878820156_R06C01,University Hospital of Frankfurt am Main,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,34,male,"supratentorial, hemispheric, frontal; ",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",70%,LGm2,DNA_FFPE,11月7日,9878820156
A_IDH_34,10003886253_R06C02,University Hospital of Freiburg ,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,34,male,"supratentorial, hemispheric, frontal;  left;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",70%,LGm2,DNA_FFPE,1月23日,10003886253
A_IDH_35,9878820113_R03C02,German Glioma Network ,"Anaplastic astrocytoma, IDH-mutant",III,Central review Duesseldorf,34,male,"supratentorial, hemispheric;  right;",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",66%,LGm2,DNA_KRYO,10月27日,9878820113
A_IDH_36,9878820066_R05C02,German Glioma Network ,"Anaplastic astrocytoma, IDH-mutant",III,Central review Duesseldorf,35,male,"supratentorial, hemispheric, frontal, temporal;  right;",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",63%,LGm2,DNA_KRYO,10月17日,9878820066
A_IDH_37,9855358018_R06C01,German Glioma Network ,"Diffuse astrocytoma, IDH-mutant",II,Central review Duesseldorf,35,female,"supratentorial, hemispheric, frontal;  right;",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",66%,LGm2,DNA_KRYO,9月12日,9855358018
A_IDH_38,9855358023_R04C01,German Glioma Network ,"Diffuse astrocytoma, IDH-mutant",II,Central review Duesseldorf,35,male,"supratentorial, hemispheric; ",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",68%,LGm2,DNA_KRYO,9月12日,9855358023
A_IDH_39,9968646113_R01C02,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,35,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",65%,LGm2,DNA_FFPE,7月8日,9968646113
A_IDH_40,9968646113_R04C02,German Glioma Network ,"Diffuse astrocytoma, IDH-mutant",II,Central review Duesseldorf,36,male,not available,not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",64%,LGm2,DNA_FFPE,7月8日,9968646113
A_IDH_41,8622007118_R02C02,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,36,female,"supratentorial, hemispheric, temporal;  right;",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",70%,LGm2,DNA_FFPE,1月16日,8622007118
A_IDH_42,8622007091_R04C01,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,36,female,"supratentorial, hemispheric, temporal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",69%,LGm2,DNA_FFPE,12月21日,8622007091
A_IDH_43,8622007091_R05C01,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,36,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",63%,LGm2,DNA_FFPE,12月21日,8622007091
A_IDH_44,9407210003_R03C01,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,36,male,"supratentorial, hemispheric, frontal, temporal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",64%,LGm2,DNA_FFPE,12月6日,9407210003
A_IDH_45,9534104010_R02C02,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,37,male,"supratentorial, hemispheric, frontal; ",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",68%,LGm2,DNA_FFPE,6月27日,9534104010
A_IDH_46,9855358018_R01C02,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,37,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",54%,LGm2,DNA_KRYO,9月12日,9855358018
A_IDH_47,9969477022_R03C01,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,37,male,"supratentorial, hemispheric, temporal; ",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",71%,LGm2,DNA_FFPE,7月25日,9969477022
A_IDH_48,9221197135_R02C02,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,37,male,"supratentorial, hemispheric, parietal;  left;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",72%,LGm2,DNA_FFPE,3月28日,9221197135
A_IDH_49,9769100023_R02C01,German Glioma Network ,"Diffuse astrocytoma, IDH-mutant",II,Central review Duesseldorf,38,male,"supratentorial, hemispheric; ",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",67%,LGm2,DNA_KRYO,5月23日,9769100023
A_IDH_50,9221197135_R01C01,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,38,female,"supratentorial, hemispheric, frontal;  left;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",66%,LGm2,DNA_FFPE,3月28日,9221197135
A_IDH_51,3999834093_R01C02,University Hospital of Muenster,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,38,male,"supratentorial, hemispheric, frontal; ",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",64%,LGm2,DNA_FFPE,2月20日,3999834093
A_IDH_52,9878820017_R02C02,University Hospital of Frankfurt am Main,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,40,female,"supratentorial, hemispheric, frontal;  left;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",72%,LGm2,DNA_FFPE,10月17日,9878820017
A_IDH_53,3998909006_R01C02,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,40,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",67%,LGm2,DNA_FFPE,4月24日,3998909006
A_IDH_54,9855358023_R06C02,German Glioma Network ,"Diffuse astrocytoma, IDH-mutant",II,Central review Duesseldorf,41,male,not available,not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",67%,LGm2,DNA_KRYO,9月12日,9855358023
A_IDH_55,9007225142_R02C01,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,42,female,"supratentorial, hemispheric, frontal;  left;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",63%,LGm2,DNA_FFPE,4月19日,9007225142
A_IDH_56,9968646113_R06C02,German Glioma Network ,"Diffuse astrocytoma, IDH-mutant",II,Central review Duesseldorf,43,male,"supratentorial, hemispheric, temporal; ",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",62%,LGm2,DNA_FFPE,7月8日,9968646113
A_IDH_57,9769100023_R06C02,German Glioma Network ,"Diffuse astrocytoma, IDH-mutant",II,Central review Duesseldorf,44,male,not available,not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",63%,LGm2,DNA_KRYO,5月23日,9769100023
A_IDH_58,3998909013_R02C01,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,44,male,not available,not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",66%,LGm2,DNA_FFPE,4月24日,3998909013
A_IDH_59,8622007091_R01C01,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,44,female,"supratentorial, hemispheric, frontal; ",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",61%,LGm1,DNA_FFPE,12月21日,8622007091
A_IDH_60,9221197132_R02C02,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,46,male,"supratentorial, hemispheric, temporal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",59%,LGm2,DNA_FFPE,3月28日,9221197132
A_IDH_61,9855358023_R03C02,German Glioma Network ,"Diffuse astrocytoma, IDH-mutant",II,Central review Duesseldorf,47,male,not available,not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",62%,LGm2,DNA_KRYO,9月12日,9855358023
A_IDH_62,9534104007_R01C01,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,47,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",63%,LGm2,DNA_FFPE,6月27日,9534104007
A_IDH_63,3999834093_R02C02,University Hospital of Muenster,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,48,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",61%,LGm2,DNA_FFPE,2月20日,3999834093
A_IDH_64,9533774023_R06C02,University Hospital of Heidelberg,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,49,female,"supratentorial, hemispheric, frontal; ",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",65%,LGm2,DNA_FFPE,5月30日,9533774023
A_IDH_65,9969477100_R05C01,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,49,male,"supratentorial, hemispheric, frontal, temporal, parietal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",62%,LGm2,DNA_FFPE,8月22日,9969477100
A_IDH_66,3999875055_R02C02,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,53,female,"supratentorial, hemispheric, frontal, temporal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",65%,LGm2,DNA_FFPE,1月16日,3999875055
A_IDH_67,10006823130_R05C01,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,56,male,"supratentorial, hemispheric, frontal;  right;",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",65%,LGm2,DNA_FFPE,1月12日,10006823130
A_IDH_68,9379086138_R05C02,Charite Universitaetsmedizin Berlin,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,58,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",67%,LGm2,DNA_FFPE,11月14日,9379086138
A_IDH_69,9370847061_R01C01,University Hospital of Tuebingen,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,59,male,"supratentorial, hemispheric, frontal;  left;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",64%,LGm2,DNA_FFPE,9月19日,9370847061
A_IDH_70,9769100024_R05C01,German Glioma Network ,"Diffuse astrocytoma, IDH-mutant",II,Central review Duesseldorf,63,female,"supratentorial, hemispheric, parietal; ",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",59%,LGm2,DNA_KRYO,5月23日,9769100024
A_IDH_71,9533774021_R04C02,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,63,female,"supratentorial, hemispheric, frontal;  left;",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",68%,LGm2,DNA_FFPE,5月30日,9533774021
A_IDH_72,9855358031_R04C01,University Hospital of Goettingen,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,64,female,"supratentorial, hemispheric, frontal, temporal, occipital;  left;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",79%,LGm2,DNA_FFPE,9月26日,9855358031
A_IDH_73,9769100024_R01C02,German Glioma Network ,"Diffuse astrocytoma, IDH-mutant",II,Central review Duesseldorf,65,male,"supratentorial, hemispheric, temporal; ",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",75%,LGm2,DNA_KRYO,5月23日,9769100024
A_IDH_74,9769100024_R04C02,German Glioma Network ,"Diffuse astrocytoma, IDH-mutant",II,Central review Duesseldorf,69,female,"supratentorial, hemispheric, temporal; ",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",64%,LGm2,DNA_KRYO,5月23日,9769100024
A_IDH_75,10006823130_R04C01,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,70,female,"supratentorial, hemispheric; ",not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",66%,LGm2,DNA_FFPE,1月12日,10006823130
A_IDH_76,9969477101_R05C01,University Hospital of Frankfurt am Main,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,71,male,"supratentorial, hemispheric, frontal;  left;",initial operation ,A_IDH,"methylation class IDH glioma, subclass astrocytoma",66%,LGm2,DNA_FFPE,8月22日,9969477101
A_IDH_77,9878820066_R03C02,German Glioma Network ,"Diffuse astrocytoma, IDH-mutant",II,Central review Duesseldorf,not available ,male,supratentorial; ,not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",62%,LGm2,DNA_KRYO,10月17日,9878820066
A_IDH_78,9769100024_R02C01,German Glioma Network ,"Diffuse astrocytoma, IDH-mutant",II,Central review Duesseldorf,not available ,female,not available,not available,A_IDH,"methylation class IDH glioma, subclass astrocytoma",70%,LGm2,DNA_KRYO,5月23日,9769100024
A_IDH_HG_01,200091640051_R06C02,University Hospital of Heidelberg,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,17,male,"supratentorial, hemispheric;  right;",recurrence ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",74%,LGm2,DNA_KRYO,10月30日,2.00092E+11
A_IDH_HG_02,9007225163_R04C02,University Hospital of Heidelberg,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,22,female,"supratentorial, hemispheric, frontal, temporal;  left;",recurrence ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",70%,LGm1,DNA_FFPE,4月19日,9007225163
A_IDH_HG_03,3999875052_R05C02,University Hospital of Giessen,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,23,female,"posterior fossa, cerebellum;  right;",recurrence ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",75%,LGm1,DNA_FFPE,3月6日,3999875052
A_IDH_HG_04,3999834021_R02C01,University Hospital of Heidelberg,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,23,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",73%,LGm2,DNA_FFPE,2月6日,3999834021
A_IDH_HG_05,9379086164_R03C02,University Hospital of Tuebingen,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,28,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",74%,LGm2,DNA_FFPE,11月14日,9379086164
A_IDH_HG_06,9297949046_R01C02,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-mutant",II,Central review Heidelberg,29,female,"supratentorial, hemispheric, frontal;  left;",recurrence ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",65%,LGm2,DNA_FFPE,6月7日,9297949046
A_IDH_HG_07,9721365197_R01C01,University Hospital of Heidelberg,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,29,female,"supratentorial, hemispheric, temporal;  right;",initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",75%,LGm1,DNA_FFPE,4月14日,9721365197
A_IDH_HG_08,10006823122_R03C02,University Hospital of Bergen,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,30,female,"supratentorial, hemispheric, frontal;  right;",not available,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",76%,LGm1,DNA_FFPE,1月12日,10006823122
A_IDH_HG_09,9376561062_R06C02,University Hospital of Heidelberg,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,30,female,"supratentorial, hemispheric, frontal;  right;",not available,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",83%,LGm2,DNA_FFPE,9月27日,9376561062
A_IDH_HG_10,9969477074_R03C01,University Hospital of Tuebingen,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,30,female,"supratentorial, hemispheric, frontal;  right;",recurrence ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",68%,LGm2,DNA_FFPE,8月15日,9969477074
A_IDH_HG_11,3999875057_R04C01,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,32,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",79%,LGm2,DNA_FFPE,1月16日,3999875057
A_IDH_HG_12,3998909026_R02C02,University Hospital of Heidelberg,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,32,male,"supratentorial, hemispheric, frontal;  right;",recurrence ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",68%,LGm2,DNA_FFPE,5月1日,3998909026
A_IDH_HG_13,9379086167_R05C02,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,32,male,not available,initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",66%,LGm2,DNA_FFPE,11月14日,9379086167
A_IDH_HG_14,9297949139_R01C02,University Hospital of Muenster,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,33,male,"supratentorial, hemispheric, frontal; ",initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",72%,LGm2,DNA_FFPE,6月21日,9297949139
A_IDH_HG_15,10006823133_R01C02,University Hospital of Freiburg ,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,34,male,"posterior fossa, cerebellum, hemispheric (cerebellum);  left;",recurrence ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",69%,LGm2,DNA_FFPE,1月12日,10006823133
A_IDH_HG_16,9741779119_R01C02,University Hospital of Heidelberg,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,35,female,"supratentorial, hemispheric, parietal;  right;",not available,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",82%,LGm1,DNA_FFPE,5月16日,9741779119
A_IDH_HG_17,8622007083_R06C02,University Hospital of Heidelberg,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,36,female,"supratentorial, hemispheric, temporal;  right;",not available,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",73%,LGm2,DNA_FFPE,12月7日,8622007083
A_IDH_HG_18,9020331028_R01C02,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,36,female,"supratentorial, hemispheric, temporal;  left;",not available,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",70%,LGm2,DNA_FFPE,3月28日,9020331028
A_IDH_HG_19,3999547123_R04C02,University Hospital of Zurich,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,36,female,supratentorial; ,initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",78%,LGm1,DNA_FFPE,4月17日,3999547123
A_IDH_HG_20,3999547136_R02C02,University Hospital of Bern,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,37,male,"supratentorial, hemispheric, parietal, occipital;  right;",initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",81%,LGm1,DNA_FFPE,4月17日,3999547136
A_IDH_HG_21,3999308203_R01C02,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,37,female,"supratentorial, hemispheric, temporal; posterior fossa, cerebellum, hemispheric (cerebellum);  right;",recurrence ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",79%,LGm1,DNA_FFPE,4月6日,3999308203
A_IDH_HG_22,9855358001_R06C02,University Hospital of Heidelberg,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,38,male,"supratentorial, hemispheric, frontal;  left;",initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",68%,LGm1,DNA_FFPE,9月12日,9855358001
A_IDH_HG_23,9379086138_R05C01,University Hospital of Tuebingen,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,38,male,"supratentorial, hemispheric, parietal, occipital;  left;",initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",66%,LGm3,DNA_FFPE,11月14日,9379086138
A_IDH_HG_24,3999875115_R02C02,University Hospital of Heidelberg,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,40,male,"supratentorial, hemispheric, temporal;  right;",not available,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",69%,LGm2,DNA_FFPE,3月6日,3999875115
A_IDH_HG_25,3999543050_R01C02,University Hospital of Muenster,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,40,female,"supratentorial, hemispheric, temporal;  left;",recurrence ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",62%,LGm1,DNA_FFPE,3月14日,3999543050
A_IDH_HG_26,8622007118_R04C01,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,41,male,"supratentorial, hemispheric, temporal;  right;",not available,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",68%,LGm2,DNA_FFPE,1月16日,8622007118
A_IDH_HG_27,9406922104_R03C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,41,male,not available,initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",64%,LGm2,DNA_FFPE,11月14日,9406922104
A_IDH_HG_28,10006823144_R06C02,University Hospital of Duesseldorf ,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,44,male,not available,initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",70%,LGm1,DNA_FFPE,1月30日,10006823144
A_IDH_HG_29,3999112137_R03C01,University Hospital of Frankfurt am Main,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,44,male,"supratentorial, hemispheric; ",not available,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",67%,LGm2,DNA_FFPE,3月27日,3999112137
A_IDH_HG_30,3999834089_R03C02,German Glioma Network ,"Glioblastoma, IDH-mutant",IV,Central review Duesseldorf,44,male,"supratentorial; posterior fossa, cerebellum, hemispheric (cerebellum);  left;",recurrence ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",72%,LGm1,DNA_FFPE,2月20日,3999834089
A_IDH_HG_31,9406922106_R04C02,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,45,female,not available,initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",71%,LGm3,DNA_FFPE,11月14日,9406922106
A_IDH_HG_32,3998909027_R01C01,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,46,male,"supratentorial, hemispheric, temporal;  left;",recurrence ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",76%,LGm3,DNA_FFPE,5月1日,3998909027
A_IDH_HG_33,3999547123_R05C02,University Hospital of Basel ,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,48,male,not available,initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",78%,LGm3,DNA_FFPE,4月17日,3999547123
A_IDH_HG_34,8622007091_R01C02,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,48,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",76%,LGm2,DNA_FFPE,12月21日,8622007091
A_IDH_HG_35,9379086163_R06C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,48,male,not available,initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",82%,LGm3,DNA_FFPE,11月14日,9379086163
A_IDH_HG_36,9878820107_R05C02,German Glioma Network ,"Anaplastic astrocytoma, IDH-mutant",III,Central review Duesseldorf,50,male,not available,not available,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",65%,LGm2,DNA_KRYO,10月27日,9878820107
A_IDH_HG_37,9406922104_R01C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,52,female,not available,initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",60%,LGm3,DNA_FFPE,11月14日,9406922104
A_IDH_HG_38,3999875055_R03C02,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,55,male,"supratentorial, hemispheric, temporal;  right;",initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",64%,LGm2,DNA_FFPE,1月16日,3999875055
A_IDH_HG_39,9007225086_R05C01,University Hospital of Heidelberg,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,55,female,supratentorial; ,not available,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",73%,LGm1,DNA_FFPE,3月28日,9007225086
A_IDH_HG_40,9379086167_R06C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,55,male,not available,initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",66%,LGm3,DNA_FFPE,11月14日,9379086167
A_IDH_HG_41,9407210003_R05C01,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,56,male,"supratentorial, hemispheric, frontal;  left;",recurrence ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",67%,LGm3,DNA_FFPE,12月6日,9407210003
A_IDH_HG_42,9878820017_R03C02,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,66,male,not available,not available,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",68%,LGm2,DNA_FFPE,10月17日,9878820017
A_IDH_HG_43,9741950025_R06C02,University Hospital of Frankfurt am Main,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,69,male,"supratentorial, hemispheric, temporal;  right;",initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",60%,LGm2,DNA_FFPE,3月28日,9741950025
A_IDH_HG_44,9741950149_R05C02,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-mutant",III,Central review Heidelberg,72,female,supratentorial; ,not available,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",73%,LGm3,DNA_FFPE,4月14日,9741950149
A_IDH_HG_45,9406922106_R01C02,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Glioblastoma, IDH-mutant",IV,Central review Heidelberg,72,male,not available,initial operation ,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",70%,LGm3,DNA_FFPE,11月14日,9406922106
A_IDH_HG_46,8622007065_R02C02,University Hospital of Muenster,"Glioblastoma, IDH-mutant",IV,Local review,not available ,male,"supratentorial, hemispheric, frontal;  right;",not available,A_IDH_HG,"methylation class IDH glioma, subclass high grade astrocytoma ",78%,LGm1,DNA_FFPE,11月26日,8622007065
ANA_PA_01,3999100031_R03C01,Charite Universitaetsmedizin Berlin,Anaplastic pilocytic astrocytoma,not available,Central review Heidelberg,24,male,"posterior fossa, brain stem, cerebellar peduncles;  right;",initial operation ,ANA_PA,methylation class anaplastic pilocytic astrocytoma,66%,Not applicable,DNA_FFPE,3月20日,3999100031
ANA_PA_02,200275560098_R02C02,University Hospital of Wuerzburg,Anaplastic pilocytic astrocytoma,not available,Central review Heidelberg,24,male,"posterior fossa, cerebellum; ",initial operation ,ANA_PA,methylation class anaplastic pilocytic astrocytoma,62%,Not applicable,DNA_FFPE,12月18日,2.00276E+11
ANA_PA_03,10006823133_R05C01,University Hospital of Freiburg ,Anaplastic pilocytic astrocytoma,not available,Central review Heidelberg,27,female,"posterior fossa, cerebellum, hemispheric (cerebellum);  right;",recurrence ,ANA_PA,methylation class anaplastic pilocytic astrocytoma,55%,Not applicable,DNA_FFPE,1月12日,10006823133
ANA_PA_04,8963311099_R04C02,University Hospital of Heidelberg,Pleomorphic xanthoastrocytoma  ,II,Central review Heidelberg,27,male,posterior fossa; ,recurrence ,ANA_PA,methylation class anaplastic pilocytic astrocytoma,53%,Not applicable,DNA_FFPE,1月28日,8963311099
ANA_PA_05,9878827220_R02C01,University Hospital of Zurich,Anaplastic pilocytic astrocytoma,not available,Central review Heidelberg,27,female,"supratentorial, diencephalic, thalamic;  right;",initial operation ,ANA_PA,methylation class anaplastic pilocytic astrocytoma,59%,Not applicable,DNA_FFPE,11月28日,9878827220
ANA_PA_06,3999543042_R02C01,University Hospital of Erlangen,Anaplastic pilocytic astrocytoma,not available,Central review Heidelberg,28,male,"posterior fossa, cerebellum;  right;",initial operation ,ANA_PA,methylation class anaplastic pilocytic astrocytoma,61%,Not applicable,DNA_FFPE,3月14日,3999543042
ANA_PA_07,10006823022_R06C01,University Hospital of Tuebingen,Anaplastic pilocytic astrocytoma,not available,Central review Heidelberg,28,male,"posterior fossa, cerebellum, vermis;  left;",initial operation ,ANA_PA,methylation class anaplastic pilocytic astrocytoma,61%,Not applicable,DNA_FFPE,12月12日,10006823022
ANA_PA_08,200275560089_R06C02,University Hospital of Wuerzburg,Anaplastic pilocytic astrocytoma,not available,Central review Heidelberg,32,female,supratentorial; spinal; ,recurrence ,ANA_PA,methylation class anaplastic pilocytic astrocytoma,60%,Not applicable,DNA_FFPE,12月18日,2.00276E+11
ANA_PA_09,3999002043_R01C01,"Johns Hopkins, Baltimore","CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,33,male,"posterior fossa, cerebellum; ",initial operation ,ANA_PA,methylation class anaplastic pilocytic astrocytoma,58%,Not applicable,DNA_FFPE,6月26日,3999002043
ANA_PA_10,3999834089_R04C02,University College London Hospitals,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,39,female,"posterior fossa, cerebellum; ",recurrence ,ANA_PA,methylation class anaplastic pilocytic astrocytoma,66%,Not applicable,DNA_FFPE,2月20日,3999834089
ANA_PA_11,9553932010_R01C01,"MD Anderson Cancer Center, Houston",Anaplastic pilocytic astrocytoma,not available,Central review Heidelberg,40,male,"posterior fossa, cerebellum; ",recurrence ,ANA_PA,methylation class anaplastic pilocytic astrocytoma,64%,Not applicable,DNA_FFPE,2月14日,9553932010
ANA_PA_12,3999834021_R06C02,University Hospital of Bonn,Anaplastic pilocytic astrocytoma,not available,Central review Bonn ,41,female,"posterior fossa, cerebellum, hemispheric (cerebellum);  left;",initial operation ,ANA_PA,methylation class anaplastic pilocytic astrocytoma,63%,Not applicable,DNA_FFPE,2月6日,3999834021
ANA_PA_13,3999834073_R04C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,46,male,"posterior fossa, cerebellum, hemispheric (cerebellum);  right;",initial operation ,ANA_PA,methylation class anaplastic pilocytic astrocytoma,65%,Not applicable,DNA_FFPE,2月20日,3999834073
ANA_PA_14,9878827220_R04C01,University Hospital of Zurich,Anaplastic pilocytic astrocytoma,not available,Central review Heidelberg,49,female,"posterior fossa, cerebellum, vermis; ",recurrence ,ANA_PA,methylation class anaplastic pilocytic astrocytoma,66%,Not applicable,DNA_FFPE,11月28日,9878827220
ANA_PA_15,3999002043_R05C01,"Johns Hopkins, Baltimore",Anaplastic pilocytic astrocytoma,not available,Central review Heidelberg,56,female,"posterior fossa, cerebellum; ",initial operation ,ANA_PA,methylation class anaplastic pilocytic astrocytoma,65%,Not applicable,DNA_FFPE,6月26日,3999002043
ANA_PA_16,200277210073_R05C01,University Hospital of Wuerzburg,Anaplastic pilocytic astrocytoma,not available,Central review Heidelberg,63,male,"posterior fossa, cerebellum, vermis; ",recurrence ,ANA_PA,methylation class anaplastic pilocytic astrocytoma,59%,Not applicable,DNA_FFPE,12月18日,2.00277E+11
ANA_PA_17,200275560113_R05C02,University Hospital of Duesseldorf ,Anaplastic pilocytic astrocytoma,not available,Central review Heidelberg,64,male,not available,not available,ANA_PA,methylation class anaplastic pilocytic astrocytoma,51%,Not applicable,DNA_FFPE,12月18日,2.00276E+11
ANA_PA_18,9741950021_R05C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,67,female,"supratentorial, diencephalic, pineal region; ",initial operation ,ANA_PA,methylation class anaplastic pilocytic astrocytoma,67%,Not applicable,DNA_FFPE,3月24日,9741950021
ANA_PA_19,10003886259_R03C02,University Hospital of Muenster,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,69,male,"posterior fossa, cerebellum; ",initial operation ,ANA_PA,methylation class anaplastic pilocytic astrocytoma,67%,Not applicable,DNA_FFPE,1月23日,10003886259
ANA_PA_20,3999002043_R04C01,"Johns Hopkins, Baltimore",Anaplastic pilocytic astrocytoma,not available,Central review Heidelberg,74,female,"posterior fossa, cerebellum; ",recurrence ,ANA_PA,methylation class anaplastic pilocytic astrocytoma,64%,Not applicable,DNA_FFPE,6月26日,3999002043
ANA_PA_21,9855358056_R06C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,75,female,"posterior fossa, cerebellum; ",initial operation ,ANA_PA,methylation class anaplastic pilocytic astrocytoma,68%,Not applicable,DNA_FFPE,10月6日,9855358056
ATRT_MYC_01,6929718026_R01C02,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,0,female,not available,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",59%,Not applicable,DNA_KRYO,12月2日,6929718026
ATRT_MYC_02,9407201022_R03C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,0,male,supratentorial; ,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",61%,Not applicable,DNA_FFPE,10月25日,9407201022
ATRT_MYC_03,9407201021_R02C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,0,male,supratentorial; ,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",58%,Not applicable,DNA_FFPE,10月25日,9407201021
ATRT_MYC_04,3999875052_R02C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,0,female,supratentorial; ,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",57%,Not applicable,DNA_FFPE,3月7日,3999875052
ATRT_MYC_05,6929718026_R06C01,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,1,male,supratentorial; ,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",56%,Not applicable,DNA_KRYO,12月2日,6929718026
ATRT_MYC_06,9878827227_R04C01,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,1,male,not available,initial operation ,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",64%,Not applicable,DNA_FFPE,11月28日,9878827227
ATRT_MYC_07,9969477044_R03C02,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,1,male,supratentorial; ,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",56%,Not applicable,DNA_KRYO,7月25日,9969477044
ATRT_MYC_08,9533774082_R05C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,1,male,supratentorial; ,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",59%,Not applicable,DNA_FFPE,6月16日,9533774082
ATRT_MYC_09,9533774084_R03C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,1,male,supratentorial; ,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",62%,Not applicable,DNA_FFPE,6月16日,9533774084
ATRT_MYC_10,9407201022_R04C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,1,female,supratentorial; ,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",60%,Not applicable,DNA_FFPE,10月25日,9407201022
ATRT_MYC_11,9407201022_R04C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,2,female,supratentorial; ,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",57%,Not applicable,DNA_FFPE,10月25日,9407201022
ATRT_MYC_12,9407201022_R05C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,2,male,supratentorial; ,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",58%,Not applicable,DNA_FFPE,10月25日,9407201022
ATRT_MYC_13,9878820127_R04C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,2,female,supratentorial; ,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",61%,Not applicable,DNA_FFPE,10月31日,9878820127
ATRT_MYC_14,9769100008_R02C01,"St. Jude Childrens Research Hospital, Memphis",Atypical teratoid/rhabdoid tumour               ,IV,Local review,3,male,not available,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",60%,Not applicable,DNA_KRYO,5月23日,9769100008
ATRT_MYC_15,9407201022_R02C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,3,female,supratentorial; ,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",62%,Not applicable,DNA_FFPE,10月25日,9407201022
ATRT_MYC_16,9534104026_R05C01,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,4,female,posterior fossa; ,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",62%,Not applicable,DNA_KRYO,6月27日,9534104026
ATRT_MYC_17,6929689168_R06C01,"Burdenko Neurosurgery Institute, Moscow",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,4,male,posterior fossa; ,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",58%,Not applicable,DNA_KRYO,11月23日,6929689168
ATRT_MYC_18,9407201022_R06C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,5,male,supratentorial; ,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",56%,Not applicable,DNA_FFPE,10月25日,9407201022
ATRT_MYC_19,9534104026_R01C01,"St. Jude Childrens Research Hospital, Memphis",Atypical teratoid/rhabdoid tumour               ,IV,Local review,7,female,posterior fossa; ,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",65%,Not applicable,DNA_KRYO,6月27日,9534104026
ATRT_MYC_20,9379086124_R02C02,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,9,female,supratentorial; ,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",61%,Not applicable,DNA_KRYO,10月4日,9379086124
ATRT_MYC_21,9007225017_R01C02,University Hospital of Tuebingen,Atypical teratoid/rhabdoid tumour               ,IV,Local review,9,male,"supratentorial, hemispheric, temporal; ",not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",62%,Not applicable,DNA_FFPE,2月20日,9007225017
ATRT_MYC_22,8622007027_R01C01,"Burdenko Neurosurgery Institute, Moscow",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,11,male,"posterior fossa, brain stem, cerebello-pontine angle; ",not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",63%,Not applicable,DNA_KRYO,10月23日,8622007027
ATRT_MYC_23,9376561062_R05C01,University Hospital of Tuebingen,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,20,female,"spinal, thoracic, T12, lumbar, L1, L2; ",initial operation ,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",56%,Not applicable,DNA_FFPE,9月27日,9376561062
ATRT_MYC_24,9422493151_R06C02,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,25,male,"supratentorial, hemispheric, temporal, parietal, occipital;  left;",initial operation ,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",63%,Not applicable,DNA_FFPE,12月13日,9422493151
ATRT_MYC_25,9379086124_R04C01,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,not available ,male,supratentorial; ,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",59%,Not applicable,DNA_KRYO,10月4日,9379086124
ATRT_MYC_26,9969477044_R04C02,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,not available ,male,not available,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",60%,Not applicable,DNA_KRYO,7月25日,9969477044
ATRT_MYC_27,3999875052_R01C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,not available ,female,"mesenchyme, abdomen; ",not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",55%,Not applicable,DNA_FFPE,3月7日,3999875052
ATRT_MYC_28,6229017022_R06C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,not available ,male,not available,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",67%,Not applicable,DNA_KRYO,3月15日,6229017022
ATRT_MYC_29,6164621144_R02C01,"Hospital for Sick Children, Toronto  ",Atypical teratoid/rhabdoid tumour               ,IV,Local review,not available ,male,not available,not available,ATRT_MYC,"methylation class atypical teratoid/rhabdoid tumor, subclass MYC",61%,Not applicable,DNA_KRYO,11月23日,6164621144
ATRT_SHH_01,6247004024_R03C01,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,0,female,posterior fossa; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",63%,Not applicable,DNA_KRYO,4月13日,6247004024
ATRT_SHH_02,9969477043_R06C02,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,0,female,posterior fossa; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",64%,Not applicable,DNA_KRYO,7月25日,9969477043
ATRT_SHH_03,9969477044_R01C01,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,0,female,posterior fossa; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",59%,Not applicable,DNA_KRYO,7月25日,9969477044
ATRT_SHH_04,9969477044_R02C01,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,0,female,posterior fossa; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",64%,Not applicable,DNA_KRYO,7月25日,9969477044
ATRT_SHH_05,9533774082_R04C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,0,male,not available,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",60%,Not applicable,DNA_FFPE,6月16日,9533774082
ATRT_SHH_06,9533774084_R06C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,0,male,not available,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",57%,Not applicable,DNA_FFPE,6月16日,9533774084
ATRT_SHH_07,9407201021_R04C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,0,male,supratentorial; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",60%,Not applicable,DNA_FFPE,10月25日,9407201021
ATRT_SHH_08,9407201022_R01C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,0,female,supratentorial; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",59%,Not applicable,DNA_FFPE,10月25日,9407201022
ATRT_SHH_09,9407201022_R02C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,0,male,posterior fossa; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",57%,Not applicable,DNA_FFPE,10月25日,9407201022
ATRT_SHH_10,9407201021_R03C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,0,male,posterior fossa; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",60%,Not applicable,DNA_FFPE,10月25日,9407201021
ATRT_SHH_11,3999875073_R01C01,"Beaumont Hospital, Dublin",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,1,male,"supratentorial, hemispheric; ",not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",58%,Not applicable,DNA_FFPE,3月6日,3999875073
ATRT_SHH_12,8622007061_R03C01,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,1,male,"supratentorial, hemispheric, frontal, parietal;  left;",not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",66%,Not applicable,DNA_KRYO,11月12日,8622007061
ATRT_SHH_13,6247004023_R04C02,"Burdenko Neurosurgery Institute, Moscow",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,1,male,posterior fossa; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",65%,Not applicable,DNA_KRYO,4月13日,6247004023
ATRT_SHH_14,9379086129_R06C01,"Burdenko Neurosurgery Institute, Moscow",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,1,male,supratentorial; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",63%,Not applicable,DNA_KRYO,10月4日,9379086129
ATRT_SHH_15,9379086129_R01C02,"Burdenko Neurosurgery Institute, Moscow",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,1,female,supratentorial; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",63%,Not applicable,DNA_KRYO,10月4日,9379086129
ATRT_SHH_16,9407201021_R06C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,1,female,posterior fossa; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",58%,Not applicable,DNA_FFPE,10月25日,9407201021
ATRT_SHH_17,9407201021_R05C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,1,male,supratentorial; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",60%,Not applicable,DNA_FFPE,10月25日,9407201021
ATRT_SHH_18,6929718049_R06C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,1,female,posterior fossa; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",57%,Not applicable,DNA_KRYO,12月23日,6929718049
ATRT_SHH_19,6969568004_R02C01,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,2,female,posterior fossa; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",63%,Not applicable,DNA_KRYO,11月23日,6969568004
ATRT_SHH_20,6164621144_R04C02,"McGill Children's Hospital, Montreal",Atypical teratoid/rhabdoid tumour               ,IV,Local review,2,male,posterior fossa; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",64%,Not applicable,DNA_KRYO,11月23日,6164621144
ATRT_SHH_21,6247004023_R03C02,"Burdenko Neurosurgery Institute, Moscow",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,2,male,posterior fossa; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",61%,Not applicable,DNA_KRYO,4月13日,6247004023
ATRT_SHH_22,6929718027_R01C01,"Burdenko Neurosurgery Institute, Moscow",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,2,female,posterior fossa; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",64%,Not applicable,DNA_KRYO,12月2日,6929718027
ATRT_SHH_23,9533774082_R06C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,2,male,supratentorial; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",56%,Not applicable,DNA_FFPE,6月16日,9533774082
ATRT_SHH_24,9533774082_R06C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,2,female,supratentorial; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",58%,Not applicable,DNA_FFPE,6月16日,9533774082
ATRT_SHH_25,9407201022_R03C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,2,male,supratentorial; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",62%,Not applicable,DNA_FFPE,10月25日,9407201022
ATRT_SHH_26,9373550131_R02C02,University Hospital of Tuebingen,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,2,male,"posterior fossa, ventricle IV; ",not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",61%,Not applicable,DNA_FFPE,8月21日,9373550131
ATRT_SHH_27,9969477079_R06C02,"Beaumont Hospital, Dublin",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,3,male,"supratentorial, intraventricular, ventricle II;  left;",initial operation ,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",60%,Not applicable,DNA_FFPE,8月15日,9969477079
ATRT_SHH_28,6929718027_R04C02,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,3,male,not available,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",59%,Not applicable,DNA_KRYO,12月2日,6929718027
ATRT_SHH_29,9376538156_R03C02,"Burdenko Neurosurgery Institute, Moscow",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,3,male,posterior fossa; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",64%,Not applicable,DNA_KRYO,9月11日,9376538156
ATRT_SHH_30,6929718027_R06C01,"Burdenko Neurosurgery Institute, Moscow",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,3,female,supratentorial; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",64%,Not applicable,DNA_KRYO,12月2日,6929718027
ATRT_SHH_31,6229017022_R02C02,"Burdenko Neurosurgery Institute, Moscow",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,3,male,supratentorial; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",66%,Not applicable,DNA_KRYO,3月15日,6229017022
ATRT_SHH_32,9533774082_R01C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,3,male,supratentorial; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",62%,Not applicable,DNA_FFPE,6月16日,9533774082
ATRT_SHH_33,9533774084_R04C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,3,male,supratentorial; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",61%,Not applicable,DNA_FFPE,6月16日,9533774084
ATRT_SHH_34,9534104026_R02C01,"St. Jude Childrens Research Hospital, Memphis",Atypical teratoid/rhabdoid tumour               ,IV,Local review,4,male,supratentorial; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",68%,Not applicable,DNA_KRYO,6月27日,9534104026
ATRT_SHH_35,9534104010_R06C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,4,male,supratentorial; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",65%,Not applicable,DNA_FFPE,6月27日,9534104010
ATRT_SHH_36,6929689168_R01C02,"Burdenko Neurosurgery Institute, Moscow",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,7,male,supratentorial; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",59%,Not applicable,DNA_KRYO,11月23日,6929689168
ATRT_SHH_37,8622007130_R04C01,"La Sapienza Hospital, Rome ",Atypical teratoid/rhabdoid tumour               ,IV,Local review,7,female,"supratentorial, hemispheric, frontal; ",not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",62%,Not applicable,DNA_FFPE,1月16日,8622007130
ATRT_SHH_38,6164621144_R06C01,"McGill Children's Hospital, Montreal",Atypical teratoid/rhabdoid tumour               ,IV,Local review,8,male,supratentorial; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",67%,Not applicable,DNA_KRYO,11月23日,6164621144
ATRT_SHH_39,9533774082_R03C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,11,male,supratentorial; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",59%,Not applicable,DNA_FFPE,6月16日,9533774082
ATRT_SHH_40,9379086124_R05C01,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,not available ,male,posterior fossa; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",67%,Not applicable,DNA_KRYO,10月4日,9379086124
ATRT_SHH_41,9969477003_R02C01,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,not available ,female,supratentorial; ,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",62%,Not applicable,DNA_KRYO,7月18日,9969477003
ATRT_SHH_42,6229017023_R05C01,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,not available ,female,not available,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",61%,Not applicable,DNA_KRYO,3月15日,6229017023
ATRT_SHH_43,6929718049_R03C01,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Local review,not available ,female,not available,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",58%,Not applicable,DNA_KRYO,12月23日,6929718049
ATRT_SHH_44,5684819013_R02C01,"Burdenko Neurosurgery Institute, Moscow",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,not available ,female,not available,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",63%,Not applicable,DNA_KRYO,6月10日,5684819013
ATRT_SHH_45,9444374147_R03C01,"Burdenko Neurosurgery Institute, Moscow",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,not available ,male,not available,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",64%,Not applicable,DNA_FFPE,2月10日,9444374147
ATRT_SHH_46,3998909027_R03C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,not available ,female,not available,not available,ATRT_SHH,"methylation class atypical teratoid/rhabdoid tumor, subclass SHH",59%,Not applicable,DNA_FFPE,5月1日,3998909027
ATRT_TYR_01,9969477003_R01C01,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,0,male,posterior fossa; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",57%,Not applicable,DNA_KRYO,7月18日,9969477003
ATRT_TYR_02,9969477044_R02C02,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,0,male,posterior fossa; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",61%,Not applicable,DNA_KRYO,7月25日,9969477044
ATRT_TYR_03,9969477044_R06C01,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,0,female,posterior fossa; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",56%,Not applicable,DNA_KRYO,7月25日,9969477044
ATRT_TYR_04,6164621144_R01C02,"McGill Children's Hospital, Montreal",Atypical teratoid/rhabdoid tumour               ,IV,Local review,0,female,posterior fossa; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",50%,Not applicable,DNA_KRYO,11月23日,6164621144
ATRT_TYR_05,9376538156_R02C01,"Burdenko Neurosurgery Institute, Moscow",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,0,female,posterior fossa; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",55%,Not applicable,DNA_KRYO,9月11日,9376538156
ATRT_TYR_06,9533774082_R01C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,0,male,posterior fossa; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",55%,Not applicable,DNA_FFPE,6月16日,9533774082
ATRT_TYR_07,9407201022_R01C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,0,female,supratentorial; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",53%,Not applicable,DNA_FFPE,10月25日,9407201022
ATRT_TYR_08,9407201022_R05C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,0,female,posterior fossa; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",55%,Not applicable,DNA_FFPE,10月25日,9407201022
ATRT_TYR_09,9407201025_R01C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,0,male,supratentorial; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",55%,Not applicable,DNA_FFPE,10月25日,9407201025
ATRT_TYR_10,9878820127_R05C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,0,male,posterior fossa; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",56%,Not applicable,DNA_FFPE,10月31日,9878820127
ATRT_TYR_11,6969568004_R01C01,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,1,female,not available,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",64%,Not applicable,DNA_KRYO,11月23日,6969568004
ATRT_TYR_12,9444374134_R02C02,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,1,female,"posterior fossa, brain stem, cerebellum;  left;",initial operation ,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",56%,Not applicable,DNA_FFPE,1月27日,9444374134
ATRT_TYR_13,9379086124_R01C02,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,1,female,posterior fossa; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",60%,Not applicable,DNA_KRYO,10月4日,9379086124
ATRT_TYR_14,6164621144_R03C02,"McGill Children's Hospital, Montreal",Atypical teratoid/rhabdoid tumour               ,IV,Local review,1,male,posterior fossa; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",55%,Not applicable,DNA_KRYO,11月23日,6164621144
ATRT_TYR_15,6164621144_R02C02,"McGill Children's Hospital, Montreal",Atypical teratoid/rhabdoid tumour               ,IV,Local review,1,female,posterior fossa; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",67%,Not applicable,DNA_KRYO,11月23日,6164621144
ATRT_TYR_16,6929718026_R05C02,"Burdenko Neurosurgery Institute, Moscow",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,1,male,posterior fossa; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",53%,Not applicable,DNA_KRYO,12月2日,6929718026
ATRT_TYR_17,9407201021_R02C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,1,male,posterior fossa; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",52%,Not applicable,DNA_FFPE,10月25日,9407201021
ATRT_TYR_18,9407201021_R01C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,1,female,posterior fossa; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",55%,Not applicable,DNA_FFPE,10月25日,9407201021
ATRT_TYR_19,3999875052_R05C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,1,female,posterior fossa; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",55%,Not applicable,DNA_FFPE,3月7日,3999875052
ATRT_TYR_20,3998909027_R04C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,1,male,posterior fossa; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",57%,Not applicable,DNA_FFPE,5月1日,3998909027
ATRT_TYR_21,9376538156_R01C02,"Burdenko Neurosurgery Institute, Moscow",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,2,male,posterior fossa; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",57%,Not applicable,DNA_KRYO,9月11日,9376538156
ATRT_TYR_22,9376538156_R03C01,"Burdenko Neurosurgery Institute, Moscow",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,2,female,posterior fossa; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",61%,Not applicable,DNA_KRYO,9月11日,9376538156
ATRT_TYR_23,6929718017_R01C01,"Burdenko Neurosurgery Institute, Moscow",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,2,female,posterior fossa; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",53%,Not applicable,DNA_KRYO,12月2日,6929718017
ATRT_TYR_24,6929718027_R02C01,"Burdenko Neurosurgery Institute, Moscow",Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,2,male,posterior fossa; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",58%,Not applicable,DNA_KRYO,12月2日,6929718027
ATRT_TYR_25,9533774082_R04C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,2,female,supratentorial; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",58%,Not applicable,DNA_FFPE,6月16日,9533774082
ATRT_TYR_26,9769100007_R02C02,"St. Jude Childrens Research Hospital, Memphis",Atypical teratoid/rhabdoid tumour               ,IV,Local review,4,male,not available,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",66%,Not applicable,DNA_KRYO,5月23日,9769100007
ATRT_TYR_27,3999834063_R02C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,5,male,posterior fossa; ,initial operation ,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",58%,Not applicable,DNA_FFPE,2月13日,3999834063
ATRT_TYR_28,3998909027_R02C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,7,female,"supratentorial, hemispheric, parietal;  left;",not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",53%,Not applicable,DNA_FFPE,5月1日,3998909027
ATRT_TYR_29,9407201022_R06C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,8,male,supratentorial; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",54%,Not applicable,DNA_FFPE,10月25日,9407201022
ATRT_TYR_30,9407201021_R05C02,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,9,male,supratentorial; ,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",61%,Not applicable,DNA_FFPE,10月25日,9407201021
ATRT_TYR_31,6929718027_R04C01,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,not available ,female,not available,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",54%,Not applicable,DNA_KRYO,12月2日,6929718027
ATRT_TYR_32,9969477098_R04C01,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,not available ,male,not available,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",58%,Not applicable,DNA_KRYO,8月22日,9969477098
ATRT_TYR_33,9969477044_R01C02,University Hospital of Heidelberg,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,not available ,female,not available,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",59%,Not applicable,DNA_KRYO,7月25日,9969477044
ATRT_TYR_34,9297949147_R02C02,International Cancer Genome Consortium ,Atypical teratoid/rhabdoid tumour               ,IV,Central review Heidelberg,not available ,female,not available,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",54%,Not applicable,DNA_KRYO,6月28日,9297949147
ATRT_TYR_35,9533774084_R02C01,University Hospital of Muenster,Atypical teratoid/rhabdoid tumour               ,IV,Central review Muenster,not available ,female,not available,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",58%,Not applicable,DNA_FFPE,6月16日,9533774084
ATRT_TYR_36,6164621144_R04C01,"Hospital for Sick Children, Toronto  ",Atypical teratoid/rhabdoid tumour               ,IV,Local review,not available ,male,not available,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",56%,Not applicable,DNA_KRYO,11月23日,6164621144
ATRT_TYR_37,6164621144_R05C01,"Hospital for Sick Children, Toronto  ",Atypical teratoid/rhabdoid tumour               ,IV,Local review,not available ,female,not available,not available,ATRT_TYR,"methylation class atypical teratoid/rhabdoid tumor, subclass TYR",58%,Not applicable,DNA_KRYO,11月23日,6164621144
CHGL_01,3999875073_R05C01,University Hospital of Vienna,Chordoid glioma of the third ventricle  ,II,Central review Heidelberg,26,male,"supratentorial, intraventricular, ventricle III; ",initial operation ,CHGL,methylation class chordoid glioma of the third ventricle,53%,Not applicable,DNA_FFPE,3月6日,3999875073
CHGL_02,3999875073_R04C02,University Hospital of Zurich,Chordoid glioma of the third ventricle  ,II,Central review Heidelberg,39,female,"supratentorial, intraventricular, ventricle III; ",initial operation ,CHGL,methylation class chordoid glioma of the third ventricle,61%,Not applicable,DNA_FFPE,3月6日,3999875073
CHGL_03,3999002044_R01C01,"Beaumont Hospital, Dublin",Chordoid glioma of the third ventricle  ,II,Central review Heidelberg,40,male,"supratentorial, intraventricular, ventricle III; ",initial operation ,CHGL,methylation class chordoid glioma of the third ventricle,62%,Not applicable,DNA_FFPE,6月26日,3999002044
CHGL_04,9741950140_R02C01,"MD Anderson Cancer Center, Houston",Chordoid glioma of the third ventricle  ,II,Central review Heidelberg,40,male,"supratentorial, intraventricular, ventricle III; ",recurrence ,CHGL,methylation class chordoid glioma of the third ventricle,55%,Not applicable,DNA_FFPE,4月14日,9741950140
CHGL_05,9296930017_R05C02,University Hospital of Hannover,Chordoid glioma of the third ventricle  ,II,Central review Heidelberg,41,male,"supratentorial, diencephalic, optic tract, intraventricular, ventricle III, sellar region, suprasellar; ",initial operation ,CHGL,methylation class chordoid glioma of the third ventricle,61%,Not applicable,DNA_FFPE,5月21日,9296930017
CHGL_06,3999308200_R03C02,University of Virginia,Chordoid glioma of the third ventricle  ,II,Central review Heidelberg,47,male,"supratentorial, intraventricular, ventricle III, sellar region, suprasellar; ",initial operation ,CHGL,methylation class chordoid glioma of the third ventricle,53%,Not applicable,DNA_FFPE,4月6日,3999308200
CHGL_07,3998909006_R06C02,University of Virginia,Chordoid glioma of the third ventricle  ,II,Central review Heidelberg,48,male,"supratentorial, intraventricular, ventricle III; ",initial operation ,CHGL,methylation class chordoid glioma of the third ventricle,64%,Not applicable,DNA_FFPE,4月24日,3998909006
CHGL_08,9553932088_R06C02,University Hospital of Hannover,Chordoid glioma of the third ventricle  ,II,Central review Heidelberg,50,male,"supratentorial, intraventricular, ventricle III, sellar region, suprasellar; peripheral nerve, cranial nerve, II; ",initial operation ,CHGL,methylation class chordoid glioma of the third ventricle,49%,Not applicable,DNA_FFPE,2月28日,9553932088
CHGL_09,9406922161_R06C01,University Hospital of Frankfurt am Main,Chordoid glioma of the third ventricle  ,II,Central review Heidelberg,53,female,"supratentorial, intraventricular, ventricle III, sellar region, suprasellar; ",initial operation ,CHGL,methylation class chordoid glioma of the third ventricle,47%,Not applicable,DNA_FFPE,10月18日,9406922161
CHGL_10,3999100092_R06C01,"Queen's Hospital, Romford",Chordoid glioma of the third ventricle  ,II,Central review Heidelberg,53,male,"supratentorial, intraventricular, ventricle III; ",initial operation ,CHGL,methylation class chordoid glioma of the third ventricle,60%,Not applicable,DNA_FFPE,7月24日,3999100092
CHGL_11,3999875073_R03C02,University Hospital of Heidelberg,Chordoid glioma of the third ventricle  ,II,Central review Heidelberg,61,male,"supratentorial, intraventricular, ventricle III; ",initial operation ,CHGL,methylation class chordoid glioma of the third ventricle,50%,Not applicable,DNA_FFPE,3月6日,3999875073
CHGL_12,3998568099_R04C01,University Hospital of Bern,Chordoid glioma of the third ventricle  ,II,Central review Heidelberg,not available ,male,"supratentorial, intraventricular, ventricle III; ",recurrence ,CHGL,methylation class chordoid glioma of the third ventricle,62%,Not applicable,DNA_FFPE,9月11日,3998568099
CHORDM_01,9878820105_R01C01,University Hospital of Heidelberg,Chordoma,not available,Central review Heidelberg,14,female,"mesenchyme, cranium, clivus; ",initial operation ,CHORDM,methylation class chordoma,52%,Not applicable,DNA_FFPE,10月27日,9878820105
CHORDM_02,9741950101_R04C01,University Hospital of Heidelberg,Chordoma,not available,Central review Heidelberg,22,female,"supratentorial, diencephalic, optic tract, sellar region, suprasellar, infundibulum; posterior fossa, cerebello-pontine angle;  right;",initial operation ,CHORDM,methylation class chordoma,57%,Not applicable,DNA_FFPE,5月16日,9741950101
CHORDM_03,9553932008_R06C02,University Hospital of Heidelberg,Chordoma,not available,Central review Heidelberg,33,male,"supratentorial, sellar region; posterior fossa, brain stem; ",initial operation ,CHORDM,methylation class chordoma,60%,Not applicable,DNA_FFPE,2月14日,9553932008
CHORDM_04,9855358058_R03C01,University Hospital of Heidelberg,Chordoma,not available,Central review Heidelberg,33,female,"mesenchyme, cranium, clivus; ",initial operation ,CHORDM,methylation class chordoma,64%,Not applicable,DNA_FFPE,10月6日,9855358058
CHORDM_05,9878820104_R04C02,University Hospital of Heidelberg,Chordoma,not available,Central review Heidelberg,37,female,"mesenchyme, cranium, clivus; ",initial operation ,CHORDM,methylation class chordoma,50%,Not applicable,DNA_FFPE,10月27日,9878820104
CHORDM_06,9553932008_R05C02,University Hospital of Heidelberg,Chordoma,not available,Central review Heidelberg,55,female,"supratentorial, sellar region; ",initial operation ,CHORDM,methylation class chordoma,65%,Not applicable,DNA_FFPE,2月14日,9553932008
CHORDM_07,9855358058_R01C01,University Hospital of Heidelberg,Chordoma,not available,Central review Heidelberg,56,female,"mesenchyme, cranium, clivus; ",initial operation ,CHORDM,methylation class chordoma,65%,Not applicable,DNA_FFPE,10月6日,9855358058
CHORDM_08,9855358058_R04C01,University Hospital of Heidelberg,Chordoma,not available,Central review Heidelberg,62,female,"supratentorial, sellar region, suprasellar, intrasellar; mesenchyme; ",initial operation ,CHORDM,methylation class chordoma,55%,Not applicable,DNA_FFPE,10月6日,9855358058
CHORDM_09,9741950007_R05C02,University Hospital of Heidelberg,Chordoma,not available,Central review Heidelberg,71,female,"supratentorial, sellar region; ",initial operation ,CHORDM,methylation class chordoma,63%,Not applicable,DNA_FFPE,3月24日,9741950007
CN_01,10006823024_R05C01,University Hospital of Frankfurt am Main,Central neurocytoma  ,II,Central review Heidelberg,14,female,"supratentorial, intraventricular, ventricle II; ",initial operation ,CN,methylation class central neurocytoma,80%,Not applicable,DNA_FFPE,12月12日,10006823024
CN_02,9296930017_R01C02,University Hospital of Hannover,Central neurocytoma  ,II,Central review Heidelberg,15,female,"supratentorial, intraventricular; ",not available,CN,methylation class central neurocytoma,65%,Not applicable,DNA_FFPE,5月21日,9296930017
CN_03,9296930017_R06C01,University Hospital of Hannover,Central neurocytoma  ,II,Central review Heidelberg,20,female,"supratentorial, intraventricular; ",not available,CN,methylation class central neurocytoma,71%,Not applicable,DNA_FFPE,5月21日,9296930017
CN_04,8622007189_R06C02,University Hospital of Heidelberg,Central neurocytoma  ,II,Central review Heidelberg,20,female,"supratentorial, intraventricular, ventricle II;  right;",not available,CN,methylation class central neurocytoma,72%,Not applicable,DNA_FFPE,1月17日,8622007189
CN_05,9829119124_R04C01,"MD Anderson Cancer Center, Houston",Central neurocytoma  ,II,Central review Heidelberg,22,female,"supratentorial, intraventricular, ventricle II; ",not available,CN,methylation class central neurocytoma,76%,Not applicable,DNA_FFPE,5月23日,9829119124
CN_06,8622007203_R06C01,University Hospital of Heidelberg,Central neurocytoma  ,II,Central review Heidelberg,23,male,"supratentorial, intraventricular, ventricle II; ",initial operation ,CN,methylation class central neurocytoma,69%,Not applicable,DNA_FFPE,1月17日,8622007203
CN_07,8622007203_R02C02,University Hospital of Heidelberg,Central neurocytoma  ,II,Central review Heidelberg,23,male,supratentorial;  right;,recurrence ,CN,methylation class central neurocytoma,72%,Not applicable,DNA_FFPE,1月17日,8622007203
CN_08,9296930017_R02C01,University Hospital of Hannover,Central neurocytoma  ,II,Central review Heidelberg,24,male,"supratentorial, intraventricular, ventricle II;  left;",not available,CN,methylation class central neurocytoma,65%,Not applicable,DNA_FFPE,5月21日,9296930017
CN_09,9296930017_R05C01,University Hospital of Hannover,Central neurocytoma  ,II,Central review Heidelberg,25,male,"supratentorial, intraventricular, ventricle II;  left;",not available,CN,methylation class central neurocytoma,77%,Not applicable,DNA_FFPE,5月21日,9296930017
CN_10,8622007203_R04C01,University Hospital of Heidelberg,Central neurocytoma  ,II,Central review Heidelberg,26,female,"supratentorial, diencephalic, thalamic, intraventricular, ventricle II;  left;",initial operation ,CN,methylation class central neurocytoma,70%,Not applicable,DNA_FFPE,1月17日,8622007203
CN_11,9296930017_R02C02,University Hospital of Hannover,Central neurocytoma  ,II,Central review Heidelberg,27,male,"supratentorial, intraventricular, ventricle II;  left;",not available,CN,methylation class central neurocytoma,68%,Not applicable,DNA_FFPE,5月21日,9296930017
CN_12,9296930017_R04C02,University Hospital of Hannover,Central neurocytoma  ,II,Central review Heidelberg,28,male,"supratentorial, intraventricular; ",not available,CN,methylation class central neurocytoma,72%,Not applicable,DNA_FFPE,5月21日,9296930017
CN_13,8622007189_R05C01,University Hospital of Heidelberg,Central neurocytoma  ,II,Central review Heidelberg,28,female,"supratentorial, intraventricular; ",initial operation ,CN,methylation class central neurocytoma,70%,Not applicable,DNA_FFPE,1月17日,8622007189
CN_14,8622007203_R03C01,University Hospital of Heidelberg,Central neurocytoma  ,II,Central review Heidelberg,28,female,"supratentorial, intraventricular; ",initial operation ,CN,methylation class central neurocytoma,72%,Not applicable,DNA_FFPE,1月17日,8622007203
CN_15,9296930014_R02C01,University Hospital of Hannover,Central neurocytoma  ,II,Central review Heidelberg,29,female,"supratentorial, intraventricular, ventricle II;  left;",not available,CN,methylation class central neurocytoma,66%,Not applicable,DNA_FFPE,5月21日,9296930014
CN_16,9533774013_R02C02,"MD Anderson Cancer Center, Houston",Central neurocytoma  ,II,Central review Heidelberg,31,male,"supratentorial, hemispheric, frontal;  left;",not available,CN,methylation class central neurocytoma,77%,Not applicable,DNA_FFPE,5月30日,9533774013
CN_17,8622007189_R01C02,University Hospital of Heidelberg,Central neurocytoma  ,II,Central review Heidelberg,33,female,"supratentorial, intraventricular, ventricle II;  right;",initial operation ,CN,methylation class central neurocytoma,70%,Not applicable,DNA_FFPE,1月17日,8622007189
CN_18,9296930017_R03C02,University Hospital of Hannover,Central neurocytoma  ,II,Central review Heidelberg,34,male,"supratentorial, intraventricular; ",not available,CN,methylation class central neurocytoma,69%,Not applicable,DNA_FFPE,5月21日,9296930017
CN_19,8622007203_R01C02,University Hospital of Heidelberg,Central neurocytoma  ,II,Central review Heidelberg,34,female,"supratentorial, intraventricular; ",initial operation ,CN,methylation class central neurocytoma,70%,Not applicable,DNA_FFPE,1月17日,8622007203
CN_20,9533774013_R04C02,"MD Anderson Cancer Center, Houston",Central neurocytoma  ,II,Central review Heidelberg,55,male,"supratentorial, intraventricular; ",not available,CN,methylation class central neurocytoma,69%,Not applicable,DNA_FFPE,5月30日,9533774013
CN_21,9373551108_R06C01,University Hospital of Heidelberg,Central neurocytoma  ,II,Central review Heidelberg,70,female,"supratentorial, intraventricular, ventricle II;  left;",initial operation ,CN,methylation class central neurocytoma,70%,Not applicable,DNA_FFPE,9月11日,9373551108
CNS_NB_FOXR2_01,9533774067_R01C01,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,2,male,"supratentorial, hemispheric, frontal;  left;",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,77%,Not applicable,DNA_KRYO,6月7日,9533774067
CNS_NB_FOXR2_02,8622007069_R03C01,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,2,female,"supratentorial, hemispheric, parietal, occipital; ",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,69%,Not applicable,DNA_FFPE,11月26日,8622007069
CNS_NB_FOXR2_03,8622007061_R05C02,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,2,not available,"supratentorial, hemispheric, frontal;  right;",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,78%,Not applicable,DNA_KRYO,11月12日,8622007061
CNS_NB_FOXR2_04,9741950038_R06C02,"St. Jude Childrens Research Hospital, Memphis","CNS embryonal tumour, NOS           ",IV,Local review,2,female,"supratentorial, hemispheric, frontal, temporal; ",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,76%,Not applicable,DNA_FFPE,2月24日,9741950038
CNS_NB_FOXR2_05,9741950056_R02C02,"St. Jude Childrens Research Hospital, Memphis","CNS embryonal tumour, NOS           ",IV,Local review,2,female,"supratentorial, hemispheric, temporal; ",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,76%,Not applicable,DNA_FFPE,2月24日,9741950056
CNS_NB_FOXR2_06,8622007070_R03C02,University Hospital of Muenster,"CNS embryonal tumour, NOS           ",IV,Local review,2,male,not available,not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,66%,Not applicable,DNA_FFPE,11月26日,8622007070
CNS_NB_FOXR2_07,6229009095_R06C02,University Hospital of Muenster,"CNS embryonal tumour, NOS           ",IV,Local review,2,female,supratentorial; ,not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,84%,Not applicable,DNA_KRYO,2月16日,6229009095
CNS_NB_FOXR2_08,3999078079_R02C01,University Hospital of Basel ,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,3,male,"supratentorial, hemispheric; ",initial operation ,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,75%,Not applicable,DNA_FFPE,7月3日,3999078079
CNS_NB_FOXR2_09,8622007061_R02C02,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,4,male,"supratentorial, hemispheric, parietal;  right;",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,76%,Not applicable,DNA_KRYO,11月12日,8622007061
CNS_NB_FOXR2_10,9741950039_R02C02,"St. Jude Childrens Research Hospital, Memphis","CNS embryonal tumour, NOS           ",IV,Local review,4,female,"supratentorial, hemispheric, frontal; ",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,74%,Not applicable,DNA_FFPE,2月24日,9741950039
CNS_NB_FOXR2_11,9741950056_R02C01,"St. Jude Childrens Research Hospital, Memphis","CNS embryonal tumour, NOS           ",IV,Local review,4,male,"supratentorial, hemispheric, frontal; ",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,72%,Not applicable,DNA_FFPE,2月24日,9741950056
CNS_NB_FOXR2_12,9741950086_R05C02,"St. Jude Childrens Research Hospital, Memphis","CNS embryonal tumour, NOS           ",IV,Local review,4,not available,not available,not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,72%,Not applicable,DNA_FFPE,2月24日,9741950086
CNS_NB_FOXR2_13,9721366138_R06C01,"University of California, San Francisco ","CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,4,female,"supratentorial, hemispheric, frontal;  left;",initial operation ,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,78%,Not applicable,DNA_FFPE,5月9日,9721366138
CNS_NB_FOXR2_14,3998909025_R05C01,University Hospital of Bonn,"CNS embryonal tumour, NOS           ",IV,Central review Bonn ,5,female,"supratentorial, hemispheric; ",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,68%,Not applicable,DNA_FFPE,5月1日,3998909025
CNS_NB_FOXR2_15,3998909025_R01C02,University Hospital of Bonn,"CNS embryonal tumour, NOS           ",IV,Central review Bonn ,5,female,"supratentorial, hemispheric; ",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,72%,Not applicable,DNA_FFPE,5月1日,3998909025
CNS_NB_FOXR2_16,8784241104_R01C02,"McGill Children's Hospital, Montreal","CNS embryonal tumour, NOS           ",IV,Local review,5,female,"supratentorial, hemispheric, temporal, parietal; ",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,70%,Not applicable,DNA_KRYO,4月14日,8784241104
CNS_NB_FOXR2_17,6229017022_R04C02,"Burdenko Neurosurgery Institute, Moscow","CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,5,female,supratentorial; ,not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,75%,Not applicable,DNA_KRYO,3月15日,6229017022
CNS_NB_FOXR2_18,8622007067_R02C01,University Hospital of Muenster,"CNS embryonal tumour, NOS           ",IV,Local review,5,female,"supratentorial, hemispheric, temporal; ",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,76%,Not applicable,DNA_FFPE,11月26日,8622007067
CNS_NB_FOXR2_19,9379086129_R01C01,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,6,male,"supratentorial, hemispheric, temporal, parietal;  right;",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,75%,Not applicable,DNA_KRYO,10月4日,9379086129
CNS_NB_FOXR2_20,9993943073_R04C01,New York University Langone,"CNS embryonal tumour, NOS           ",IV,Local review,6,female,"supratentorial, hemispheric, frontal;  left;",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,68%,Not applicable,DNA_FFPE,5月15日,9993943073
CNS_NB_FOXR2_21,8622007130_R02C01,"La Sapienza Hospital, Rome ","CNS embryonal tumour, NOS           ",IV,Local review,6,female,"supratentorial, sellar region; ",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,77%,Not applicable,DNA_FFPE,1月16日,8622007130
CNS_NB_FOXR2_22,6929718020_R05C02,University Hospital of Duesseldorf ,"CNS embryonal tumour, NOS           ",IV,Local review,7,male,"supratentorial, hemispheric, parietal, occipital; ",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,68%,Not applicable,DNA_KRYO,12月23日,6929718020
CNS_NB_FOXR2_23,9297949146_R05C02,"Burdenko Neurosurgery Institute, Moscow","CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,7,female,supratentorial; ,not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,76%,Not applicable,DNA_KRYO,6月28日,9297949146
CNS_NB_FOXR2_24,9283265033_R01C02,"Burdenko Neurosurgery Institute, Moscow","CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,7,male,supratentorial; ,not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,79%,Not applicable,DNA_KRYO,4月29日,9283265033
CNS_NB_FOXR2_25,9969477079_R05C02,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,8,male,"supratentorial, hemispheric, temporal;  right;",initial operation ,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,76%,Not applicable,DNA_FFPE,8月15日,9969477079
CNS_NB_FOXR2_26,6969568075_R02C02,"McGill Children's Hospital, Montreal","CNS embryonal tumour, NOS           ",IV,Local review,8,male,"supratentorial, intraventricular, ventricle II;  left;",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,78%,Not applicable,DNA_KRYO,4月14日,6969568075
CNS_NB_FOXR2_27,8622007069_R02C01,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,9,female,"supratentorial, hemispheric, occipital; ",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,75%,Not applicable,DNA_FFPE,11月26日,8622007069
CNS_NB_FOXR2_28,9283265033_R06C02,"Hospital for Sick Children, Toronto  ","CNS embryonal tumour, NOS           ",IV,Local review,9,male,not available,not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,79%,Not applicable,DNA_FFPE,4月29日,9283265033
CNS_NB_FOXR2_29,9007225017_R04C01,Amsterdam Academic Medical Center,"CNS embryonal tumour, NOS           ",IV,Local review,10,not available,"supratentorial, hemispheric, parietal, occipital; ",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,72%,Not applicable,DNA_FFPE,2月20日,9007225017
CNS_NB_FOXR2_30,9379086124_R05C02,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,10,male,"supratentorial, hemispheric, temporal, parietal; ",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,72%,Not applicable,DNA_KRYO,10月4日,9379086124
CNS_NB_FOXR2_31,6229017023_R04C02,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,11,male,not available,not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,75%,Not applicable,DNA_KRYO,3月15日,6229017023
CNS_NB_FOXR2_32,9741950173_R06C02,"St. Jude Childrens Research Hospital, Memphis","CNS embryonal tumour, NOS           ",IV,Local review,11,female,"supratentorial, hemispheric, temporal; ",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,69%,Not applicable,DNA_FFPE,2月24日,9741950173
CNS_NB_FOXR2_33,9297949146_R04C02,"Burdenko Neurosurgery Institute, Moscow","CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,11,female,supratentorial; ,not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,74%,Not applicable,DNA_KRYO,6月28日,9297949146
CNS_NB_FOXR2_34,3998909025_R02C01,University Hospital of Bonn,"CNS embryonal tumour, NOS           ",IV,Central review Bonn ,12,female,"supratentorial, hemispheric, frontal, temporal, diencephalic, basal ganglia; ",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,73%,Not applicable,DNA_FFPE,5月1日,3998909025
CNS_NB_FOXR2_35,9373551039_R02C01,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,12,male,"supratentorial, hemispheric, temporal;  left;",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,71%,Not applicable,DNA_FFPE,8月23日,9373551039
CNS_NB_FOXR2_36,9407210157_R03C01,"St. Jude Childrens Research Hospital, Memphis","CNS embryonal tumour, NOS           ",IV,Local review,12,female,"supratentorial, hemispheric, frontal, parietal; ",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,66%,Not applicable,DNA_FFPE,2月24日,9407210157
CNS_NB_FOXR2_37,9611519028_R04C01,University Hospital of Tuebingen,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,14,male,"supratentorial, hemispheric, frontal;  left;",not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,74%,Not applicable,DNA_FFPE,3月10日,9611519028
CNS_NB_FOXR2_38,8622007066_R04C01,University Hospital of Muenster,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,16,female,"supratentorial, hemispheric, frontal;  left;",recurrence ,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,71%,Not applicable,DNA_FFPE,11月26日,8622007066
CNS_NB_FOXR2_39,9379086095_R06C02,International Cancer Genome Consortium ,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,CNS_NB_FOXR2,methylation class CNS neuroblastoma with FOXR2 activation,76%,Not applicable,DNA_KRYO,11月18日,9379086095
CONTR_ADENOPIT_01,9407201029_R04C01,University Hospital of Heidelberg,"Normal pituitary anterior lobe (fetal tissue, gestation week 20)",not available,Central review Heidelberg,0,female,"supratentorial, sellar region, intrasellar; mesenchyme, cranium, nasal cavity; ",not available,CONTR_ADENOPIT,"methylation class control tissue, pituitary gland anterior lobe",63%,Not applicable,DNA_FFPE,12月2日,9407201029
CONTR_ADENOPIT_02,3999834096_R05C02,University Hospital of Heidelberg,Normal pituitary anterior lobe,not available,Central review Heidelberg,40,male,"supratentorial, sellar region, intrasellar; ",not available,CONTR_ADENOPIT,"methylation class control tissue, pituitary gland anterior lobe",63%,Not applicable,DNA_FFPE,2月20日,3999834096
CONTR_ADENOPIT_03,9420867121_R06C01,University Hospital of Heidelberg,Normal pituitary anterior lobe,not available,Central review Heidelberg,51,female,"supratentorial, sellar region, intrasellar; ",not available,CONTR_ADENOPIT,"methylation class control tissue, pituitary gland anterior lobe",63%,Not applicable,DNA_FFPE,1月17日,9420867121
CONTR_ADENOPIT_04,9420867121_R01C02,University Hospital of Heidelberg,Normal pituitary anterior lobe,not available,Central review Heidelberg,52,male,"supratentorial, sellar region, intrasellar; ",not available,CONTR_ADENOPIT,"methylation class control tissue, pituitary gland anterior lobe",63%,Not applicable,DNA_FFPE,1月17日,9420867121
CONTR_ADENOPIT_05,9407201029_R02C01,University Hospital of Heidelberg,Normal pituitary anterior lobe,not available,Central review Heidelberg,53,male,"supratentorial, sellar region, intrasellar; ",not available,CONTR_ADENOPIT,"methylation class control tissue, pituitary gland anterior lobe",65%,Not applicable,DNA_FFPE,12月2日,9407201029
CONTR_ADENOPIT_06,9420867121_R05C01,University Hospital of Heidelberg,Normal pituitary anterior lobe,not available,Central review Heidelberg,56,male,"supratentorial, sellar region, intrasellar; ",not available,CONTR_ADENOPIT,"methylation class control tissue, pituitary gland anterior lobe",66%,Not applicable,DNA_FFPE,1月17日,9420867121
CONTR_ADENOPIT_07,9407201029_R03C01,University Hospital of Heidelberg,Normal pituitary anterior lobe,not available,Central review Heidelberg,57,male,"supratentorial, sellar region, intrasellar; ",not available,CONTR_ADENOPIT,"methylation class control tissue, pituitary gland anterior lobe",61%,Not applicable,DNA_FFPE,12月2日,9407201029
CONTR_ADENOPIT_08,3999834094_R05C02,University Hospital of Heidelberg,Normal pituitary anterior lobe,not available,Central review Heidelberg,59,male,"supratentorial, sellar region, intrasellar; ",not available,CONTR_ADENOPIT,"methylation class control tissue, pituitary gland anterior lobe",63%,Not applicable,DNA_FFPE,2月20日,3999834094
CONTR_ADENOPIT_09,9553932113_R01C02,University Hospital of Heidelberg,Normal pituitary anterior lobe,not available,Central review Heidelberg,76,male,"supratentorial, sellar region, intrasellar; ",not available,CONTR_ADENOPIT,"methylation class control tissue, pituitary gland anterior lobe",62%,Not applicable,DNA_FFPE,2月28日,9553932113
CONTR_CEBM_01,3999095103_R02C02,University Hospital of Heidelberg,Normal cerebellum cortex,not available,Central review Heidelberg,74,male,"posterior fossa, cerebellum, hemispheric (cerebellum); ",not available,CONTR_CEBM,"methylation class control tissue, cerebellar hemisphere",61%,Not applicable,DNA_FFPE,7月17日,3999095103
CONTR_CEBM_02,5911815023_R01C01,"BioChain Institute, Inc. (commercial)",Normal cerebellum cortex,not available,No review (commercial),not available ,male,"posterior fossa, cerebellum, hemispheric (cerebellum); ",not available,CONTR_CEBM,"methylation class control tissue, cerebellar hemisphere",61%,Not applicable,DNA_KRYO,6月10日,5911815023
CONTR_CEBM_03,5911815023_R02C01,"BioChain Institute, Inc. (commercial)",Normal cerebellum cortex,not available,No review (commercial),not available ,female,"posterior fossa, cerebellum, hemispheric (cerebellum); ",not available,CONTR_CEBM,"methylation class control tissue, cerebellar hemisphere",60%,Not applicable,DNA_KRYO,6月10日,5911815023
CONTR_CEBM_04,5911815023_R04C01,"BioChain Institute, Inc. (commercial)",Normal cerebellum cortex,not available,No review (commercial),not available ,male,"posterior fossa, cerebellum, hemispheric (cerebellum); ",not available,CONTR_CEBM,"methylation class control tissue, cerebellar hemisphere",66%,Not applicable,DNA_KRYO,6月10日,5911815023
CONTR_CEBM_05,5911815023_R05C01,"BioChain Institute, Inc. (commercial)",Normal cerebellum cortex,not available,No review (commercial),not available ,female,"posterior fossa, cerebellum, hemispheric (cerebellum); ",not available,CONTR_CEBM,"methylation class control tissue, cerebellar hemisphere",64%,Not applicable,DNA_KRYO,6月10日,5911815023
CONTR_CEBM_06,5911815023_R06C01,"BioChain Institute, Inc. (commercial)",Normal cerebellum cortex,not available,No review (commercial),not available ,female,"posterior fossa, cerebellum, hemispheric (cerebellum); ",not available,CONTR_CEBM,"methylation class control tissue, cerebellar hemisphere",66%,Not applicable,DNA_KRYO,6月10日,5911815023
CONTR_CEBM_07,7310440006_R03C01,"BioChain Institute, Inc. (commercial)",Normal cerebellum cortex,not available,No review (commercial),not available ,male,"posterior fossa, cerebellum, hemispheric (cerebellum); ",not available,CONTR_CEBM,"methylation class control tissue, cerebellar hemisphere",61%,Not applicable,DNA_KRYO,7月13日,7310440006
CONTR_CEBM_08,7310440006_R02C01,"BioChain Institute, Inc. (commercial)",Normal cerebellum cortex,not available,No review (commercial),not available ,male,"posterior fossa, cerebellum, hemispheric (cerebellum); ",not available,CONTR_CEBM,"methylation class control tissue, cerebellar hemisphere",61%,Not applicable,DNA_KRYO,7月13日,7310440006
CONTR_HEMI_01,3999095103_R03C02,University Hospital of Heidelberg,Normal cortex,not available,Central review Heidelberg,74,male,"supratentorial, hemispheric, temporal; ",not available,CONTR_HEMI,"methylation class control tissue, hemispheric cortex",56%,Not applicable,DNA_FFPE,7月17日,3999095103
CONTR_HEMI_02,8622007080_R01C01,"BioChain Institute, Inc. (commercial)",Normal cortex,not available,No review (commercial),not available ,male,"supratentorial, hemispheric; ",not available,CONTR_HEMI,"methylation class control tissue, hemispheric cortex",47%,Not applicable,DNA_KRYO,12月6日,8622007080
CONTR_HEMI_03,8622007080_R02C01,"BioChain Institute, Inc. (commercial)",Normal cortex,not available,No review (commercial),not available ,female,"supratentorial, hemispheric; ",not available,CONTR_HEMI,"methylation class control tissue, hemispheric cortex",53%,Not applicable,DNA_KRYO,12月6日,8622007080
CONTR_HEMI_04,8622007080_R03C01,"BioChain Institute, Inc. (commercial)",Normal cortex,not available,No review (commercial),not available ,male,"supratentorial, hemispheric; ",not available,CONTR_HEMI,"methylation class control tissue, hemispheric cortex",43%,Not applicable,DNA_KRYO,12月6日,8622007080
CONTR_HEMI_05,8622007080_R04C01,"BioChain Institute, Inc. (commercial)",Normal cortex,not available,No review (commercial),not available ,male,"supratentorial, hemispheric; ",not available,CONTR_HEMI,"methylation class control tissue, hemispheric cortex",46%,Not applicable,DNA_KRYO,12月6日,8622007080
CONTR_HEMI_06,8622007080_R06C01,"BioChain Institute, Inc. (commercial)",Normal cortex,not available,No review (commercial),not available ,male,"supratentorial, hemispheric, occipital; ",not available,CONTR_HEMI,"methylation class control tissue, hemispheric cortex",47%,Not applicable,DNA_KRYO,12月6日,8622007080
CONTR_HEMI_07,8622007080_R03C02,"BioChain Institute, Inc. (commercial)",Normal cortex,not available,No review (commercial),not available ,male,"supratentorial, hemispheric, temporal; ",not available,CONTR_HEMI,"methylation class control tissue, hemispheric cortex",47%,Not applicable,DNA_KRYO,12月6日,8622007080
CONTR_HEMI_08,7310440006_R05C01,"BioChain Institute, Inc. (commercial)",Normal cortex,not available,No review (commercial),not available ,male,"supratentorial, hemispheric, occipital; ",not available,CONTR_HEMI,"methylation class control tissue, hemispheric cortex",57%,Not applicable,DNA_KRYO,7月13日,7310440006
CONTR_HEMI_09,7310440006_R05C02,"BioChain Institute, Inc. (commercial)",Normal cortex,not available,No review (commercial),not available ,male,"supratentorial, hemispheric, temporal; ",not available,CONTR_HEMI,"methylation class control tissue, hemispheric cortex",55%,Not applicable,DNA_KRYO,7月13日,7310440006
CONTR_HEMI_10,7310440006_R06C01,"BioChain Institute, Inc. (commercial)",Normal cortex,not available,No review (commercial),not available ,male,"supratentorial, hemispheric, occipital; ",not available,CONTR_HEMI,"methylation class control tissue, hemispheric cortex",43%,Not applicable,DNA_KRYO,7月13日,7310440006
CONTR_HEMI_11,7310440006_R03C02,"BioChain Institute, Inc. (commercial)",Normal cortex,not available,No review (commercial),not available ,male,"supratentorial, hemispheric, parietal; ",not available,CONTR_HEMI,"methylation class control tissue, hemispheric cortex",50%,Not applicable,DNA_KRYO,7月13日,7310440006
CONTR_HEMI_12,7310440006_R04C02,"BioChain Institute, Inc. (commercial)",Normal cortex,not available,No review (commercial),not available ,male,"supratentorial, hemispheric, parietal; ",not available,CONTR_HEMI,"methylation class control tissue, hemispheric cortex",47%,Not applicable,DNA_KRYO,7月13日,7310440006
CONTR_HEMI_13,7310440009_R01C01,"BioChain Institute, Inc. (commercial)",Normal cortex,not available,No review (commercial),not available ,male,"supratentorial, hemispheric, temporal; ",not available,CONTR_HEMI,"methylation class control tissue, hemispheric cortex",52%,Not applicable,DNA_KRYO,7月13日,7310440009
CONTR_HYPTHAL_01,3998523003_R03C01,Charite Universitaetsmedizin Berlin,Normal hypothalamus,not available,Central review Heidelberg,48,male,"supratentorial, diencephalic, hypothalamic; ",not available,CONTR_HYPTHAL,"methylation class control tissue, hypothalamus",52%,Not applicable,DNA_FFPE,7月24日,3998523003
CONTR_HYPTHAL_02,3998523003_R06C01,Charite Universitaetsmedizin Berlin,Normal hypothalamus,not available,Central review Heidelberg,57,male,"supratentorial, diencephalic, hypothalamic; ",not available,CONTR_HYPTHAL,"methylation class control tissue, hypothalamus",52%,Not applicable,DNA_FFPE,7月24日,3998523003
CONTR_HYPTHAL_03,3998523003_R01C01,Charite Universitaetsmedizin Berlin,Normal hypothalamus,not available,Central review Heidelberg,61,male,"supratentorial, diencephalic, hypothalamic; ",not available,CONTR_HYPTHAL,"methylation class control tissue, hypothalamus",48%,Not applicable,DNA_FFPE,7月24日,3998523003
CONTR_HYPTHAL_04,3998523003_R03C02,Charite Universitaetsmedizin Berlin,Normal hypothalamus,not available,Central review Heidelberg,63,female,"supratentorial, diencephalic, hypothalamic; ",not available,CONTR_HYPTHAL,"methylation class control tissue, hypothalamus",53%,Not applicable,DNA_FFPE,7月24日,3998523003
CONTR_HYPTHAL_05,3998523003_R01C02,Charite Universitaetsmedizin Berlin,Normal hypothalamus,not available,Central review Heidelberg,70,female,"supratentorial, diencephalic, hypothalamic; ",not available,CONTR_HYPTHAL,"methylation class control tissue, hypothalamus",47%,Not applicable,DNA_FFPE,7月24日,3998523003
CONTR_HYPTHAL_06,3998523003_R04C01,Charite Universitaetsmedizin Berlin,Normal hypothalamus,not available,Central review Heidelberg,71,male,"supratentorial, diencephalic, hypothalamic; ",not available,CONTR_HYPTHAL,"methylation class control tissue, hypothalamus",58%,Not applicable,DNA_FFPE,7月24日,3998523003
CONTR_HYPTHAL_07,3998523003_R02C01,Charite Universitaetsmedizin Berlin,Normal hypothalamus,not available,Central review Heidelberg,73,male,"supratentorial, diencephalic, hypothalamic; ",not available,CONTR_HYPTHAL,"methylation class control tissue, hypothalamus",53%,Not applicable,DNA_FFPE,7月24日,3998523003
CONTR_HYPTHAL_08,3998523003_R05C01,Charite Universitaetsmedizin Berlin,Normal hypothalamus,not available,Central review Heidelberg,81,female,"supratentorial, diencephalic, hypothalamic; ",not available,CONTR_HYPTHAL,"methylation class control tissue, hypothalamus",48%,Not applicable,DNA_FFPE,7月24日,3998523003
CONTR_HYPTHAL_09,3998523003_R02C02,Charite Universitaetsmedizin Berlin,Normal hypothalamus,not available,Central review Heidelberg,88,male,"supratentorial, diencephalic, hypothalamic; ",not available,CONTR_HYPTHAL,"methylation class control tissue, hypothalamus",48%,Not applicable,DNA_FFPE,7月24日,3998523003
CONTR_INFLAM_01,9980102032_R05C01,University Hospital of Goettingen,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Heidelberg,39,female,not available,initial operation ,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",43%,Not applicable,DNA_FFPE,11月14日,9980102032
CONTR_INFLAM_02,8959312010_R02C02,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Duesseldorf,48,male,"supratentorial, hemispheric, frontal; ",not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",42%,Not applicable,DNA_KRYO,1月28日,8959312010
CONTR_INFLAM_03,9611518115_R06C02,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Duesseldorf,49,female,"supratentorial, hemispheric, temporal; ",not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",42%,Not applicable,DNA_KRYO,3月15日,9611518115
CONTR_INFLAM_04,9611518109_R04C01,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Heidelberg,49,female,"supratentorial, hemispheric, frontal; ",not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",44%,Not applicable,DNA_KRYO,3月7日,9611518109
CONTR_INFLAM_05,9878820106_R05C02,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Duesseldorf,50,male,"supratentorial, hemispheric, frontal; ",not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",39%,Not applicable,DNA_KRYO,10月27日,9878820106
CONTR_INFLAM_06,9855358066_R01C02,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Duesseldorf,52,female,"supratentorial, hemispheric, parietal; ",not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",39%,Not applicable,DNA_KRYO,10月6日,9855358066
CONTR_INFLAM_07,9878820119_R02C01,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Duesseldorf,56,male,"supratentorial, hemispheric, temporal; ",not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",41%,Not applicable,DNA_KRYO,10月27日,9878820119
CONTR_INFLAM_08,9611518099_R02C02,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Heidelberg,58,male,supratentorial;  right;,not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",35%,Not applicable,DNA_KRYO,3月7日,9611518099
CONTR_INFLAM_09,9721365095_R01C02,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Duesseldorf,59,male,"supratentorial, hemispheric, frontal; ",not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",40%,Not applicable,DNA_KRYO,3月25日,9721365095
CONTR_INFLAM_10,9611518117_R02C02,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Duesseldorf,59,female,"supratentorial, hemispheric, frontal; ",not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",41%,Not applicable,DNA_KRYO,3月15日,9611518117
CONTR_INFLAM_11,9611518117_R03C01,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Duesseldorf,60,male,"supratentorial, hemispheric, frontal; ",not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",44%,Not applicable,DNA_KRYO,3月15日,9611518117
CONTR_INFLAM_12,9721365104_R03C02,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Duesseldorf,62,female,not available,not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",42%,Not applicable,DNA_KRYO,3月25日,9721365104
CONTR_INFLAM_13,9611518110_R03C01,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Duesseldorf,62,female,"supratentorial, hemispheric, temporal; ",not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",44%,Not applicable,DNA_KRYO,3月7日,9611518110
CONTR_INFLAM_14,9611518166_R03C01,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Duesseldorf,64,male,not available,not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",41%,Not applicable,DNA_KRYO,3月15日,9611518166
CONTR_INFLAM_15,9611518113_R01C01,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Duesseldorf,65,male,not available,not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",39%,Not applicable,DNA_KRYO,3月7日,9611518113
CONTR_INFLAM_16,9611518117_R05C02,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Duesseldorf,65,male,"supratentorial, hemispheric, temporal; ",not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",38%,Not applicable,DNA_KRYO,3月15日,9611518117
CONTR_INFLAM_17,9878820119_R03C01,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Duesseldorf,67,male,"supratentorial, hemispheric, frontal; ",not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",43%,Not applicable,DNA_KRYO,10月27日,9878820119
CONTR_INFLAM_18,9721365105_R04C01,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Duesseldorf,69,male,"supratentorial, hemispheric, parietal; ",not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",46%,Not applicable,DNA_KRYO,3月25日,9721365105
CONTR_INFLAM_19,9721365104_R06C02,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Duesseldorf,71,female,"supratentorial, hemispheric, frontal; ",not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",39%,Not applicable,DNA_KRYO,3月25日,9721365104
CONTR_INFLAM_20,9855358068_R06C01,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Duesseldorf,73,male,not available,not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",42%,Not applicable,DNA_KRYO,10月6日,9855358068
CONTR_INFLAM_21,9611518110_R06C01,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Duesseldorf,74,female,not available,not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",38%,Not applicable,DNA_KRYO,3月7日,9611518110
CONTR_INFLAM_22,9721365105_R02C02,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Duesseldorf,75,female,"supratentorial, hemispheric, parietal; ",not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",47%,Not applicable,DNA_KRYO,3月25日,9721365105
CONTR_INFLAM_23,9721365104_R04C01,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Duesseldorf,78,female,not available,not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",41%,Not applicable,DNA_KRYO,3月25日,9721365104
CONTR_INFLAM_24,9611518099_R03C01,German Glioma Network ,"Low tumor cell content Glioblastoma, IDH wildtype with high inflammatory cell infiltration ",IV,Central review Heidelberg,not available ,female,"supratentorial, hemispheric, frontal;  right;",not available,CONTR_INFLAM,"methylation class control tissue, inflammatory tumor microenvironment",35%,Not applicable,DNA_KRYO,3月7日,9611518099
CONTR_PINEAL_01,9407210090_R06C01,University Hospital of Frankfurt am Main,Normal pineal gland,not available,Central review Heidelberg,30,female,"supratentorial, diencephalic, pineal region; ",not available,CONTR_PINEAL,"methylation class control tissue, pineal gland",59%,Not applicable,DNA_FFPE,12月6日,9407210090
CONTR_PINEAL_02,9553932123_R02C01,University Hospital of Heidelberg,Normal pineal gland,not available,Central review Heidelberg,40,male,"supratentorial, diencephalic, pineal region; ",not available,CONTR_PINEAL,"methylation class control tissue, pineal gland",58%,Not applicable,DNA_FFPE,2月28日,9553932123
CONTR_PINEAL_03,9221197132_R04C02,University Hospital of Heidelberg,Normal pineal gland,not available,Central review Heidelberg,46,male,"supratentorial, diencephalic, pineal region; ",not available,CONTR_PINEAL,"methylation class control tissue, pineal gland",62%,Not applicable,DNA_FFPE,3月28日,9221197132
CONTR_PINEAL_04,3999834095_R06C01,University Hospital of Heidelberg,Normal pineal gland,not available,Central review Heidelberg,46,female,"supratentorial, diencephalic, pineal region; ",not available,CONTR_PINEAL,"methylation class control tissue, pineal gland",60%,Not applicable,DNA_FFPE,2月20日,3999834095
CONTR_PINEAL_05,3999834096_R01C02,University Hospital of Heidelberg,Normal pineal gland,not available,Central review Heidelberg,50,male,"supratentorial, diencephalic, pineal region; ",not available,CONTR_PINEAL,"methylation class control tissue, pineal gland",56%,Not applicable,DNA_FFPE,2月20日,3999834096
CONTR_PINEAL_06,9420867121_R02C01,University Hospital of Heidelberg,Normal pineal gland,not available,Central review Heidelberg,51,female,"supratentorial, diencephalic, pineal region; ",not available,CONTR_PINEAL,"methylation class control tissue, pineal gland",60%,Not applicable,DNA_FFPE,1月17日,9420867121
CONTR_PINEAL_07,3999834095_R01C02,University Hospital of Heidelberg,Normal pineal gland,not available,Central review Heidelberg,59,male,"supratentorial, diencephalic, pineal region; ",not available,CONTR_PINEAL,"methylation class control tissue, pineal gland",62%,Not applicable,DNA_FFPE,2月20日,3999834095
CONTR_PINEAL_08,9647455131_R04C01,University Hospital of Heidelberg,Normal pineal gland,not available,Central review Heidelberg,61,male,"supratentorial, diencephalic, pineal region; ",not available,CONTR_PINEAL,"methylation class control tissue, pineal gland",61%,Not applicable,DNA_FFPE,4月11日,9647455131
CONTR_PINEAL_09,9741950023_R03C01,University Hospital of Heidelberg,Normal pineal gland,not available,Central review Heidelberg,65,female,"supratentorial, diencephalic, pineal region; ",not available,CONTR_PINEAL,"methylation class control tissue, pineal gland",62%,Not applicable,DNA_FFPE,3月24日,9741950023
CONTR_PINEAL_10,9373551023_R03C01,University Hospital of Heidelberg,Normal pineal gland,not available,Central review Heidelberg,71,male,"supratentorial, diencephalic, pineal region; ",not available,CONTR_PINEAL,"methylation class control tissue, pineal gland",56%,Not applicable,DNA_FFPE,8月23日,9373551023
CONTR_PINEAL_11,9553932010_R02C01,University Hospital of Heidelberg,Normal pineal gland,not available,Central review Heidelberg,76,male,"supratentorial, diencephalic, pineal region; ",not available,CONTR_PINEAL,"methylation class control tissue, pineal gland",53%,Not applicable,DNA_FFPE,2月14日,9553932010
CONTR_PINEAL_12,9007225142_R05C02,University Hospital of Heidelberg,Normal pineal gland,not available,Central review Heidelberg,81,male,"supratentorial, diencephalic, pineal region; ",not available,CONTR_PINEAL,"methylation class control tissue, pineal gland",59%,Not applicable,DNA_FFPE,4月19日,9007225142
CONTR_PONS_01,3999834096_R04C01,University Hospital of Heidelberg,Normal Pons,not available,Central review Heidelberg,5,male,"posterior fossa, brain stem, pons; ",not available,CONTR_PONS,"methylation class control tissue, pons",55%,Not applicable,DNA_FFPE,2月20日,3999834096
CONTR_PONS_02,3999834095_R03C01,University Hospital of Heidelberg,Normal Pons,not available,Central review Heidelberg,40,male,"posterior fossa, brain stem, pons; ",not available,CONTR_PONS,"methylation class control tissue, pons",53%,Not applicable,DNA_FFPE,2月20日,3999834095
CONTR_PONS_03,3999834096_R02C01,University Hospital of Heidelberg,Normal Pons,not available,Central review Heidelberg,46,female,"posterior fossa, brain stem, pons; ",not available,CONTR_PONS,"methylation class control tissue, pons",51%,Not applicable,DNA_FFPE,2月20日,3999834096
CONTR_PONS_04,3999834096_R03C02,University Hospital of Heidelberg,Normal Pons,not available,Central review Heidelberg,51,female,"posterior fossa, brain stem, pons; ",not available,CONTR_PONS,"methylation class control tissue, pons",56%,Not applicable,DNA_FFPE,2月20日,3999834096
CONTR_PONS_05,3999834096_R02C02,University Hospital of Heidelberg,Normal Pons,not available,Central review Heidelberg,52,male,"posterior fossa, brain stem, pons; ",not available,CONTR_PONS,"methylation class control tissue, pons",53%,Not applicable,DNA_FFPE,2月20日,3999834096
CONTR_PONS_06,3999834095_R02C02,University Hospital of Heidelberg,Normal Pons,not available,Central review Heidelberg,59,male,"posterior fossa, brain stem, pons; ",not available,CONTR_PONS,"methylation class control tissue, pons",52%,Not applicable,DNA_FFPE,2月20日,3999834095
CONTR_PONS_07,3999834096_R01C01,University Hospital of Heidelberg,Normal Pons,not available,Central review Heidelberg,61,male,"posterior fossa, brain stem, pons; ",not available,CONTR_PONS,"methylation class control tissue, pons",55%,Not applicable,DNA_FFPE,2月20日,3999834096
CONTR_PONS_08,3999834095_R02C01,University Hospital of Heidelberg,Normal Pons,not available,Central review Heidelberg,65,female,"posterior fossa, brain stem, pons; ",not available,CONTR_PONS,"methylation class control tissue, pons",53%,Not applicable,DNA_FFPE,2月20日,3999834095
CONTR_PONS_09,3999834096_R06C01,University Hospital of Heidelberg,Normal Pons,not available,Central review Heidelberg,68,male,"posterior fossa, brain stem, pons; ",not available,CONTR_PONS,"methylation class control tissue, pons",54%,Not applicable,DNA_FFPE,2月20日,3999834096
CONTR_PONS_10,3999834096_R04C02,University Hospital of Heidelberg,Normal Pons,not available,Central review Heidelberg,71,female,"posterior fossa, brain stem, pons; ",not available,CONTR_PONS,"methylation class control tissue, pons",54%,Not applicable,DNA_FFPE,2月20日,3999834096
CONTR_PONS_11,3999834095_R03C02,University Hospital of Heidelberg,Normal Pons,not available,Central review Heidelberg,78,female,"posterior fossa, brain stem, pons; ",not available,CONTR_PONS,"methylation class control tissue, pons",50%,Not applicable,DNA_FFPE,2月20日,3999834095
CONTR_PONS_12,3999834096_R03C01,University Hospital of Heidelberg,Normal Pons,not available,Central review Heidelberg,86,male,"posterior fossa, brain stem, pons; ",not available,CONTR_PONS,"methylation class control tissue, pons",53%,Not applicable,DNA_FFPE,2月20日,3999834096
CONTR_REACT_01,3998909006_R02C02,University Hospital of Heidelberg,Gangliocytoma  ,I,Central review Heidelberg,3,male,"posterior fossa, brain stem, medulla oblongata (craniocervical); spinal, cervical, C1, C2, C3, C4, C5, C6; ",initial operation ,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",54%,Not applicable,DNA_FFPE,4月24日,3998909006
CONTR_REACT_02,8622007067_R06C02,University Hospital of Heidelberg,Ganglioglioma ,I,Central review Heidelberg,9,male,"posterior fossa, brain stem; ",recurrence ,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",43%,Not applicable,DNA_FFPE,11月26日,8622007067
CONTR_REACT_03,6929689152_R02C01,University Hospital of Cambridge,Pilocytic astrocytoma  ,I,Local review,10,male,"supratentorial, diencephalic, optic tract; ",not available,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",43%,Not applicable,DNA_KRYO,11月23日,6929689152
CONTR_REACT_04,8622007069_R03C02,University Hospital of Heidelberg,Ganglioglioma ,I,Central review Heidelberg,12,female,"posterior fossa, brain stem, medulla oblongata (craniocervical); ",initial operation ,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",44%,Not applicable,DNA_FFPE,11月26日,8622007069
CONTR_REACT_05,7310440067_R03C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,12,female,"supratentorial, hemispheric; ",not available,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",42%,Not applicable,DNA_KRYO,7月2日,7310440067
CONTR_REACT_06,6929718017_R02C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,13,female,"posterior fossa, cerebellum; ",not available,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",39%,Not applicable,DNA_KRYO,12月2日,6929718017
CONTR_REACT_07,8622007119_R05C01,University Hospital of Muenster,Ganglioglioma ,I,Central review Heidelberg,13,female,"supratentorial, hemispheric, temporal;  left;",not available,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",40%,Not applicable,DNA_FFPE,1月16日,8622007119
CONTR_REACT_08,8622007069_R04C02,University Hospital of Heidelberg,Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos)  ,I,Central review Heidelberg,14,female,"posterior fossa, cerebellum, hemispheric (cerebellum);  right;",not available,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",42%,Not applicable,DNA_FFPE,11月26日,8622007069
CONTR_REACT_09,9969477101_R01C02,University Hospital of Frankfurt am Main,Pleomorphic xanthoastrocytoma  ,II,Central review Heidelberg,15,male,"supratentorial, hemispheric, temporal;  left;",initial operation ,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",44%,Not applicable,DNA_FFPE,8月22日,9969477101
CONTR_REACT_10,8622007069_R05C02,University Hospital of Heidelberg,Ganglioglioma ,I,Central review Heidelberg,15,female,"supratentorial, hemispheric, temporal;  right;",initial operation ,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",46%,Not applicable,DNA_FFPE,11月26日,8622007069
CONTR_REACT_11,8622007023_R02C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,15,male,"posterior fossa, cerebellum; ",not available,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",48%,Not applicable,DNA_KRYO,10月23日,8622007023
CONTR_REACT_12,10006823141_R05C01,University Hospital of Freiburg ,Pleomorphic xanthoastrocytoma  ,II,Central review Heidelberg,16,male,"supratentorial, hemispheric, occipital;  right;",initial operation ,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",44%,Not applicable,DNA_FFPE,1月12日,10006823141
CONTR_REACT_13,8622007069_R02C02,University Hospital of Heidelberg,Ganglioglioma ,I,Central review Heidelberg,16,male,"supratentorial, hemispheric, temporal;  left;",initial operation ,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",46%,Not applicable,DNA_FFPE,11月26日,8622007069
CONTR_REACT_14,6969568005_R03C01,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,16,male,"supratentorial, hemispheric; ",not available,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",48%,Not applicable,DNA_KRYO,11月23日,6969568005
CONTR_REACT_15,8622007119_R03C01,University Hospital of Muenster,Ganglioglioma ,I,Central review Heidelberg,24,male,"posterior fossa, ventricle IV; ",not available,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",43%,Not applicable,DNA_FFPE,1月16日,8622007119
CONTR_REACT_16,8622007119_R04C01,University Hospital of Muenster,Ganglioglioma ,I,Central review Heidelberg,25,female,"supratentorial, hemispheric, temporal; ",not available,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",43%,Not applicable,DNA_FFPE,1月16日,8622007119
CONTR_REACT_17,10006823123_R06C02,University Hospital of Heidelberg,"Diffuse astrocytoma, IDH-wildtype ",not available,Central review Heidelberg,27,female,"supratentorial, hemispheric, parietal;  right;",initial operation ,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",46%,Not applicable,DNA_FFPE,1月12日,10006823123
CONTR_REACT_18,3999112147_R03C02,University Hospital of Bonn,Ganglioglioma ,I,Central review Bonn ,not available ,male,not available,not available,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",42%,Not applicable,DNA_FFPE,4月6日,3999112147
CONTR_REACT_19,9533774047_R05C02,University Hospital of Heidelberg,"Medulloblastoma, NOS",IV,Central review Heidelberg,not available ,female,not available,not available,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",54%,Not applicable,DNA_KRYO,6月7日,9533774047
CONTR_REACT_20,9444375019_R01C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",45%,Not applicable,DNA_FFPE,1月31日,9444375019
CONTR_REACT_21,9340996032_R03C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",44%,Not applicable,DNA_FFPE,8月9日,9340996032
CONTR_REACT_22,9305651054_R04C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",45%,Not applicable,DNA_KRYO,7月19日,9305651054
CONTR_REACT_23,9007225026_R02C01,University Hospital of Muenster,Pilocytic astrocytoma  ,I,Local review,not available ,female,not available,not available,CONTR_REACT,"methylation class control tissue, reactive tumor microenvironment",45%,Not applicable,DNA_FFPE,2月20日,9007225026
CONTR_WM_01,3999834095_R04C01,University Hospital of Heidelberg,Normal corpus callosum,not available,Central review Heidelberg,40,male,"supratentorial, hemispheric, corpus callosum; ",not available,CONTR_WM,"methylation class control tissue, white matter",54%,Not applicable,DNA_FFPE,2月20日,3999834095
CONTR_WM_02,9420867097_R04C02,University Hospital of Heidelberg,Normal corpus callosum,not available,Central review Heidelberg,51,female,supratentorial; ,not available,CONTR_WM,"methylation class control tissue, white matter",49%,Not applicable,DNA_FFPE,1月17日,9420867097
CONTR_WM_03,9420867097_R03C02,University Hospital of Heidelberg,Normal corpus callosum,not available,Central review Heidelberg,52,male,supratentorial; ,not available,CONTR_WM,"methylation class control tissue, white matter",51%,Not applicable,DNA_FFPE,1月17日,9420867097
CONTR_WM_04,9420867097_R02C02,University Hospital of Heidelberg,Normal corpus callosum,not available,Central review Heidelberg,56,male,supratentorial; ,not available,CONTR_WM,"methylation class control tissue, white matter",51%,Not applicable,DNA_FFPE,1月17日,9420867097
CONTR_WM_05,9647455131_R06C01,University Hospital of Heidelberg,Normal corpus callosum,not available,Central review Heidelberg,61,male,supratentorial; ,not available,CONTR_WM,"methylation class control tissue, white matter",49%,Not applicable,DNA_FFPE,4月11日,9647455131
CONTR_WM_06,9741950023_R01C01,University Hospital of Heidelberg,Normal corpus callosum,not available,Central review Heidelberg,65,female,supratentorial; ,not available,CONTR_WM,"methylation class control tissue, white matter",51%,Not applicable,DNA_FFPE,3月24日,9741950023
CONTR_WM_07,3999834095_R06C02,University Hospital of Heidelberg,Normal corpus callosum,not available,Central review Heidelberg,69,male,"supratentorial, hemispheric, corpus callosum; ",not available,CONTR_WM,"methylation class control tissue, white matter",50%,Not applicable,DNA_FFPE,2月20日,3999834095
CONTR_WM_08,3998568167_R04C02,University Hospital of Heidelberg,Normal corpus callosum,not available,Central review Heidelberg,76,male,"supratentorial, hemispheric, corpus callosum; ",not available,CONTR_WM,"methylation class control tissue, white matter",52%,Not applicable,DNA_FFPE,9月11日,3998568167
CONTR_WM_09,9741950021_R06C02,University Hospital of Heidelberg,Normal corpus callosum,not available,Central review Heidelberg,76,male,supratentorial; ,not available,CONTR_WM,"methylation class control tissue, white matter",52%,Not applicable,DNA_FFPE,3月24日,9741950021
CPH_ADM_01,9407201033_R01C01,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,3,male,"supratentorial, sellar region, suprasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",64%,Not applicable,DNA_FFPE,10月25日,9407201033
CPH_ADM_02,9969477081_R03C02,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,7,male,"supratentorial, sellar region, suprasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",66%,Not applicable,DNA_KRYO,8月15日,9969477081
CPH_ADM_03,9969477081_R02C02,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,9,female,"supratentorial, sellar region, suprasellar, intrasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",62%,Not applicable,DNA_KRYO,8月15日,9969477081
CPH_ADM_04,9407201033_R02C01,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,9,female,"supratentorial, sellar region, suprasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",62%,Not applicable,DNA_FFPE,10月25日,9407201033
CPH_ADM_05,9407201033_R04C01,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,9,female,"supratentorial, sellar region, suprasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",61%,Not applicable,DNA_FFPE,10月25日,9407201033
CPH_ADM_06,9305651095_R06C02,University Hospital of Tuebingen,Adamantinomatous craniopharyngioma  ,I,Central review Heidelberg,9,female,"supratentorial, sellar region; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",64%,Not applicable,DNA_FFPE,7月30日,9305651095
CPH_ADM_07,9407201033_R06C01,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,11,male,"supratentorial, sellar region, suprasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",62%,Not applicable,DNA_FFPE,10月25日,9407201033
CPH_ADM_08,9969477081_R06C02,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,14,male,"supratentorial, sellar region, suprasellar, intrasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",65%,Not applicable,DNA_KRYO,8月15日,9969477081
CPH_ADM_09,9969477081_R01C02,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,15,male,"supratentorial, sellar region, suprasellar, intrasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",64%,Not applicable,DNA_KRYO,8月15日,9969477081
CPH_ADM_10,9407201033_R05C01,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,15,female,"supratentorial, sellar region, suprasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",65%,Not applicable,DNA_FFPE,10月25日,9407201033
CPH_ADM_11,9407201032_R06C02,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,16,female,"supratentorial, sellar region, suprasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",67%,Not applicable,DNA_FFPE,10月25日,9407201032
CPH_ADM_12,9969477081_R05C02,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,32,male,"supratentorial, sellar region, suprasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",60%,Not applicable,DNA_KRYO,8月15日,9969477081
CPH_ADM_13,9007225017_R03C02,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,37,male,"supratentorial, sellar region, suprasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",65%,Not applicable,DNA_FFPE,2月20日,9007225017
CPH_ADM_14,9007225017_R01C01,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,37,male,"supratentorial, sellar region, suprasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",63%,Not applicable,DNA_FFPE,2月20日,9007225017
CPH_ADM_15,9296930031_R05C02,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,38,female,"supratentorial, sellar region, suprasellar, intrasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",60%,Not applicable,DNA_FFPE,5月21日,9296930031
CPH_ADM_16,9007225026_R02C02,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,39,male,"supratentorial, sellar region, suprasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",65%,Not applicable,DNA_FFPE,2月20日,9007225026
CPH_ADM_17,9296930089_R06C02,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,45,male,"posterior fossa, cerebellum, hemispheric (cerebellum); ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",67%,Not applicable,DNA_FFPE,5月27日,9296930089
CPH_ADM_18,9296930094_R01C01,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,48,male,"supratentorial, sellar region, suprasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",59%,Not applicable,DNA_FFPE,5月27日,9296930094
CPH_ADM_19,9296930094_R06C02,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,50,female,"supratentorial, intraventricular, ventricle III, sellar region, suprasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",64%,Not applicable,DNA_FFPE,5月27日,9296930094
CPH_ADM_20,9969477083_R01C01,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,50,male,"supratentorial, sellar region, suprasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",64%,Not applicable,DNA_KRYO,8月15日,9969477083
CPH_ADM_21,9296930094_R02C02,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,51,male,"supratentorial, sellar region, suprasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",61%,Not applicable,DNA_FFPE,5月27日,9296930094
CPH_ADM_22,9741950007_R03C02,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,56,male,"supratentorial, sellar region, suprasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",64%,Not applicable,DNA_FFPE,3月24日,9741950007
CPH_ADM_23,9296930031_R06C02,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,58,male,"supratentorial, sellar region, suprasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",62%,Not applicable,DNA_FFPE,5月21日,9296930031
CPH_ADM_24,9296930094_R03C02,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,59,male,"supratentorial, sellar region, suprasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",60%,Not applicable,DNA_FFPE,5月27日,9296930094
CPH_ADM_25,9969477081_R04C01,University Hospital of Erlangen,Adamantinomatous craniopharyngioma  ,I,Local review,66,male,"supratentorial, sellar region, suprasellar, intrasellar; ",not available,CPH_ADM,"methylation class craniopharyngioma, adamantinomatous",70%,Not applicable,DNA_KRYO,8月15日,9969477081
CPH_PAP_01,9305216209_R01C02,University Hospital of Heidelberg,Papillary craniopharyngioma  ,I,Central review Heidelberg,23,female,"supratentorial, intraventricular, ventricle III; ",initial operation ,CPH_PAP,"methylation class craniopharyngioma, papillary",54%,Not applicable,DNA_FFPE,7月5日,9305216209
CPH_PAP_02,9878827225_R03C01,University Hospital of Heidelberg,Papillary craniopharyngioma  ,I,Central review Heidelberg,28,male,"supratentorial, sellar region, suprasellar, intrasellar; ",initial operation ,CPH_PAP,"methylation class craniopharyngioma, papillary",52%,Not applicable,DNA_FFPE,11月28日,9878827225
CPH_PAP_03,9007225017_R05C01,University Hospital of Erlangen,Papillary craniopharyngioma  ,I,Local review,34,male,"supratentorial, sellar region, suprasellar; ",not available,CPH_PAP,"methylation class craniopharyngioma, papillary",59%,Not applicable,DNA_FFPE,2月20日,9007225017
CPH_PAP_04,9407201033_R03C01,University Hospital of Erlangen,Papillary craniopharyngioma  ,I,Local review,36,male,"supratentorial, sellar region, suprasellar; ",not available,CPH_PAP,"methylation class craniopharyngioma, papillary",53%,Not applicable,DNA_FFPE,10月25日,9407201033
CPH_PAP_05,9969477081_R06C01,University Hospital of Erlangen,Papillary craniopharyngioma  ,I,Local review,38,male,"supratentorial, sellar region, suprasellar, intrasellar; ",not available,CPH_PAP,"methylation class craniopharyngioma, papillary",53%,Not applicable,DNA_KRYO,8月15日,9969477081
CPH_PAP_06,9007225026_R01C01,University Hospital of Erlangen,Papillary craniopharyngioma  ,I,Local review,39,male,"supratentorial, sellar region, suprasellar; ",not available,CPH_PAP,"methylation class craniopharyngioma, papillary",58%,Not applicable,DNA_FFPE,2月20日,9007225026
CPH_PAP_07,9969477081_R03C01,University Hospital of Erlangen,Papillary craniopharyngioma  ,I,Local review,40,male,"supratentorial, sellar region, suprasellar; ",not available,CPH_PAP,"methylation class craniopharyngioma, papillary",52%,Not applicable,DNA_KRYO,8月15日,9969477081
CPH_PAP_08,9305651037_R02C02,University Hospital of Heidelberg,Papillary craniopharyngioma  ,I,Central review Heidelberg,41,female,"supratentorial, sellar region, suprasellar; ",initial operation ,CPH_PAP,"methylation class craniopharyngioma, papillary",51%,Not applicable,DNA_FFPE,6月28日,9305651037
CPH_PAP_09,9407201033_R01C02,University Hospital of Erlangen,Papillary craniopharyngioma  ,I,Local review,42,male,"supratentorial, sellar region, suprasellar; ",not available,CPH_PAP,"methylation class craniopharyngioma, papillary",55%,Not applicable,DNA_FFPE,10月25日,9407201033
CPH_PAP_10,9969477081_R04C02,University Hospital of Erlangen,Papillary craniopharyngioma  ,I,Local review,45,male,"supratentorial, sellar region, suprasellar; ",not available,CPH_PAP,"methylation class craniopharyngioma, papillary",53%,Not applicable,DNA_KRYO,8月15日,9969477081
CPH_PAP_11,9741950007_R02C02,University Hospital of Erlangen,Papillary craniopharyngioma  ,I,Local review,48,female,"supratentorial, sellar region; ",not available,CPH_PAP,"methylation class craniopharyngioma, papillary",54%,Not applicable,DNA_FFPE,3月24日,9741950007
CPH_PAP_12,9376538149_R01C01,University Hospital of Erlangen,Papillary craniopharyngioma  ,I,Local review,48,female,"supratentorial, sellar region, suprasellar; ",not available,CPH_PAP,"methylation class craniopharyngioma, papillary",53%,Not applicable,DNA_FFPE,10月25日,9376538149
CPH_PAP_13,9296930094_R05C02,University Hospital of Erlangen,Papillary craniopharyngioma  ,I,Local review,49,female,"supratentorial, sellar region, suprasellar; ",not available,CPH_PAP,"methylation class craniopharyngioma, papillary",59%,Not applicable,DNA_FFPE,5月27日,9296930094
CPH_PAP_14,9305216208_R06C02,University Hospital of Heidelberg,Papillary craniopharyngioma  ,I,Central review Heidelberg,50,female,"supratentorial, sellar region, suprasellar; ",initial operation ,CPH_PAP,"methylation class craniopharyngioma, papillary",51%,Not applicable,DNA_FFPE,7月5日,9305216208
CPH_PAP_15,9305216209_R04C01,University Hospital of Heidelberg,Papillary craniopharyngioma  ,I,Central review Heidelberg,50,male,"supratentorial, intraventricular, ventricle III; ",initial operation ,CPH_PAP,"methylation class craniopharyngioma, papillary",54%,Not applicable,DNA_FFPE,7月5日,9305216209
CPH_PAP_16,9305651037_R04C02,University Hospital of Heidelberg,Papillary craniopharyngioma  ,I,Central review Heidelberg,51,female,"supratentorial, sellar region, suprasellar; ",initial operation ,CPH_PAP,"methylation class craniopharyngioma, papillary",49%,Not applicable,DNA_FFPE,6月28日,9305651037
CPH_PAP_17,9305651037_R06C01,University Hospital of Heidelberg,Papillary craniopharyngioma  ,I,Central review Heidelberg,53,female,"supratentorial, sellar region, suprasellar, intrasellar; ",recurrence ,CPH_PAP,"methylation class craniopharyngioma, papillary",54%,Not applicable,DNA_FFPE,6月28日,9305651037
CPH_PAP_18,9296930094_R04C02,University Hospital of Erlangen,Papillary craniopharyngioma  ,I,Local review,58,male,"supratentorial, sellar region, suprasellar; ",not available,CPH_PAP,"methylation class craniopharyngioma, papillary",53%,Not applicable,DNA_FFPE,5月27日,9296930094
CPH_PAP_19,9878827239_R04C02,University Hospital of Heidelberg,Papillary craniopharyngioma  ,I,Central review Heidelberg,58,male,"supratentorial, intraventricular, ventricle III, sellar region, suprasellar; ",initial operation ,CPH_PAP,"methylation class craniopharyngioma, papillary",56%,Not applicable,DNA_FFPE,12月5日,9878827239
CPH_PAP_20,9305216209_R01C01,University Hospital of Heidelberg,Papillary craniopharyngioma  ,I,Central review Heidelberg,69,female,"supratentorial, sellar region, suprasellar; ",initial operation ,CPH_PAP,"methylation class craniopharyngioma, papillary",55%,Not applicable,DNA_FFPE,7月5日,9305216209
DLGNT_01,3998909070_R04C01,University Hospital of Hannover,Diffuse leptomeningeal glioneuronal tumour  ,not available,Central review Heidelberg,5,male,spinal; ,not available,DLGNT,methylation class diffuse leptomeningeal glioneuronal tumor,61%,Not applicable,DNA_FFPE,5月22日,3998909070
DLGNT_02,3998909071_R02C01,University Hospital of Heidelberg,Diffuse leptomeningeal glioneuronal tumour  ,not available,Central review Heidelberg,5,female,spinal; ,recurrence ,DLGNT,methylation class diffuse leptomeningeal glioneuronal tumor,59%,Not applicable,DNA_FFPE,5月22日,3998909071
DLGNT_03,3999543047_R01C01,"La Sapienza Hospital, Rome ",Diffuse leptomeningeal glioneuronal tumour  ,not available,Central review Heidelberg,9,female,"spinal, intramedullary; ",initial operation ,DLGNT,methylation class diffuse leptomeningeal glioneuronal tumor,51%,Not applicable,DNA_FFPE,4月10日,3999543047
DLGNT_04,3998909182_R02C02,University Hospital of Tuebingen,Diffuse leptomeningeal glioneuronal tumour  ,not available,Central review Heidelberg,12,female,"spinal, intramedullary, cervical; ",initial operation ,DLGNT,methylation class diffuse leptomeningeal glioneuronal tumor,63%,Not applicable,DNA_FFPE,5月29日,3998909182
DLGNT_05,3998909182_R06C01,University Hospital of Tuebingen,Diffuse leptomeningeal glioneuronal tumour  ,not available,Central review Heidelberg,14,female,"spinal, intramedullary, meningeal (spinal), thoracic; ",initial operation ,DLGNT,methylation class diffuse leptomeningeal glioneuronal tumor,61%,Not applicable,DNA_FFPE,5月29日,3998909182
DLGNT_06,3999095104_R05C01,University Hospital of Heidelberg,Diffuse leptomeningeal glioneuronal tumour  ,not available,Central review Heidelberg,16,male,"supratentorial, hemispheric, temporal, meningeal (supratentorial);  left;",recurrence ,DLGNT,methylation class diffuse leptomeningeal glioneuronal tumor,57%,Not applicable,DNA_FFPE,7月17日,3999095104
DLGNT_07,9373550164_R06C01,University Hospital of Muenster,Diffuse leptomeningeal glioneuronal tumour  ,not available,Central review Heidelberg,26,female,"supratentorial, diencephalic, pineal region; ",not available,DLGNT,methylation class diffuse leptomeningeal glioneuronal tumor,58%,Not applicable,DNA_FFPE,8月21日,9373550164
DLGNT_08,9969477022_R03C02,University Hospital of Heidelberg,Diffuse leptomeningeal glioneuronal tumour  ,not available,Central review Heidelberg,39,male,"supratentorial, sellar region, suprasellar; ",initial operation ,DLGNT,methylation class diffuse leptomeningeal glioneuronal tumor,63%,Not applicable,DNA_FFPE,7月25日,9969477022
DMG_K27_01,10006823165_R02C01,INFORM (INdividualized Therapy FOr Relapsed Malignancies in Childhood) Registry,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,1,female,"posterior fossa, brain stem, pons; ",initial operation ,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,61%,LGm6,DNA_KRYO,1月16日,10006823165
DMG_K27_02,9829119122_R06C01,"MD Anderson Cancer Center, Houston","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,3,female,"posterior fossa, brain stem, pons; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,67%,LGm6,DNA_FFPE,5月23日,9829119122
DMG_K27_03,9829119122_R05C01,"MD Anderson Cancer Center, Houston","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,4,female,"posterior fossa, brain stem, pons; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,67%,LGm6,DNA_FFPE,5月23日,9829119122
DMG_K27_04,9741950109_R04C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,4,male,"supratentorial, diencephalic, thalamic; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,64%,LGm6,DNA_FFPE,4月7日,9741950109
DMG_K27_05,3999078088_R06C02,INFORM (INdividualized Therapy FOr Relapsed Malignancies in Childhood) Registry,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,5,female,posterior fossa; ,initial operation ,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,67%,LGm6,DNA_KRYO,7月3日,3999078088
DMG_K27_06,9741950102_R02C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,5,male,"spinal, cervical, C7, thoracic, T1, T2, T3; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,66%,LGm6,DNA_FFPE,4月7日,9741950102
DMG_K27_07,9721366150_R06C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,6,female,"supratentorial, diencephalic, thalamic; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,73%,LGm6,DNA_FFPE,5月9日,9721366150
DMG_K27_08,9741950102_R05C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,6,female,"posterior fossa, brain stem, medulla oblongata (craniocervical); ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,71%,LGm6,DNA_FFPE,4月7日,9741950102
DMG_K27_09,9283265032_R05C01,International Cancer Genome Consortium ,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,7,female,posterior fossa; ,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,74%,LGm6,DNA_KRYO,4月29日,9283265032
DMG_K27_10,9741950099_R05C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,7,male,"supratentorial, diencephalic, thalamic, intraventricular, ventricle II; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,73%,LGm6,DNA_FFPE,4月7日,9741950099
DMG_K27_11,9741950102_R02C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,7,male,"spinal, thoracic, T4, T5, T6, T7, T8, T9, T10; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,66%,LGm6,DNA_FFPE,4月7日,9741950102
DMG_K27_12,9533774033_R01C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,7,male,"supratentorial, diencephalic, thalamic; ",initial operation ,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,68%,LGm5,DNA_FFPE,6月7日,9533774033
DMG_K27_13,9420867122_R02C02,University Hospital of Heidelberg,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,8,female,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,64%,LGm6,DNA_FFPE,1月17日,9420867122
DMG_K27_14,9741950109_R01C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,8,female,"posterior fossa, brain stem, pons; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,69%,LGm6,DNA_FFPE,4月7日,9741950109
DMG_K27_15,9741950109_R02C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,8,female,"supratentorial, diencephalic, thalamic; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,69%,LGm6,DNA_FFPE,4月7日,9741950109
DMG_K27_16,9513149129_R06C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,8,male,"supratentorial, diencephalic, thalamic, intraventricular, ventricle II; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,74%,LGm6,DNA_FFPE,4月14日,9513149129
DMG_K27_17,9533774041_R06C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,8,female,"posterior fossa, brain stem; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,68%,LGm6,DNA_FFPE,6月7日,9533774041
DMG_K27_18,9741950099_R01C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,8,female,"supratentorial, hemispheric, occipital; posterior fossa, brain stem; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,62%,LGm6,DNA_FFPE,4月7日,9741950099
DMG_K27_19,10006823165_R04C01,INFORM (INdividualized Therapy FOr Relapsed Malignancies in Childhood) Registry,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,9,male,"posterior fossa, brain stem, pons; ",recurrence ,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,64%,LGm6,DNA_KRYO,1月16日,10006823165
DMG_K27_20,9533774024_R06C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,9,male,"spinal, intramedullary; ",initial operation ,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,68%,LGm6,DNA_FFPE,6月7日,9533774024
DMG_K27_21,9533774018_R05C02,University Hospital of Heidelberg,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,11,female,posterior fossa; ,initial operation ,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,78%,LGm6,DNA_FFPE,5月30日,9533774018
DMG_K27_22,9741950109_R04C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,11,male,"posterior fossa, brain stem; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,66%,LGm6,DNA_FFPE,4月7日,9741950109
DMG_K27_23,9741950030_R04C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,12,male,"supratentorial, diencephalic, thalamic; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,74%,LGm6,DNA_FFPE,3月28日,9741950030
DMG_K27_24,9721365197_R02C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,12,male,"supratentorial, diencephalic, thalamic; ",recurrence ,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,66%,LGm6,DNA_FFPE,4月14日,9721365197
DMG_K27_25,9283265032_R03C01,International Cancer Genome Consortium ,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,13,male,"spinal, thoracic, T7; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,69%,LGm6,DNA_KRYO,4月29日,9283265032
DMG_K27_26,9741950109_R01C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,13,female,"supratentorial, diencephalic, thalamic; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,65%,LGm1,DNA_FFPE,4月7日,9741950109
DMG_K27_27,9741950109_R06C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,13,male,"supratentorial, diencephalic, thalamic, intraventricular, ventricle II; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,70%,LGm6,DNA_FFPE,4月7日,9741950109
DMG_K27_28,9533774046_R04C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,13,male,"supratentorial, diencephalic, thalamic; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,68%,LGm6,DNA_FFPE,6月7日,9533774046
DMG_K27_29,9741950099_R05C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,13,female,"supratentorial, diencephalic, thalamic; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,65%,LGm6,DNA_FFPE,4月7日,9741950099
DMG_K27_30,9741950102_R01C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,13,female,"posterior fossa, brain stem, pons; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,74%,LGm6,DNA_FFPE,4月7日,9741950102
DMG_K27_31,9968646118_R02C01,University Hospital of Frankfurt am Main,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,14,male,"posterior fossa, brain stem, pons; ",initial operation ,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,73%,LGm6,DNA_FFPE,7月8日,9968646118
DMG_K27_32,9553932008_R02C02,University Hospital of Heidelberg,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,15,male,"supratentorial, diencephalic, basal ganglia;  left;",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,65%,LGm6,DNA_FFPE,2月14日,9553932008
DMG_K27_33,9007225163_R02C02,University Hospital of Heidelberg,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,15,male,"supratentorial, hemispheric, intraventricular, ventricle II;  left;",initial operation ,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,66%,LGm6,DNA_FFPE,4月19日,9007225163
DMG_K27_34,9533774041_R04C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,15,female,"spinal, intramedullary, thoracic, T6, T7, T8, T9; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,73%,LGm6,DNA_FFPE,6月7日,9533774041
DMG_K27_35,9741950021_R02C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,15,female,"supratentorial, diencephalic, thalamic; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,64%,LGm6,DNA_FFPE,3月24日,9741950021
DMG_K27_36,9283265032_R04C01,International Cancer Genome Consortium ,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,16,female,posterior fossa; ,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,71%,LGm6,DNA_KRYO,4月29日,9283265032
DMG_K27_37,9741950109_R03C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,16,male,"posterior fossa, brain stem; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,68%,LGm1,DNA_FFPE,4月7日,9741950109
DMG_K27_38,9533774046_R06C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,17,male,"supratentorial, diencephalic, thalamic; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,64%,LGm6,DNA_FFPE,6月7日,9533774046
DMG_K27_39,9741950102_R05C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,17,female,"supratentorial, diencephalic, thalamic; posterior fossa, brain stem; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,66%,LGm6,DNA_FFPE,4月7日,9741950102
DMG_K27_40,9741950021_R03C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,17,female,"supratentorial, diencephalic, thalamic; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,69%,LGm1,DNA_FFPE,3月24日,9741950021
DMG_K27_41,9297949046_R03C01,University Hospital of Heidelberg,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,19,female,"supratentorial, diencephalic, thalamic; ",initial operation ,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,74%,LGm6,DNA_FFPE,6月7日,9297949046
DMG_K27_42,10006823165_R01C01,INFORM (INdividualized Therapy FOr Relapsed Malignancies in Childhood) Registry,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,20,female,"posterior fossa, brain stem; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,65%,LGm6,DNA_KRYO,1月16日,10006823165
DMG_K27_43,8622007074_R03C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,20,female,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,73%,LGm6,DNA_KRYO,12月6日,8622007074
DMG_K27_44,9376561042_R04C01,University Hospital of Heidelberg,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,21,female,"supratentorial, diencephalic, thalamic;  right;",initial operation ,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,69%,LGm6,DNA_FFPE,11月8日,9376561042
DMG_K27_45,9444374134_R03C01,University Hospital of Tuebingen,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,21,male,"supratentorial; posterior fossa, brain stem; ",initial operation ,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,76%,LGm5,DNA_FFPE,1月27日,9444374134
DMG_K27_46,9340996003_R03C01,University Hospital of Heidelberg,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,28,male,"supratentorial, intraventricular; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,65%,LGm6,DNA_FFPE,8月6日,9340996003
DMG_K27_47,9370847051_R03C02,University Hospital of Heidelberg,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,51,male,"posterior fossa, brain stem, medulla oblongata (craniocervical); ",initial operation ,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,66%,LGm1,DNA_FFPE,9月19日,9370847051
DMG_K27_48,9969477014_R01C01,University Hospital of Heidelberg,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,51,female,"spinal, intramedullary, thoracic, T1, T2, T3, T4; ",initial operation ,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,66%,LGm6,DNA_FFPE,7月18日,9969477014
DMG_K27_49,9373550164_R04C02,University Hospital of Heidelberg,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,54,female,"supratentorial, hemispheric, parietal, occipital; ",not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,71%,LGm5,DNA_FFPE,8月21日,9373550164
DMG_K27_50,6164621155_R03C01,University Hospital of Cambridge,"Diffuse midline glioma, H3 K27M-mutant",IV,Local review,not available ,male,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,67%,LGm6,DNA_KRYO,9月29日,6164621155
DMG_K27_51,5684819026_R02C01,University Hospital of Heidelberg,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,female,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,67%,LGm1,DNA_KRYO,6月10日,5684819026
DMG_K27_52,6969568103_R03C01,University Hospital of Heidelberg,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,female,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,70%,LGm6,DNA_KRYO,4月27日,6969568103
DMG_K27_53,6969568103_R01C01,University Hospital of Heidelberg,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,female,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,80%,LGm6,DNA_KRYO,4月27日,6969568103
DMG_K27_54,6969568103_R02C01,University Hospital of Heidelberg,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,female,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,67%,LGm6,DNA_KRYO,4月27日,6969568103
DMG_K27_55,6969568103_R04C01,University Hospital of Heidelberg,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,male,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,79%,LGm6,DNA_KRYO,4月27日,6969568103
DMG_K27_56,8622007059_R03C02,International Cancer Genome Consortium ,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,male,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,71%,LGm6,DNA_KRYO,11月12日,8622007059
DMG_K27_57,9878820117_R03C02,International Cancer Genome Consortium ,"Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,male,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,76%,LGm6,DNA_KRYO,10月27日,9878820117
DMG_K27_58,5684819014_R03C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,female,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,78%,LGm6,DNA_KRYO,6月10日,5684819014
DMG_K27_59,5684819013_R04C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,female,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,61%,LGm6,DNA_KRYO,6月10日,5684819013
DMG_K27_60,5684819013_R05C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,male,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,76%,LGm6,DNA_KRYO,6月10日,5684819013
DMG_K27_61,5684819013_R03C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,female,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,68%,LGm6,DNA_KRYO,6月10日,5684819013
DMG_K27_62,5684819014_R02C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,female,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,68%,LGm6,DNA_KRYO,6月10日,5684819014
DMG_K27_63,5911815001_R03C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,female,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,80%,LGm6,DNA_KRYO,6月10日,5911815001
DMG_K27_64,5684819014_R05C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,male,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,70%,LGm6,DNA_KRYO,6月10日,5684819014
DMG_K27_65,5684819014_R06C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,male,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,73%,LGm6,DNA_KRYO,6月10日,5684819014
DMG_K27_66,6164621081_R06C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,female,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,65%,LGm1,DNA_KRYO,9月29日,6164621081
DMG_K27_67,9444375014_R05C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,female,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,61%,LGm6,DNA_FFPE,1月31日,9444375014
DMG_K27_68,9444375014_R01C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,male,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,69%,LGm1,DNA_FFPE,1月31日,9444375014
DMG_K27_69,9444375014_R02C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,male,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,67%,LGm6,DNA_FFPE,1月31日,9444375014
DMG_K27_70,9444375014_R04C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,female,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,66%,LGm6,DNA_FFPE,1月31日,9444375014
DMG_K27_71,9444375017_R05C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,female,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,71%,LGm6,DNA_FFPE,1月31日,9444375017
DMG_K27_72,9444375017_R01C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,female,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,64%,LGm6,DNA_FFPE,1月31日,9444375017
DMG_K27_73,9444375017_R05C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,male,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,61%,LGm6,DNA_FFPE,1月31日,9444375017
DMG_K27_74,9444375018_R05C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,female,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,67%,LGm6,DNA_FFPE,1月31日,9444375018
DMG_K27_75,9444375018_R02C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,female,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,72%,LGm6,DNA_FFPE,1月31日,9444375018
DMG_K27_76,9444375018_R06C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,female,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,65%,LGm6,DNA_FFPE,1月31日,9444375018
DMG_K27_77,9444375018_R04C01,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,female,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,73%,LGm6,DNA_FFPE,1月31日,9444375018
DMG_K27_78,5911815001_R03C02,"Burdenko Neurosurgery Institute, Moscow","Diffuse midline glioma, H3 K27M-mutant",IV,Central review Heidelberg,not available ,male,not available,not available,DMG_K27,methylation class diffuse midline glioma H3 K27M mutant,66%,LGm6,DNA_KRYO,6月10日,5911815001
EFT_CIC_01,9007225035_R04C02,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,0,female,"supratentorial, hemispheric, frontal; ",not available,EFT_CIC,methylation class CNS Ewing sarcoma family tumor with CIC alteration,59%,Not applicable,DNA_KRYO,2月19日,9007225035
EFT_CIC_02,9969477089_R06C02,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,1,female,not available,not available,EFT_CIC,methylation class CNS Ewing sarcoma family tumor with CIC alteration,60%,Not applicable,DNA_FFPE,8月22日,9969477089
EFT_CIC_03,9741950039_R04C01,"St. Jude Childrens Research Hospital, Memphis","CNS embryonal tumour, NOS           ",IV,Local review,1,male,"supratentorial, hemispheric, parietal; ",not available,EFT_CIC,methylation class CNS Ewing sarcoma family tumor with CIC alteration,57%,Not applicable,DNA_FFPE,5月15日,9741950039
EFT_CIC_04,6929718001_R01C02,University Hospital of Cambridge,"CNS embryonal tumour, NOS           ",IV,Local review,3,female,"supratentorial, hemispheric, temporal, parietal; ",not available,EFT_CIC,methylation class CNS Ewing sarcoma family tumor with CIC alteration,73%,Not applicable,DNA_KRYO,12月23日,6929718001
EFT_CIC_05,8622007027_R02C01,"Burdenko Neurosurgery Institute, Moscow","CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,3,female,supratentorial; ,not available,EFT_CIC,methylation class CNS Ewing sarcoma family tumor with CIC alteration,70%,Not applicable,DNA_KRYO,10月23日,8622007027
EFT_CIC_06,9007225026_R04C01,Amsterdam Academic Medical Center,"CNS embryonal tumour, NOS           ",IV,Local review,11,male,"supratentorial, hemispheric, temporal, parietal; ",not available,EFT_CIC,methylation class CNS Ewing sarcoma family tumor with CIC alteration,66%,Not applicable,DNA_FFPE,2月20日,9007225026
EFT_CIC_07,6969568075_R05C01,"McGill Children's Hospital, Montreal","CNS embryonal tumour, NOS           ",IV,Local review,11,male,"supratentorial, hemispheric, temporal, parietal; ",not available,EFT_CIC,methylation class CNS Ewing sarcoma family tumor with CIC alteration,70%,Not applicable,DNA_KRYO,4月14日,6969568075
EFT_CIC_08,9855358003_R02C02,University Hospital of Heidelberg,"Gliosarcoma, IDH-wildtype ",IV,Central review Heidelberg,42,male,"spinal, cervical, C4, C5; ",initial operation ,EFT_CIC,methylation class CNS Ewing sarcoma family tumor with CIC alteration,71%,Not applicable,DNA_FFPE,9月12日,9855358003
EFT_CIC_09,9969477122_R01C02,University Hospital of Duesseldorf ,"Gliosarcoma, IDH-wildtype ",IV,Central review Heidelberg,71,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,EFT_CIC,methylation class CNS Ewing sarcoma family tumor with CIC alteration,67%,Not applicable,DNA_FFPE,9月6日,9969477122
EFT_CIC_10,9829119256_R01C02,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,not available ,female,not available,not available,EFT_CIC,methylation class CNS Ewing sarcoma family tumor with CIC alteration,65%,Not applicable,DNA_KRYO,5月30日,9829119256
EFT_CIC_11,7497398017_R06C02,"Hospital for Sick Children, Toronto  ","CNS embryonal tumour, NOS           ",IV,Local review,not available ,male,not available,not available,EFT_CIC,methylation class CNS Ewing sarcoma family tumor with CIC alteration,52%,Not applicable,DNA_KRYO,1月28日,7497398017
EFT_CIC_12,8622007149_R02C02,"Hospital for Sick Children, Toronto  ","CNS embryonal tumour, NOS           ",IV,Local review,not available ,female,not available,not available,EFT_CIC,methylation class CNS Ewing sarcoma family tumor with CIC alteration,67%,Not applicable,DNA_KRYO,1月16日,8622007149
EFT_CIC_13,7497398022_R05C02,"Hospital for Sick Children, Toronto  ","CNS embryonal tumour, NOS           ",IV,Local review,not available ,male,not available,not available,EFT_CIC,methylation class CNS Ewing sarcoma family tumor with CIC alteration,64%,Not applicable,DNA_KRYO,1月28日,7497398022
ENB_A_01,200091640050_R05C02,University College London Hospitals,Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,20,male,not available,initial operation ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",70%,Not applicable,DNA_FFPE,10月30日,2.00092E+11
ENB_A_02,9878827235_R06C01,"Ludwig-Maximilians University Hospital, Munich ",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,34,female,"mesenchyme, cranium, frontobasal, nasal cavity; ",initial operation ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",68%,Not applicable,DNA_FFPE,12月5日,9878827235
ENB_A_03,200091640051_R06C01,University College London Hospitals,Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,37,male,not available,initial operation ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",69%,Not applicable,DNA_FFPE,10月30日,2.00092E+11
ENB_A_04,9878827221_R02C02,"Ludwig-Maximilians University Hospital, Munich ",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,39,female,"mesenchyme, cranium, nasal cavity;  left;",initial operation ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",64%,Not applicable,DNA_FFPE,11月28日,9878827221
ENB_A_05,9741950120_R02C02,"MD Anderson Cancer Center, Houston",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,43,not available,"mesenchyme, cranium, frontobasal; ",recurrence ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",67%,Not applicable,DNA_FFPE,5月16日,9741950120
ENB_A_06,9444375028_R05C01,"Ludwig-Maximilians University Hospital, Munich ",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,44,male,"peripheral nerve; mesenchyme, cranium, nasal cavity; ",initial operation ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",57%,Not applicable,DNA_FFPE,1月31日,9444375028
ENB_A_07,9878827235_R03C02,"Ludwig-Maximilians University Hospital, Munich ",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,45,female,"mesenchyme, cranium, frontobasal, nasal cavity; ",initial operation ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",63%,Not applicable,DNA_FFPE,12月5日,9878827235
ENB_A_08,9741950120_R02C01,"MD Anderson Cancer Center, Houston",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,51,male,"peripheral nerve; mesenchyme, cranium, frontobasal; ",initial operation ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",68%,Not applicable,DNA_FFPE,5月16日,9741950120
ENB_A_09,9007225064_R02C02,University Hospital of Heidelberg,Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,59,female,"supratentorial, hemispheric, frontal; ",recurrence ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",67%,Not applicable,DNA_FFPE,2月25日,9007225064
ENB_A_10,9444375028_R04C02,"Ludwig-Maximilians University Hospital, Munich ",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,59,male,"mesenchyme, cranium, nasal cavity;  left;",initial operation ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",66%,Not applicable,DNA_FFPE,1月31日,9444375028
ENB_A_11,9741950120_R04C02,"MD Anderson Cancer Center, Houston",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,62,not available,"supratentorial, meningeal (supratentorial), frontal; peripheral nerve; mesenchyme, cranium, frontobasal, nasal cavity; ",initial operation ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",64%,Not applicable,DNA_FFPE,5月16日,9741950120
ENB_A_12,9721366135_R03C02,"MD Anderson Cancer Center, Houston",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,63,male,"supratentorial, hemispheric, frontal;  left;",initial operation ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",69%,Not applicable,DNA_FFPE,5月9日,9721366135
ENB_A_13,9878827235_R05C01,"Ludwig-Maximilians University Hospital, Munich ",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,64,male,"mesenchyme, cranium, nasal cavity;  right;",recurrence ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",63%,Not applicable,DNA_FFPE,12月5日,9878827235
ENB_A_14,200091640051_R03C02,University College London Hospitals,Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,65,not available,not available,initial operation ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",64%,Not applicable,DNA_FFPE,10月30日,2.00092E+11
ENB_A_15,200091640051_R03C01,University College London Hospitals,Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,66,female,not available,initial operation ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",68%,Not applicable,DNA_FFPE,10月30日,2.00092E+11
ENB_A_16,9878827221_R05C01,"Ludwig-Maximilians University Hospital, Munich ",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,66,male,"mesenchyme, cranium, frontobasal, nasal cavity;  left;",initial operation ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",66%,Not applicable,DNA_FFPE,11月28日,9878827221
ENB_A_17,9741950111_R05C02,"MD Anderson Cancer Center, Houston",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,68,male,"mesenchyme, cranium, frontobasal; ",initial operation ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",64%,Not applicable,DNA_FFPE,5月16日,9741950111
ENB_A_18,200091640051_R01C01,University College London Hospitals,Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,70,not available,not available,initial operation ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",65%,Not applicable,DNA_FFPE,10月30日,2.00092E+11
ENB_A_19,200091640051_R04C02,University College London Hospitals,Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,73,male,not available,initial operation ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",66%,Not applicable,DNA_FFPE,10月30日,2.00092E+11
ENB_A_20,9422491056_R04C01,"Ludwig-Maximilians University Hospital, Munich ",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,73,female,"supratentorial, hemispheric, frontal; mesenchyme, cranium, nasal cavity; ",initial operation ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",66%,Not applicable,DNA_FFPE,11月18日,9422491056
ENB_A_21,200091640051_R01C02,University College London Hospitals,Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,74,male,not available,initial operation ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",67%,Not applicable,DNA_FFPE,10月30日,2.00092E+11
ENB_A_22,9422491056_R01C02,"Ludwig-Maximilians University Hospital, Munich ",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,76,female,"mesenchyme, cranium, frontobasal, nasal cavity; ",recurrence ,ENB_A,"methylation class esthesioneuroblastoma, subclass A",68%,Not applicable,DNA_FFPE,11月18日,9422491056
ENB_A_23,9297949139_R06C01,University Hospital of Muenster,Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,81,female,not available,not available,ENB_A,"methylation class esthesioneuroblastoma, subclass A",59%,Not applicable,DNA_FFPE,6月21日,9297949139
ENB_B_01,9878827221_R01C02,"Ludwig-Maximilians University Hospital, Munich ",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,32,male,"supratentorial; mesenchyme, cranium, frontobasal; ",initial operation ,ENB_B,"methylation class esthesioneuroblastoma, subclass B",66%,Not applicable,DNA_FFPE,11月28日,9878827221
ENB_B_02,9422491056_R05C01,"Ludwig-Maximilians University Hospital, Munich ",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,39,female,"supratentorial, hemispheric, frontal; peripheral nerve; mesenchyme, cranium, frontobasal, nasal cavity; ",initial operation ,ENB_B,"methylation class esthesioneuroblastoma, subclass B",63%,Not applicable,DNA_FFPE,11月18日,9422491056
ENB_B_03,9533774041_R01C02,"MD Anderson Cancer Center, Houston",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,42,not available,"mesenchyme, cranium, nasal cavity; ",initial operation ,ENB_B,"methylation class esthesioneuroblastoma, subclass B",69%,Not applicable,DNA_FFPE,6月7日,9533774041
ENB_B_04,9422491056_R05C02,"Ludwig-Maximilians University Hospital, Munich ",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,42,female,"mesenchyme, cranium, nasal cavity; ",initial operation ,ENB_B,"methylation class esthesioneuroblastoma, subclass B",57%,Not applicable,DNA_FFPE,11月18日,9422491056
ENB_B_05,9741950120_R01C02,"MD Anderson Cancer Center, Houston",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,44,female,"mesenchyme, cranium, frontobasal, nasal cavity; ",initial operation ,ENB_B,"methylation class esthesioneuroblastoma, subclass B",64%,Not applicable,DNA_FFPE,5月16日,9741950120
ENB_B_06,9878827235_R04C01,"Ludwig-Maximilians University Hospital, Munich ",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,45,male,"mesenchyme, cranium, frontobasal, nasal cavity; ",initial operation ,ENB_B,"methylation class esthesioneuroblastoma, subclass B",68%,Not applicable,DNA_FFPE,12月5日,9878827235
ENB_B_07,9741950120_R06C01,"MD Anderson Cancer Center, Houston",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,47,not available,"mesenchyme, cranium, frontobasal, nasal cavity; ",initial operation ,ENB_B,"methylation class esthesioneuroblastoma, subclass B",67%,Not applicable,DNA_FFPE,5月16日,9741950120
ENB_B_08,9741950120_R05C02,"MD Anderson Cancer Center, Houston",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,55,female,"supratentorial, meningeal (supratentorial), frontal; peripheral nerve;  left;",recurrence ,ENB_B,"methylation class esthesioneuroblastoma, subclass B",65%,Not applicable,DNA_FFPE,5月16日,9741950120
ENB_B_09,9878827235_R01C02,"Ludwig-Maximilians University Hospital, Munich ",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,56,female,"mesenchyme, cranium, frontobasal, nasal cavity; ",initial operation ,ENB_B,"methylation class esthesioneuroblastoma, subclass B",63%,Not applicable,DNA_FFPE,12月5日,9878827235
ENB_B_10,9422491056_R03C02,"Ludwig-Maximilians University Hospital, Munich ",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,58,male,not available,metastasis,ENB_B,"methylation class esthesioneuroblastoma, subclass B",64%,Not applicable,DNA_FFPE,11月18日,9422491056
ENB_B_11,9721366150_R01C02,University Hospital of Heidelberg,Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,62,female,not available,metastasis,ENB_B,"methylation class esthesioneuroblastoma, subclass B",66%,Not applicable,DNA_FFPE,5月9日,9721366150
ENB_B_12,9741950120_R04C01,"MD Anderson Cancer Center, Houston",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,70,male,"mesenchyme, cranium, frontobasal; ",initial operation ,ENB_B,"methylation class esthesioneuroblastoma, subclass B",65%,Not applicable,DNA_FFPE,5月16日,9741950120
ENB_B_13,9741950120_R03C02,"MD Anderson Cancer Center, Houston",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,70,male,"mesenchyme, cranium, nasal cavity; ",initial operation ,ENB_B,"methylation class esthesioneuroblastoma, subclass B",63%,Not applicable,DNA_FFPE,5月16日,9741950120
ENB_B_14,9297949139_R04C01,University Hospital of Muenster,Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,77,not available,not available,not available,ENB_B,"methylation class esthesioneuroblastoma, subclass B",68%,Not applicable,DNA_FFPE,6月21日,9297949139
ENB_B_15,9406921148_R04C02,"Ludwig-Maximilians University Hospital, Munich ",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,78,not available,"mesenchyme, cranium, frontobasal; ",recurrence ,ENB_B,"methylation class esthesioneuroblastoma, subclass B",67%,Not applicable,DNA_FFPE,11月18日,9406921148
ENB_B_16,9878827235_R02C01,"Ludwig-Maximilians University Hospital, Munich ",Esthesioneuroblastoma/Olfactory neuroblastoma,not available,Central review Heidelberg,82,male,"mesenchyme, cranium, frontobasal, nasal cavity; ",initial operation ,ENB_B,"methylation class esthesioneuroblastoma, subclass B",69%,Not applicable,DNA_FFPE,12月5日,9878827235
EPN_MPE_01,9741950111_R06C01,University Hospital of Muenster,Ependymoma  ,II,Central review Heidelberg,16,female,"spinal, intramedullary; ",initial operation ,EPN_MPE,"methylation class ependymoma, myxopapillary",65%,Not applicable,DNA_FFPE,5月16日,9741950111
EPN_MPE_02,8622007068_R02C01,University Hospital of Heidelberg,Myxopapillary ependymoma  ,I,Central review Heidelberg,18,male,"spinal, lumbar, L3, L4, L5, sacral, S1; ",initial operation ,EPN_MPE,"methylation class ependymoma, myxopapillary",61%,Not applicable,DNA_FFPE,11月26日,8622007068
EPN_MPE_03,9305216209_R05C01,University Hospital of Heidelberg,Myxopapillary ependymoma  ,I,Central review Heidelberg,19,female,"spinal, extramedullary intradural, lumbar, L5, sacral, S1; ",initial operation ,EPN_MPE,"methylation class ependymoma, myxopapillary",61%,Not applicable,DNA_FFPE,7月5日,9305216209
EPN_MPE_04,3999834003_R03C02,University Hospital of Frankfurt am Main,Myxopapillary ependymoma  ,I,Central review Heidelberg,23,female,"supratentorial, sellar region; ",metastasis,EPN_MPE,"methylation class ependymoma, myxopapillary",61%,Not applicable,DNA_FFPE,2月6日,3999834003
EPN_MPE_05,9297949046_R02C02,University Hospital of Heidelberg,Myxopapillary ependymoma  ,I,Central review Heidelberg,23,female,spinal; ,not available,EPN_MPE,"methylation class ependymoma, myxopapillary",62%,Not applicable,DNA_FFPE,6月7日,9297949046
EPN_MPE_06,9305651146_R06C01,University Hospital of Heidelberg,Myxopapillary ependymoma  ,I,Central review Heidelberg,23,male,"spinal, extramedullary intradural, cauda equina region; ",initial operation ,EPN_MPE,"methylation class ependymoma, myxopapillary",64%,Not applicable,DNA_FFPE,7月30日,9305651146
EPN_MPE_07,9007225086_R01C01,University Hospital of Heidelberg,Myxopapillary ependymoma  ,I,Central review Heidelberg,27,male,"spinal, lumbar, L2, L3; ",initial operation ,EPN_MPE,"methylation class ependymoma, myxopapillary",65%,Not applicable,DNA_FFPE,3月28日,9007225086
EPN_MPE_08,9533774057_R03C02,University Hospital of Cambridge,Myxopapillary ependymoma  ,I,Local review,28,male,spinal; ,not available,EPN_MPE,"methylation class ependymoma, myxopapillary",67%,Not applicable,DNA_KRYO,6月7日,9533774057
EPN_MPE_09,9533774066_R05C02,University Hospital of Cambridge,Myxopapillary ependymoma  ,I,Local review,29,male,supratentorial; ,not available,EPN_MPE,"methylation class ependymoma, myxopapillary",63%,Not applicable,DNA_KRYO,6月7日,9533774066
EPN_MPE_10,9007225163_R06C01,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,32,male,"spinal, lumbar, L2, L3; ",initial operation ,EPN_MPE,"methylation class ependymoma, myxopapillary",68%,Not applicable,DNA_FFPE,4月19日,9007225163
EPN_MPE_11,9878820104_R01C02,University Hospital of Frankfurt am Main,Tanycytic ependymoma  ,II,Central review Heidelberg,33,female,"spinal, lumbar, L1, L2, L3, L4; ",initial operation ,EPN_MPE,"methylation class ependymoma, myxopapillary",70%,Not applicable,DNA_FFPE,10月27日,9878820104
EPN_MPE_12,9969477100_R01C02,University Hospital of Heidelberg,Myxopapillary ependymoma  ,I,Central review Heidelberg,33,male,spinal; ,initial operation ,EPN_MPE,"methylation class ependymoma, myxopapillary",68%,Not applicable,DNA_FFPE,8月22日,9969477100
EPN_MPE_13,9533774057_R04C02,University Hospital of Cambridge,Myxopapillary ependymoma  ,I,Local review,34,female,spinal; ,not available,EPN_MPE,"methylation class ependymoma, myxopapillary",62%,Not applicable,DNA_KRYO,6月7日,9533774057
EPN_MPE_14,9407201027_R06C01,University Hospital of Tuebingen,Ependymoma  ,II,Central review Heidelberg,37,female,"spinal, extramedullary intradural, lumbar, L2, L3; ",initial operation ,EPN_MPE,"methylation class ependymoma, myxopapillary",70%,Not applicable,DNA_FFPE,12月2日,9407201027
EPN_MPE_15,9407201027_R04C01,University Hospital of Tuebingen,Ependymoma  ,II,Central review Heidelberg,38,female,"spinal, intramedullary, lumbar, L2, L3; ",initial operation ,EPN_MPE,"methylation class ependymoma, myxopapillary",68%,Not applicable,DNA_FFPE,12月2日,9407201027
EPN_MPE_16,9878820030_R02C01,University Hospital of Heidelberg,Myxopapillary ependymoma  ,I,Central review Heidelberg,39,male,"spinal, extramedullary intradural; ",initial operation ,EPN_MPE,"methylation class ependymoma, myxopapillary",61%,Not applicable,DNA_FFPE,10月17日,9878820030
EPN_MPE_17,9721366138_R04C02,University Hospital of Heidelberg,Myxopapillary ependymoma  ,I,Central review Heidelberg,40,female,"spinal, extramedullary intradural, lumbar, L3, L4; ",initial operation ,EPN_MPE,"methylation class ependymoma, myxopapillary",65%,Not applicable,DNA_FFPE,5月9日,9721366138
EPN_MPE_18,9007225086_R01C02,University Hospital of Heidelberg,Myxopapillary ependymoma  ,I,Central review Heidelberg,46,female,"spinal, lumbar, sacral; ",initial operation ,EPN_MPE,"methylation class ependymoma, myxopapillary",68%,Not applicable,DNA_FFPE,3月28日,9007225086
EPN_MPE_19,9305216209_R02C01,University Hospital of Heidelberg,Myxopapillary ependymoma  ,I,Central review Heidelberg,49,female,"spinal, lumbar, L3, L4, L5, sacral, S1, S2; ",initial operation ,EPN_MPE,"methylation class ependymoma, myxopapillary",63%,Not applicable,DNA_FFPE,7月5日,9305216209
EPN_MPE_20,9305651095_R03C01,University Hospital of Heidelberg,Myxopapillary ependymoma  ,I,Central review Heidelberg,52,female,"spinal, lumbar, L3; ",initial operation ,EPN_MPE,"methylation class ependymoma, myxopapillary",64%,Not applicable,DNA_FFPE,7月30日,9305651095
EPN_MPE_21,9533774057_R05C02,University Hospital of Cambridge,Myxopapillary ependymoma  ,I,Local review,55,male,spinal; ,not available,EPN_MPE,"methylation class ependymoma, myxopapillary",67%,Not applicable,DNA_KRYO,6月7日,9533774057
EPN_MPE_22,9305651037_R05C01,University Hospital of Heidelberg,Myxopapillary ependymoma  ,I,Central review Heidelberg,55,female,"spinal, lumbar, L1, L2; ",initial operation ,EPN_MPE,"methylation class ependymoma, myxopapillary",68%,Not applicable,DNA_FFPE,6月28日,9305651037
EPN_MPE_23,9533774066_R05C01,University Hospital of Cambridge,Myxopapillary ependymoma  ,I,Local review,58,male,spinal; ,not available,EPN_MPE,"methylation class ependymoma, myxopapillary",61%,Not applicable,DNA_KRYO,6月7日,9533774066
EPN_MPE_24,9305216209_R06C01,University Hospital of Heidelberg,Myxopapillary ependymoma  ,I,Central review Heidelberg,58,female,"spinal, lumbar, L1, L2; ",initial operation ,EPN_MPE,"methylation class ependymoma, myxopapillary",62%,Not applicable,DNA_FFPE,7月5日,9305216209
EPN_MPE_25,9553932008_R06C01,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,62,male,"spinal, extramedullary intradural, lumbar, L2; ",initial operation ,EPN_MPE,"methylation class ependymoma, myxopapillary",70%,Not applicable,DNA_FFPE,2月14日,9553932008
EPN_MPE_26,9533774057_R01C02,University Hospital of Cambridge,Myxopapillary ependymoma  ,I,Local review,66,male,not available,not available,EPN_MPE,"methylation class ependymoma, myxopapillary",59%,Not applicable,DNA_KRYO,6月7日,9533774057
EPN_MPE_27,9305651037_R04C01,University Hospital of Heidelberg,Myxopapillary ependymoma  ,I,Central review Heidelberg,72,female,"spinal, lumbar, L2, L3; ",initial operation ,EPN_MPE,"methylation class ependymoma, myxopapillary",64%,Not applicable,DNA_FFPE,6月28日,9305651037
EPN_MPE_28,8622007120_R02C01,University Hospital of Heidelberg,Myxopapillary ependymoma  ,I,Central review Heidelberg,75,female,"spinal, lumbar, L1, L2, L3, L4, L5; ",initial operation ,EPN_MPE,"methylation class ependymoma, myxopapillary",61%,Not applicable,DNA_FFPE,12月17日,8622007120
EPN_PF_A_01,9296930066_R06C02,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,0,male,supratentorial; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",70%,Not applicable,DNA_FFPE,5月27日,9296930066
EPN_PF_A_02,9305651003_R06C01,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,1,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",66%,Not applicable,DNA_FFPE,6月28日,9305651003
EPN_PF_A_03,9305651027_R03C02,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,1,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",69%,Not applicable,DNA_FFPE,6月28日,9305651027
EPN_PF_A_04,9305651016_R06C02,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,1,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",68%,Not applicable,DNA_FFPE,6月28日,9305651016
EPN_PF_A_05,9297949078_R05C02,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,1,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",65%,Not applicable,DNA_FFPE,6月7日,9297949078
EPN_PF_A_06,9297949046_R04C02,University Hospital of Frankfurt am Main,Anaplastic ependymoma  ,III,Central review Heidelberg,1,male,not available,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",66%,Not applicable,DNA_FFPE,6月7日,9297949046
EPN_PF_A_07,6026818110_R06C02,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,1,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",67%,Not applicable,DNA_KRYO,7月20日,6026818110
EPN_PF_A_08,9426020064_R06C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,1,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",68%,Not applicable,DNA_KRYO,12月20日,9426020064
EPN_PF_A_09,9403904111_R01C02,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,1,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",74%,Not applicable,DNA_KRYO,12月3日,9403904111
EPN_PF_A_10,9420867124_R06C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,1,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",75%,Not applicable,DNA_KRYO,1月22日,9420867124
EPN_PF_A_11,9305651013_R06C01,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,2,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",72%,Not applicable,DNA_FFPE,6月28日,9305651013
EPN_PF_A_12,9305651005_R04C02,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,2,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",71%,Not applicable,DNA_FFPE,6月28日,9305651005
EPN_PF_A_13,9305651005_R04C01,University Hospital of Bonn,Ependymoma  ,II,Central review Bonn ,2,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",68%,Not applicable,DNA_FFPE,6月28日,9305651005
EPN_PF_A_14,9305651013_R04C01,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,2,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",65%,Not applicable,DNA_FFPE,6月28日,9305651013
EPN_PF_A_15,9305651013_R06C02,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,2,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",67%,Not applicable,DNA_FFPE,6月28日,9305651013
EPN_PF_A_16,9297949078_R05C01,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,2,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",69%,Not applicable,DNA_FFPE,6月7日,9297949078
EPN_PF_A_17,9297949078_R04C02,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,2,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",65%,Not applicable,DNA_FFPE,6月7日,9297949078
EPN_PF_A_18,9296930094_R04C01,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,2,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",68%,Not applicable,DNA_FFPE,5月27日,9296930094
EPN_PF_A_19,9296930094_R05C01,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,2,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",63%,Not applicable,DNA_FFPE,5月27日,9296930094
EPN_PF_A_20,6026818094_R03C02,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,2,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",63%,Not applicable,DNA_KRYO,7月20日,6026818094
EPN_PF_A_21,6026818110_R05C02,University Hospital of Heidelberg,Anaplastic ependymoma  ,III,Central review Heidelberg,2,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",61%,Not applicable,DNA_KRYO,7月20日,6026818110
EPN_PF_A_22,8622007106_R01C02,University Hospital of Heidelberg,Anaplastic ependymoma  ,III,Central review Heidelberg,2,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",71%,Not applicable,DNA_KRYO,1月16日,8622007106
EPN_PF_A_23,9403904109_R05C02,University Hospital of Heidelberg,Anaplastic ependymoma  ,III,Central review Heidelberg,2,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",72%,Not applicable,DNA_KRYO,12月3日,9403904109
EPN_PF_A_24,9969477098_R02C01,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,2,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",67%,Not applicable,DNA_KRYO,8月22日,9969477098
EPN_PF_A_25,6929689149_R05C01,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,2,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",60%,Not applicable,DNA_KRYO,12月23日,6929689149
EPN_PF_A_26,6929689149_R04C01,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,2,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",63%,Not applicable,DNA_KRYO,12月23日,6929689149
EPN_PF_A_27,9373551108_R06C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,2,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",67%,Not applicable,DNA_FFPE,9月11日,9373551108
EPN_PF_A_28,9403904109_R03C02,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,2,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",68%,Not applicable,DNA_KRYO,12月3日,9403904109
EPN_PF_A_29,9426020064_R03C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,2,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",69%,Not applicable,DNA_KRYO,12月20日,9426020064
EPN_PF_A_30,9426020065_R04C01,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,2,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",68%,Not applicable,DNA_KRYO,12月20日,9426020065
EPN_PF_A_31,9305651005_R05C02,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,3,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",72%,Not applicable,DNA_FFPE,6月28日,9305651005
EPN_PF_A_32,9305651003_R05C01,University Hospital of Bonn,Ependymoma  ,II,Central review Bonn ,3,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",77%,Not applicable,DNA_FFPE,6月28日,9305651003
EPN_PF_A_33,9305651005_R03C01,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,3,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",71%,Not applicable,DNA_FFPE,6月28日,9305651005
EPN_PF_A_34,9305651013_R02C01,University Hospital of Bonn,Ependymoma  ,II,Central review Bonn ,3,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",67%,Not applicable,DNA_FFPE,6月28日,9305651013
EPN_PF_A_35,9305651013_R03C01,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,3,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",66%,Not applicable,DNA_FFPE,6月28日,9305651013
EPN_PF_A_36,9305651016_R03C02,University Hospital of Bonn,Ependymoma  ,II,Central review Bonn ,3,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",70%,Not applicable,DNA_FFPE,6月28日,9305651016
EPN_PF_A_37,9305651027_R04C02,University Hospital of Bonn,Ependymoma  ,II,Central review Bonn ,3,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",63%,Not applicable,DNA_FFPE,6月28日,9305651027
EPN_PF_A_38,9297949078_R06C02,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,3,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",67%,Not applicable,DNA_FFPE,6月7日,9297949078
EPN_PF_A_39,9406921039_R04C01,University Hospital of Hannover,Anaplastic ependymoma  ,III,Central review Heidelberg,3,male,"posterior fossa, ventricle IV; ",not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",70%,Not applicable,DNA_FFPE,11月18日,9406921039
EPN_PF_A_40,6026818091_R06C01,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,3,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",61%,Not applicable,DNA_KRYO,7月20日,6026818091
EPN_PF_A_41,9373551020_R05C01,"MD Anderson Cancer Center, Houston",Anaplastic ependymoma  ,III,Local review,3,female,supratentorial; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",66%,Not applicable,DNA_FFPE,8月23日,9373551020
EPN_PF_A_42,6752625107_R01C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,3,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",65%,Not applicable,DNA_KRYO,6月22日,6752625107
EPN_PF_A_43,9403904111_R04C02,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,3,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",67%,Not applicable,DNA_KRYO,12月3日,9403904111
EPN_PF_A_44,9426020065_R02C01,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,3,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",71%,Not applicable,DNA_KRYO,12月20日,9426020065
EPN_PF_A_45,9420867125_R04C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,3,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",67%,Not applicable,DNA_KRYO,1月22日,9420867125
EPN_PF_A_46,9403904125_R02C01,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,3,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",73%,Not applicable,DNA_KRYO,12月3日,9403904125
EPN_PF_A_47,9305651005_R06C02,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,4,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",72%,Not applicable,DNA_FFPE,6月28日,9305651005
EPN_PF_A_48,9305651016_R01C02,University Hospital of Bonn,Ependymoma  ,II,Central review Bonn ,4,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",65%,Not applicable,DNA_FFPE,6月28日,9305651016
EPN_PF_A_49,9305651016_R02C02,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,4,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",69%,Not applicable,DNA_FFPE,6月28日,9305651016
EPN_PF_A_50,9305651027_R06C01,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,4,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",71%,Not applicable,DNA_FFPE,6月28日,9305651027
EPN_PF_A_51,9305651003_R03C02,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,4,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",65%,Not applicable,DNA_FFPE,6月28日,9305651003
EPN_PF_A_52,9305651027_R02C02,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,4,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",68%,Not applicable,DNA_FFPE,6月28日,9305651027
EPN_PF_A_53,9305651005_R02C02,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,4,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",68%,Not applicable,DNA_FFPE,6月28日,9305651005
EPN_PF_A_54,9297949098_R02C01,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,4,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",68%,Not applicable,DNA_FFPE,6月7日,9297949098
EPN_PF_A_55,9379082092_R02C02,University Hospital of Heidelberg,Anaplastic ependymoma  ,III,Central review Heidelberg,4,female,"posterior fossa, brain stem; ",recurrence ,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",68%,Not applicable,DNA_FFPE,11月8日,9379082092
EPN_PF_A_56,7310440009_R04C02,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,4,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",64%,Not applicable,DNA_KRYO,7月13日,7310440009
EPN_PF_A_57,9403904125_R04C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,4,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",68%,Not applicable,DNA_KRYO,12月3日,9403904125
EPN_PF_A_58,9403904071_R03C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,4,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",71%,Not applicable,DNA_KRYO,12月3日,9403904071
EPN_PF_A_59,9444375114_R03C02,University Hospital of Tuebingen,Ependymoma  ,II,Central review Heidelberg,4,male,"posterior fossa, brain stem, ventricle IV; ",initial operation ,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",68%,Not applicable,DNA_FFPE,2月10日,9444375114
EPN_PF_A_60,9305651016_R05C01,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,5,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",66%,Not applicable,DNA_FFPE,6月28日,9305651016
EPN_PF_A_61,9305651005_R01C01,University Hospital of Bonn,Ependymoma  ,II,Central review Bonn ,5,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",68%,Not applicable,DNA_FFPE,6月28日,9305651005
EPN_PF_A_62,9305651005_R01C02,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,5,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",70%,Not applicable,DNA_FFPE,6月28日,9305651005
EPN_PF_A_63,9297949078_R01C02,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,5,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",68%,Not applicable,DNA_FFPE,6月7日,9297949078
EPN_PF_A_64,9297949078_R02C02,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,5,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",69%,Not applicable,DNA_FFPE,6月7日,9297949078
EPN_PF_A_65,9297949098_R04C01,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,5,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",73%,Not applicable,DNA_FFPE,6月7日,9297949098
EPN_PF_A_66,6026818110_R03C02,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,5,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",70%,Not applicable,DNA_KRYO,7月20日,6026818110
EPN_PF_A_67,8622007106_R04C02,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,5,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",74%,Not applicable,DNA_KRYO,1月16日,8622007106
EPN_PF_A_68,9426020064_R01C01,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,5,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",69%,Not applicable,DNA_KRYO,12月20日,9426020064
EPN_PF_A_69,9422493133_R06C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,5,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",75%,Not applicable,DNA_KRYO,12月20日,9422493133
EPN_PF_A_70,9426020064_R06C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,5,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",73%,Not applicable,DNA_KRYO,12月20日,9426020064
EPN_PF_A_71,9534104010_R01C01,University Hospital of Tuebingen,Anaplastic ependymoma  ,III,Central review Heidelberg,5,male,"posterior fossa, ventricle IV; ",initial operation ,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",71%,Not applicable,DNA_FFPE,6月27日,9534104010
EPN_PF_A_72,9296930094_R03C01,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,6,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",76%,Not applicable,DNA_FFPE,5月27日,9296930094
EPN_PF_A_73,6026818091_R05C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,6,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",68%,Not applicable,DNA_KRYO,7月20日,6026818091
EPN_PF_A_74,9305651016_R06C01,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,7,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",67%,Not applicable,DNA_FFPE,6月28日,9305651016
EPN_PF_A_75,9305651003_R02C02,University Hospital of Bonn,Ependymoma  ,II,Central review Bonn ,7,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",64%,Not applicable,DNA_FFPE,6月28日,9305651003
EPN_PF_A_76,9297949139_R04C02,University Hospital of Homburg/Saar,Anaplastic ependymoma  ,III,Central review Heidelberg,7,male,not available,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",75%,Not applicable,DNA_FFPE,6月21日,9297949139
EPN_PF_A_77,9403904111_R06C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,7,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",72%,Not applicable,DNA_KRYO,12月3日,9403904111
EPN_PF_A_78,6026818091_R06C02,University Hospital of Heidelberg,Anaplastic ependymoma  ,III,Central review Heidelberg,8,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",65%,Not applicable,DNA_KRYO,7月20日,6026818091
EPN_PF_A_79,9969477098_R03C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,8,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",76%,Not applicable,DNA_KRYO,8月22日,9969477098
EPN_PF_A_80,9305651003_R03C01,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,11,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",68%,Not applicable,DNA_FFPE,6月28日,9305651003
EPN_PF_A_81,6929806024_R03C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,12,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",73%,Not applicable,DNA_KRYO,7月2日,6929806024
EPN_PF_A_82,9426020065_R01C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,12,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",69%,Not applicable,DNA_KRYO,12月20日,9426020065
EPN_PF_A_83,9611519028_R02C01,University Hospital of Heidelberg,Anaplastic ependymoma  ,III,Central review Heidelberg,14,male,posterior fossa; ,initial operation ,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",71%,Not applicable,DNA_FFPE,3月10日,9611519028
EPN_PF_A_84,9305651003_R05C02,University Hospital of Bonn,Ependymoma  ,II,Central review Bonn ,15,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",67%,Not applicable,DNA_FFPE,6月28日,9305651003
EPN_PF_A_85,6026818091_R04C02,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,20,female,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",78%,Not applicable,DNA_KRYO,7月20日,6026818091
EPN_PF_A_86,9379086117_R04C02,University Hospital of Bonn,Ependymoma  ,II,Central review Bonn ,not available ,female,not available,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",78%,Not applicable,DNA_KRYO,9月27日,9379086117
EPN_PF_A_87,9407201032_R04C01,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,not available ,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",63%,Not applicable,DNA_FFPE,10月25日,9407201032
EPN_PF_A_88,9407201032_R03C01,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,not available ,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",70%,Not applicable,DNA_FFPE,10月25日,9407201032
EPN_PF_A_89,6026818101_R06C02,"Hospital for Sick Children, Toronto  ",Ependymoma  ,II,Local review,not available ,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",67%,Not applicable,DNA_KRYO,7月20日,6026818101
EPN_PF_A_90,6026818110_R04C01,"Hospital for Sick Children, Toronto  ",Ependymoma  ,II,Local review,not available ,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",71%,Not applicable,DNA_KRYO,7月20日,6026818110
EPN_PF_A_91,6026818110_R06C01,"Hospital for Sick Children, Toronto  ",Ependymoma  ,II,Local review,not available ,male,posterior fossa; ,not available,EPN_PF_A,"methylation class ependymoma, posterior fossa group A",63%,Not applicable,DNA_KRYO,7月20日,6026818110
EPN_PF_B_01,9969477057_R01C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,8,female,posterior fossa; ,initial operation ,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",73%,Not applicable,DNA_FFPE,8月4日,9969477057
EPN_PF_B_02,9305651013_R01C02,University Hospital of Bonn,Ependymoma  ,II,Central review Bonn ,10,male,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",70%,Not applicable,DNA_FFPE,6月28日,9305651013
EPN_PF_B_03,9968646098_R03C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,10,male,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",78%,Not applicable,DNA_KRYO,7月23日,9968646098
EPN_PF_B_04,9969477055_R02C02,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,10,male,posterior fossa; ,initial operation ,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",68%,Not applicable,DNA_FFPE,8月4日,9969477055
EPN_PF_B_05,9968646156_R02C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,11,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",73%,Not applicable,DNA_KRYO,7月11日,9968646156
EPN_PF_B_06,6026818091_R05C01,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,13,male,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",69%,Not applicable,DNA_KRYO,7月20日,6026818091
EPN_PF_B_07,6929689149_R04C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,14,male,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",64%,Not applicable,DNA_KRYO,12月23日,6929689149
EPN_PF_B_08,9305651003_R04C01,University Hospital of Bonn,Ependymoma  ,II,Central review Bonn ,16,male,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",70%,Not applicable,DNA_FFPE,6月28日,9305651003
EPN_PF_B_09,9533774106_R05C02,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,17,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",68%,Not applicable,DNA_FFPE,6月27日,9533774106
EPN_PF_B_10,9533774102_R02C02,"MD Anderson Cancer Center, Houston",Anaplastic ependymoma  ,III,Local review,17,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",66%,Not applicable,DNA_FFPE,6月27日,9533774102
EPN_PF_B_11,9426020065_R03C01,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,17,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",72%,Not applicable,DNA_KRYO,12月20日,9426020065
EPN_PF_B_12,9968646096_R05C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,23,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",65%,Not applicable,DNA_KRYO,7月23日,9968646096
EPN_PF_B_13,9829119072_R04C01,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,24,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",68%,Not applicable,DNA_FFPE,5月23日,9829119072
EPN_PF_B_14,9968646098_R06C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,25,male,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",65%,Not applicable,DNA_KRYO,7月23日,9968646098
EPN_PF_B_15,9968646156_R03C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,25,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",70%,Not applicable,DNA_KRYO,7月11日,9968646156
EPN_PF_B_16,6026818094_R04C02,University Hospital of Heidelberg,Anaplastic ependymoma  ,III,Central review Heidelberg,26,male,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",77%,Not applicable,DNA_KRYO,7月20日,6026818094
EPN_PF_B_17,6752625135_R01C01,University Hospital of Heidelberg,Anaplastic ependymoma  ,III,Central review Heidelberg,26,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",68%,Not applicable,DNA_FFPE,7月2日,6752625135
EPN_PF_B_18,6285641010_R02C01,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,26,male,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",63%,Not applicable,DNA_FFPE,6月13日,6285641010
EPN_PF_B_19,9968646155_R05C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,27,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",70%,Not applicable,DNA_KRYO,7月11日,9968646155
EPN_PF_B_20,9533774101_R03C02,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,29,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",68%,Not applicable,DNA_FFPE,6月27日,9533774101
EPN_PF_B_21,9968646156_R03C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,29,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",66%,Not applicable,DNA_KRYO,7月11日,9968646156
EPN_PF_B_22,9426020061_R06C02,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,29,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",65%,Not applicable,DNA_KRYO,12月20日,9426020061
EPN_PF_B_23,9420867124_R01C02,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,29,male,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",70%,Not applicable,DNA_KRYO,1月22日,9420867124
EPN_PF_B_24,6026818091_R03C01,University Hospital of Heidelberg,Anaplastic ependymoma  ,III,Central review Heidelberg,30,male,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",71%,Not applicable,DNA_KRYO,7月20日,6026818091
EPN_PF_B_25,9968646139_R02C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,31,male,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",65%,Not applicable,DNA_KRYO,7月8日,9968646139
EPN_PF_B_26,9968646096_R06C02,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,31,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",72%,Not applicable,DNA_KRYO,7月23日,9968646096
EPN_PF_B_27,9426020064_R05C01,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,31,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",71%,Not applicable,DNA_KRYO,12月20日,9426020064
EPN_PF_B_28,9553932012_R04C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,32,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",67%,Not applicable,DNA_FFPE,2月21日,9553932012
EPN_PF_B_29,6752625133_R06C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,32,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",71%,Not applicable,DNA_FFPE,7月2日,6752625133
EPN_PF_B_30,9373550018_R06C01,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,34,male,supratentorial; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",71%,Not applicable,DNA_FFPE,8月22日,9373550018
EPN_PF_B_31,9533774102_R06C01,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,36,male,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",65%,Not applicable,DNA_FFPE,6月27日,9533774102
EPN_PF_B_32,9533774101_R03C01,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,38,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",66%,Not applicable,DNA_FFPE,6月27日,9533774101
EPN_PF_B_33,6026818094_R03C01,University Hospital of Heidelberg,Anaplastic ependymoma  ,III,Central review Heidelberg,39,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",64%,Not applicable,DNA_KRYO,7月20日,6026818094
EPN_PF_B_34,6026818094_R04C01,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,39,male,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",68%,Not applicable,DNA_KRYO,7月20日,6026818094
EPN_PF_B_35,9533774101_R01C01,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,39,male,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",66%,Not applicable,DNA_FFPE,6月27日,9533774101
EPN_PF_B_36,9533774102_R05C01,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,39,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",68%,Not applicable,DNA_FFPE,6月27日,9533774102
EPN_PF_B_37,6285641010_R03C01,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,40,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",70%,Not applicable,DNA_FFPE,6月13日,6285641010
EPN_PF_B_38,9769100071_R04C02,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,41,male,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",66%,Not applicable,DNA_FFPE,5月23日,9769100071
EPN_PF_B_39,9533774102_R04C02,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,41,male,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",63%,Not applicable,DNA_FFPE,6月27日,9533774102
EPN_PF_B_40,9968646096_R04C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,41,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",70%,Not applicable,DNA_KRYO,7月23日,9968646096
EPN_PF_B_41,9533774046_R05C02,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,45,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",66%,Not applicable,DNA_FFPE,6月7日,9533774046
EPN_PF_B_42,9968646155_R06C02,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,49,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",72%,Not applicable,DNA_KRYO,7月11日,9968646155
EPN_PF_B_43,9533774046_R03C02,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,50,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",65%,Not applicable,DNA_FFPE,6月7日,9533774046
EPN_PF_B_44,6969568124_R02C01,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,54,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",65%,Not applicable,DNA_KRYO,7月13日,6969568124
EPN_PF_B_45,9426020065_R06C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,65,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",68%,Not applicable,DNA_KRYO,12月20日,9426020065
EPN_PF_B_46,9305651005_R03C02,University Hospital of Bonn,Ependymoma  ,II,Central review Bonn ,not available ,female,not available,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",68%,Not applicable,DNA_FFPE,6月28日,9305651005
EPN_PF_B_47,7310440009_R03C01,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,not available ,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",64%,Not applicable,DNA_KRYO,7月13日,7310440009
EPN_PF_B_48,9407201032_R04C02,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,not available ,female,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",65%,Not applicable,DNA_FFPE,10月25日,9407201032
EPN_PF_B_49,9878820138_R03C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,not available ,not available,not available,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",67%,Not applicable,DNA_KRYO,10月31日,9878820138
EPN_PF_B_50,9969477057_R02C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,not available ,male,posterior fossa; ,initial operation ,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",73%,Not applicable,DNA_FFPE,8月4日,9969477057
EPN_PF_B_51,6026818101_R06C01,"Hospital for Sick Children, Toronto  ",Ependymoma  ,II,Local review,not available ,male,posterior fossa; ,not available,EPN_PF_B,"methylation class ependymoma, posterior fossa group B",71%,Not applicable,DNA_KRYO,7月20日,6026818101
EPN_RELA_01,9373550034_R05C02,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,0,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",70%,Not applicable,DNA_FFPE,8月22日,9373550034
EPN_RELA_02,9305651003_R02C01,University Hospital of Bonn,"Ependymoma, RELA fusion-positive",II or III,Central review Bonn ,1,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",69%,Not applicable,DNA_FFPE,6月28日,9305651003
EPN_RELA_03,8622007061_R04C01,University Hospital of Heidelberg,"Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,1,male,"supratentorial, hemispheric, parietal, occipital;  right;",not available,EPN_RELA,"methylation class ependymoma, RELA fusion",73%,Not applicable,DNA_KRYO,11月12日,8622007061
EPN_RELA_04,9296930047_R04C02,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,1,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",68%,Not applicable,DNA_FFPE,5月27日,9296930047
EPN_RELA_05,6929806046_R04C01,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,1,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",70%,Not applicable,DNA_KRYO,7月2日,6929806046
EPN_RELA_06,9296930089_R02C02,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,2,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",67%,Not applicable,DNA_FFPE,5月27日,9296930089
EPN_RELA_07,9373550035_R06C01,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,2,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",68%,Not applicable,DNA_FFPE,8月22日,9373550035
EPN_RELA_08,9340996050_R04C02,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,2,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",66%,Not applicable,DNA_FFPE,8月9日,9340996050
EPN_RELA_09,9296930066_R02C01,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,2,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",68%,Not applicable,DNA_FFPE,5月27日,9296930066
EPN_RELA_10,6929806038_R05C01,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,2,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",69%,Not applicable,DNA_KRYO,7月2日,6929806038
EPN_RELA_11,6929806038_R06C02,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,2,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",67%,Not applicable,DNA_KRYO,7月2日,6929806038
EPN_RELA_12,6929806046_R03C02,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,2,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",66%,Not applicable,DNA_KRYO,7月2日,6929806046
EPN_RELA_13,6929718001_R03C02,University Hospital of Cambridge,"Ependymoma, RELA fusion-positive",II or III,Local review,3,female,"supratentorial, hemispheric, parietal; ",not available,EPN_RELA,"methylation class ependymoma, RELA fusion",66%,Not applicable,DNA_KRYO,12月23日,6929718001
EPN_RELA_14,9296930052_R01C02,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,3,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",63%,Not applicable,DNA_FFPE,5月27日,9296930052
EPN_RELA_15,9296930066_R03C02,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,3,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",68%,Not applicable,DNA_FFPE,5月27日,9296930066
EPN_RELA_16,6929806048_R02C02,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,3,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",72%,Not applicable,DNA_KRYO,7月2日,6929806048
EPN_RELA_17,6929806024_R06C02,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,4,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",67%,Not applicable,DNA_KRYO,7月2日,6929806024
EPN_RELA_18,9305651027_R05C01,University Hospital of Bonn,"Ependymoma, RELA fusion-positive",II or III,Central review Bonn ,5,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",69%,Not applicable,DNA_FFPE,6月28日,9305651027
EPN_RELA_19,6929806038_R03C01,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,5,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",57%,Not applicable,DNA_KRYO,7月2日,6929806038
EPN_RELA_20,9426020061_R01C02,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,5,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",77%,Not applicable,DNA_KRYO,12月20日,9426020061
EPN_RELA_21,9426020061_R01C01,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,5,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",71%,Not applicable,DNA_KRYO,12月20日,9426020061
EPN_RELA_22,9305651003_R06C02,University Hospital of Bonn,"Ependymoma, RELA fusion-positive",II or III,Central review Bonn ,6,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",66%,Not applicable,DNA_FFPE,6月28日,9305651003
EPN_RELA_23,8622007106_R05C02,University Hospital of Heidelberg,"Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,6,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",75%,Not applicable,DNA_KRYO,1月16日,8622007106
EPN_RELA_24,9426021175_R06C01,University Hospital of Heidelberg,"Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,6,female,"supratentorial, hemispheric;  left;",recurrence ,EPN_RELA,"methylation class ependymoma, RELA fusion",65%,Not applicable,DNA_FFPE,12月20日,9426021175
EPN_RELA_25,9296930052_R01C01,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,6,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",66%,Not applicable,DNA_FFPE,5月27日,9296930052
EPN_RELA_26,9296930066_R02C02,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,6,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",68%,Not applicable,DNA_FFPE,5月27日,9296930066
EPN_RELA_27,9296930089_R06C01,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,6,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",66%,Not applicable,DNA_FFPE,5月27日,9296930089
EPN_RELA_28,6929806046_R02C01,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,6,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",61%,Not applicable,DNA_KRYO,7月2日,6929806046
EPN_RELA_29,6929806046_R05C02,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,6,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",65%,Not applicable,DNA_KRYO,7月2日,6929806046
EPN_RELA_30,9374342010_R01C01,University Hospital of Heidelberg,"Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,7,male,"supratentorial, hemispheric, parietal, occipital;  right;",initial operation ,EPN_RELA,"methylation class ependymoma, RELA fusion",68%,Not applicable,DNA_FFPE,9月11日,9374342010
EPN_RELA_31,9373550018_R01C02,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,7,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",59%,Not applicable,DNA_FFPE,8月22日,9373550018
EPN_RELA_32,9296930052_R05C01,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,8,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",71%,Not applicable,DNA_FFPE,5月27日,9296930052
EPN_RELA_33,7310440009_R06C01,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,8,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",73%,Not applicable,DNA_KRYO,7月13日,7310440009
EPN_RELA_34,6752625106_R01C02,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,8,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",73%,Not applicable,DNA_KRYO,6月22日,6752625106
EPN_RELA_35,6929806038_R01C01,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,8,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",74%,Not applicable,DNA_KRYO,7月2日,6929806038
EPN_RELA_36,6929806046_R01C01,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,8,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",63%,Not applicable,DNA_KRYO,7月2日,6929806046
EPN_RELA_37,6752625107_R01C02,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,8,female,not available,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",65%,Not applicable,DNA_KRYO,6月22日,6752625107
EPN_RELA_38,9296930052_R04C01,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,9,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",72%,Not applicable,DNA_FFPE,5月27日,9296930052
EPN_RELA_39,9296930066_R03C01,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,9,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",66%,Not applicable,DNA_FFPE,5月27日,9296930066
EPN_RELA_40,6929689149_R03C01,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,9,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",67%,Not applicable,DNA_KRYO,12月23日,6929689149
EPN_RELA_41,6752625107_R05C02,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,9,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",72%,Not applicable,DNA_KRYO,6月22日,6752625107
EPN_RELA_42,6929806048_R04C02,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,9,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",73%,Not applicable,DNA_KRYO,7月2日,6929806048
EPN_RELA_43,6929806048_R06C02,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,9,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",75%,Not applicable,DNA_KRYO,7月2日,6929806048
EPN_RELA_44,9296930047_R05C02,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,10,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",65%,Not applicable,DNA_FFPE,5月27日,9296930047
EPN_RELA_45,6929689149_R01C01,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,10,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",68%,Not applicable,DNA_KRYO,12月23日,6929689149
EPN_RELA_46,6929806024_R04C02,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,10,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",64%,Not applicable,DNA_KRYO,7月2日,6929806024
EPN_RELA_47,6929718027_R03C02,University Hospital of Heidelberg,"Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,12,female,not available,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",76%,Not applicable,DNA_KRYO,12月2日,6929718027
EPN_RELA_48,6929806048_R01C02,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,12,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",80%,Not applicable,DNA_KRYO,7月2日,6929806048
EPN_RELA_49,6929806048_R05C02,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,12,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",63%,Not applicable,DNA_KRYO,7月2日,6929806048
EPN_RELA_50,9305651013_R01C01,University Hospital of Bonn,"Ependymoma, RELA fusion-positive",II or III,Central review Bonn ,13,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",65%,Not applicable,DNA_FFPE,6月28日,9305651013
EPN_RELA_51,6929806048_R05C01,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,14,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",65%,Not applicable,DNA_KRYO,7月2日,6929806048
EPN_RELA_52,9296930089_R03C01,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,16,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",66%,Not applicable,DNA_FFPE,5月27日,9296930089
EPN_RELA_53,6285641012_R03C02,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,19,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",70%,Not applicable,DNA_FFPE,6月13日,6285641012
EPN_RELA_54,6929806038_R02C01,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,19,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",75%,Not applicable,DNA_KRYO,7月2日,6929806038
EPN_RELA_55,9296930076_R02C02,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,21,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",67%,Not applicable,DNA_FFPE,5月27日,9296930076
EPN_RELA_56,9373550018_R01C01,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,21,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",67%,Not applicable,DNA_FFPE,8月22日,9373550018
EPN_RELA_57,9296930076_R01C02,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,22,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",68%,Not applicable,DNA_FFPE,5月27日,9296930076
EPN_RELA_58,9296930089_R04C01,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,22,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",65%,Not applicable,DNA_FFPE,5月27日,9296930089
EPN_RELA_59,9305651053_R01C02,University Hospital of Heidelberg,"Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,32,male,"supratentorial, hemispheric, parietal;  right;",initial operation ,EPN_RELA,"methylation class ependymoma, RELA fusion",72%,Not applicable,DNA_FFPE,7月12日,9305651053
EPN_RELA_60,9422491056_R01C01,University Hospital of Heidelberg,"Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,32,female,"supratentorial, hemispheric, frontal;  left;",initial operation ,EPN_RELA,"methylation class ependymoma, RELA fusion",73%,Not applicable,DNA_FFPE,11月18日,9422491056
EPN_RELA_61,9296930089_R03C02,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,35,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",67%,Not applicable,DNA_FFPE,5月27日,9296930089
EPN_RELA_62,9296930066_R01C02,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,38,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",69%,Not applicable,DNA_FFPE,5月27日,9296930066
EPN_RELA_63,6752625107_R04C02,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,41,male,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",71%,Not applicable,DNA_KRYO,6月22日,6752625107
EPN_RELA_64,9296930089_R01C01,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,58,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",68%,Not applicable,DNA_FFPE,5月27日,9296930089
EPN_RELA_65,9296930066_R01C01,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,69,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",65%,Not applicable,DNA_FFPE,5月27日,9296930066
EPN_RELA_66,9373550035_R01C02,"MD Anderson Cancer Center, Houston","Ependymoma, RELA fusion-positive",II or III,Local review,not available ,female,supratentorial; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",73%,Not applicable,DNA_FFPE,8月22日,9373550035
EPN_RELA_67,6752625135_R06C02,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,not available ,male,not available,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",71%,Not applicable,DNA_FFPE,7月2日,6752625135
EPN_RELA_68,9969477098_R01C01,"Burdenko Neurosurgery Institute, Moscow","Ependymoma, RELA fusion-positive",II or III,Central review Heidelberg,not available ,female,not available,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",64%,Not applicable,DNA_KRYO,8月22日,9969477098
EPN_RELA_69,6026818094_R05C02,"Hospital for Sick Children, Toronto  ","Ependymoma, RELA fusion-positive",II or III,Local review,not available ,male,posterior fossa; ,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",66%,Not applicable,DNA_KRYO,7月20日,6026818094
EPN_RELA_70,6229017057_R01C01,"Hospital for Sick Children, Toronto  ","Ependymoma, RELA fusion-positive",II or III,Local review,not available ,male,not available,not available,EPN_RELA,"methylation class ependymoma, RELA fusion",75%,Not applicable,DNA_KRYO,3月15日,6229017057
EPN_SPINE_01,9420867124_R04C02,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,11,female,spinal; ,not available,EPN_SPINE,"methylation class ependymoma, spinal",67%,Not applicable,DNA_KRYO,1月22日,9420867124
EPN_SPINE_02,9407201027_R05C01,University Hospital of Tuebingen,Ependymoma  ,II,Central review Heidelberg,20,male,"spinal, intramedullary, cervical, C7, thoracic, T1; ",initial operation ,EPN_SPINE,"methylation class ependymoma, spinal",69%,Not applicable,DNA_FFPE,12月2日,9407201027
EPN_SPINE_03,9406922161_R05C01,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,29,male,"spinal, intramedullary, cervical, C4, C5; ",initial operation ,EPN_SPINE,"methylation class ependymoma, spinal",68%,Not applicable,DNA_FFPE,10月18日,9406922161
EPN_SPINE_04,9407201027_R03C01,University Hospital of Tuebingen,Ependymoma  ,II,Central review Heidelberg,29,male,"spinal, intramedullary, cervical, C3, C4, C5; ",initial operation ,EPN_SPINE,"methylation class ependymoma, spinal",68%,Not applicable,DNA_FFPE,12月2日,9407201027
EPN_SPINE_05,9422493152_R04C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,33,female,spinal; ,not available,EPN_SPINE,"methylation class ependymoma, spinal",74%,Not applicable,DNA_KRYO,12月20日,9422493152
EPN_SPINE_06,9407201028_R06C02,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,34,male,"spinal, intramedullary, cervical, C7; ",initial operation ,EPN_SPINE,"methylation class ependymoma, spinal",68%,Not applicable,DNA_FFPE,12月2日,9407201028
EPN_SPINE_07,9426020065_R04C02,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,35,male,spinal; ,not available,EPN_SPINE,"methylation class ependymoma, spinal",73%,Not applicable,DNA_KRYO,12月20日,9426020065
EPN_SPINE_08,9420867087_R04C02,University Hospital of Frankfurt am Main,Ependymoma  ,II,Central review Heidelberg,37,female,"spinal, intramedullary, cervical, C2, C3, C4, C5, C6, C7; ",not available,EPN_SPINE,"methylation class ependymoma, spinal",67%,Not applicable,DNA_FFPE,1月17日,9420867087
EPN_SPINE_09,9305216209_R05C02,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,39,female,"spinal, lumbar, L1, conus region; ",initial operation ,EPN_SPINE,"methylation class ependymoma, spinal",63%,Not applicable,DNA_FFPE,7月5日,9305216209
EPN_SPINE_10,9426020065_R03C02,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,41,male,spinal; ,not available,EPN_SPINE,"methylation class ependymoma, spinal",65%,Not applicable,DNA_KRYO,12月20日,9426020065
EPN_SPINE_11,9426020065_R06C02,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,41,female,spinal; ,not available,EPN_SPINE,"methylation class ependymoma, spinal",66%,Not applicable,DNA_KRYO,12月20日,9426020065
EPN_SPINE_12,9426020065_R05C02,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,42,male,spinal; ,not available,EPN_SPINE,"methylation class ependymoma, spinal",67%,Not applicable,DNA_KRYO,12月20日,9426020065
EPN_SPINE_13,9422493152_R02C01,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,43,not available,spinal; ,not available,EPN_SPINE,"methylation class ependymoma, spinal",75%,Not applicable,DNA_KRYO,12月20日,9422493152
EPN_SPINE_14,9422491130_R03C02,University Hospital of Tuebingen,Ependymoma  ,II,Central review Heidelberg,43,male,"spinal, intramedullary, cervical; ",initial operation ,EPN_SPINE,"methylation class ependymoma, spinal",64%,Not applicable,DNA_FFPE,11月18日,9422491130
EPN_SPINE_15,9422491130_R02C02,University Hospital of Tuebingen,Ependymoma  ,II,Central review Heidelberg,47,female,"spinal, intramedullary, thoracic, T1, T2; ",initial operation ,EPN_SPINE,"methylation class ependymoma, spinal",65%,Not applicable,DNA_FFPE,11月18日,9422491130
EPN_SPINE_16,9379086132_R06C01,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,48,male,"spinal, intramedullary, cervical, C6, C7, thoracic, T1, T2; ",initial operation ,EPN_SPINE,"methylation class ependymoma, spinal",65%,Not applicable,DNA_FFPE,10月4日,9379086132
EPN_SPINE_17,9407201029_R06C01,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,49,male,"spinal, intramedullary, thoracic, T1, T2, T3, T4; ",initial operation ,EPN_SPINE,"methylation class ependymoma, spinal",66%,Not applicable,DNA_FFPE,12月2日,9407201029
EPN_SPINE_18,9533774097_R01C02,University Hospital of Duesseldorf ,Ependymoma  ,II,Central review Heidelberg,51,female,"posterior fossa, brain stem, medulla oblongata (craniocervical); spinal, intramedullary, cervical; ",recurrence ,EPN_SPINE,"methylation class ependymoma, spinal",65%,Not applicable,DNA_FFPE,6月16日,9533774097
EPN_SPINE_19,9407201027_R02C01,University Hospital of Tuebingen,Ependymoma  ,II,Central review Heidelberg,54,male,"spinal, intramedullary, thoracic, T1, T2; ",initial operation ,EPN_SPINE,"methylation class ependymoma, spinal",69%,Not applicable,DNA_FFPE,12月2日,9407201027
EPN_SPINE_20,9422493152_R03C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,55,female,spinal; ,not available,EPN_SPINE,"methylation class ependymoma, spinal",71%,Not applicable,DNA_KRYO,12月20日,9422493152
EPN_SPINE_21,9422491130_R06C02,University Hospital of Tuebingen,Ependymoma  ,II,Central review Heidelberg,55,male,"spinal, intramedullary, cervical, C2, C3, C4, C5; ",initial operation ,EPN_SPINE,"methylation class ependymoma, spinal",64%,Not applicable,DNA_FFPE,11月18日,9422491130
EPN_SPINE_22,9855358001_R02C01,University Hospital of Frankfurt am Main,Ependymoma  ,II,Central review Heidelberg,57,female,"spinal, intramedullary; ",initial operation ,EPN_SPINE,"methylation class ependymoma, spinal",72%,Not applicable,DNA_FFPE,9月12日,9855358001
EPN_SPINE_23,9855358001_R05C01,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,58,male,"posterior fossa, brain stem, medulla oblongata (craniocervical); spinal, cervical, C1, C2; ",initial operation ,EPN_SPINE,"methylation class ependymoma, spinal",62%,Not applicable,DNA_FFPE,9月12日,9855358001
EPN_SPINE_24,9969477079_R05C01,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,66,male,"spinal, intramedullary, thoracic, T11; ",initial operation ,EPN_SPINE,"methylation class ependymoma, spinal",63%,Not applicable,DNA_FFPE,8月15日,9969477079
EPN_SPINE_25,9647455233_R02C01,University Hospital of Frankfurt am Main,Ependymoma  ,II,Central review Heidelberg,67,male,"spinal, intramedullary, thoracic, T10, T11, T12, lumbar, L1; ",initial operation ,EPN_SPINE,"methylation class ependymoma, spinal",63%,Not applicable,DNA_FFPE,4月11日,9647455233
EPN_SPINE_26,9533774041_R05C01,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,70,male,"spinal, intramedullary, thoracic, T8; ",initial operation ,EPN_SPINE,"methylation class ependymoma, spinal",66%,Not applicable,DNA_FFPE,6月7日,9533774041
EPN_SPINE_27,9969477017_R02C01,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,74,male,"spinal, intramedullary, thoracic, T9; ",initial operation ,EPN_SPINE,"methylation class ependymoma, spinal",68%,Not applicable,DNA_FFPE,7月25日,9969477017
EPN_YAP_01,9373550028_R05C01,"MD Anderson Cancer Center, Houston",Anaplastic ependymoma  ,III,Local review,0,female,supratentorial; ,not available,EPN_YAP,"methylation class ependymoma, YAP fusion",65%,Not applicable,DNA_FFPE,8月22日,9373550028
EPN_YAP_02,9373550131_R06C02,University Hospital of Tuebingen,Anaplastic ependymoma  ,III,Central review Heidelberg,0,female,"supratentorial, hemispheric, parietal; ",not available,EPN_YAP,"methylation class ependymoma, YAP fusion",75%,Not applicable,DNA_FFPE,8月21日,9373550131
EPN_YAP_03,9305651016_R04C01,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,1,female,supratentorial; ,not available,EPN_YAP,"methylation class ependymoma, YAP fusion",70%,Not applicable,DNA_FFPE,6月28日,9305651016
EPN_YAP_04,9969477003_R01C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,1,female,supratentorial; ,not available,EPN_YAP,"methylation class ependymoma, YAP fusion",72%,Not applicable,DNA_KRYO,7月18日,9969477003
EPN_YAP_05,6929689149_R03C02,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,1,female,supratentorial; ,not available,EPN_YAP,"methylation class ependymoma, YAP fusion",78%,Not applicable,DNA_KRYO,12月23日,6929689149
EPN_YAP_06,6929806048_R06C01,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,1,female,supratentorial; ,not available,EPN_YAP,"methylation class ependymoma, YAP fusion",76%,Not applicable,DNA_KRYO,7月2日,6929806048
EPN_YAP_07,9968646139_R04C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,1,male,supratentorial; ,not available,EPN_YAP,"methylation class ependymoma, YAP fusion",71%,Not applicable,DNA_KRYO,7月8日,9968646139
EPN_YAP_08,9305651027_R03C01,University Hospital of Bonn,Anaplastic ependymoma  ,III,Central review Bonn ,2,female,supratentorial; ,not available,EPN_YAP,"methylation class ependymoma, YAP fusion",77%,Not applicable,DNA_FFPE,6月28日,9305651027
EPN_YAP_09,6026818091_R02C01,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,9,female,posterior fossa; ,not available,EPN_YAP,"methylation class ependymoma, YAP fusion",70%,Not applicable,DNA_KRYO,7月20日,6026818091
EPN_YAP_10,9296930076_R05C01,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,10,female,supratentorial; ,not available,EPN_YAP,"methylation class ependymoma, YAP fusion",68%,Not applicable,DNA_FFPE,5月27日,9296930076
EPN_YAP_11,6929806046_R03C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,51,female,supratentorial; ,not available,EPN_YAP,"methylation class ependymoma, YAP fusion",77%,Not applicable,DNA_KRYO,7月2日,6929806046
ETMR_01,8622007028_R03C01,Amsterdam Academic Medical Center,"Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Local review,2,female,not available,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,70%,Not applicable,DNA_KRYO,10月23日,8622007028
ETMR_02,6929718020_R03C02,University Hospital of Duesseldorf ,"Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Local review,2,female,"supratentorial, hemispheric, frontal, temporal; ",not available,ETMR,methylation class embryonal tumor with multilayered rosettes,73%,Not applicable,DNA_KRYO,12月23日,6929718020
ETMR_03,9379082039_R02C02,University Hospital of Heidelberg,"Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,2,female,"supratentorial, hemispheric;  right;",not available,ETMR,methylation class embryonal tumor with multilayered rosettes,69%,Not applicable,DNA_FFPE,9月19日,9379082039
ETMR_04,6229017057_R05C02,University Hospital of Heidelberg,"Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,2,female,"supratentorial, diencephalic, pineal region; ",not available,ETMR,methylation class embryonal tumor with multilayered rosettes,72%,Not applicable,DNA_KRYO,3月15日,6229017057
ETMR_05,9003865058_R05C02,University Hospital of Heidelberg,"Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,2,male,"supratentorial, hemispheric, frontal; ",not available,ETMR,methylation class embryonal tumor with multilayered rosettes,68%,Not applicable,DNA_FFPE,1月28日,9003865058
ETMR_06,9969477101_R03C01,University Hospital of Heidelberg,"Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,2,female,"supratentorial, hemispheric, occipital; ",initial operation ,ETMR,methylation class embryonal tumor with multilayered rosettes,65%,Not applicable,DNA_FFPE,8月22日,9969477101
ETMR_07,8622007061_R06C01,University Hospital of Heidelberg,"Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,2,female,"supratentorial, hemispheric, parietal;  right;",not available,ETMR,methylation class embryonal tumor with multilayered rosettes,72%,Not applicable,DNA_KRYO,11月12日,8622007061
ETMR_08,9373551108_R03C02,"Burdenko Neurosurgery Institute, Moscow","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,2,female,posterior fossa; ,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,69%,Not applicable,DNA_FFPE,9月11日,9373551108
ETMR_09,9003865058_R03C01,"Burdenko Neurosurgery Institute, Moscow","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,2,male,supratentorial; ,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,72%,Not applicable,DNA_FFPE,1月28日,9003865058
ETMR_10,8622007065_R01C01,"Burdenko Neurosurgery Institute, Moscow","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,2,male,supratentorial; ,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,70%,Not applicable,DNA_FFPE,11月26日,8622007065
ETMR_11,9305651053_R02C02,"Burdenko Neurosurgery Institute, Moscow","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,2,male,"supratentorial, hemispheric, frontal, parietal; ",not available,ETMR,methylation class embryonal tumor with multilayered rosettes,66%,Not applicable,DNA_FFPE,7月12日,9305651053
ETMR_12,9741950101_R06C02,"Burdenko Neurosurgery Institute, Moscow","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,2,male,"supratentorial, hemispheric, temporal, parietal; ",initial operation ,ETMR,methylation class embryonal tumor with multilayered rosettes,75%,Not applicable,DNA_FFPE,5月16日,9741950101
ETMR_13,9741950107_R01C01,"Burdenko Neurosurgery Institute, Moscow","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,2,female,"supratentorial, hemispheric, parietal; ",initial operation ,ETMR,methylation class embryonal tumor with multilayered rosettes,69%,Not applicable,DNA_FFPE,5月16日,9741950107
ETMR_14,9007225017_R03C01,University Hospital of Tuebingen,"Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,2,male,"supratentorial, hemispheric, frontal; ",not available,ETMR,methylation class embryonal tumor with multilayered rosettes,69%,Not applicable,DNA_FFPE,2月20日,9007225017
ETMR_15,3998568066_R04C02,University Hospital of Heidelberg,"Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,3,female,"supratentorial, hemispheric, parietal, occipital;  left;",initial operation ,ETMR,methylation class embryonal tumor with multilayered rosettes,71%,Not applicable,DNA_FFPE,9月11日,3998568066
ETMR_16,8622007068_R01C02,University Hospital of Heidelberg,"Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,3,not available,"supratentorial, hemispheric, frontal;  left; right;",not available,ETMR,methylation class embryonal tumor with multilayered rosettes,65%,Not applicable,DNA_FFPE,11月26日,8622007068
ETMR_17,9373551108_R02C02,"Burdenko Neurosurgery Institute, Moscow","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,3,male,supratentorial; ,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,70%,Not applicable,DNA_FFPE,9月11日,9373551108
ETMR_18,9373551108_R04C02,"Burdenko Neurosurgery Institute, Moscow","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,3,female,supratentorial; ,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,68%,Not applicable,DNA_FFPE,9月11日,9373551108
ETMR_19,8622007027_R03C01,"Burdenko Neurosurgery Institute, Moscow","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,3,male,posterior fossa; ,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,71%,Not applicable,DNA_KRYO,10月23日,8622007027
ETMR_20,9003865058_R01C02,"Burdenko Neurosurgery Institute, Moscow","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,3,female,supratentorial; ,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,71%,Not applicable,DNA_FFPE,1月28日,9003865058
ETMR_21,9003865058_R04C02,"Burdenko Neurosurgery Institute, Moscow","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,3,female,supratentorial; ,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,70%,Not applicable,DNA_FFPE,1月28日,9003865058
ETMR_22,9003865058_R04C01,"Burdenko Neurosurgery Institute, Moscow","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,3,female,supratentorial; ,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,70%,Not applicable,DNA_FFPE,1月28日,9003865058
ETMR_23,8622007066_R06C02,"Burdenko Neurosurgery Institute, Moscow","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,3,male,supratentorial; ,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,69%,Not applicable,DNA_FFPE,11月26日,8622007066
ETMR_24,9003865058_R06C01,"Burdenko Neurosurgery Institute, Moscow","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,3,male,posterior fossa; ,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,73%,Not applicable,DNA_FFPE,1月28日,9003865058
ETMR_25,9003865058_R03C02,"Burdenko Neurosurgery Institute, Moscow","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,3,male,posterior fossa; ,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,65%,Not applicable,DNA_FFPE,1月28日,9003865058
ETMR_26,9379086117_R03C02,"Burdenko Neurosurgery Institute, Moscow","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,3,male,posterior fossa; ,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,68%,Not applicable,DNA_KRYO,9月27日,9379086117
ETMR_27,9305651053_R05C02,"Burdenko Neurosurgery Institute, Moscow","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,3,male,"supratentorial, hemispheric, frontal, temporal;  left;",not available,ETMR,methylation class embryonal tumor with multilayered rosettes,68%,Not applicable,DNA_FFPE,7月12日,9305651053
ETMR_28,6229009095_R02C02,University Hospital of Muenster,"Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Local review,3,female,"supratentorial, hemispheric, frontal, parietal;  right;",not available,ETMR,methylation class embryonal tumor with multilayered rosettes,72%,Not applicable,DNA_KRYO,2月16日,6229009095
ETMR_29,8622007065_R06C01,"Ludwig-Maximilians University Hospital, Munich ","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,3,not available,"supratentorial, hemispheric, frontal; ",not available,ETMR,methylation class embryonal tumor with multilayered rosettes,70%,Not applicable,DNA_FFPE,11月26日,8622007065
ETMR_30,8622007130_R03C01,"La Sapienza Hospital, Rome ","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Local review,3,female,"supratentorial, hemispheric, occipital; ",not available,ETMR,methylation class embryonal tumor with multilayered rosettes,69%,Not applicable,DNA_FFPE,1月16日,8622007130
ETMR_31,6929718057_R03C02,University Hospital of Heidelberg,"Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,not available ,female,not available,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,69%,Not applicable,DNA_KRYO,12月23日,6929718057
ETMR_32,6929718057_R04C02,University Hospital of Heidelberg,"Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,not available ,male,not available,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,72%,Not applicable,DNA_KRYO,12月23日,6929718057
ETMR_33,7990895159_R06C02,University Hospital of Heidelberg,"Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,not available ,male,not available,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,65%,Not applicable,DNA_FFPE,7月30日,7990895159
ETMR_34,9878820138_R02C01,University Hospital of Heidelberg,"Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,not available ,male,not available,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,70%,Not applicable,DNA_KRYO,10月31日,9878820138
ETMR_35,6929718049_R01C01,University Hospital of Heidelberg,"Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,not available ,male,not available,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,68%,Not applicable,DNA_KRYO,12月23日,6929718049
ETMR_36,9007217016_R02C02,International Cancer Genome Consortium ,"Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,not available ,male,not available,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,71%,Not applicable,DNA_KRYO,2月19日,9007217016
ETMR_37,6247004023_R01C01,"Burdenko Neurosurgery Institute, Moscow","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,not available ,female,not available,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,68%,Not applicable,DNA_KRYO,4月13日,6247004023
ETMR_38,6247004023_R02C01,"Burdenko Neurosurgery Institute, Moscow","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,not available ,male,not available,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,68%,Not applicable,DNA_KRYO,4月13日,6247004023
ETMR_39,6247004023_R03C01,"Burdenko Neurosurgery Institute, Moscow","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,not available ,female,not available,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,73%,Not applicable,DNA_KRYO,4月13日,6247004023
ETMR_40,8622007066_R02C01,University Hospital of Muenster,"Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Central review Heidelberg,not available ,female,not available,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,69%,Not applicable,DNA_FFPE,11月26日,8622007066
ETMR_41,9007217108_R05C02,"Hospital for Sick Children, Toronto  ","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Local review,not available ,female,not available,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,71%,Not applicable,DNA_KRYO,2月19日,9007217108
ETMR_42,6229017023_R02C01,"Hospital for Sick Children, Toronto  ","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Local review,not available ,female,not available,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,69%,Not applicable,DNA_KRYO,3月15日,6229017023
ETMR_43,6229017057_R04C01,"Hospital for Sick Children, Toronto  ","Embryonal tumour with multilayered rosettes, C19MC-altered           ",IV,Local review,not available ,male,not available,not available,ETMR,methylation class embryonal tumor with multilayered rosettes,73%,Not applicable,DNA_KRYO,3月15日,6229017057
EWS_01,9968646165_R03C02,University Hospital of Freiburg ,Ewing sarcoma / peripheral primitive neuroectodermal tumour  ,not available,Central review Heidelberg,8,male,"supratentorial, meningeal (supratentorial), frontal; mesenchyme, cranium; ",recurrence ,EWS,methylation class Ewing sarcoma,62%,Not applicable,DNA_FFPE,7月11日,9968646165
EWS_02,9533774067_R04C02,INFORM (INdividualized Therapy FOr Relapsed Malignancies in Childhood) Registry,Ewing sarcoma / peripheral primitive neuroectodermal tumour  ,not available,Central review Heidelberg,12,male,"mesenchyme, thorax; ",not available,EWS,methylation class Ewing sarcoma,73%,Not applicable,DNA_KRYO,6月7日,9533774067
EWS_03,9878820009_R06C02,INFORM (INdividualized Therapy FOr Relapsed Malignancies in Childhood) Registry,Ewing sarcoma / peripheral primitive neuroectodermal tumour  ,not available,Central review Heidelberg,13,male,"mesenchyme, thorax; ",metastasis,EWS,methylation class Ewing sarcoma,69%,Not applicable,DNA_KRYO,10月10日,9878820009
EWS_04,9553932123_R05C02,University Hospital of Tuebingen,Ewing sarcoma / peripheral primitive neuroectodermal tumour  ,not available,Central review Heidelberg,13,female,"spinal, extradural, thoracic, T3; ",initial operation ,EWS,methylation class Ewing sarcoma,70%,Not applicable,DNA_FFPE,2月28日,9553932123
EWS_05,9533774024_R01C02,University Hospital of Bern,Ewing sarcoma / peripheral primitive neuroectodermal tumour  ,not available,Central review Heidelberg,15,female,"mesenchyme, thorax; ",metastasis,EWS,methylation class Ewing sarcoma,64%,Not applicable,DNA_FFPE,6月7日,9533774024
EWS_06,9376561024_R01C01,"Burdenko Neurosurgery Institute, Moscow",Ewing sarcoma / peripheral primitive neuroectodermal tumour  ,not available,Central review Heidelberg,16,male,"mesenchyme, cranium; ",not available,EWS,methylation class Ewing sarcoma,72%,Not applicable,DNA_FFPE,11月4日,9376561024
EWS_07,9829119119_R04C02,University Hospital of Heidelberg,Ewing sarcoma / peripheral primitive neuroectodermal tumour  ,not available,Central review Heidelberg,17,female,"mesenchyme, pelvis; ",initial operation ,EWS,methylation class Ewing sarcoma,68%,Not applicable,DNA_FFPE,5月23日,9829119119
EWS_08,9376538153_R06C02,"Burdenko Neurosurgery Institute, Moscow",Ewing sarcoma / peripheral primitive neuroectodermal tumour  ,not available,Central review Heidelberg,20,male,"mesenchyme, cranium; ",not available,EWS,methylation class Ewing sarcoma,57%,Not applicable,DNA_FFPE,10月25日,9376538153
EWS_09,10005839017_R06C01,INFORM (INdividualized Therapy FOr Relapsed Malignancies in Childhood) Registry,Ewing sarcoma / peripheral primitive neuroectodermal tumour  ,not available,Central review Heidelberg,24,female,"mesenchyme, thorax; ",metastasis,EWS,methylation class Ewing sarcoma,66%,Not applicable,DNA_KRYO,1月30日,10005839017
EWS_10,10006823143_R04C02,INFORM (INdividualized Therapy FOr Relapsed Malignancies in Childhood) Registry,Ewing sarcoma / peripheral primitive neuroectodermal tumour  ,not available,Central review Heidelberg,25,male,not available,recurrence ,EWS,methylation class Ewing sarcoma,77%,Not applicable,DNA_KRYO,1月12日,10006823143
EWS_11,9769100024_R06C02,INFORM (INdividualized Therapy FOr Relapsed Malignancies in Childhood) Registry,Ewing sarcoma / peripheral primitive neuroectodermal tumour  ,not available,Central review Heidelberg,25,female,"mesenchyme, thorax; ",metastasis,EWS,methylation class Ewing sarcoma,71%,Not applicable,DNA_KRYO,5月23日,9769100024
EWS_12,9721367020_R04C02,INFORM (INdividualized Therapy FOr Relapsed Malignancies in Childhood) Registry,Ewing sarcoma / peripheral primitive neuroectodermal tumour  ,not available,Central review Heidelberg,28,male,"mesenchyme, thorax; ",recurrence ,EWS,methylation class Ewing sarcoma,66%,Not applicable,DNA_KRYO,5月9日,9721367020
EWS_13,9426021086_R01C02,University Hospital of Tuebingen,Ewing sarcoma / peripheral primitive neuroectodermal tumour  ,not available,Central review Heidelberg,34,female,"spinal, extramedullary intradural, extradural; ",initial operation ,EWS,methylation class Ewing sarcoma,58%,Not applicable,DNA_FFPE,12月20日,9426021086
EWS_14,3999834063_R02C01,University Hospital of Heidelberg,Ewing sarcoma / peripheral primitive neuroectodermal tumour  ,not available,Central review Heidelberg,36,male,"spinal, extradural; ",initial operation ,EWS,methylation class Ewing sarcoma,71%,Not applicable,DNA_FFPE,2月13日,3999834063
GBM_G34_01,9969477058_R05C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,0,male,supratentorial; ,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",77%,LGm1,DNA_FFPE,8月4日,9969477058
GBM_G34_02,9444374134_R02C01,University Hospital of Tuebingen,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,10,male,"supratentorial, hemispheric, temporal;  right;",initial operation ,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",71%,LGm6,DNA_FFPE,1月27日,9444374134
GBM_G34_03,9741950030_R01C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,11,female,"supratentorial, hemispheric, temporal; ",not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",72%,LGm6,DNA_FFPE,3月28日,9741950030
GBM_G34_04,3999002049_R05C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,12,female,"supratentorial, hemispheric, parietal; ",initial operation ,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",73%,LGm6,DNA_FFPE,6月26日,3999002049
GBM_G34_05,9741950021_R02C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,13,male,"supratentorial, hemispheric; ",not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",72%,LGm6,DNA_FFPE,3月24日,9741950021
GBM_G34_06,9741950109_R03C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,14,male,"supratentorial, hemispheric, temporal; ",not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",65%,LGm5,DNA_FFPE,4月7日,9741950109
GBM_G34_07,9406922158_R06C01,University Hospital of Muenster,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,16,female,"supratentorial, hemispheric, temporal; ",not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",72%,LGm5,DNA_FFPE,10月18日,9406922158
GBM_G34_08,9406921073_R06C01,University Hospital of Muenster,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,18,male,"supratentorial, hemispheric, frontal; ",not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",79%,LGm6,DNA_FFPE,10月11日,9406921073
GBM_G34_09,9407210090_R01C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,19,male,supratentorial; ,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",83%,LGm6,DNA_FFPE,12月6日,9407210090
GBM_G34_10,9444375037_R04C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,20,female,"supratentorial, hemispheric; ",not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",83%,LGm6,DNA_FFPE,1月31日,9444375037
GBM_G34_11,9007225163_R01C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,20,male,"supratentorial, hemispheric, frontal;  left;",initial operation ,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",76%,LGm6,DNA_FFPE,4月19日,9007225163
GBM_G34_12,3999002051_R01C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,22,female,"supratentorial, hemispheric, parietal; ",initial operation ,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",67%,LGm5,DNA_FFPE,6月26日,3999002051
GBM_G34_13,9534104010_R02C01,University Hospital of Tuebingen,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,22,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",69%,LGm5,DNA_FFPE,6月27日,9534104010
GBM_G34_14,3999002051_R04C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,23,male,"supratentorial, hemispheric, parietal; ",initial operation ,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",67%,LGm5,DNA_FFPE,6月26日,3999002051
GBM_G34_15,9741950025_R05C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,30,female,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",77%,LGm4,DNA_FFPE,3月28日,9741950025
GBM_G34_16,3999002051_R05C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,32,female,"supratentorial, hemispheric, parietal; ",initial operation ,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",69%,LGm6,DNA_FFPE,6月26日,3999002051
GBM_G34_17,3999002049_R06C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,34,male,"supratentorial, hemispheric, parietal; ",initial operation ,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",73%,LGm5,DNA_FFPE,6月26日,3999002049
GBM_G34_18,9007225163_R05C02,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-wildtype ",not available,Central review Heidelberg,40,male,"supratentorial, hemispheric, occipital;  right;",recurrence ,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",68%,LGm5,DNA_FFPE,4月19日,9007225163
GBM_G34_19,6164621131_R02C01,University Hospital of Cambridge,"Glioblastoma, IDH-wildtype ",IV,Local review,not available ,not available,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",78%,LGm5,DNA_KRYO,9月29日,6164621131
GBM_G34_20,6164621131_R05C02,University Hospital of Cambridge,"Glioblastoma, IDH-wildtype ",IV,Local review,not available ,female,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",86%,LGm6,DNA_KRYO,9月29日,6164621131
GBM_G34_21,6164621131_R02C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",86%,LGm6,DNA_KRYO,9月29日,6164621131
GBM_G34_22,6164621155_R05C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",69%,LGm6,DNA_KRYO,9月29日,6164621155
GBM_G34_23,6164621081_R06C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",82%,LGm1,DNA_KRYO,9月29日,6164621081
GBM_G34_24,6969568103_R03C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",77%,LGm4,DNA_KRYO,4月27日,6969568103
GBM_G34_25,6969568103_R06C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",86%,LGm2,DNA_KRYO,4月27日,6969568103
GBM_G34_26,6969568103_R02C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",67%,LGm6,DNA_KRYO,4月27日,6969568103
GBM_G34_27,6969568103_R05C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",67%,LGm6,DNA_KRYO,4月27日,6969568103
GBM_G34_28,8622007029_R06C02,International Cancer Genome Consortium ,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",74%,LGm5,DNA_KRYO,10月23日,8622007029
GBM_G34_29,9878820117_R04C02,International Cancer Genome Consortium ,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",72%,LGm6,DNA_KRYO,10月27日,9878820117
GBM_G34_30,5684819014_R03C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",77%,LGm6,DNA_KRYO,6月10日,5684819014
GBM_G34_31,5684819014_R01C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",81%,LGm6,DNA_KRYO,6月10日,5684819014
GBM_G34_32,5911815001_R04C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",69%,LGm6,DNA_KRYO,6月10日,5911815001
GBM_G34_33,6929806024_R02C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",83%,LGm5,DNA_KRYO,7月2日,6929806024
GBM_G34_34,5684819013_R05C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",84%,LGm6,DNA_KRYO,6月10日,5684819013
GBM_G34_35,5911815001_R02C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",75%,LGm6,DNA_KRYO,6月10日,5911815001
GBM_G34_36,6164621081_R04C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",75%,LGm6,DNA_KRYO,9月29日,6164621081
GBM_G34_37,9444375004_R06C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",76%,LGm6,DNA_FFPE,1月31日,9444375004
GBM_G34_38,9444375004_R01C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",75%,LGm5,DNA_FFPE,1月31日,9444375004
GBM_G34_39,9444375004_R05C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,not available,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",80%,LGm6,DNA_FFPE,1月31日,9444375004
GBM_G34_40,9444375017_R03C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,not available,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",73%,LGm6,DNA_FFPE,1月31日,9444375017
GBM_G34_41,9741950100_R02C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_G34,"methylation class glioblastoma, IDH wildtype, H3.3 G34 mutant",69%,LGm6,DNA_FFPE,4月7日,9741950100
GBM_MES_01,6229017120_R01C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,40,female,not available,not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",65%,LGm5,DNA_KRYO,4月13日,6229017120
GBM_MES_02,9969477058_R03C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,43,female,"supratentorial, hemispheric, temporal;  right;",initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",54%,LGm4,DNA_FFPE,8月4日,9969477058
GBM_MES_03,8942326114_R02C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,44,female,"supratentorial, hemispheric, frontal; ",not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",78%,LGm5,DNA_KRYO,1月18日,8942326114
GBM_MES_04,3999875073_R02C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,44,female,supratentorial; ,initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",68%,LGm4,DNA_FFPE,3月6日,3999875073
GBM_MES_05,6229017111_R04C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,45,female,not available,not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",61%,LGm5,DNA_KRYO,4月13日,6229017111
GBM_MES_06,9407210003_R06C01,University Hospital of Heidelberg,"Gliosarcoma, IDH-wildtype ",IV,Central review Heidelberg,46,male,"supratentorial, hemispheric, temporal;  left;",not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",60%,LGm5,DNA_FFPE,12月6日,9407210003
GBM_MES_07,3998952003_R04C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,48,female,"supratentorial, hemispheric, frontal; ",not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",59%,LGm5,DNA_FFPE,6月12日,3998952003
GBM_MES_08,9611518109_R01C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,48,female,"supratentorial, hemispheric, frontal; ",not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",71%,LGm5,DNA_KRYO,3月7日,9611518109
GBM_MES_09,6229017120_R02C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,48,male,not available,not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",62%,LGm4,DNA_KRYO,4月13日,6229017120
GBM_MES_10,6229017120_R04C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,48,male,not available,not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",63%,LGm4,DNA_KRYO,4月13日,6229017120
GBM_MES_11,6229017120_R02C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,49,male,not available,not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",62%,LGm4,DNA_KRYO,4月13日,6229017120
GBM_MES_12,6229017111_R01C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,49,female,not available,not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",68%,LGm5,DNA_KRYO,4月13日,6229017111
GBM_MES_13,9611518110_R04C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,50,female,"supratentorial, hemispheric, frontal; ",not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",65%,LGm5,DNA_KRYO,3月7日,9611518110
GBM_MES_14,9969477074_R03C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,50,male,not available,not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",67%,LGm4,DNA_FFPE,8月15日,9969477074
GBM_MES_15,9534104007_R03C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,51,male,"supratentorial, hemispheric, temporal, parietal;  right;",recurrence ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",64%,LGm4,DNA_FFPE,6月27日,9534104007
GBM_MES_16,9878820127_R06C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,51,female,"supratentorial, hemispheric;  left;",initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",67%,LGm4,DNA_FFPE,10月31日,9878820127
GBM_MES_17,9513149129_R05C01,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,52,male,"supratentorial, hemispheric, frontal;  left;",initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",68%,LGm4,DNA_FFPE,4月14日,9513149129
GBM_MES_18,6229017111_R06C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,52,female,not available,not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",66%,LGm5,DNA_KRYO,4月13日,6229017111
GBM_MES_19,9878827210_R05C01,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,54,female,"supratentorial, hemispheric, temporal;  right;",initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",63%,LGm5,DNA_FFPE,11月21日,9878827210
GBM_MES_20,3999308200_R06C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,54,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",69%,LGm4,DNA_FFPE,4月6日,3999308200
GBM_MES_21,9855358058_R05C02,Charite Universitaetsmedizin Berlin,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,55,female,"supratentorial, hemispheric, parietal;  left;",initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",67%,LGm4,DNA_FFPE,10月6日,9855358058
GBM_MES_22,9878820082_R04C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,55,female,"supratentorial, hemispheric, parietal; ",not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",65%,LGm4,DNA_KRYO,10月17日,9878820082
GBM_MES_23,9878820030_R01C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,56,female,"supratentorial, hemispheric, parietal;  left;",initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",65%,LGm5,DNA_FFPE,10月17日,9878820030
GBM_MES_24,9969477102_R06C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,57,female,"supratentorial, hemispheric, parietal;  right;",recurrence ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",50%,LGm5,DNA_FFPE,8月22日,9969477102
GBM_MES_25,9969477022_R04C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,58,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",67%,LGm5,DNA_FFPE,7月25日,9969477022
GBM_MES_26,9007225086_R02C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,59,female,"supratentorial, hemispheric, frontal;  left;",not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",61%,LGm4,DNA_FFPE,3月28日,9007225086
GBM_MES_27,9969477088_R06C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,59,male,supratentorial; ,initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",71%,LGm4,DNA_FFPE,8月22日,9969477088
GBM_MES_28,9533774033_R05C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,60,male,"supratentorial, hemispheric, temporal;  right;",initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",67%,LGm4,DNA_FFPE,6月7日,9533774033
GBM_MES_29,9407201028_R01C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,60,male,"supratentorial, hemispheric, temporal, parietal;  left;",not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",65%,LGm4,DNA_FFPE,12月2日,9407201028
GBM_MES_30,8963282062_R03C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,61,female,"supratentorial, hemispheric, parietal; ",not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",67%,LGm5,DNA_KRYO,1月28日,8963282062
GBM_MES_31,9721365103_R01C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,61,female,not available,not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",61%,LGm5,DNA_KRYO,3月25日,9721365103
GBM_MES_32,9855358066_R02C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,62,female,"supratentorial, hemispheric, frontal; ",not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",63%,LGm4,DNA_KRYO,10月6日,9855358066
GBM_MES_33,9611518117_R05C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,63,male,"supratentorial, hemispheric, occipital; ",not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",64%,LGm5,DNA_KRYO,3月15日,9611518117
GBM_MES_34,9611518115_R03C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,63,male,not available,not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",65%,LGm5,DNA_KRYO,3月15日,9611518115
GBM_MES_35,9969477100_R02C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,63,female,not available,initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",65%,LGm4,DNA_FFPE,8月22日,9969477100
GBM_MES_36,9968646165_R02C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,64,male,"supratentorial, hemispheric, frontal, temporal;  left;",initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",55%,LGm5,DNA_FFPE,7月11日,9968646165
GBM_MES_37,9553932029_R05C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,65,female,"supratentorial, hemispheric, temporal, occipital; ",initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",66%,LGm4,DNA_FFPE,2月21日,9553932029
GBM_MES_38,10006823155_R04C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,65,male,"supratentorial, hemispheric, frontal;  left;",initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",66%,LGm4,DNA_FFPE,1月30日,10006823155
GBM_MES_39,8963282018_R02C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,66,male,"supratentorial, hemispheric, parietal; ",not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",64%,LGm5,DNA_KRYO,1月28日,8963282018
GBM_MES_40,10003886256_R01C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,66,female,"supratentorial, hemispheric, parietal;  right;",initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",66%,LGm4,DNA_FFPE,1月23日,10003886256
GBM_MES_41,9878820117_R06C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,67,female,not available,not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",70%,LGm4,DNA_KRYO,10月27日,9878820117
GBM_MES_42,3999834094_R04C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,68,female,"supratentorial, hemispheric, frontal;  right;",not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",63%,LGm5,DNA_FFPE,2月20日,3999834094
GBM_MES_43,3999547142_R02C02,University Hospital of Heidelberg,"Gliosarcoma, IDH-wildtype ",IV,Central review Heidelberg,71,male,"supratentorial, hemispheric, parietal;  left;",initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",72%,LGm4,DNA_FFPE,3月14日,3999547142
GBM_MES_44,3999100034_R03C02,University Hospital of Heidelberg,"Gliosarcoma, IDH-wildtype ",IV,Central review Heidelberg,71,female,"supratentorial, hemispheric, temporal;  right;",not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",53%,LGm5,DNA_FFPE,3月20日,3999100034
GBM_MES_45,9721365105_R01C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,72,male,not available,not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",70%,LGm5,DNA_KRYO,3月25日,9721365105
GBM_MES_46,9968646167_R05C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,72,male,"supratentorial, hemispheric, frontal, parietal;  right;",initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",61%,LGm5,DNA_FFPE,7月11日,9968646167
GBM_MES_47,3999875057_R05C01,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,73,male,"supratentorial, hemispheric, temporal;  right;",initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",64%,LGm5,DNA_FFPE,1月16日,3999875057
GBM_MES_48,8963311098_R02C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,73,male,"supratentorial, hemispheric, temporal; ",not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",69%,LGm4,DNA_KRYO,1月28日,8963311098
GBM_MES_49,9533774041_R03C01,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,74,male,"supratentorial, hemispheric, temporal;  left;",initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",68%,LGm4,DNA_FFPE,6月7日,9533774041
GBM_MES_50,3999112137_R02C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,76,male,"supratentorial, hemispheric, occipital;  left;",initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",63%,LGm4,DNA_FFPE,3月27日,3999112137
GBM_MES_51,9855358065_R05C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,78,male,"supratentorial, hemispheric, temporal; ",not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",67%,LGm4,DNA_KRYO,10月6日,9855358065
GBM_MES_52,9969477065_R01C01,University Hospital of Frankfurt am Main,"Gliosarcoma, IDH-wildtype ",IV,Central review Heidelberg,86,female,supratentorial;  right;,initial operation ,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",54%,LGm5,DNA_FFPE,8月8日,9969477065
GBM_MES_53,3999100065_R06C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,not available ,male,not available,not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",69%,LGm5,DNA_KRYO,3月23日,3999100065
GBM_MES_54,6969568010_R04C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",65%,LGm4,DNA_KRYO,4月27日,6969568010
GBM_MES_55,6969568010_R01C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",71%,LGm5,DNA_KRYO,4月27日,6969568010
GBM_MES_56,3999112158_R04C01,University Hospital of Zurich,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_MES,"methylation class glioblastoma, IDH wildtype, subclass mesenchymal",66%,LGm5,DNA_KRYO,4月6日,3999112158
GBM_MID_01,9969477031_R04C02,"The Institute of Cancer Research, London","Glioblastoma, IDH-wildtype ",IV,Local review,2,female,"supratentorial, hemispheric, frontal; ",not available,GBM_MID,"methylation class glioblastoma, IDH wildtype, subclass midline ",73%,LGm6,DNA_FFPE,7月25日,9969477031
GBM_MID_02,3999834105_R02C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,10,male,"posterior fossa, cerebellum, hemispheric (cerebellum), vermis; ",initial operation ,GBM_MID,"methylation class glioblastoma, IDH wildtype, subclass midline ",67%,LGm6,DNA_FFPE,2月27日,3999834105
GBM_MID_03,9969477063_R02C02,"The Institute of Cancer Research, London","Glioblastoma, IDH-wildtype ",IV,Local review,11,female,"posterior fossa, cerebellum; ",not available,GBM_MID,"methylation class glioblastoma, IDH wildtype, subclass midline ",67%,LGm1,DNA_FFPE,8月4日,9969477063
GBM_MID_04,9741950099_R02C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,11,female,"supratentorial, hemispheric, frontal; ",not available,GBM_MID,"methylation class glioblastoma, IDH wildtype, subclass midline ",79%,LGm6,DNA_FFPE,4月7日,9741950099
GBM_MID_05,9533774097_R01C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,12,male,"supratentorial, hemispheric, frontal;  left;",recurrence ,GBM_MID,"methylation class glioblastoma, IDH wildtype, subclass midline ",76%,LGm6,DNA_FFPE,6月16日,9533774097
GBM_MID_06,9741950100_R04C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,13,male,"supratentorial, hemispheric, parietal; ",not available,GBM_MID,"methylation class glioblastoma, IDH wildtype, subclass midline ",76%,LGm1,DNA_FFPE,4月7日,9741950100
GBM_MID_07,9969477086_R01C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,59,male,"supratentorial, hemispheric, parietal;  left;",initial operation ,GBM_MID,"methylation class glioblastoma, IDH wildtype, subclass midline ",79%,LGm6,DNA_FFPE,8月22日,9969477086
GBM_MID_08,3999834021_R05C01,University Hospital of Tuebingen,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,60,male,"posterior fossa, cerebellum, hemispheric (cerebellum), vermis;  right;",initial operation ,GBM_MID,"methylation class glioblastoma, IDH wildtype, subclass midline ",67%,LGm6,DNA_FFPE,2月6日,3999834021
GBM_MID_09,3999543050_R02C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,63,female,"supratentorial, diencephalic, thalamic;  left;",not available,GBM_MID,"methylation class glioblastoma, IDH wildtype, subclass midline ",68%,LGm6,DNA_FFPE,3月14日,3999543050
GBM_MID_10,3999834021_R04C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,71,male,"posterior fossa, cerebellum;  right;",initial operation ,GBM_MID,"methylation class glioblastoma, IDH wildtype, subclass midline ",76%,LGm5,DNA_FFPE,2月6日,3999834021
GBM_MID_11,9878820018_R01C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,79,male,"supratentorial, hemispheric, frontal, temporal;  left;",initial operation ,GBM_MID,"methylation class glioblastoma, IDH wildtype, subclass midline ",69%,LGm6,DNA_FFPE,10月17日,9878820018
GBM_MID_12,9855358032_R03C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,not available ,not available,not available,not available,GBM_MID,"methylation class glioblastoma, IDH wildtype, subclass midline ",71%,LGm6,DNA_FFPE,9月26日,9855358032
GBM_MID_13,8622007063_R01C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_MID,"methylation class glioblastoma, IDH wildtype, subclass midline ",82%,LGm6,DNA_KRYO,11月12日,8622007063
GBM_MID_14,9374341006_R04C02,International Cancer Genome Consortium ,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_MID,"methylation class glioblastoma, IDH wildtype, subclass midline ",73%,LGm6,DNA_KRYO,8月23日,9374341006
GBM_MYCN_01,9297949146_R06C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,3,male,"posterior fossa, brain stem; ",not available,GBM_MYCN,"methylation class glioblastoma, IDH wildtype, subclass MYCN",72%,LGm6,DNA_KRYO,6月28日,9297949146
GBM_MYCN_02,9969477031_R04C01,"The Institute of Cancer Research, London","Glioblastoma, IDH-wildtype ",IV,Local review,5,male,"posterior fossa, brain stem, pons; ",not available,GBM_MYCN,"methylation class glioblastoma, IDH wildtype, subclass MYCN",75%,LGm6,DNA_FFPE,7月25日,9969477031
GBM_MYCN_03,9741950008_R06C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,5,female,"posterior fossa, cerebellum, hemispheric (cerebellum), vermis; ",initial operation ,GBM_MYCN,"methylation class glioblastoma, IDH wildtype, subclass MYCN",73%,LGm6,DNA_FFPE,3月24日,9741950008
GBM_MYCN_04,9533774046_R05C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,10,female,"supratentorial, hemispheric, temporal; ",not available,GBM_MYCN,"methylation class glioblastoma, IDH wildtype, subclass MYCN",67%,LGm6,DNA_FFPE,6月7日,9533774046
GBM_MYCN_05,3998909073_R04C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,11,male,"supratentorial, hemispheric, parietal; ",initial operation ,GBM_MYCN,"methylation class glioblastoma, IDH wildtype, subclass MYCN",75%,LGm1,DNA_FFPE,5月22日,3998909073
GBM_MYCN_06,9741950099_R01C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,13,female,"supratentorial, hemispheric, frontal; ",not available,GBM_MYCN,"methylation class glioblastoma, IDH wildtype, subclass MYCN",68%,LGm6,DNA_FFPE,4月7日,9741950099
GBM_MYCN_07,9741950100_R06C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,15,male,"supratentorial, hemispheric, frontal, temporal; ",not available,GBM_MYCN,"methylation class glioblastoma, IDH wildtype, subclass MYCN",66%,LGm6,DNA_FFPE,4月7日,9741950100
GBM_MYCN_08,10003886258_R06C01,University Hospital of Muenster,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,56,male,"posterior fossa, cerebellum; ",initial operation ,GBM_MYCN,"methylation class glioblastoma, IDH wildtype, subclass MYCN",70%,LGm6,DNA_FFPE,1月23日,10003886258
GBM_MYCN_09,101231000030_R03C02,University Hospital of Giessen,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,"supratentorial, hemispheric, frontal, diencephalic, sellar region; ",not available,GBM_MYCN,"methylation class glioblastoma, IDH wildtype, subclass MYCN",75%,LGm5,DNA_FFPE,9月25日,1.01231E+11
GBM_MYCN_10,3999547085_R02C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_MYCN,"methylation class glioblastoma, IDH wildtype, subclass MYCN",68%,LGm6,DNA_KRYO,4月17日,3999547085
GBM_MYCN_11,9969477029_R03C02,"The Institute of Cancer Research, London","Glioblastoma, IDH-wildtype ",IV,Local review,not available ,female,not available,not available,GBM_MYCN,"methylation class glioblastoma, IDH wildtype, subclass MYCN",69%,LGm1,DNA_FFPE,7月25日,9969477029
GBM_MYCN_12,9340996014_R02C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_MYCN,"methylation class glioblastoma, IDH wildtype, subclass MYCN",67%,LGm6,DNA_FFPE,8月9日,9340996014
GBM_MYCN_13,9444375019_R04C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,not available,not available,not available,GBM_MYCN,"methylation class glioblastoma, IDH wildtype, subclass MYCN",71%,LGm6,DNA_FFPE,1月31日,9444375019
GBM_MYCN_14,9444375019_R05C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_MYCN,"methylation class glioblastoma, IDH wildtype, subclass MYCN",75%,LGm6,DNA_FFPE,1月31日,9444375019
GBM_MYCN_15,9444375014_R03C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_MYCN,"methylation class glioblastoma, IDH wildtype, subclass MYCN",68%,LGm6,DNA_FFPE,1月31日,9444375014
GBM_MYCN_16,5684819026_R01C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_MYCN,"methylation class glioblastoma, IDH wildtype, subclass MYCN",82%,LGm6,DNA_KRYO,6月10日,5684819026
GBM_RTK_I_01,9969477121_R01C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,29,male,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",68%,LGm5,DNA_FFPE,9月6日,9969477121
GBM_RTK_I_02,8622007144_R03C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,32,female,"supratentorial, hemispheric, parietal; ",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",84%,LGm4,DNA_KRYO,1月16日,8622007144
GBM_RTK_I_03,9721365095_R03C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,33,male,"supratentorial, hemispheric, parietal; ",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",72%,LGm5,DNA_KRYO,3月25日,9721365095
GBM_RTK_I_04,9969477031_R06C02,"The Institute of Cancer Research, London","Glioblastoma, IDH-wildtype ",IV,Local review,34,male,not available,not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",69%,LGm5,DNA_FFPE,7月25日,9969477031
GBM_RTK_I_05,9533774088_R02C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,39,male,"supratentorial, hemispheric, temporal;  right;",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",74%,LGm5,DNA_FFPE,6月16日,9533774088
GBM_RTK_I_06,9741950075_R01C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,46,male,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",68%,LGm5,DNA_KRYO,4月7日,9741950075
GBM_RTK_I_07,9878820018_R03C02,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,48,male,"supratentorial, hemispheric, temporal;  right;",initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",71%,LGm5,DNA_FFPE,10月17日,9878820018
GBM_RTK_I_08,9969477101_R02C02,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,49,male,"supratentorial, hemispheric, parietal;  left;",initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",69%,LGm4,DNA_FFPE,8月22日,9969477101
GBM_RTK_I_09,6229017111_R02C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,49,female,not available,not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",83%,LGm5,DNA_KRYO,4月13日,6229017111
GBM_RTK_I_10,9878820030_R04C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,52,male,"supratentorial, hemispheric; ",initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",78%,LGm4,DNA_FFPE,10月17日,9878820030
GBM_RTK_I_11,3999875055_R02C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,53,male,"supratentorial, hemispheric, temporal;  left;",initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",79%,LGm4,DNA_FFPE,1月16日,3999875055
GBM_RTK_I_12,9721365137_R03C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,54,female,not available,not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",69%,LGm5,DNA_KRYO,3月25日,9721365137
GBM_RTK_I_13,9878820083_R06C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,56,male,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",71%,LGm5,DNA_KRYO,10月17日,9878820083
GBM_RTK_I_14,9721366149_R02C02,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,57,female,"supratentorial, hemispheric, frontal;  left;",initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",75%,LGm4,DNA_FFPE,5月9日,9721366149
GBM_RTK_I_15,9878820106_R06C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,57,male,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",69%,LGm4,DNA_KRYO,10月27日,9878820106
GBM_RTK_I_16,3999875115_R01C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,57,female,"supratentorial, hemispheric, temporal;  right;",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",68%,LGm5,DNA_FFPE,3月6日,3999875115
GBM_RTK_I_17,9379082092_R03C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,57,male,"supratentorial, hemispheric, frontal;  left;",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",74%,LGm4,DNA_FFPE,11月8日,9379082092
GBM_RTK_I_18,9721365095_R02C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,58,male,not available,not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",69%,LGm5,DNA_KRYO,3月25日,9721365095
GBM_RTK_I_19,9969477018_R05C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,58,male,"supratentorial, hemispheric, occipital; ",initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",80%,LGm4,DNA_FFPE,7月25日,9969477018
GBM_RTK_I_20,9534104007_R02C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,59,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",76%,LGm4,DNA_FFPE,6月27日,9534104007
GBM_RTK_I_21,10006823123_R02C01,University Hospital of Bergen,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,60,female,"supratentorial, hemispheric, frontal;  right;",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",68%,LGm5,DNA_FFPE,1月12日,10006823123
GBM_RTK_I_22,9855358026_R01C02,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,61,male,"supratentorial, hemispheric, parietal;  left;",initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",69%,LGm5,DNA_FFPE,9月26日,9855358026
GBM_RTK_I_23,9878820140_R05C02,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,63,male,"supratentorial, diencephalic, basal ganglia;  left;",initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",68%,LGm5,DNA_FFPE,11月7日,9878820140
GBM_RTK_I_24,9611518113_R01C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,63,male,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",80%,LGm5,DNA_KRYO,3月7日,9611518113
GBM_RTK_I_25,9855358065_R05C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,64,male,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",80%,LGm5,DNA_KRYO,10月6日,9855358065
GBM_RTK_I_26,9878820082_R06C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,64,female,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",81%,LGm4,DNA_KRYO,10月17日,9878820082
GBM_RTK_I_27,9611518116_R02C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,64,female,not available,not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",70%,LGm4,DNA_KRYO,3月15日,9611518116
GBM_RTK_I_28,9373551023_R03C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,64,female,"supratentorial, hemispheric, frontal, temporal;  right;",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",77%,LGm5,DNA_FFPE,8月23日,9373551023
GBM_RTK_I_29,3999308203_R02C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,64,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",68%,LGm4,DNA_FFPE,4月6日,3999308203
GBM_RTK_I_30,9721365095_R06C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,65,male,not available,not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",87%,LGm5,DNA_KRYO,3月25日,9721365095
GBM_RTK_I_31,9878820018_R03C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,65,male,"supratentorial, hemispheric, temporal, occipital; ",initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",66%,LGm5,DNA_FFPE,10月17日,9878820018
GBM_RTK_I_32,10006823069_R04C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,65,female,supratentorial; ,initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",72%,LGm5,DNA_FFPE,12月19日,10006823069
GBM_RTK_I_33,3999112130_R01C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,65,female,"supratentorial, hemispheric, temporal;  right;",initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",75%,LGm5,DNA_FFPE,3月27日,3999112130
GBM_RTK_I_34,9855358065_R03C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,67,male,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",75%,LGm5,DNA_KRYO,10月6日,9855358065
GBM_RTK_I_35,8963311098_R04C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,67,male,"supratentorial, hemispheric, frontal; ",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",67%,LGm5,DNA_KRYO,1月28日,8963311098
GBM_RTK_I_36,3999834118_R01C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,67,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",67%,LGm4,DNA_FFPE,2月27日,3999834118
GBM_RTK_I_37,3999834068_R03C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,68,male,"supratentorial, hemispheric, parietal;  left;",initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",68%,LGm4,DNA_FFPE,2月13日,3999834068
GBM_RTK_I_38,9741779119_R05C02,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,71,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",73%,LGm4,DNA_FFPE,5月16日,9741779119
GBM_RTK_I_39,9007217139_R02C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,71,female,"supratentorial, hemispheric, parietal; ",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",85%,LGm5,DNA_KRYO,2月19日,9007217139
GBM_RTK_I_40,9855358065_R01C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,71,male,"supratentorial, hemispheric, frontal; ",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",71%,LGm5,DNA_KRYO,10月6日,9855358065
GBM_RTK_I_41,9969477074_R06C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,72,male,supratentorial;  left; right;,initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",76%,LGm5,DNA_FFPE,8月15日,9969477074
GBM_RTK_I_42,9878820105_R02C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,73,male,"supratentorial, hemispheric, parietal;  right;",initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",67%,LGm4,DNA_FFPE,10月27日,9878820105
GBM_RTK_I_43,8942326114_R05C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,76,male,"supratentorial, hemispheric, parietal; ",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",70%,LGm5,DNA_KRYO,1月18日,8942326114
GBM_RTK_I_44,9969477014_R02C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,76,female,"supratentorial, hemispheric, temporal, parietal;  right;",initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",77%,LGm4,DNA_FFPE,7月18日,9969477014
GBM_RTK_I_45,3999875071_R01C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,76,male,supratentorial; ,initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",73%,LGm4,DNA_FFPE,3月6日,3999875071
GBM_RTK_I_46,9878827221_R05C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,77,male,"supratentorial, hemispheric, parietal, occipital;  right;",initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",69%,LGm5,DNA_FFPE,11月28日,9878827221
GBM_RTK_I_47,9007217139_R01C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,78,male,"supratentorial, hemispheric, parietal; ",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",82%,LGm5,DNA_KRYO,2月19日,9007217139
GBM_RTK_I_48,8963282062_R02C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,78,male,not available,not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",69%,LGm4,DNA_KRYO,1月28日,8963282062
GBM_RTK_I_49,9611518099_R04C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,80,male,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",77%,LGm5,DNA_KRYO,3月7日,9611518099
GBM_RTK_I_50,9407210090_R04C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,82,male,"supratentorial, hemispheric, frontal, parietal;  right;",initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",84%,LGm4,DNA_FFPE,12月6日,9407210090
GBM_RTK_I_51,9969477018_R03C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,84,male,"supratentorial, hemispheric, parietal; ",initial operation ,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",69%,LGm4,DNA_FFPE,7月25日,9969477018
GBM_RTK_I_52,9878820091_R01C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,not available ,female,not available,not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",71%,LGm4,DNA_FFPE,10月27日,9878820091
GBM_RTK_I_53,9878820078_R05C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,not available ,not available,not available,not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",78%,LGm5,DNA_KRYO,10月17日,9878820078
GBM_RTK_I_54,9878820119_R01C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,not available ,female,not available,not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",80%,LGm4,DNA_KRYO,10月27日,9878820119
GBM_RTK_I_55,9878820082_R02C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,not available ,female,not available,not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",65%,LGm5,DNA_KRYO,10月17日,9878820082
GBM_RTK_I_56,9878820119_R02C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,not available ,female,not available,not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",82%,LGm4,DNA_KRYO,10月27日,9878820119
GBM_RTK_I_57,8622007011_R03C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",70%,LGm5,DNA_KRYO,10月27日,8622007011
GBM_RTK_I_58,8622007019_R06C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",81%,LGm4,DNA_KRYO,10月27日,8622007019
GBM_RTK_I_59,8622007013_R04C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",73%,LGm4,DNA_KRYO,10月27日,8622007013
GBM_RTK_I_60,8622007013_R05C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",83%,LGm5,DNA_KRYO,10月27日,8622007013
GBM_RTK_I_61,8622007014_R06C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",73%,LGm5,DNA_KRYO,10月27日,8622007014
GBM_RTK_I_62,8622007020_R02C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",77%,LGm4,DNA_KRYO,10月27日,8622007020
GBM_RTK_I_63,6285641005_R06C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",72%,LGm4,DNA_FFPE,6月13日,6285641005
GBM_RTK_I_64,6969568010_R02C02,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_RTK_I,"methylation class glioblastoma, IDH wildtype, subclass RTK I",67%,LGm5,DNA_KRYO,4月27日,6969568010
GBM_RTK_II_01,9969477121_R05C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,36,female,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",70%,LGm4,DNA_FFPE,9月6日,9969477121
GBM_RTK_II_02,8963311098_R02C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,37,male,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",74%,LGm4,DNA_FFPE,1月28日,8963311098
GBM_RTK_II_03,9855358068_R05C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,39,female,"supratentorial, hemispheric, frontal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",81%,LGm4,DNA_KRYO,10月6日,9855358068
GBM_RTK_II_04,6229017103_R03C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,39,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",72%,LGm4,DNA_KRYO,4月13日,6229017103
GBM_RTK_II_05,9534104008_R02C02,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,40,male,"supratentorial, hemispheric, temporal;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",68%,LGm5,DNA_FFPE,6月27日,9534104008
GBM_RTK_II_06,8963282018_R01C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,42,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",66%,LGm5,DNA_KRYO,1月28日,8963282018
GBM_RTK_II_07,8963282039_R05C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,44,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",78%,LGm5,DNA_KRYO,1月28日,8963282039
GBM_RTK_II_08,9373550164_R05C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,46,female,"supratentorial, hemispheric, frontal;  left;",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",76%,LGm4,DNA_FFPE,8月21日,9373550164
GBM_RTK_II_09,9721366150_R01C01,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,47,female,"supratentorial, hemispheric, frontal;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",68%,LGm5,DNA_FFPE,5月9日,9721366150
GBM_RTK_II_10,9611518116_R01C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,47,female,"supratentorial, hemispheric, frontal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",72%,LGm4,DNA_KRYO,3月15日,9611518116
GBM_RTK_II_100,9878820140_R03C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,74,female,"supratentorial, hemispheric, parietal;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",75%,LGm4,DNA_FFPE,11月7日,9878820140
GBM_RTK_II_101,10006823022_R03C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,74,male,"supratentorial, hemispheric, temporal;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",68%,LGm4,DNA_FFPE,12月12日,10006823022
GBM_RTK_II_102,9855358026_R03C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,74,male,"supratentorial, hemispheric, occipital;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",67%,LGm4,DNA_FFPE,9月26日,9855358026
GBM_RTK_II_103,9721365105_R05C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,74,male,"supratentorial, hemispheric, parietal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",70%,LGm4,DNA_KRYO,3月25日,9721365105
GBM_RTK_II_104,9980102013_R01C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,75,male,"supratentorial, hemispheric, temporal, occipital;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",73%,LGm4,DNA_FFPE,11月14日,9980102013
GBM_RTK_II_105,10006823069_R02C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,75,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",76%,LGm4,DNA_FFPE,12月19日,10006823069
GBM_RTK_II_106,3999875115_R01C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,75,female,"supratentorial, hemispheric, frontal;  right;",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",78%,LGm5,DNA_FFPE,3月6日,3999875115
GBM_RTK_II_107,9221197135_R04C01,University Hospital of Heidelberg,"Gliosarcoma, IDH-wildtype ",IV,Central review Heidelberg,75,female,"supratentorial, hemispheric, temporal;  right;",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",59%,LGm5,DNA_FFPE,3月28日,9221197135
GBM_RTK_II_108,3999875076_R06C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,76,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",68%,LGm4,DNA_FFPE,3月6日,3999875076
GBM_RTK_II_109,3999100033_R01C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,76,male,"supratentorial, hemispheric, frontal;  left;",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",66%,LGm4,DNA_FFPE,3月20日,3999100033
GBM_RTK_II_11,9878820082_R05C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,47,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",71%,LGm4,DNA_KRYO,10月17日,9878820082
GBM_RTK_II_110,3998952004_R02C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,77,female,"supratentorial, hemispheric, parietal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",72%,LGm4,DNA_KRYO,6月12日,3998952004
GBM_RTK_II_111,9969477088_R05C01,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,78,female,"supratentorial, hemispheric, occipital;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",69%,LGm5,DNA_FFPE,8月22日,9969477088
GBM_RTK_II_112,9534104007_R04C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,78,female,"supratentorial, hemispheric, parietal;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",71%,LGm4,DNA_FFPE,6月27日,9534104007
GBM_RTK_II_113,3999834104_R04C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,78,male,"supratentorial, hemispheric; ",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",68%,LGm4,DNA_FFPE,2月27日,3999834104
GBM_RTK_II_114,8959312010_R03C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,79,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",78%,LGm4,DNA_KRYO,1月28日,8959312010
GBM_RTK_II_115,9647455008_R06C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,81,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",78%,LGm4,DNA_FFPE,4月11日,9647455008
GBM_RTK_II_116,8963311098_R05C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,82,female,"supratentorial, hemispheric, parietal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",73%,LGm4,DNA_KRYO,1月28日,8963311098
GBM_RTK_II_117,3998952004_R02C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,86,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",80%,LGm4,DNA_KRYO,6月12日,3998952004
GBM_RTK_II_118,9878820106_R06C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,not available ,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",68%,LGm4,DNA_FFPE,10月27日,9878820106
GBM_RTK_II_119,9855358032_R01C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,not available ,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",65%,LGm4,DNA_FFPE,9月26日,9855358032
GBM_RTK_II_12,9611518117_R06C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,47,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",73%,LGm5,DNA_KRYO,3月15日,9611518117
GBM_RTK_II_120,3999834063_R05C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,not available ,male,"posterior fossa, cerebellum; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",64%,LGm4,DNA_FFPE,2月13日,3999834063
GBM_RTK_II_121,8622007011_R01C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",67%,LGm4,DNA_KRYO,10月27日,8622007011
GBM_RTK_II_122,8622007019_R04C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",63%,LGm4,DNA_KRYO,10月27日,8622007019
GBM_RTK_II_123,8622007019_R05C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",67%,LGm4,DNA_KRYO,10月27日,8622007019
GBM_RTK_II_124,8622007011_R05C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",79%,LGm4,DNA_KRYO,10月27日,8622007011
GBM_RTK_II_125,8622007013_R02C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",80%,LGm4,DNA_KRYO,10月27日,8622007013
GBM_RTK_II_126,8622007013_R01C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",80%,LGm5,DNA_KRYO,10月27日,8622007013
GBM_RTK_II_127,8622007013_R06C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",73%,LGm4,DNA_KRYO,10月27日,8622007013
GBM_RTK_II_128,8622007014_R02C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",66%,LGm4,DNA_KRYO,10月27日,8622007014
GBM_RTK_II_129,8622007014_R02C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",75%,LGm4,DNA_KRYO,10月27日,8622007014
GBM_RTK_II_13,6229017111_R05C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,47,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",71%,LGm4,DNA_KRYO,4月13日,6229017111
GBM_RTK_II_130,8622007014_R04C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",68%,LGm4,DNA_KRYO,10月27日,8622007014
GBM_RTK_II_131,8622007019_R06C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",75%,LGm4,DNA_KRYO,10月27日,8622007019
GBM_RTK_II_132,8622007020_R06C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",71%,LGm4,DNA_KRYO,10月27日,8622007020
GBM_RTK_II_133,6969568010_R02C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",78%,LGm4,DNA_KRYO,4月27日,6969568010
GBM_RTK_II_134,6969568010_R03C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",78%,LGm4,DNA_KRYO,4月27日,6969568010
GBM_RTK_II_135,6929793058_R01C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",65%,LGm4,DNA_KRYO,4月20日,6929793058
GBM_RTK_II_136,6929793058_R02C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",76%,LGm4,DNA_KRYO,4月20日,6929793058
GBM_RTK_II_137,6285641004_R02C02,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",77%,LGm4,DNA_FFPE,6月13日,6285641004
GBM_RTK_II_138,6285641004_R05C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",68%,LGm4,DNA_FFPE,6月13日,6285641004
GBM_RTK_II_139,6285641005_R05C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",70%,LGm4,DNA_FFPE,6月13日,6285641005
GBM_RTK_II_14,9534104008_R06C02,University Hospital of Tuebingen,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,47,male,"supratentorial, hemispheric, parietal, occipital;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",69%,LGm5,DNA_FFPE,6月27日,9534104008
GBM_RTK_II_140,6969568010_R05C02,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",72%,LGm4,DNA_KRYO,4月27日,6969568010
GBM_RTK_II_141,6285641005_R01C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",73%,LGm5,DNA_FFPE,6月13日,6285641005
GBM_RTK_II_142,6969568010_R04C02,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",68%,LGm4,DNA_KRYO,4月27日,6969568010
GBM_RTK_II_143,6285641004_R06C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",72%,LGm4,DNA_FFPE,6月13日,6285641004
GBM_RTK_II_15,8963282039_R06C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,48,male,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",72%,LGm4,DNA_FFPE,1月28日,8963282039
GBM_RTK_II_16,3999875055_R01C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,48,female,"supratentorial, hemispheric, parietal, occipital;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",68%,LGm5,DNA_FFPE,1月16日,3999875055
GBM_RTK_II_17,10006823144_R01C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,48,male,"supratentorial, hemispheric, parietal;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",73%,LGm5,DNA_FFPE,1月30日,10006823144
GBM_RTK_II_18,6229017120_R05C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,48,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",72%,LGm4,DNA_KRYO,4月13日,6229017120
GBM_RTK_II_19,8959312010_R04C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,49,male,"supratentorial, hemispheric, frontal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",71%,LGm4,DNA_KRYO,1月28日,8959312010
GBM_RTK_II_20,9878820104_R06C01,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,50,female,"supratentorial, hemispheric, parietal;  left;",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",69%,LGm4,DNA_FFPE,10月27日,9878820104
GBM_RTK_II_21,8963282039_R02C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,50,male,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",72%,LGm4,DNA_KRYO,1月28日,8963282039
GBM_RTK_II_22,9741950008_R02C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,50,female,"supratentorial, hemispheric, parietal; ",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",68%,LGm4,DNA_FFPE,3月24日,9741950008
GBM_RTK_II_23,6229017103_R04C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,50,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",65%,LGm5,DNA_KRYO,4月13日,6229017103
GBM_RTK_II_24,3999834092_R06C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,51,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",79%,LGm5,DNA_FFPE,2月20日,3999834092
GBM_RTK_II_25,6229017103_R05C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,51,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",73%,LGm4,DNA_KRYO,4月13日,6229017103
GBM_RTK_II_26,6229017111_R04C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,51,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",76%,LGm5,DNA_KRYO,4月13日,6229017111
GBM_RTK_II_27,9721365103_R03C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,52,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",84%,LGm4,DNA_KRYO,3月25日,9721365103
GBM_RTK_II_28,9969477100_R06C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,52,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",81%,LGm4,DNA_FFPE,8月22日,9969477100
GBM_RTK_II_29,9444375114_R06C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,52,male,"supratentorial, hemispheric, temporal, parietal;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",67%,LGm5,DNA_FFPE,2月10日,9444375114
GBM_RTK_II_30,9969477064_R01C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,52,male,"supratentorial, hemispheric, parietal;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",69%,LGm5,DNA_FFPE,8月8日,9969477064
GBM_RTK_II_31,6229017111_R01C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,52,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",80%,LGm5,DNA_KRYO,4月13日,6229017111
GBM_RTK_II_32,9855358066_R02C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,53,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",68%,LGm4,DNA_KRYO,10月6日,9855358066
GBM_RTK_II_33,9969477086_R03C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,53,male,"supratentorial, hemispheric, temporal;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",76%,LGm4,DNA_FFPE,8月22日,9969477086
GBM_RTK_II_34,3999308203_R05C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,54,male,"supratentorial, hemispheric, frontal;  left; right;",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",75%,LGm4,DNA_FFPE,4月6日,3999308203
GBM_RTK_II_35,6229017103_R06C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,54,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",86%,LGm4,DNA_KRYO,4月13日,6229017103
GBM_RTK_II_36,8963282018_R03C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,55,male,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",82%,LGm4,DNA_KRYO,1月28日,8963282018
GBM_RTK_II_37,8963282018_R01C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,55,male,"supratentorial, hemispheric, parietal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",75%,LGm4,DNA_KRYO,1月28日,8963282018
GBM_RTK_II_38,8963282062_R04C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,55,male,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",71%,LGm4,DNA_KRYO,1月28日,8963282062
GBM_RTK_II_39,9611518113_R02C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,56,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",72%,LGm4,DNA_KRYO,3月7日,9611518113
GBM_RTK_II_40,9610361003_R05C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,56,male,"supratentorial, hemispheric, occipital;  right;",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",81%,LGm4,DNA_KRYO,2月14日,9610361003
GBM_RTK_II_41,9611518099_R06C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,56,male,"supratentorial, hemispheric, frontal;  right;",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",76%,LGm5,DNA_KRYO,3月7日,9611518099
GBM_RTK_II_42,3999112130_R02C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,56,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",68%,LGm5,DNA_FFPE,3月27日,3999112130
GBM_RTK_II_43,9721365103_R03C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,57,male,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",74%,LGm4,DNA_KRYO,3月25日,9721365103
GBM_RTK_II_44,9611518117_R04C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,57,female,"supratentorial, hemispheric, frontal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",75%,LGm4,DNA_KRYO,3月15日,9611518117
GBM_RTK_II_45,8963282046_R03C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,57,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",72%,LGm5,DNA_KRYO,1月28日,8963282046
GBM_RTK_II_46,9376561024_R03C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,57,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",75%,LGm4,DNA_FFPE,11月4日,9376561024
GBM_RTK_II_47,3999100033_R06C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,57,male,"supratentorial, hemispheric;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",73%,LGm4,DNA_FFPE,3月20日,3999100033
GBM_RTK_II_48,9969477088_R02C02,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,58,female,"supratentorial, hemispheric, parietal;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",68%,LGm4,DNA_FFPE,8月22日,9969477088
GBM_RTK_II_49,8622007144_R01C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,58,male,"supratentorial, hemispheric, frontal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",76%,LGm4,DNA_KRYO,1月16日,8622007144
GBM_RTK_II_50,9611518113_R03C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,58,male,"supratentorial, hemispheric, frontal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",69%,LGm5,DNA_KRYO,3月7日,9611518113
GBM_RTK_II_51,9444374168_R06C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,58,male,supratentorial;  right;,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",84%,LGm4,DNA_KRYO,2月10日,9444374168
GBM_RTK_II_52,3999834070_R01C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,59,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",68%,LGm4,DNA_FFPE,2月13日,3999834070
GBM_RTK_II_53,9513149129_R02C02,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,61,male,"supratentorial, hemispheric, parietal;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",72%,LGm4,DNA_FFPE,4月14日,9513149129
GBM_RTK_II_54,9721365137_R03C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,61,male,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",73%,LGm4,DNA_KRYO,3月25日,9721365137
GBM_RTK_II_55,9721365137_R06C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,61,female,"supratentorial, hemispheric, frontal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",73%,LGm5,DNA_KRYO,3月25日,9721365137
GBM_RTK_II_56,8963282046_R05C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,61,female,"supratentorial, hemispheric, parietal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",84%,LGm4,DNA_KRYO,1月28日,8963282046
GBM_RTK_II_57,9007217139_R03C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,61,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",73%,LGm4,DNA_KRYO,2月19日,9007217139
GBM_RTK_II_58,9878827235_R05C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,61,male,"supratentorial, hemispheric, temporal;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",69%,LGm4,DNA_FFPE,12月5日,9878827235
GBM_RTK_II_59,10006823141_R01C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,61,female,"supratentorial, hemispheric, temporal;  left;",recurrence ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",67%,LGm5,DNA_FFPE,1月12日,10006823141
GBM_RTK_II_60,3999308200_R01C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,61,male,"supratentorial, hemispheric;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",70%,LGm5,DNA_FFPE,4月6日,3999308200
GBM_RTK_II_61,9611518116_R01C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,62,female,"supratentorial, hemispheric, frontal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",74%,LGm4,DNA_KRYO,3月15日,9611518116
GBM_RTK_II_62,9611518117_R01C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,62,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",68%,LGm5,DNA_KRYO,3月15日,9611518117
GBM_RTK_II_63,9647455008_R02C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,62,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",75%,LGm4,DNA_FFPE,4月11日,9647455008
GBM_RTK_II_64,10003886258_R02C02,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,63,male,"supratentorial, hemispheric, parietal;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",69%,LGm4,DNA_FFPE,1月23日,10003886258
GBM_RTK_II_65,8622007144_R04C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,63,female,"supratentorial, hemispheric, frontal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",77%,LGm4,DNA_KRYO,1月16日,8622007144
GBM_RTK_II_66,8942326114_R03C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,63,male,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",69%,LGm4,DNA_KRYO,1月18日,8942326114
GBM_RTK_II_67,3999112136_R06C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,63,female,"supratentorial, hemispheric, frontal;  left;",recurrence ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",78%,LGm4,DNA_FFPE,3月27日,3999112136
GBM_RTK_II_68,3999543047_R05C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,63,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",69%,LGm5,DNA_FFPE,4月10日,3999543047
GBM_RTK_II_69,9969477017_R04C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,63,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",68%,LGm4,DNA_FFPE,7月25日,9969477017
GBM_RTK_II_70,9611518110_R05C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,64,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",75%,LGm5,DNA_KRYO,3月7日,9611518110
GBM_RTK_II_71,9878827225_R02C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,64,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",75%,LGm5,DNA_FFPE,11月28日,9878827225
GBM_RTK_II_72,10006823144_R02C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,64,male,"supratentorial, hemispheric, parietal;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",68%,LGm4,DNA_FFPE,1月30日,10006823144
GBM_RTK_II_73,10006823155_R03C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,64,male,"supratentorial, hemispheric, temporal, parietal;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",70%,LGm4,DNA_FFPE,1月30日,10006823155
GBM_RTK_II_74,3999875115_R02C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,64,female,"supratentorial, hemispheric, occipital; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",71%,LGm4,DNA_FFPE,3月6日,3999875115
GBM_RTK_II_75,9878820018_R06C02,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,65,female,"supratentorial, hemispheric, temporal;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",67%,LGm5,DNA_FFPE,10月17日,9878820018
GBM_RTK_II_76,9721365104_R02C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,65,female,"supratentorial, hemispheric, frontal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",73%,LGm4,DNA_KRYO,3月25日,9721365104
GBM_RTK_II_77,9878820008_R06C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,65,female,"supratentorial, hemispheric, frontal, temporal;  left;",recurrence ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",67%,LGm4,DNA_FFPE,10月10日,9878820008
GBM_RTK_II_78,9878820084_R01C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,66,male,"supratentorial, hemispheric, parietal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",70%,LGm4,DNA_KRYO,10月17日,9878820084
GBM_RTK_II_79,9968646164_R06C02,University Hospital of Duesseldorf ,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,67,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",75%,LGm4,DNA_FFPE,7月11日,9968646164
GBM_RTK_II_80,9855358068_R03C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,67,male,"supratentorial, hemispheric, frontal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",69%,LGm4,DNA_KRYO,10月6日,9855358068
GBM_RTK_II_81,9878820105_R03C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,67,male,"supratentorial, hemispheric, frontal, temporal;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",67%,LGm5,DNA_FFPE,10月27日,9878820105
GBM_RTK_II_82,10003886252_R04C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,67,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",68%,LGm4,DNA_FFPE,1月23日,10003886252
GBM_RTK_II_83,9969477064_R06C02,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,68,female,"supratentorial, hemispheric, temporal;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",73%,LGm4,DNA_FFPE,8月8日,9969477064
GBM_RTK_II_84,8963282062_R01C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,68,female,"supratentorial, hemispheric, frontal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",87%,LGm4,DNA_KRYO,1月28日,8963282062
GBM_RTK_II_85,9878820083_R05C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,68,female,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",68%,LGm4,DNA_KRYO,10月17日,9878820083
GBM_RTK_II_86,3999100034_R06C01,University Hospital of Heidelberg,"Gliosarcoma, IDH-wildtype ",IV,Central review Heidelberg,69,male,"supratentorial, hemispheric, temporal;  right;",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",71%,LGm5,DNA_FFPE,3月20日,3999100034
GBM_RTK_II_87,9007225082_R05C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,70,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",69%,LGm4,DNA_KRYO,3月1日,9007225082
GBM_RTK_II_88,9611518099_R03C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,70,male,not available,not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",80%,LGm4,DNA_KRYO,3月7日,9611518099
GBM_RTK_II_89,3999834070_R01C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,70,male,"supratentorial, hemispheric, occipital;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",70%,LGm4,DNA_FFPE,2月13日,3999834070
GBM_RTK_II_90,9721366149_R05C01,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,71,female,"supratentorial, hemispheric, parietal, occipital;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",69%,LGm4,DNA_FFPE,5月9日,9721366149
GBM_RTK_II_91,9533774033_R05C01,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,71,male,"supratentorial, hemispheric, temporal;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",69%,LGm4,DNA_FFPE,6月7日,9533774033
GBM_RTK_II_92,10003886259_R03C01,University Hospital of Freiburg ,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,71,female,"posterior fossa, cerebellum;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",66%,LGm5,DNA_FFPE,1月23日,10003886259
GBM_RTK_II_93,8959312010_R06C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,71,female,"supratentorial, hemispheric, parietal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",70%,LGm5,DNA_KRYO,1月28日,8959312010
GBM_RTK_II_94,9968646118_R03C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,71,male,"supratentorial, hemispheric, intraventricular, ventricle II;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",76%,LGm4,DNA_FFPE,7月8日,9968646118
GBM_RTK_II_95,9969477022_R01C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,71,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",80%,LGm4,DNA_FFPE,7月25日,9969477022
GBM_RTK_II_96,9741779119_R06C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,72,female,"supratentorial, intraventricular, ventricle II; posterior fossa, cerebellum, ventricle IV;  left;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",75%,LGm4,DNA_FFPE,5月16日,9741779119
GBM_RTK_II_97,10006823122_R05C02,University Hospital of Bergen,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,73,male,"supratentorial, hemispheric, frontal;  left;",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",67%,LGm5,DNA_FFPE,1月12日,10006823122
GBM_RTK_II_98,9855358001_R06C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,73,female,"supratentorial, hemispheric, temporal, occipital;  right;",initial operation ,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",69%,LGm4,DNA_FFPE,9月12日,9855358001
GBM_RTK_II_99,8963282062_R06C02,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,74,male,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_II,"methylation class glioblastoma, IDH wildtype, subclass RTK II",70%,LGm5,DNA_KRYO,1月28日,8963282062
GBM_RTK_III_01,9406921073_R04C01,University Hospital of Muenster,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,0,male,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_III,"methylation class glioblastoma, IDH wildtype, subclass RTK III",83%,LGm5,DNA_FFPE,10月11日,9406921073
GBM_RTK_III_02,3999834089_R06C01,German Glioma Network ,"Glioblastoma, IDH-wildtype ",IV,Central review Duesseldorf,7,male,"posterior fossa, cerebellum, hemispheric (cerebellum);  left;",initial operation ,GBM_RTK_III,"methylation class glioblastoma, IDH wildtype, subclass RTK III",76%,LGm6,DNA_FFPE,2月20日,3999834089
GBM_RTK_III_03,9741950099_R04C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,7,male,"supratentorial, hemispheric, frontal, temporal; ",not available,GBM_RTK_III,"methylation class glioblastoma, IDH wildtype, subclass RTK III",77%,LGm6,DNA_FFPE,4月7日,9741950099
GBM_RTK_III_04,9969477029_R06C02,"The Institute of Cancer Research, London","Glioblastoma, IDH-wildtype ",IV,Local review,8,male,"supratentorial, hemispheric, temporal; ",not available,GBM_RTK_III,"methylation class glioblastoma, IDH wildtype, subclass RTK III",72%,LGm6,DNA_FFPE,7月25日,9969477029
GBM_RTK_III_05,9878820156_R06C02,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,9,male,not available,not available,GBM_RTK_III,"methylation class glioblastoma, IDH wildtype, subclass RTK III",72%,LGm6,DNA_KRYO,11月7日,9878820156
GBM_RTK_III_06,9741950021_R01C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,9,female,"supratentorial, diencephalic, thalamic; ",not available,GBM_RTK_III,"methylation class glioblastoma, IDH wildtype, subclass RTK III",69%,LGm5,DNA_FFPE,3月24日,9741950021
GBM_RTK_III_07,9969477032_R06C01,"The Institute of Cancer Research, London","Glioblastoma, IDH-wildtype ",IV,Local review,10,female,not available,not available,GBM_RTK_III,"methylation class glioblastoma, IDH wildtype, subclass RTK III",70%,LGm6,DNA_FFPE,7月25日,9969477032
GBM_RTK_III_08,9741950109_R02C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,14,male,"supratentorial, hemispheric, frontal, temporal; ",not available,GBM_RTK_III,"methylation class glioblastoma, IDH wildtype, subclass RTK III",74%,LGm6,DNA_FFPE,4月7日,9741950109
GBM_RTK_III_09,9741950100_R06C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,15,female,"posterior fossa, cerebellum, hemispheric (cerebellum); ",not available,GBM_RTK_III,"methylation class glioblastoma, IDH wildtype, subclass RTK III",80%,LGm6,DNA_FFPE,4月7日,9741950100
GBM_RTK_III_10,9741950109_R06C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,16,female,"supratentorial, diencephalic, thalamic; ",not available,GBM_RTK_III,"methylation class glioblastoma, IDH wildtype, subclass RTK III",80%,LGm6,DNA_FFPE,4月7日,9741950109
GBM_RTK_III_11,9340996014_R04C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_III,"methylation class glioblastoma, IDH wildtype, subclass RTK III",70%,LGm5,DNA_FFPE,8月9日,9340996014
GBM_RTK_III_12,9340996014_R05C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,GBM_RTK_III,"methylation class glioblastoma, IDH wildtype, subclass RTK III",67%,LGm5,DNA_FFPE,8月9日,9340996014
GBM_RTK_III_13,9444375017_R01C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,GBM_RTK_III,"methylation class glioblastoma, IDH wildtype, subclass RTK III",68%,LGm6,DNA_FFPE,1月31日,9444375017
HGNET_BCOR_01,3998568089_R02C02,University Hospital of Heidelberg,Anaplastic ependymoma  ,III,Central review Heidelberg,1,female,"supratentorial, hemispheric;  right;",initial operation ,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,75%,Not applicable,DNA_FFPE,9月4日,3998568089
HGNET_BCOR_02,9003865025_R02C02,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,1,female,"supratentorial, hemispheric, parietal;  left;",not available,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,66%,Not applicable,DNA_KRYO,4月29日,9003865025
HGNET_BCOR_03,3999834003_R03C01,University Hospital of Heidelberg,Anaplastic ependymoma  ,III,Central review Heidelberg,2,male,"posterior fossa, cerebellum;  right;",recurrence ,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,76%,Not applicable,DNA_FFPE,2月6日,3999834003
HGNET_BCOR_04,8622007061_R04C02,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,2,female,"supratentorial, hemispheric, frontal, parietal;  left;",not available,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,77%,Not applicable,DNA_KRYO,11月12日,8622007061
HGNET_BCOR_05,9968646160_R01C02,"Burdenko Neurosurgery Institute, Moscow",Anaplastic ependymoma  ,III,Central review Heidelberg,3,male,posterior fossa; ,initial operation ,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,67%,Not applicable,DNA_FFPE,7月11日,9968646160
HGNET_BCOR_06,9007217139_R03C01,"Hospital for Sick Children, Toronto  ","CNS embryonal tumour, NOS           ",IV,Local review,3,female,"supratentorial, hemispheric, frontal;  right;",not available,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,76%,Not applicable,DNA_KRYO,2月19日,9007217139
HGNET_BCOR_07,9003865025_R06C02,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,4,female,"supratentorial, hemispheric, temporal, parietal;  right;",not available,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,82%,Not applicable,DNA_KRYO,4月29日,9003865025
HGNET_BCOR_08,9761749097_R04C01,International Cancer Genome Consortium ,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,5,male,"posterior fossa, brain stem; ",not available,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,79%,Not applicable,DNA_KRYO,5月16日,9761749097
HGNET_BCOR_09,6929806024_R02C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,7,female,supratentorial; ,not available,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,68%,Not applicable,DNA_KRYO,7月2日,6929806024
HGNET_BCOR_10,9283265153_R03C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,9,male,"supratentorial, hemispheric, temporal;  left;",not available,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,71%,Not applicable,DNA_FFPE,4月29日,9283265153
HGNET_BCOR_11,9969477013_R04C02,University Hospital of Goettingen,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,11,female,"supratentorial, hemispheric, frontal;  right;",recurrence ,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,70%,Not applicable,DNA_FFPE,7月18日,9969477013
HGNET_BCOR_12,9878820140_R03C02,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,12,male,posterior fossa; ,recurrence ,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,68%,Not applicable,DNA_FFPE,11月7日,9878820140
HGNET_BCOR_13,9741950054_R06C02,"St. Jude Childrens Research Hospital, Memphis","CNS embryonal tumour, NOS           ",IV,Local review,12,male,not available,not available,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,67%,Not applicable,DNA_FFPE,2月24日,9741950054
HGNET_BCOR_14,9968646144_R04C02,INFORM (INdividualized Therapy FOr Relapsed Malignancies in Childhood) Registry,Anaplastic ependymoma  ,III,Central review Heidelberg,13,male,"supratentorial, hemispheric, frontal;  right;",recurrence ,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,80%,Not applicable,DNA_KRYO,7月8日,9968646144
HGNET_BCOR_15,9969477101_R03C02,University Hospital of Heidelberg,"Anaplastic astrocytoma, IDH-wildtype ",not available,Central review Heidelberg,13,female,"supratentorial, hemispheric, temporal, parietal; ",recurrence ,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,76%,Not applicable,DNA_FFPE,8月22日,9969477101
HGNET_BCOR_16,9969477104_R04C02,University Hospital of Freiburg ,Astroblastoma  ,not available,Central review Heidelberg,26,male,"supratentorial, hemispheric, temporal;  right;",initial operation ,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,73%,Not applicable,DNA_FFPE,8月22日,9969477104
HGNET_BCOR_17,9980102125_R05C01,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,not available ,male,supratentorial; ,not available,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,82%,Not applicable,DNA_KRYO,11月14日,9980102125
HGNET_BCOR_18,9374341144_R02C02,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,not available ,female,not available,not available,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,76%,Not applicable,DNA_KRYO,8月23日,9374341144
HGNET_BCOR_19,9297949037_R03C01,International Cancer Genome Consortium ,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,not available ,female,not available,not available,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,77%,Not applicable,DNA_KRYO,6月10日,9297949037
HGNET_BCOR_20,9878820127_R04C02,University Hospital of Magdeburg,Meningioma,I,Central review Heidelberg,not available ,female,"supratentorial, meningeal (supratentorial), frontal; ",not available,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,71%,Not applicable,DNA_FFPE,10月31日,9878820127
HGNET_BCOR_21,9444375004_R02C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,73%,Not applicable,DNA_FFPE,1月31日,9444375004
HGNET_BCOR_22,6229017057_R05C01,University Hospital of Muenster,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,not available ,male,not available,not available,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,81%,Not applicable,DNA_KRYO,3月15日,6229017057
HGNET_BCOR_23,9993943118_R02C02,New York University Langone,"CNS embryonal tumour, NOS           ",IV,Local review,not available ,male,not available,not available,HGNET_BCOR,methylation class CNS high grade neuroepithelial tumor with BCOR alteration,72%,Not applicable,DNA_FFPE,5月15日,9993943118
HGNET_MN1_01,9968646155_R02C01,"Burdenko Neurosurgery Institute, Moscow","CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,5,female,"supratentorial, hemispheric, frontal; ",not available,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,67%,Not applicable,DNA_KRYO,7月11日,9968646155
HGNET_MN1_02,3998568129_R05C02,University Hospital of Lyon,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,6,female,"supratentorial, hemispheric;  right;",initial operation ,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,65%,Not applicable,DNA_FFPE,8月28日,3998568129
HGNET_MN1_03,3998568129_R06C02,University Hospital of Lyon,Astroblastoma  ,not available,Central review Heidelberg,7,female,"supratentorial, hemispheric, parietal;  right;",initial operation ,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,66%,Not applicable,DNA_FFPE,8月28日,3998568129
HGNET_MN1_04,9296930011_R02C01,"Hospital for Sick Children, Toronto  ","CNS embryonal tumour, NOS           ",IV,Local review,8,female,not available,not available,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,71%,Not applicable,DNA_KRYO,5月22日,9296930011
HGNET_MN1_05,3999543047_R06C02,University Hospital of Freiburg ,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,14,female,"supratentorial, hemispheric, frontal, temporal;  left;",initial operation ,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,76%,Not applicable,DNA_FFPE,4月10日,3999543047
HGNET_MN1_06,3998568129_R04C02,University Hospital of Lyon,Astroblastoma  ,not available,Central review Heidelberg,14,female,"supratentorial, hemispheric, frontal, temporal; ",initial operation ,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,62%,Not applicable,DNA_FFPE,8月28日,3998568129
HGNET_MN1_07,9426020061_R02C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,15,female,supratentorial; ,not available,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,65%,Not applicable,DNA_KRYO,12月20日,9426020061
HGNET_MN1_08,3999308159_R04C01,University Hospital of Cork,Astroblastoma  ,not available,Central review Heidelberg,16,female,"supratentorial, hemispheric, frontal;  right;",not available,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,73%,Not applicable,DNA_FFPE,4月6日,3999308159
HGNET_MN1_09,3999308159_R05C01,University Hospital of Cork,Astroblastoma  ,not available,Central review Heidelberg,19,female,"supratentorial, hemispheric, frontal; ",initial operation ,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,68%,Not applicable,DNA_FFPE,4月6日,3999308159
HGNET_MN1_10,9741950008_R06C01,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,20,female,"supratentorial, hemispheric, frontal, parietal;  right;",initial operation ,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,71%,Not applicable,DNA_FFPE,3月24日,9741950008
HGNET_MN1_11,9340996003_R05C02,University Hospital of Heidelberg,Anaplastic ependymoma  ,III,Central review Heidelberg,22,female,"supratentorial, hemispheric, frontal; ",not available,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,69%,Not applicable,DNA_FFPE,8月6日,9340996003
HGNET_MN1_12,9444375028_R06C02,"MD Anderson Cancer Center, Houston",Astroblastoma  ,not available,Central review Heidelberg,27,female,"supratentorial, hemispheric, parietal;  left;",not available,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,72%,Not applicable,DNA_FFPE,1月31日,9444375028
HGNET_MN1_13,9855358031_R06C01,University Hospital of Duesseldorf ,Astroblastoma  ,not available,Central review Heidelberg,32,female,not available,initial operation ,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,71%,Not applicable,DNA_FFPE,9月26日,9855358031
HGNET_MN1_14,9611519054_R04C01,University Hospital of Hannover,Chordoid meningioma  ,II,Central review Heidelberg,36,female,"supratentorial, meningeal (supratentorial), temporal, occipital;  right;",not available,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,68%,Not applicable,DNA_FFPE,3月15日,9611519054
HGNET_MN1_15,9533774024_R04C02,"MD Anderson Cancer Center, Houston",Astroblastoma  ,not available,Central review Heidelberg,40,female,"supratentorial, hemispheric, frontal;  left;",not available,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,65%,Not applicable,DNA_FFPE,6月7日,9533774024
HGNET_MN1_16,7990895142_R06C01,University Hospital of Heidelberg,"CNS embryonal tumour, NOS           ",IV,Central review Heidelberg,not available ,female,not available,not available,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,69%,Not applicable,DNA_FFPE,7月30日,7990895142
HGNET_MN1_17,9296930052_R06C01,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,not available ,not available,not available,not available,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,70%,Not applicable,DNA_FFPE,5月27日,9296930052
HGNET_MN1_18,9007217139_R02C01,"The Institute of Cancer Research, London",Astroblastoma  ,not available,Local review,not available ,not available,not available,not available,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,70%,Not applicable,DNA_KRYO,2月19日,9007217139
HGNET_MN1_19,9340996012_R04C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,not available,not available,not available,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,65%,Not applicable,DNA_FFPE,8月9日,9340996012
HGNET_MN1_20,10005771148_R01C02,New York University Langone,"CNS embryonal tumour, NOS           ",IV,Local review,not available ,not available,not available,not available,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,64%,Not applicable,DNA_FFPE,5月15日,10005771148
HGNET_MN1_21,8622007149_R02C01,"Hospital for Sick Children, Toronto  ","CNS embryonal tumour, NOS           ",IV,Local review,not available ,female,not available,not available,HGNET_MN1,methylation class CNS high grade neuroepithelial tumor with MN1 alteration,73%,Not applicable,DNA_KRYO,1月16日,8622007149
HMB_01,8622007067_R05C02,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,14,female,"posterior fossa, cerebellum, hemispheric (cerebellum);  right;",initial operation ,HMB,methylation class hemangioblastoma,54%,Not applicable,DNA_FFPE,11月26日,8622007067
HMB_02,9855358056_R01C02,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,18,male,"supratentorial, intraventricular, ventricle II; ",initial operation ,HMB,methylation class hemangioblastoma,58%,Not applicable,DNA_FFPE,10月6日,9855358056
HMB_03,9305651051_R05C02,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,19,female,"posterior fossa, cerebellum, hemispheric (cerebellum);  left;",initial operation ,HMB,methylation class hemangioblastoma,52%,Not applicable,DNA_FFPE,7月12日,9305651051
HMB_04,9305651051_R06C02,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,22,male,"posterior fossa, cerebellum;  right;",initial operation ,HMB,methylation class hemangioblastoma,66%,Not applicable,DNA_FFPE,7月12日,9305651051
HMB_05,9305216208_R03C02,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,22,male,"spinal, cervical, C7, thoracic, T1, T3, T4; ",initial operation ,HMB,methylation class hemangioblastoma,57%,Not applicable,DNA_FFPE,7月5日,9305216208
HMB_06,9305216208_R04C01,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,23,female,"spinal, thoracic, T3, T4, T5, T6; ",initial operation ,HMB,methylation class hemangioblastoma,51%,Not applicable,DNA_FFPE,7月5日,9305216208
HMB_07,9305216208_R06C01,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,25,male,"spinal, cervical, C3, C4; ",initial operation ,HMB,methylation class hemangioblastoma,59%,Not applicable,DNA_FFPE,7月5日,9305216208
HMB_08,9305651053_R04C01,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,26,male,"spinal, extramedullary intradural, cervical, C5, C6; ",initial operation ,HMB,methylation class hemangioblastoma,54%,Not applicable,DNA_FFPE,7月12日,9305651053
HMB_09,9305216208_R02C01,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,26,male,"posterior fossa, cerebellum; ",recurrence ,HMB,methylation class hemangioblastoma,55%,Not applicable,DNA_FFPE,7月5日,9305216208
HMB_10,9305216208_R01C02,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,26,female,"posterior fossa, ventricle IV; ",initial operation ,HMB,methylation class hemangioblastoma,50%,Not applicable,DNA_FFPE,7月5日,9305216208
HMB_11,9305651051_R04C02,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,26,female,"posterior fossa, cerebellum; ",initial operation ,HMB,methylation class hemangioblastoma,53%,Not applicable,DNA_FFPE,7月12日,9305651051
HMB_12,9305651053_R05C01,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,28,female,posterior fossa; ,initial operation ,HMB,methylation class hemangioblastoma,58%,Not applicable,DNA_FFPE,7月12日,9305651053
HMB_13,9305216208_R05C01,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,28,female,"posterior fossa, brain stem; ",initial operation ,HMB,methylation class hemangioblastoma,56%,Not applicable,DNA_FFPE,7月5日,9305216208
HMB_14,9305216208_R02C02,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,31,male,"posterior fossa, brain stem, medulla oblongata (craniocervical), cerebellum;  left;",initial operation ,HMB,methylation class hemangioblastoma,54%,Not applicable,DNA_FFPE,7月5日,9305216208
HMB_15,9305216208_R01C01,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,32,male,"posterior fossa, brain stem, medulla oblongata (craniocervical); ",not available,HMB,methylation class hemangioblastoma,51%,Not applicable,DNA_FFPE,7月5日,9305216208
HMB_16,9305651055_R04C02,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,32,female,"posterior fossa, cerebellum, hemispheric (cerebellum);  right;",initial operation ,HMB,methylation class hemangioblastoma,58%,Not applicable,DNA_FFPE,7月19日,9305651055
HMB_17,9305216208_R04C02,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,33,male,"posterior fossa, cerebellum;  left;",initial operation ,HMB,methylation class hemangioblastoma,53%,Not applicable,DNA_FFPE,7月5日,9305216208
HMB_18,9305216208_R05C02,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,34,female,"posterior fossa, cerebellum, hemispheric (cerebellum);  right;",initial operation ,HMB,methylation class hemangioblastoma,50%,Not applicable,DNA_FFPE,7月5日,9305216208
HMB_19,9305651053_R01C01,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,36,male,"posterior fossa, cerebellum; ",initial operation ,HMB,methylation class hemangioblastoma,52%,Not applicable,DNA_FFPE,7月12日,9305651053
HMB_20,9305651053_R02C01,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,38,male,"posterior fossa, cerebello-pontine angle; ",initial operation ,HMB,methylation class hemangioblastoma,51%,Not applicable,DNA_FFPE,7月12日,9305651053
HMB_21,9305216208_R03C01,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,40,female,"spinal, lumbar, L1, conus region; ",initial operation ,HMB,methylation class hemangioblastoma,53%,Not applicable,DNA_FFPE,7月5日,9305216208
HMB_22,9305651053_R06C01,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,43,male,"posterior fossa, cerebellum;  right;",initial operation ,HMB,methylation class hemangioblastoma,54%,Not applicable,DNA_FFPE,7月12日,9305651053
HMB_23,9305651053_R03C01,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,45,female,"spinal, intramedullary; ",initial operation ,HMB,methylation class hemangioblastoma,51%,Not applicable,DNA_FFPE,7月12日,9305651053
HMB_24,9340996003_R01C01,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,50,female,spinal; ,initial operation ,HMB,methylation class hemangioblastoma,52%,Not applicable,DNA_FFPE,8月6日,9340996003
HMB_25,9855358056_R02C02,University Hospital of Heidelberg,Haemangioblastoma  ,I,Central review Heidelberg,66,male,"posterior fossa, brain stem, medulla oblongata (craniocervical); ",initial operation ,HMB,methylation class hemangioblastoma,52%,Not applicable,DNA_FFPE,10月6日,9855358056
IHG_01,3999875057_R01C02,"Beaumont Hospital, Dublin","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,0,male,"supratentorial; peripheral nerve, dermal, head; mesenchyme, cranium; ",initial operation ,IHG,methylation class infantile hemispheric glioma,65%,Not applicable,DNA_FFPE,1月16日,3999875057
IHG_02,3998579150_R01C02,"Istituto Giannina Gaslini, Genoa ",Paediatric diffuse astrocytoma (unresolved status) ,not available,Local review,0,not available,"supratentorial, hemispheric; ",not available,IHG,methylation class infantile hemispheric glioma,72%,Not applicable,DNA_KRYO,8月28日,3998579150
IHG_03,3998523077_R05C01,"Istituto Giannina Gaslini, Genoa ",Pilocytic astrocytoma  ,I,Local review,0,not available,"supratentorial, hemispheric; ",not available,IHG,methylation class infantile hemispheric glioma,68%,Not applicable,DNA_KRYO,8月28日,3998523077
IHG_04,9721366135_R03C01,University Hospital of Heidelberg,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,0,male,"supratentorial, diencephalic, basal ganglia;  left;",initial operation ,IHG,methylation class infantile hemispheric glioma,62%,Not applicable,DNA_FFPE,5月9日,9721366135
IHG_05,9553932098_R03C02,"Burdenko Neurosurgery Institute, Moscow","Anaplastic astrocytoma, IDH-wildtype ",not available,Central review Heidelberg,0,male,"supratentorial, intraventricular, ventricle II; ",not available,IHG,methylation class infantile hemispheric glioma,66%,Not applicable,DNA_FFPE,2月28日,9553932098
IHG_06,10003886252_R03C02,University Hospital of Leipzig,Anaplastic pilocytic astrocytoma,not available,Central review Heidelberg,1,female,"supratentorial, hemispheric, parietal, occipital;  right;",not available,IHG,methylation class infantile hemispheric glioma,63%,Not applicable,DNA_FFPE,1月23日,10003886252
IHG_07,9741950021_R06C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,1,female,not available,not available,IHG,methylation class infantile hemispheric glioma,64%,Not applicable,DNA_FFPE,3月24日,9741950021
IHG_08,9340996032_R01C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,IHG,methylation class infantile hemispheric glioma,64%,Not applicable,DNA_FFPE,8月9日,9340996032
IHG_09,9980102125_R04C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,IHG,methylation class infantile hemispheric glioma,67%,Not applicable,DNA_KRYO,11月14日,9980102125
IHG_10,3999834121_R04C01,"Hospital for Sick Children, Toronto  ","Glioblastoma, IDH-wildtype ",IV,Local review,not available ,male,not available,not available,IHG,methylation class infantile hemispheric glioma,67%,Not applicable,DNA_KRYO,3月4日,3999834121
LGG_DIG_DIA_01,3998579150_R04C01,"Istituto Giannina Gaslini, Genoa ",Desmoplastic infantile astrocytoma and ganglioglioma  ,I,Local review,0,female,"supratentorial, hemispheric; ",not available,LGG_DIG_DIA,"methylation class low grade glioma, desmoplastic infantile astrocytoma / ganglioglioma",49%,Not applicable,DNA_KRYO,8月28日,3998579150
LGG_DIG_DIA_02,3998579150_R01C01,"Istituto Giannina Gaslini, Genoa ",Desmoplastic infantile astrocytoma and ganglioglioma  ,I,Local review,0,not available,"supratentorial, diencephalic; ",not available,LGG_DIG_DIA,"methylation class low grade glioma, desmoplastic infantile astrocytoma / ganglioglioma",51%,Not applicable,DNA_KRYO,8月28日,3998579150
LGG_DIG_DIA_03,9741950101_R05C01,University Hospital of Heidelberg,Desmoplastic infantile astrocytoma and ganglioglioma  ,I,Central review Heidelberg,0,female,"supratentorial, hemispheric; ",initial operation ,LGG_DIG_DIA,"methylation class low grade glioma, desmoplastic infantile astrocytoma / ganglioglioma",49%,Not applicable,DNA_FFPE,5月16日,9741950101
LGG_DIG_DIA_04,9407201030_R06C02,University Hospital of Bern,Desmoplastic infantile astrocytoma and ganglioglioma  ,I,Central review Heidelberg,1,female,"supratentorial, hemispheric, parietal;  left;",not available,LGG_DIG_DIA,"methylation class low grade glioma, desmoplastic infantile astrocytoma / ganglioglioma",50%,Not applicable,DNA_FFPE,12月2日,9407201030
LGG_DIG_DIA_05,9969477104_R02C02,University Hospital of Freiburg ,Desmoplastic infantile astrocytoma and ganglioglioma  ,I,Central review Heidelberg,1,male,"supratentorial, hemispheric, occipital; ",initial operation ,LGG_DIG_DIA,"methylation class low grade glioma, desmoplastic infantile astrocytoma / ganglioglioma",53%,Not applicable,DNA_FFPE,8月22日,9969477104
LGG_DIG_DIA_06,3999078159_R05C01,University Hospital of Leipzig,Desmoplastic infantile astrocytoma and ganglioglioma  ,I,Central review Heidelberg,1,female,not available,not available,LGG_DIG_DIA,"methylation class low grade glioma, desmoplastic infantile astrocytoma / ganglioglioma",47%,Not applicable,DNA_FFPE,7月17日,3999078159
LGG_DIG_DIA_07,9407210090_R02C02,"Burdenko Neurosurgery Institute, Moscow",Desmoplastic infantile astrocytoma and ganglioglioma  ,I,Central review Heidelberg,2,male,supratentorial; ,not available,LGG_DIG_DIA,"methylation class low grade glioma, desmoplastic infantile astrocytoma / ganglioglioma",51%,Not applicable,DNA_FFPE,12月6日,9407210090
LGG_DIG_DIA_08,200091640059_R02C01,University Hospital of Heidelberg,Desmoplastic infantile astrocytoma and ganglioglioma  ,I,Central review Heidelberg,11,female,"supratentorial, hemispheric, temporal;  right;",recurrence ,LGG_DIG_DIA,"methylation class low grade glioma, desmoplastic infantile astrocytoma / ganglioglioma",47%,Not applicable,DNA_FFPE,11月6日,2.00092E+11
LGG_DNT_01,3998909062_R03C02,"Centre Hospitalier Sainte Anne, Paris ",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,3,male,"supratentorial, hemispheric, frontal;  left;",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",62%,Not applicable,DNA_FFPE,5月8日,3998909062
LGG_DNT_02,3999100031_R06C02,"Centre Hospitalier Sainte Anne, Paris ",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,4,male,"supratentorial, hemispheric, frontal;  right;",recurrence ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",70%,Not applicable,DNA_FFPE,3月20日,3999100031
LGG_DNT_03,9878827240_R04C01,University Hospital of Heidelberg,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,5,male,"supratentorial, hemispheric, frontal; ",recurrence ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",65%,Not applicable,DNA_FFPE,12月5日,9878827240
LGG_DNT_04,3999543051_R05C01,"Centre Hospitalier Sainte Anne, Paris ",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,6,female,"supratentorial, hemispheric, temporal, parietal;  left;",recurrence ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",71%,Not applicable,DNA_FFPE,3月14日,3999543051
LGG_DNT_05,3998909063_R06C01,"Centre Hospitalier Sainte Anne, Paris ",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,6,male,"supratentorial, hemispheric, occipital;  left;",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",63%,Not applicable,DNA_FFPE,5月8日,3998909063
LGG_DNT_06,9444374134_R04C01,University Hospital of Tuebingen,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,6,male,"supratentorial, hemispheric, frontal;  left;",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",65%,Not applicable,DNA_FFPE,1月27日,9444374134
LGG_DNT_07,3998909072_R02C01,"Centre Hospitalier Sainte Anne, Paris ",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,7,female,"supratentorial, hemispheric, frontal; ",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",57%,Not applicable,DNA_FFPE,5月22日,3998909072
LGG_DNT_08,10006823130_R03C01,University Hospital of Frankfurt am Main,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,8,male,"supratentorial, hemispheric, temporal;  left;",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",58%,Not applicable,DNA_FFPE,1月12日,10006823130
LGG_DNT_09,3999100031_R04C02,"Centre Hospitalier Sainte Anne, Paris ",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,9,male,"supratentorial, hemispheric, parietal;  right;",recurrence ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",60%,Not applicable,DNA_FFPE,3月20日,3999100031
LGG_DNT_10,3998909071_R03C02,"Centre Hospitalier Sainte Anne, Paris ",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,9,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",59%,Not applicable,DNA_FFPE,5月22日,3998909071
LGG_DNT_11,3999543051_R02C02,"Centre Hospitalier Sainte Anne, Paris ",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,10,female,"supratentorial, hemispheric, temporal, occipital; ",recurrence ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",63%,Not applicable,DNA_FFPE,3月14日,3999543051
LGG_DNT_12,3999100047_R01C02,"Centre Hospitalier Sainte Anne, Paris ",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,10,male,"supratentorial, hemispheric, occipital; ",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",66%,Not applicable,DNA_FFPE,3月20日,3999100047
LGG_DNT_13,9407201029_R01C02,University Hospital of Tuebingen,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,10,male,"supratentorial, hemispheric, temporal, occipital;  left;",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",61%,Not applicable,DNA_FFPE,12月2日,9407201029
LGG_DNT_14,9444375114_R06C02,University Hospital of Tuebingen,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,10,male,"supratentorial, hemispheric, frontal; ",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",65%,Not applicable,DNA_FFPE,2月10日,9444375114
LGG_DNT_15,9422492026_R06C02,Amsterdam Academic Medical Center,Dysembryoplastic neuroepithelial tumour  ,I,Local review,11,female,"supratentorial, hemispheric, frontal; ",not available,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",65%,Not applicable,DNA_FFPE,12月6日,9422492026
LGG_DNT_16,9422492035_R06C01,Amsterdam Academic Medical Center,Dysembryoplastic neuroepithelial tumour  ,I,Local review,11,male,"supratentorial, hemispheric, temporal; ",not available,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",68%,Not applicable,DNA_FFPE,12月6日,9422492035
LGG_DNT_17,10003886259_R02C01,University Hospital of Heidelberg,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,11,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",66%,Not applicable,DNA_FFPE,1月23日,10003886259
LGG_DNT_18,9297949139_R03C02,University Hospital of Heidelberg,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,12,male,"supratentorial, hemispheric, frontal, parietal;  right;",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",57%,Not applicable,DNA_FFPE,6月21日,9297949139
LGG_DNT_19,9305651095_R02C02,University Hospital of Tuebingen,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,13,female,not available,not available,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",55%,Not applicable,DNA_FFPE,7月30日,9305651095
LGG_DNT_20,9422492035_R01C01,Amsterdam Academic Medical Center,Dysembryoplastic neuroepithelial tumour  ,I,Local review,16,female,"supratentorial, hemispheric, temporal; ",not available,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",64%,Not applicable,DNA_FFPE,12月6日,9422492035
LGG_DNT_21,3998909063_R01C01,"Centre Hospitalier Sainte Anne, Paris ",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,16,female,"supratentorial, hemispheric, parietal;  right;",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",66%,Not applicable,DNA_FFPE,5月8日,3998909063
LGG_DNT_22,9422492074_R01C02,Amsterdam Academic Medical Center,Dysembryoplastic neuroepithelial tumour  ,I,Local review,18,male,"supratentorial, hemispheric, frontal; ",not available,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",64%,Not applicable,DNA_FFPE,12月6日,9422492074
LGG_DNT_23,9534104007_R04C02,University Hospital of Freiburg ,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,18,male,"supratentorial, hemispheric, occipital;  left;",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",57%,Not applicable,DNA_FFPE,6月27日,9534104007
LGG_DNT_24,9283265153_R06C01,University Hospital of Heidelberg,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,18,male,"supratentorial, hemispheric, temporal;  left;",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",63%,Not applicable,DNA_FFPE,4月29日,9283265153
LGG_DNT_25,9283265153_R01C02,University Hospital of Heidelberg,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,18,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",66%,Not applicable,DNA_FFPE,4月29日,9283265153
LGG_DNT_26,9444375114_R05C01,"MD Anderson Cancer Center, Houston",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,19,female,"supratentorial, hemispheric, temporal;  right;",not available,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",56%,Not applicable,DNA_FFPE,2月10日,9444375114
LGG_DNT_27,9283265153_R02C01,University Hospital of Heidelberg,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,21,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",53%,Not applicable,DNA_FFPE,4月29日,9283265153
LGG_DNT_28,9829119122_R03C02,"MD Anderson Cancer Center, Houston",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,22,male,"supratentorial, hemispheric, frontal, intraventricular, ventricle II;  right;",not available,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",61%,Not applicable,DNA_FFPE,5月23日,9829119122
LGG_DNT_29,9283265153_R06C02,University Hospital of Heidelberg,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,23,male,"supratentorial, hemispheric, parietal;  right;",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",62%,Not applicable,DNA_FFPE,4月29日,9283265153
LGG_DNT_30,9878827211_R02C01,University Hospital of Heidelberg,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,24,female,"supratentorial, hemispheric, frontal;  right;",not available,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",65%,Not applicable,DNA_FFPE,11月21日,9878827211
LGG_DNT_31,9283265153_R04C01,University Hospital of Heidelberg,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,25,female,"supratentorial, hemispheric, temporal;  right;",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",61%,Not applicable,DNA_FFPE,4月29日,9283265153
LGG_DNT_32,9533774097_R06C01,University Hospital of Duesseldorf ,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,27,female,"supratentorial, hemispheric, temporal; ",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",61%,Not applicable,DNA_FFPE,6月16日,9533774097
LGG_DNT_33,9296930016_R03C02,University Hospital of Heidelberg,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,28,female,"supratentorial, hemispheric, parietal;  right;",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",63%,Not applicable,DNA_FFPE,5月21日,9296930016
LGG_DNT_34,9422492074_R01C01,Amsterdam Academic Medical Center,Dysembryoplastic neuroepithelial tumour  ,I,Local review,35,male,"supratentorial, hemispheric, temporal; ",not available,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",65%,Not applicable,DNA_FFPE,12月6日,9422492074
LGG_DNT_35,9422492035_R01C02,Amsterdam Academic Medical Center,Dysembryoplastic neuroepithelial tumour  ,I,Local review,36,female,"supratentorial, hemispheric, temporal; ",not available,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",60%,Not applicable,DNA_FFPE,12月6日,9422492035
LGG_DNT_36,9376561024_R01C02,University Hospital of Heidelberg,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,40,female,"supratentorial, sellar region, suprasellar; ",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",60%,Not applicable,DNA_FFPE,11月4日,9376561024
LGG_DNT_37,9340996058_R04C02,University Hospital of Muenster,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,43,female,"supratentorial, hemispheric, temporal;  right;",recurrence ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",63%,Not applicable,DNA_FFPE,8月9日,9340996058
LGG_DNT_38,9969477107_R05C01,University Hospital of Heidelberg,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,44,female,"supratentorial, hemispheric, parietal; ",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",62%,Not applicable,DNA_FFPE,9月4日,9969477107
LGG_DNT_39,9420867051_R01C02,University Hospital of Heidelberg,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,52,female,"supratentorial, hemispheric, temporal; ",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",68%,Not applicable,DNA_FFPE,1月14日,9420867051
LGG_DNT_40,9407201029_R05C01,University Hospital of Heidelberg,Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,73,female,"supratentorial, hemispheric, temporal;  right;",initial operation ,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",64%,Not applicable,DNA_FFPE,12月2日,9407201029
LGG_DNT_41,9444375033_R05C01,"MD Anderson Cancer Center, Houston",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,not available ,male,"supratentorial, hemispheric, temporal;  left;",not available,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",65%,Not applicable,DNA_FFPE,1月31日,9444375033
LGG_DNT_42,9444375033_R06C01,"MD Anderson Cancer Center, Houston",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,not available ,female,"supratentorial, hemispheric, parietal;  left;",not available,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",63%,Not applicable,DNA_FFPE,1月31日,9444375033
LGG_DNT_43,9444375033_R01C02,"MD Anderson Cancer Center, Houston",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,not available ,female,"supratentorial, intraventricular, ventricle III; ",not available,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",69%,Not applicable,DNA_FFPE,1月31日,9444375033
LGG_DNT_44,9553932010_R04C01,"MD Anderson Cancer Center, Houston",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,not available ,male,"supratentorial, hemispheric, frontal;  left;",not available,LGG_DNT,"methylation class low grade glioma, dysembryoplastic neuroepithelial tumor",61%,Not applicable,DNA_FFPE,2月14日,9553932010
LGG_GG_01,3998909063_R05C01,"Centre Hospitalier Sainte Anne, Paris ",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,7,male,"supratentorial, hemispheric, temporal;  left;",initial operation ,LGG_GG,"methylation class low grade glioma, ganglioglioma",59%,Not applicable,DNA_FFPE,5月8日,3998909063
LGG_GG_02,9422492074_R05C02,Amsterdam Academic Medical Center,Ganglioglioma ,I,Local review,8,male,"supratentorial, hemispheric, parietal; ",not available,LGG_GG,"methylation class low grade glioma, ganglioglioma",69%,Not applicable,DNA_FFPE,12月6日,9422492074
LGG_GG_03,9422492026_R04C02,Amsterdam Academic Medical Center,Ganglioglioma ,I,Local review,10,male,"supratentorial, hemispheric, temporal; ",not available,LGG_GG,"methylation class low grade glioma, ganglioglioma",68%,Not applicable,DNA_FFPE,12月6日,9422492026
LGG_GG_04,9297949098_R05C01,Amsterdam Academic Medical Center,Ganglioglioma ,I,Local review,10,male,"supratentorial, hemispheric, temporal; ",not available,LGG_GG,"methylation class low grade glioma, ganglioglioma",64%,Not applicable,DNA_FFPE,6月7日,9297949098
LGG_GG_05,3998909071_R02C02,"Centre Hospitalier Sainte Anne, Paris ",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,10,male,"supratentorial, hemispheric, temporal;  right;",initial operation ,LGG_GG,"methylation class low grade glioma, ganglioglioma",61%,Not applicable,DNA_FFPE,5月22日,3998909071
LGG_GG_06,9444374133_R05C02,University Hospital of Tuebingen,Ganglioglioma ,I,Central review Heidelberg,10,male,"supratentorial, hemispheric, temporal;  left;",initial operation ,LGG_GG,"methylation class low grade glioma, ganglioglioma",61%,Not applicable,DNA_FFPE,1月27日,9444374133
LGG_GG_07,9422492075_R04C01,Amsterdam Academic Medical Center,Ganglioglioma ,I,Local review,11,female,"supratentorial, hemispheric, temporal; ",not available,LGG_GG,"methylation class low grade glioma, ganglioglioma",69%,Not applicable,DNA_FFPE,12月6日,9422492075
LGG_GG_08,3998909063_R03C01,"Centre Hospitalier Sainte Anne, Paris ",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,11,male,"supratentorial, hemispheric, temporal;  right;",initial operation ,LGG_GG,"methylation class low grade glioma, ganglioglioma",55%,Not applicable,DNA_FFPE,5月8日,3998909063
LGG_GG_09,8622007189_R04C01,University Hospital of Heidelberg,Ganglioglioma ,I,Central review Heidelberg,18,female,"supratentorial, hemispheric, temporal, parietal, occipital;  right;",initial operation ,LGG_GG,"methylation class low grade glioma, ganglioglioma",62%,Not applicable,DNA_FFPE,1月17日,8622007189
LGG_GG_10,9422492026_R02C02,Amsterdam Academic Medical Center,Ganglioglioma ,I,Local review,19,female,"supratentorial, hemispheric, temporal; ",not available,LGG_GG,"methylation class low grade glioma, ganglioglioma",66%,Not applicable,DNA_FFPE,12月6日,9422492026
LGG_GG_11,9422492035_R04C01,Amsterdam Academic Medical Center,Ganglioglioma ,I,Local review,20,female,"supratentorial, hemispheric, occipital; ",not available,LGG_GG,"methylation class low grade glioma, ganglioglioma",61%,Not applicable,DNA_FFPE,12月6日,9422492035
LGG_GG_12,9422492075_R03C01,Amsterdam Academic Medical Center,Ganglioglioma ,I,Local review,21,male,"supratentorial, hemispheric, temporal; ",not available,LGG_GG,"methylation class low grade glioma, ganglioglioma",65%,Not applicable,DNA_FFPE,12月6日,9422492075
LGG_GG_13,9422492075_R01C02,Amsterdam Academic Medical Center,Ganglioglioma ,I,Local review,25,female,"supratentorial, hemispheric, temporal; ",not available,LGG_GG,"methylation class low grade glioma, ganglioglioma",66%,Not applicable,DNA_FFPE,12月6日,9422492075
LGG_GG_14,3999834093_R04C02,University Hospital of Heidelberg,Ganglioglioma ,I,Central review Heidelberg,28,male,"supratentorial, hemispheric, parietal;  right;",initial operation ,LGG_GG,"methylation class low grade glioma, ganglioglioma",62%,Not applicable,DNA_FFPE,2月20日,3999834093
LGG_GG_15,9426021175_R05C02,Amsterdam Academic Medical Center,Ganglioglioma ,I,Local review,32,male,"supratentorial, hemispheric, temporal; ",not available,LGG_GG,"methylation class low grade glioma, ganglioglioma",59%,Not applicable,DNA_FFPE,12月20日,9426021175
LGG_GG_16,9422492035_R02C01,Amsterdam Academic Medical Center,Ganglioglioma ,I,Local review,32,male,"supratentorial, hemispheric, temporal; ",not available,LGG_GG,"methylation class low grade glioma, ganglioglioma",61%,Not applicable,DNA_FFPE,12月6日,9422492035
LGG_GG_17,9422492075_R06C01,Amsterdam Academic Medical Center,Ganglioglioma ,I,Local review,32,male,"supratentorial, hemispheric, temporal; ",not available,LGG_GG,"methylation class low grade glioma, ganglioglioma",64%,Not applicable,DNA_FFPE,12月6日,9422492075
LGG_GG_18,9422492035_R06C02,Amsterdam Academic Medical Center,Dysembryoplastic neuroepithelial tumour  ,I,Local review,36,male,"supratentorial, hemispheric, temporal; ",not available,LGG_GG,"methylation class low grade glioma, ganglioglioma",60%,Not applicable,DNA_FFPE,12月6日,9422492035
LGG_GG_19,9422492035_R02C02,Amsterdam Academic Medical Center,Ganglioglioma ,I,Local review,39,male,"supratentorial, hemispheric, temporal; ",not available,LGG_GG,"methylation class low grade glioma, ganglioglioma",60%,Not applicable,DNA_FFPE,12月6日,9422492035
LGG_GG_20,9422492075_R06C02,Amsterdam Academic Medical Center,Ganglioglioma ,I,Local review,43,male,"supratentorial, hemispheric, temporal; ",not available,LGG_GG,"methylation class low grade glioma, ganglioglioma",68%,Not applicable,DNA_FFPE,12月6日,9422492075
LGG_GG_21,9422492035_R03C02,Amsterdam Academic Medical Center,Ganglioglioma ,I,Local review,49,female,"supratentorial, hemispheric, temporal; ",not available,LGG_GG,"methylation class low grade glioma, ganglioglioma",61%,Not applicable,DNA_FFPE,12月6日,9422492035
LGG_MYB_01,9969477104_R01C02,University Hospital of Freiburg ,Angiocentric glioma  ,I,Central review Heidelberg,3,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",77%,Not applicable,DNA_FFPE,8月22日,9969477104
LGG_MYB_02,3999543051_R03C02,"Centre Hospitalier Sainte Anne, Paris ",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,4,male,not available,initial operation ,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",63%,Not applicable,DNA_FFPE,3月14日,3999543051
LGG_MYB_03,9444375114_R02C01,"MD Anderson Cancer Center, Houston",Angiocentric glioma  ,I,Central review Heidelberg,5,male,"supratentorial, hemispheric, frontal;  left;",not available,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",68%,Not applicable,DNA_FFPE,2月10日,9444375114
LGG_MYB_04,8622007083_R05C01,University Hospital of Erlangen,Angiocentric glioma  ,I,Central review Heidelberg,6,male,supratentorial; ,initial operation ,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",66%,Not applicable,DNA_FFPE,12月7日,8622007083
LGG_MYB_05,3998909063_R04C01,"Centre Hospitalier Sainte Anne, Paris ",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,7,female,"supratentorial, hemispheric, frontal, parietal;  right;",initial operation ,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",59%,Not applicable,DNA_FFPE,5月8日,3998909063
LGG_MYB_06,3999112136_R03C01,Charite Universitaetsmedizin Berlin,Paediatric diffuse astrocytoma (unresolved status) ,not available,Central review Heidelberg,10,female,"posterior fossa, brain stem, cerebellum; ",initial operation ,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",64%,Not applicable,DNA_FFPE,3月27日,3999112136
LGG_MYB_07,9741950111_R01C02,"MD Anderson Cancer Center, Houston",Pilomyxoid astrocytoma  ,not available,Central review Heidelberg,10,male,"posterior fossa, brain stem; ",not available,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",66%,Not applicable,DNA_FFPE,5月16日,9741950111
LGG_MYB_08,8622007083_R02C01,University Hospital of Erlangen,Angiocentric glioma  ,I,Central review Heidelberg,12,female,"supratentorial, hemispheric;  left;",initial operation ,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",65%,Not applicable,DNA_FFPE,12月7日,8622007083
LGG_MYB_09,9379082039_R06C01,University Hospital of Heidelberg,Pilocytic astrocytoma  ,I,Central review Heidelberg,13,female,"posterior fossa, cerebellum;  left;",initial operation ,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",63%,Not applicable,DNA_FFPE,9月19日,9379082039
LGG_MYB_10,8622007083_R04C02,University Hospital of Erlangen,Angiocentric glioma  ,I,Central review Heidelberg,15,female,supratentorial; ,initial operation ,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",68%,Not applicable,DNA_FFPE,12月7日,8622007083
LGG_MYB_11,8622007083_R04C01,University Hospital of Vienna,Angiocentric glioma  ,I,Central review Heidelberg,15,male,supratentorial; ,initial operation ,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",64%,Not applicable,DNA_FFPE,12月7日,8622007083
LGG_MYB_12,9422492035_R05C01,Amsterdam Academic Medical Center,Ganglioglioma ,I,Local review,17,male,"supratentorial, hemispheric, temporal; ",not available,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",64%,Not applicable,DNA_FFPE,12月6日,9422492035
LGG_MYB_13,8622007084_R02C02,University Hospital of Erlangen,Angiocentric glioma  ,I,Central review Heidelberg,17,male,supratentorial; ,initial operation ,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",69%,Not applicable,DNA_FFPE,12月7日,8622007084
LGG_MYB_14,3999100047_R06C01,"Centre Hospitalier Sainte Anne, Paris ",Dysembryoplastic neuroepithelial tumour  ,I,Central review Heidelberg,24,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",64%,Not applicable,DNA_FFPE,3月20日,3999100047
LGG_MYB_15,6929806048_R02C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,27,female,supratentorial; ,not available,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",76%,Not applicable,DNA_KRYO,7月2日,6929806048
LGG_MYB_16,8622007083_R01C02,University Hospital of Erlangen,Angiocentric glioma  ,I,Central review Heidelberg,28,male,supratentorial; ,initial operation ,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",65%,Not applicable,DNA_FFPE,12月7日,8622007083
LGG_MYB_17,9370847051_R04C01,University Hospital of Bonn,Angiocentric glioma  ,I,Central review Heidelberg,37,male,supratentorial; ,initial operation ,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",64%,Not applicable,DNA_FFPE,9月19日,9370847051
LGG_MYB_18,8622007083_R02C02,University Hospital of Vienna,Angiocentric glioma  ,I,Central review Heidelberg,37,female,supratentorial; ,initial operation ,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",65%,Not applicable,DNA_FFPE,12月7日,8622007083
LGG_MYB_19,9422492075_R03C02,Amsterdam Academic Medical Center,Ganglioglioma ,I,Local review,39,male,"supratentorial, hemispheric, frontal; ",not available,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",66%,Not applicable,DNA_FFPE,12月6日,9422492075
LGG_MYB_20,8622007084_R03C02,University Hospital of Erlangen,Angiocentric glioma  ,I,Central review Heidelberg,45,male,supratentorial; ,initial operation ,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",54%,Not applicable,DNA_FFPE,12月7日,8622007084
LGG_MYB_21,9422492026_R05C01,Amsterdam Academic Medical Center,Ganglioglioma ,I,Local review,50,male,"supratentorial, hemispheric, temporal; ",not available,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",68%,Not applicable,DNA_FFPE,12月6日,9422492026
LGG_MYB_22,8622007083_R03C02,University Hospital of Vienna,Angiocentric glioma  ,I,Central review Heidelberg,70,female,supratentorial; ,initial operation ,LGG_MYB,"methylation class low grade glioma, MYB/MYBL1",65%,Not applicable,DNA_FFPE,12月7日,8622007083
LGG_PA_GG_ST_01,9444374133_R02C02,University Hospital of Tuebingen,Pilocytic astrocytoma  ,I,Central review Heidelberg,4,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",64%,Not applicable,DNA_FFPE,1月27日,9444374133
LGG_PA_GG_ST_02,6929689152_R05C02,University Hospital of Cambridge,Paediatric diffuse astrocytoma (unresolved status) ,not available,Local review,6,male,"supratentorial, hemispheric; ",not available,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",53%,Not applicable,DNA_KRYO,11月23日,6929689152
LGG_PA_GG_ST_03,3999308200_R02C02,"Beaumont Hospital, Dublin",Pilomyxoid astrocytoma  ,not available,Central review Heidelberg,8,male,supratentorial; ,not available,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",50%,Not applicable,DNA_FFPE,4月6日,3999308200
LGG_PA_GG_ST_04,9007217153_R03C02,University Hospital of Heidelberg,Pilocytic astrocytoma  ,I,Central review Heidelberg,16,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",52%,Not applicable,DNA_FFPE,2月20日,9007217153
LGG_PA_GG_ST_05,9878820017_R05C01,University Hospital of Heidelberg,Anaplastic pilocytic astrocytoma,not available,Central review Heidelberg,16,female,"supratentorial, hemispheric, temporal; ",initial operation ,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",53%,Not applicable,DNA_FFPE,10月17日,9878820017
LGG_PA_GG_ST_06,9007225091_R05C01,University Hospital of Vienna,Ganglioglioma ,I,Central review Heidelberg,16,male,"supratentorial, hemispheric, temporal;  left;",not available,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",54%,Not applicable,DNA_FFPE,4月19日,9007225091
LGG_PA_GG_ST_07,8622007070_R04C01,University Hospital of Heidelberg,Ganglioglioma ,I,Central review Heidelberg,17,male,"supratentorial, hemispheric, temporal;  right;",initial operation ,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",57%,Not applicable,DNA_FFPE,11月26日,8622007070
LGG_PA_GG_ST_08,9533774088_R01C02,University Hospital of Heidelberg,Pilocytic astrocytoma  ,I,Central review Heidelberg,17,male,"supratentorial, hemispheric, occipital;  left;",not available,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",64%,Not applicable,DNA_FFPE,6月16日,9533774088
LGG_PA_GG_ST_09,9878827227_R03C01,University Hospital of Tuebingen,Pilocytic astrocytoma  ,I,Central review Heidelberg,17,female,"supratentorial, hemispheric, parietal, occipital; ",recurrence ,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",47%,Not applicable,DNA_FFPE,11月28日,9878827227
LGG_PA_GG_ST_10,9422492075_R01C01,Amsterdam Academic Medical Center,Dysembryoplastic neuroepithelial tumour  ,I,Local review,18,female,"supratentorial, hemispheric, temporal; ",not available,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",63%,Not applicable,DNA_FFPE,12月6日,9422492075
LGG_PA_GG_ST_11,9829119124_R02C01,"MD Anderson Cancer Center, Houston",Pilocytic astrocytoma  ,I,Central review Heidelberg,18,male,"supratentorial, hemispheric, temporal;  left;",not available,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",57%,Not applicable,DNA_FFPE,5月23日,9829119124
LGG_PA_GG_ST_12,9373550131_R03C01,University Hospital of Heidelberg,Pilocytic astrocytoma  ,I,Central review Heidelberg,19,male,"supratentorial, hemispheric; ",recurrence ,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",57%,Not applicable,DNA_FFPE,8月21日,9373550131
LGG_PA_GG_ST_13,8622007119_R01C01,University Hospital of Heidelberg,Ganglioglioma ,I,Central review Heidelberg,19,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",55%,Not applicable,DNA_FFPE,1月16日,8622007119
LGG_PA_GG_ST_14,9007217153_R04C02,University Hospital of Heidelberg,Pilocytic astrocytoma  ,I,Central review Heidelberg,19,female,"supratentorial, hemispheric, temporal; ",initial operation ,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",62%,Not applicable,DNA_FFPE,2月20日,9007217153
LGG_PA_GG_ST_15,9611519028_R01C01,University Hospital of Heidelberg,Pilocytic astrocytoma  ,I,Central review Heidelberg,20,male,"supratentorial, hemispheric, temporal; ",initial operation ,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",64%,Not applicable,DNA_FFPE,3月10日,9611519028
LGG_PA_GG_ST_16,8963311099_R03C02,University Hospital of Heidelberg,Pleomorphic xanthoastrocytoma  ,II,Central review Heidelberg,20,male,"supratentorial, hemispheric, parietal;  right;",not available,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",58%,Not applicable,DNA_FFPE,1月28日,8963311099
LGG_PA_GG_ST_17,8622007119_R06C01,University Hospital of Muenster,Ganglioglioma ,I,Central review Heidelberg,20,female,"supratentorial, hemispheric, temporal;  left;",not available,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",58%,Not applicable,DNA_FFPE,1月16日,8622007119
LGG_PA_GG_ST_18,10006823130_R02C01,University Hospital of Goettingen,Pilocytic astrocytoma  ,I,Central review Heidelberg,22,male,"supratentorial, hemispheric, temporal;  right;",initial operation ,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",57%,Not applicable,DNA_FFPE,1月12日,10006823130
LGG_PA_GG_ST_19,9297949098_R01C02,Amsterdam Academic Medical Center,Ganglioglioma ,I,Local review,24,female,"supratentorial, hemispheric, parietal; ",not available,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",59%,Not applicable,DNA_FFPE,6月7日,9297949098
LGG_PA_GG_ST_20,9829119122_R06C02,"MD Anderson Cancer Center, Houston",Pilocytic astrocytoma  ,I,Central review Heidelberg,27,male,"supratentorial, hemispheric, temporal, occipital;  right;",not available,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",51%,Not applicable,DNA_FFPE,5月23日,9829119122
LGG_PA_GG_ST_21,9422492026_R03C02,Amsterdam Academic Medical Center,Ganglioglioma ,I,Local review,29,male,"supratentorial, hemispheric, temporal; ",not available,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",62%,Not applicable,DNA_FFPE,12月6日,9422492026
LGG_PA_GG_ST_22,9007217153_R05C02,University Hospital of Heidelberg,Pilocytic astrocytoma  ,I,Central review Heidelberg,29,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",64%,Not applicable,DNA_FFPE,2月20日,9007217153
LGG_PA_GG_ST_23,10006823160_R05C01,University Hospital of Duesseldorf ,Pilocytic astrocytoma  ,I,Central review Heidelberg,32,female,"supratentorial, hemispheric, parietal;  left;",not available,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",47%,Not applicable,DNA_FFPE,1月30日,10006823160
LGG_PA_GG_ST_24,3999834001_R02C01,"Teleton Kids Institute, Perth ",Pilomyxoid astrocytoma  ,not available,Central review Heidelberg,not available ,male,not available,not available,LGG_PA_GG_ST,"methylation class low grade glioma, subclass hemispheric pilocytic astrocytoma and ganglioglioma",49%,Not applicable,DNA_FFPE,2月6日,3999834001
LGG_PA_MID_01,6929689152_R04C01,University Hospital of Cambridge,Pilocytic astrocytoma  ,I,Local review,0,male,"supratentorial, diencephalic, optic tract; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",61%,Not applicable,DNA_KRYO,11月23日,6929689152
LGG_PA_MID_02,3999834100_R05C01,University Hospital of Hannover,Pilocytic astrocytoma  ,I,Central review Heidelberg,0,female,"supratentorial, diencephalic, optic tract, sellar region, suprasellar; peripheral nerve, cranial nerve; ",initial operation ,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",65%,Not applicable,DNA_FFPE,2月27日,3999834100
LGG_PA_MID_03,9553932030_R05C01,University Hospital of Heidelberg,Pilocytic astrocytoma  ,I,Central review Heidelberg,1,female,"supratentorial, sellar region; peripheral nerve, cranial nerve, II; ",initial operation ,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",64%,Not applicable,DNA_FFPE,2月21日,9553932030
LGG_PA_MID_04,8622007022_R05C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,1,male,"supratentorial, intraventricular, ventricle III; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",62%,Not applicable,DNA_KRYO,10月23日,8622007022
LGG_PA_MID_05,8622007022_R02C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,2,female,"supratentorial, diencephalic, optic tract; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",60%,Not applicable,DNA_KRYO,10月23日,8622007022
LGG_PA_MID_06,6752625089_R01C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,2,female,"supratentorial, diencephalic, optic tract; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",50%,Not applicable,DNA_KRYO,6月22日,6752625089
LGG_PA_MID_07,6164621144_R06C02,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,2,female,"supratentorial, diencephalic; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",61%,Not applicable,DNA_KRYO,11月23日,6164621144
LGG_PA_MID_08,9376538153_R04C01,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,2,male,"supratentorial, hemispheric, frontal, parietal; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",65%,Not applicable,DNA_FFPE,10月25日,9376538153
LGG_PA_MID_09,9373550164_R05C01,University Hospital of Muenster,Pilomyxoid astrocytoma  ,not available,Central review Heidelberg,2,male,"supratentorial, diencephalic; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",66%,Not applicable,DNA_FFPE,8月21日,9373550164
LGG_PA_MID_10,6929718017_R03C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,3,female,"supratentorial, diencephalic, optic tract; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",50%,Not applicable,DNA_KRYO,12月2日,6929718017
LGG_PA_MID_11,8622007021_R04C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,3,female,"supratentorial, intraventricular, ventricle III; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",64%,Not applicable,DNA_KRYO,10月23日,8622007021
LGG_PA_MID_12,6969568005_R05C02,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,3,male,"supratentorial, diencephalic; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",62%,Not applicable,DNA_KRYO,11月23日,6969568005
LGG_PA_MID_13,6929689153_R02C01,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,3,female,"supratentorial, diencephalic; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",60%,Not applicable,DNA_KRYO,11月23日,6929689153
LGG_PA_MID_14,9373550131_R05C02,University Hospital of Tuebingen,Pilocytic astrocytoma  ,I,Central review Heidelberg,3,female,"supratentorial, diencephalic, optic tract; peripheral nerve, cranial nerve, II; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",55%,Not applicable,DNA_FFPE,8月21日,9373550131
LGG_PA_MID_15,6929689152_R03C01,University Hospital of Cambridge,Pilocytic astrocytoma  ,I,Local review,4,male,"supratentorial, diencephalic, optic tract; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",62%,Not applicable,DNA_KRYO,11月23日,6929689152
LGG_PA_MID_16,10006823069_R06C02,University Hospital of Goettingen,Pilomyxoid astrocytoma  ,not available,Central review Heidelberg,4,female,"supratentorial, sellar region, suprasellar; ",initial operation ,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",52%,Not applicable,DNA_FFPE,12月19日,10006823069
LGG_PA_MID_17,8622007058_R06C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,4,female,"supratentorial, diencephalic, optic tract; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",53%,Not applicable,DNA_KRYO,11月12日,8622007058
LGG_PA_MID_18,6752625095_R02C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,4,female,"supratentorial, intraventricular, ventricle III; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",64%,Not applicable,DNA_KRYO,6月22日,6752625095
LGG_PA_MID_19,6247004024_R05C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,5,female,"supratentorial, intraventricular, ventricle III; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",60%,Not applicable,DNA_KRYO,4月13日,6247004024
LGG_PA_MID_20,9878827227_R01C02,University Hospital of Tuebingen,Pilocytic astrocytoma  ,I,Central review Heidelberg,5,female,"supratentorial, diencephalic, optic tract; ",initial operation ,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",45%,Not applicable,DNA_FFPE,11月28日,9878827227
LGG_PA_MID_21,7310440067_R06C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,6,female,"posterior fossa, brain stem; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",60%,Not applicable,DNA_KRYO,7月2日,7310440067
LGG_PA_MID_22,9829119124_R01C01,"MD Anderson Cancer Center, Houston",Pilocytic astrocytoma  ,I,Central review Heidelberg,7,female,"supratentorial, hemispheric, temporal;  left;",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",55%,Not applicable,DNA_FFPE,5月23日,9829119124
LGG_PA_MID_23,9855358026_R06C01,University Hospital of Frankfurt am Main,Pilocytic astrocytoma  ,I,Central review Heidelberg,8,male,"supratentorial, hemispheric, temporal; ",initial operation ,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",57%,Not applicable,DNA_FFPE,9月26日,9855358026
LGG_PA_MID_24,6929689161_R04C01,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,8,female,supratentorial; ,not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",60%,Not applicable,DNA_KRYO,11月23日,6929689161
LGG_PA_MID_25,8622007023_R03C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,9,female,"supratentorial, diencephalic, optic tract; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",51%,Not applicable,DNA_KRYO,10月23日,8622007023
LGG_PA_MID_26,6752625088_R03C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,9,male,"supratentorial, diencephalic, optic tract; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",58%,Not applicable,DNA_KRYO,6月22日,6752625088
LGG_PA_MID_27,6752625091_R02C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,9,male,"supratentorial, intraventricular, ventricle III; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",64%,Not applicable,DNA_KRYO,6月22日,6752625091
LGG_PA_MID_28,6929718017_R05C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,12,male,"supratentorial, diencephalic, hypothalamic; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",49%,Not applicable,DNA_KRYO,12月2日,6929718017
LGG_PA_MID_29,9878820140_R04C02,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,14,male,"supratentorial, diencephalic, thalamic; ",initial operation ,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",56%,Not applicable,DNA_FFPE,11月7日,9878820140
LGG_PA_MID_30,3999547123_R03C01,University Hospital of Tuebingen,Pilocytic astrocytoma  ,I,Central review Heidelberg,16,female,"peripheral nerve, cranial nerve, II; ",initial operation ,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",64%,Not applicable,DNA_FFPE,4月17日,3999547123
LGG_PA_MID_31,7310440067_R04C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,33,female,"supratentorial, diencephalic, optic tract; ",not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",57%,Not applicable,DNA_KRYO,7月2日,7310440067
LGG_PA_MID_32,6929793058_R03C02,University Hospital of Heidelberg,Pilocytic astrocytoma  ,I,Central review Heidelberg,not available ,male,not available,not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",62%,Not applicable,DNA_FFPE,1月24日,6929793058
LGG_PA_MID_33,10011071031_R05C01,University Hospital of Heidelberg,Pilocytic astrocytoma  ,I,Central review Heidelberg,not available ,male,not available,not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",53%,Not applicable,DNA_KRYO,2月13日,10011071031
LGG_PA_MID_34,8622007021_R05C01,University Hospital of Heidelberg,Pilomyxoid astrocytoma  ,not available,Central review Heidelberg,not available ,male,not available,not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",63%,Not applicable,DNA_KRYO,10月23日,8622007021
LGG_PA_MID_35,8622007021_R01C02,University Hospital of Heidelberg,Pilomyxoid astrocytoma  ,not available,Central review Heidelberg,not available ,female,not available,not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",62%,Not applicable,DNA_KRYO,10月23日,8622007021
LGG_PA_MID_36,8622007021_R02C02,University Hospital of Heidelberg,Pilomyxoid astrocytoma  ,not available,Central review Heidelberg,not available ,female,not available,not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",62%,Not applicable,DNA_KRYO,10月23日,8622007021
LGG_PA_MID_37,8622007073_R04C02,University Hospital of Heidelberg,Pilocytic astrocytoma  ,I,Central review Heidelberg,not available ,female,not available,not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",63%,Not applicable,DNA_KRYO,12月6日,8622007073
LGG_PA_MID_38,8622007084_R04C02,University Hospital of Muenster,Pilocytic astrocytoma  ,I,Local review,not available ,female,not available,not available,LGG_PA_MID,"methylation class low grade glioma, subclass midline pilocytic astrocytoma",67%,Not applicable,DNA_FFPE,12月7日,8622007084
LGG_PA_PF_01,9553932030_R04C01,University Hospital of Frankfurt am Main,Pilocytic astrocytoma  ,I,Central review Heidelberg,1,male,posterior fossa; ,not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",59%,Not applicable,DNA_FFPE,2月21日,9553932030
LGG_PA_PF_02,6752625095_R05C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,1,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",62%,Not applicable,DNA_KRYO,6月22日,6752625095
LGG_PA_PF_03,8622007021_R06C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,1,female,spinal; ,not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",58%,Not applicable,DNA_KRYO,10月23日,8622007021
LGG_PA_PF_04,8622007023_R03C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,1,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",65%,Not applicable,DNA_KRYO,10月23日,8622007023
LGG_PA_PF_05,6752625051_R06C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,1,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",59%,Not applicable,DNA_KRYO,6月18日,6752625051
LGG_PA_PF_06,3999100031_R03C02,Charite Universitaetsmedizin Berlin,Anaplastic pilocytic astrocytoma,not available,Central review Heidelberg,2,male,"posterior fossa, ventricle IV; ",initial operation ,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",65%,Not applicable,DNA_FFPE,3月20日,3999100031
LGG_PA_PF_07,8622007023_R01C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,2,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",60%,Not applicable,DNA_KRYO,10月23日,8622007023
LGG_PA_PF_08,6969568005_R04C01,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,2,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",64%,Not applicable,DNA_KRYO,11月23日,6969568005
LGG_PA_PF_09,6929689153_R04C02,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,2,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",62%,Not applicable,DNA_KRYO,11月23日,6929689153
LGG_PA_PF_10,6929718017_R02C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,3,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",62%,Not applicable,DNA_KRYO,12月2日,6929718017
LGG_PA_PF_100,6969568005_R06C02,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,19,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",49%,Not applicable,DNA_KRYO,11月23日,6969568005
LGG_PA_PF_101,7310440067_R05C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,20,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",60%,Not applicable,DNA_KRYO,7月2日,7310440067
LGG_PA_PF_102,6752625091_R05C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,21,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",60%,Not applicable,DNA_KRYO,6月22日,6752625091
LGG_PA_PF_103,8622007022_R06C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,22,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",54%,Not applicable,DNA_KRYO,10月23日,8622007022
LGG_PA_PF_104,6929689153_R06C01,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,22,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",58%,Not applicable,DNA_KRYO,11月23日,6929689153
LGG_PA_PF_105,8622007021_R03C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,23,female,"supratentorial, diencephalic, optic tract; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",62%,Not applicable,DNA_KRYO,10月23日,8622007021
LGG_PA_PF_106,9406921149_R02C01,University Hospital of Heidelberg,Pilocytic astrocytoma  ,I,Central review Heidelberg,24,female,"supratentorial; posterior fossa, brain stem, tectum; ",initial operation ,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",55%,Not applicable,DNA_FFPE,11月18日,9406921149
LGG_PA_PF_107,7310440067_R06C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,25,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",56%,Not applicable,DNA_KRYO,7月2日,7310440067
LGG_PA_PF_108,7310440067_R01C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,26,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",57%,Not applicable,DNA_KRYO,7月2日,7310440067
LGG_PA_PF_109,7310440067_R04C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,26,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",60%,Not applicable,DNA_KRYO,7月2日,7310440067
LGG_PA_PF_11,6929718026_R02C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,3,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",64%,Not applicable,DNA_KRYO,12月2日,6929718026
LGG_PA_PF_110,7310440067_R02C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,40,female,"posterior fossa, ventricle IV; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",56%,Not applicable,DNA_KRYO,7月2日,7310440067
LGG_PA_PF_111,7310440067_R01C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,50,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",56%,Not applicable,DNA_KRYO,7月2日,7310440067
LGG_PA_PF_112,6929793058_R06C02,University Hospital of Heidelberg,Pilocytic astrocytoma  ,I,Central review Heidelberg,not available ,female,not available,not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",63%,Not applicable,DNA_FFPE,1月24日,6929793058
LGG_PA_PF_113,6929793058_R05C02,University Hospital of Heidelberg,Pilocytic astrocytoma  ,I,Central review Heidelberg,not available ,female,not available,not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",60%,Not applicable,DNA_FFPE,1月24日,6929793058
LGG_PA_PF_114,9513149159_R02C02,University Hospital of Heidelberg,Pilocytic astrocytoma  ,I,Central review Heidelberg,not available ,female,not available,not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",67%,Not applicable,DNA_KRYO,6月4日,9513149159
LGG_PA_PF_12,8622007058_R01C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,3,male,"posterior fossa, ventricle IV; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",61%,Not applicable,DNA_KRYO,11月12日,8622007058
LGG_PA_PF_13,6247004024_R03C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,3,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",61%,Not applicable,DNA_KRYO,4月13日,6247004024
LGG_PA_PF_14,8622007022_R02C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,3,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",58%,Not applicable,DNA_KRYO,10月23日,8622007022
LGG_PA_PF_15,6247004027_R01C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,3,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",59%,Not applicable,DNA_KRYO,4月13日,6247004027
LGG_PA_PF_16,6752625091_R03C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,3,female,"posterior fossa, brain stem; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",59%,Not applicable,DNA_KRYO,6月22日,6752625091
LGG_PA_PF_17,3999875055_R05C02,University Hospital of Frankfurt am Main,Pilocytic astrocytoma  ,I,Central review Heidelberg,4,female,"posterior fossa, brain stem; ",initial operation ,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",63%,Not applicable,DNA_FFPE,1月16日,3999875055
LGG_PA_PF_18,6752625051_R03C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,4,male,"posterior fossa, brain stem; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",58%,Not applicable,DNA_KRYO,6月18日,6752625051
LGG_PA_PF_19,6752625051_R05C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,4,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",62%,Not applicable,DNA_KRYO,6月18日,6752625051
LGG_PA_PF_20,6752625089_R01C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,4,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",60%,Not applicable,DNA_KRYO,6月22日,6752625089
LGG_PA_PF_21,6752625089_R03C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,4,male,"posterior fossa, brain stem; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",62%,Not applicable,DNA_KRYO,6月22日,6752625089
LGG_PA_PF_22,6752625091_R03C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,4,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",62%,Not applicable,DNA_KRYO,6月22日,6752625091
LGG_PA_PF_23,6752625091_R05C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,4,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",60%,Not applicable,DNA_KRYO,6月22日,6752625091
LGG_PA_PF_24,6752625091_R06C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,4,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",63%,Not applicable,DNA_KRYO,6月22日,6752625091
LGG_PA_PF_25,9878820021_R04C02,University Hospital of Leipzig,Pilocytic astrocytoma  ,I,Central review Heidelberg,4,female,"posterior fossa, brain stem, pons, cerebellar peduncles, medulla oblongata (craniocervical); ",initial operation ,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",60%,Not applicable,DNA_FFPE,10月17日,9878820021
LGG_PA_PF_26,6969568005_R02C01,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,4,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",61%,Not applicable,DNA_KRYO,11月23日,6969568005
LGG_PA_PF_27,6929689168_R03C02,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,4,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",64%,Not applicable,DNA_KRYO,11月23日,6929689168
LGG_PA_PF_28,6929689153_R05C02,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,4,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",63%,Not applicable,DNA_KRYO,11月23日,6929689153
LGG_PA_PF_29,6929689168_R05C02,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,4,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",62%,Not applicable,DNA_KRYO,11月23日,6929689168
LGG_PA_PF_30,9422493151_R02C02,University Hospital of Tuebingen,Pilocytic astrocytoma  ,I,Central review Heidelberg,4,male,"posterior fossa, cerebellum, vermis; ",initial operation ,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",63%,Not applicable,DNA_FFPE,12月13日,9422493151
LGG_PA_PF_31,3999100031_R01C02,Charite Universitaetsmedizin Berlin,Anaplastic pilocytic astrocytoma,not available,Central review Heidelberg,5,female,"posterior fossa, cerebellum; ",initial operation ,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",47%,Not applicable,DNA_FFPE,3月20日,3999100031
LGG_PA_PF_32,6929689136_R04C02,University Hospital of Cambridge,Pilocytic astrocytoma  ,I,Local review,5,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",56%,Not applicable,DNA_KRYO,11月23日,6929689136
LGG_PA_PF_33,6929689152_R01C01,University Hospital of Cambridge,Pilocytic astrocytoma  ,I,Local review,5,female,"posterior fossa, ventricle IV; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",60%,Not applicable,DNA_KRYO,11月23日,6929689152
LGG_PA_PF_34,6752625095_R03C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,5,female,"posterior fossa, brain stem; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",61%,Not applicable,DNA_KRYO,6月22日,6752625095
LGG_PA_PF_35,6752625095_R04C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,5,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",63%,Not applicable,DNA_KRYO,6月22日,6752625095
LGG_PA_PF_36,8622007023_R06C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,5,male,"posterior fossa, brain stem; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",65%,Not applicable,DNA_KRYO,10月23日,8622007023
LGG_PA_PF_37,6752625088_R06C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,5,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",62%,Not applicable,DNA_KRYO,6月22日,6752625088
LGG_PA_PF_38,6929689168_R02C02,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,5,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",60%,Not applicable,DNA_KRYO,11月23日,6929689168
LGG_PA_PF_39,6929689161_R01C01,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,5,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",63%,Not applicable,DNA_KRYO,11月23日,6929689161
LGG_PA_PF_40,6929689136_R06C02,University Hospital of Cambridge,Pilocytic astrocytoma  ,I,Local review,6,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",56%,Not applicable,DNA_KRYO,11月23日,6929689136
LGG_PA_PF_41,6752625088_R04C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,6,male,"posterior fossa, brain stem; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",61%,Not applicable,DNA_KRYO,6月22日,6752625088
LGG_PA_PF_42,6752625088_R05C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,6,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",57%,Not applicable,DNA_KRYO,6月22日,6752625088
LGG_PA_PF_43,6752625088_R04C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,6,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",61%,Not applicable,DNA_KRYO,6月22日,6752625088
LGG_PA_PF_44,6752625089_R06C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,6,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",57%,Not applicable,DNA_KRYO,6月22日,6752625089
LGG_PA_PF_45,6752625089_R04C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,6,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",59%,Not applicable,DNA_KRYO,6月22日,6752625089
LGG_PA_PF_46,6752625091_R06C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,6,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",55%,Not applicable,DNA_KRYO,6月22日,6752625091
LGG_PA_PF_47,6969568005_R04C02,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,6,male,"posterior fossa, brain stem, ventricle IV; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",59%,Not applicable,DNA_KRYO,11月23日,6969568005
LGG_PA_PF_48,6929689153_R06C02,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,6,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",52%,Not applicable,DNA_KRYO,11月23日,6929689153
LGG_PA_PF_49,6929689161_R06C01,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,6,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",61%,Not applicable,DNA_KRYO,11月23日,6929689161
LGG_PA_PF_50,9533774018_R03C02,University Hospital of Tuebingen,Pilocytic astrocytoma  ,I,Central review Heidelberg,6,female,"posterior fossa, cerebellum; ",initial operation ,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",65%,Not applicable,DNA_FFPE,5月30日,9533774018
LGG_PA_PF_51,8622007069_R01C02,University Hospital of Heidelberg,Pilocytic astrocytoma  ,I,Central review Heidelberg,7,male,"posterior fossa, cerebellum; ",recurrence ,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",55%,Not applicable,DNA_FFPE,11月26日,8622007069
LGG_PA_PF_52,8622007058_R03C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,7,male,"supratentorial, intraventricular, ventricle III; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",54%,Not applicable,DNA_KRYO,11月12日,8622007058
LGG_PA_PF_53,8622007022_R01C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,7,male,"posterior fossa, brain stem; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",55%,Not applicable,DNA_KRYO,10月23日,8622007022
LGG_PA_PF_54,8622007022_R03C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,7,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",62%,Not applicable,DNA_KRYO,10月23日,8622007022
LGG_PA_PF_55,8622007023_R04C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,7,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",58%,Not applicable,DNA_KRYO,10月23日,8622007023
LGG_PA_PF_56,8622007021_R05C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,7,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",60%,Not applicable,DNA_KRYO,10月23日,8622007021
LGG_PA_PF_57,6752625095_R01C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,7,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",61%,Not applicable,DNA_KRYO,6月22日,6752625095
LGG_PA_PF_58,6929689161_R05C01,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,7,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",57%,Not applicable,DNA_KRYO,11月23日,6929689161
LGG_PA_PF_59,6929689152_R06C01,University Hospital of Cambridge,Pilocytic astrocytoma  ,I,Local review,8,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",52%,Not applicable,DNA_KRYO,11月23日,6929689152
LGG_PA_PF_60,6929689152_R01C02,University Hospital of Cambridge,Pilocytic astrocytoma  ,I,Local review,8,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",58%,Not applicable,DNA_KRYO,11月23日,6929689152
LGG_PA_PF_61,6929718017_R04C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,8,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",51%,Not applicable,DNA_KRYO,12月2日,6929718017
LGG_PA_PF_62,6752625091_R01C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,8,female,"posterior fossa, brain stem; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",58%,Not applicable,DNA_KRYO,6月22日,6752625091
LGG_PA_PF_63,6752625091_R01C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,8,male,"posterior fossa, brain stem; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",66%,Not applicable,DNA_KRYO,6月22日,6752625091
LGG_PA_PF_64,6752625095_R03C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,8,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",59%,Not applicable,DNA_KRYO,6月22日,6752625095
LGG_PA_PF_65,9855358027_R04C02,University Hospital of Tuebingen,Pilocytic astrocytoma  ,I,Central review Heidelberg,8,female,"posterior fossa, cerebellum, hemispheric (cerebellum);  left;",initial operation ,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",59%,Not applicable,DNA_FFPE,9月26日,9855358027
LGG_PA_PF_66,6929718017_R01C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,9,male,"posterior fossa, ventricle IV; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",46%,Not applicable,DNA_KRYO,12月2日,6929718017
LGG_PA_PF_67,6929718017_R06C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,9,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",56%,Not applicable,DNA_KRYO,12月2日,6929718017
LGG_PA_PF_68,6929718026_R01C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,9,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",59%,Not applicable,DNA_KRYO,12月2日,6929718026
LGG_PA_PF_69,6752625088_R03C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,9,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",62%,Not applicable,DNA_KRYO,6月22日,6752625088
LGG_PA_PF_70,6752625089_R02C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,9,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",60%,Not applicable,DNA_KRYO,6月22日,6752625089
LGG_PA_PF_71,6752625095_R04C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,9,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",59%,Not applicable,DNA_KRYO,6月22日,6752625095
LGG_PA_PF_72,6752625088_R06C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,10,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",55%,Not applicable,DNA_KRYO,6月22日,6752625088
LGG_PA_PF_73,6929689153_R02C02,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,10,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",60%,Not applicable,DNA_KRYO,11月23日,6929689153
LGG_PA_PF_74,9420867051_R02C02,University Hospital of Heidelberg,Pilocytic astrocytoma  ,I,Central review Heidelberg,11,male,"posterior fossa, cerebellum; ",initial operation ,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",65%,Not applicable,DNA_FFPE,1月14日,9420867051
LGG_PA_PF_75,8622007022_R04C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,11,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",61%,Not applicable,DNA_KRYO,10月23日,8622007022
LGG_PA_PF_76,8622007023_R05C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,11,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",62%,Not applicable,DNA_KRYO,10月23日,8622007023
LGG_PA_PF_77,6752625091_R04C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,11,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",60%,Not applicable,DNA_KRYO,6月22日,6752625091
LGG_PA_PF_78,6969568005_R05C01,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,11,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",53%,Not applicable,DNA_KRYO,11月23日,6969568005
LGG_PA_PF_79,6929689153_R01C02,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,11,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",60%,Not applicable,DNA_KRYO,11月23日,6929689153
LGG_PA_PF_80,8622007058_R04C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,12,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",57%,Not applicable,DNA_KRYO,11月12日,8622007058
LGG_PA_PF_81,6752625095_R05C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,12,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",55%,Not applicable,DNA_KRYO,6月22日,6752625095
LGG_PA_PF_82,8622007022_R04C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,12,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",59%,Not applicable,DNA_KRYO,10月23日,8622007022
LGG_PA_PF_83,9534104010_R06C01,University Hospital of Tuebingen,Pilocytic astrocytoma  ,I,Central review Heidelberg,12,male,"posterior fossa, brain stem, ventricle IV; ",initial operation ,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",61%,Not applicable,DNA_FFPE,6月27日,9534104010
LGG_PA_PF_84,9533774041_R04C01,University Hospital of Frankfurt am Main,Pilocytic astrocytoma  ,I,Central review Heidelberg,13,male,"supratentorial, intraventricular, ventricle III; ",initial operation ,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",65%,Not applicable,DNA_FFPE,6月7日,9533774041
LGG_PA_PF_85,6752625095_R01C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,13,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",57%,Not applicable,DNA_KRYO,6月22日,6752625095
LGG_PA_PF_86,6969568005_R03C02,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,13,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",58%,Not applicable,DNA_KRYO,11月23日,6969568005
LGG_PA_PF_87,8622007119_R02C01,University Hospital of Muenster,Ganglioglioma ,I,Central review Heidelberg,13,male,posterior fossa; ,not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",58%,Not applicable,DNA_FFPE,1月16日,8622007119
LGG_PA_PF_88,9553932098_R05C01,University Hospital of Heidelberg,Pilocytic astrocytoma  ,I,Central review Heidelberg,14,male,"posterior fossa, cerebellum;  left;",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",66%,Not applicable,DNA_FFPE,2月28日,9553932098
LGG_PA_PF_89,6929718017_R06C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,14,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",57%,Not applicable,DNA_KRYO,12月2日,6929718017
LGG_PA_PF_90,6752625051_R02C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,14,female,"posterior fossa, ventricle IV; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",59%,Not applicable,DNA_KRYO,6月18日,6752625051
LGG_PA_PF_91,8622007022_R03C01,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,14,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",57%,Not applicable,DNA_KRYO,10月23日,8622007022
LGG_PA_PF_92,6752625089_R05C02,International Cancer Genome Consortium ,Pilocytic astrocytoma  ,I,Central review Heidelberg,14,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",58%,Not applicable,DNA_KRYO,6月22日,6752625089
LGG_PA_PF_93,9305651095_R05C02,University Hospital of Tuebingen,Pilocytic astrocytoma  ,I,Central review Heidelberg,14,female,"posterior fossa, brain stem, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",61%,Not applicable,DNA_FFPE,7月30日,9305651095
LGG_PA_PF_94,9968646167_R04C01,University Hospital of Tuebingen,Pilocytic astrocytoma  ,I,Central review Heidelberg,14,female,"posterior fossa, cerebellum;  right;",initial operation ,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",61%,Not applicable,DNA_FFPE,7月11日,9968646167
LGG_PA_PF_95,6969568005_R01C02,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,16,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",59%,Not applicable,DNA_KRYO,11月23日,6969568005
LGG_PA_PF_96,6929689136_R03C02,University Hospital of Cambridge,Pilocytic astrocytoma  ,I,Local review,17,female,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",59%,Not applicable,DNA_KRYO,11月23日,6929689136
LGG_PA_PF_97,3998909026_R03C01,University Hospital of Tuebingen,Pilocytic astrocytoma  ,I,Central review Heidelberg,17,male,"posterior fossa, ventricle IV; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",60%,Not applicable,DNA_FFPE,5月1日,3998909026
LGG_PA_PF_98,6969568005_R06C01,"Burdenko Neurosurgery Institute, Moscow",Pilocytic astrocytoma  ,I,Central review Heidelberg,18,male,"posterior fossa, cerebellum; ",not available,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",59%,Not applicable,DNA_KRYO,11月23日,6969568005
LGG_PA_PF_99,9534104008_R04C02,University Hospital of Frankfurt am Main,Pilocytic astrocytoma  ,I,Central review Heidelberg,19,male,"posterior fossa, cerebellum; ",initial operation ,LGG_PA_PF,"methylation class low grade glioma, subclass posterior fossa pilocytic astrocytoma",59%,Not applicable,DNA_FFPE,6月27日,9534104008
LGG_RGNT_01,6929689161_R01C02,"Burdenko Neurosurgery Institute, Moscow",Rosette-forming glioneuronal tumour  ,I,Central review Heidelberg,10,female,"posterior fossa, cerebellum; ",not available,LGG_RGNT,"methylation class low grade glioma, rosette forming glioneuronal tumor",64%,Not applicable,DNA_KRYO,11月23日,6929689161
LGG_RGNT_02,3998568167_R01C02,University Hospital of Zurich,Rosette-forming glioneuronal tumour  ,I,Central review Heidelberg,14,female,"supratentorial, diencephalic, pineal region; posterior fossa, ventricle IV; ",recurrence ,LGG_RGNT,"methylation class low grade glioma, rosette forming glioneuronal tumor",65%,Not applicable,DNA_FFPE,9月11日,3998568167
LGG_RGNT_03,9969477124_R05C01,University Hospital of Heidelberg,Rosette-forming glioneuronal tumour  ,I,Central review Heidelberg,18,female,"posterior fossa, ventricle IV; ",initial operation ,LGG_RGNT,"methylation class low grade glioma, rosette forming glioneuronal tumor",59%,Not applicable,DNA_FFPE,9月6日,9969477124
LGG_RGNT_04,9283265153_R04C02,University Hospital of Heidelberg,Rosette-forming glioneuronal tumour  ,I,Central review Heidelberg,20,male,"posterior fossa, ventricle IV; ",not available,LGG_RGNT,"methylation class low grade glioma, rosette forming glioneuronal tumor",63%,Not applicable,DNA_FFPE,4月29日,9283265153
LGG_RGNT_05,9878820105_R06C01,University Hospital of Bonn,Rosette-forming glioneuronal tumour  ,I,Central review Bonn ,21,female,"posterior fossa, cerebellum; ",not available,LGG_RGNT,"methylation class low grade glioma, rosette forming glioneuronal tumor",52%,Not applicable,DNA_FFPE,10月27日,9878820105
LGG_RGNT_06,9553932029_R06C01,University Hospital of Erlangen,Rosette-forming glioneuronal tumour  ,I,Central review Heidelberg,38,female,"posterior fossa, ventricle IV; ",not available,LGG_RGNT,"methylation class low grade glioma, rosette forming glioneuronal tumor",67%,Not applicable,DNA_FFPE,2月21日,9553932029
LGG_RGNT_07,3999834062_R01C02,University College London Hospitals,Rosette-forming glioneuronal tumour  ,I,Central review Heidelberg,40,male,"posterior fossa, ventricle IV; ",not available,LGG_RGNT,"methylation class low grade glioma, rosette forming glioneuronal tumor",62%,Not applicable,DNA_FFPE,2月13日,3999834062
LGG_RGNT_08,3999834062_R04C02,University College London Hospitals,Rosette-forming glioneuronal tumour  ,I,Central review Heidelberg,50,male,"posterior fossa, cerebellum;  left;",not available,LGG_RGNT,"methylation class low grade glioma, rosette forming glioneuronal tumor",64%,Not applicable,DNA_FFPE,2月13日,3999834062
LGG_RGNT_09,3999834118_R06C02,University Hospital of Heidelberg,Rosette-forming glioneuronal tumour  ,I,Central review Heidelberg,65,female,"supratentorial, diencephalic, pineal region; ",initial operation ,LGG_RGNT,"methylation class low grade glioma, rosette forming glioneuronal tumor",67%,Not applicable,DNA_FFPE,2月27日,3999834118
LGG_SEGA_01,9553932113_R04C02,University Hospital of Frankfurt am Main,Subependymal giant cell astrocytoma  ,I,Central review Heidelberg,0,female,"supratentorial, intraventricular, ventricle II;  left;",initial operation ,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",54%,Not applicable,DNA_FFPE,2月28日,9553932113
LGG_SEGA_02,9553932113_R05C02,University Hospital of Frankfurt am Main,Subependymal giant cell astrocytoma  ,I,Central review Heidelberg,0,male,"supratentorial, intraventricular, ventricle II;  right;",initial operation ,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",50%,Not applicable,DNA_FFPE,2月28日,9553932113
LGG_SEGA_03,6929689136_R05C02,University Hospital of Cambridge,Subependymal giant cell astrocytoma  ,I,Local review,1,male,"supratentorial, diencephalic, hypothalamic; ",not available,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",42%,Not applicable,DNA_KRYO,11月23日,6929689136
LGG_SEGA_04,9741950021_R03C02,"Burdenko Neurosurgery Institute, Moscow",Subependymal giant cell astrocytoma  ,I,Central review Heidelberg,1,male,"supratentorial, hemispheric, frontal; ",not available,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",52%,Not applicable,DNA_FFPE,3月24日,9741950021
LGG_SEGA_05,9407201030_R05C02,University Hospital of Bern,Subependymal giant cell astrocytoma  ,I,Central review Heidelberg,5,male,not available,initial operation ,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",62%,Not applicable,DNA_FFPE,12月2日,9407201030
LGG_SEGA_06,9611519030_R01C01,University Hospital of Heidelberg,Subependymal giant cell astrocytoma  ,I,Central review Heidelberg,6,male,"supratentorial, hemispheric, frontal, intraventricular, ventricle II; ",initial operation ,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",53%,Not applicable,DNA_FFPE,3月10日,9611519030
LGG_SEGA_07,9007225064_R06C01,University Hospital of Heidelberg,Subependymal giant cell astrocytoma  ,I,Central review Heidelberg,8,female,"supratentorial, intraventricular, ventricle II;  left;",initial operation ,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",61%,Not applicable,DNA_FFPE,2月25日,9007225064
LGG_SEGA_08,9553932113_R06C02,University Hospital of Frankfurt am Main,Subependymal giant cell astrocytoma  ,I,Central review Heidelberg,9,female,"supratentorial, intraventricular, ventricle II;  right;",initial operation ,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",67%,Not applicable,DNA_FFPE,2月28日,9553932113
LGG_SEGA_09,8622007189_R05C02,University Hospital of Heidelberg,Subependymal giant cell astrocytoma  ,I,Central review Heidelberg,11,male,"supratentorial, intraventricular, ventricle II;  left; right;",initial operation ,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",56%,Not applicable,DNA_FFPE,1月17日,8622007189
LGG_SEGA_10,9741950101_R01C02,University Hospital of Heidelberg,Subependymal giant cell astrocytoma  ,I,Central review Heidelberg,13,female,"supratentorial, intraventricular, ventricle II;  left;",initial operation ,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",59%,Not applicable,DNA_FFPE,5月16日,9741950101
LGG_SEGA_11,9968646158_R01C01,Amsterdam Academic Medical Center,Subependymal giant cell astrocytoma  ,I,Local review,14,male,not available,not available,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",50%,Not applicable,DNA_FFPE,7月11日,9968646158
LGG_SEGA_12,8622007189_R02C02,University Hospital of Heidelberg,Subependymal giant cell astrocytoma  ,I,Central review Heidelberg,14,female,"supratentorial, intraventricular, ventricle II;  left;",initial operation ,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",44%,Not applicable,DNA_FFPE,1月17日,8622007189
LGG_SEGA_13,8942351007_R05C01,University Hospital of Heidelberg,Subependymal giant cell astrocytoma  ,I,Central review Heidelberg,16,female,"supratentorial, intraventricular; ",initial operation ,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",49%,Not applicable,DNA_FFPE,1月18日,8942351007
LGG_SEGA_14,8622007067_R04C01,University Hospital of Heidelberg,Subependymal giant cell astrocytoma  ,I,Central review Heidelberg,17,male,not available,not available,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",61%,Not applicable,DNA_FFPE,11月26日,8622007067
LGG_SEGA_15,9829119124_R03C01,"MD Anderson Cancer Center, Houston",Subependymal giant cell astrocytoma  ,I,Central review Heidelberg,20,male,"supratentorial, intraventricular; ",not available,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",53%,Not applicable,DNA_FFPE,5月23日,9829119124
LGG_SEGA_16,9407201030_R04C02,University Hospital of Bern,Subependymal giant cell astrocytoma  ,I,Central review Heidelberg,22,female,not available,not available,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",44%,Not applicable,DNA_FFPE,12月2日,9407201030
LGG_SEGA_17,9968646099_R02C01,Amsterdam Academic Medical Center,Subependymal giant cell astrocytoma  ,I,Local review,23,male,not available,not available,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",55%,Not applicable,DNA_FFPE,7月8日,9968646099
LGG_SEGA_18,8942351007_R06C01,University Hospital of Heidelberg,Subependymal giant cell astrocytoma  ,I,Central review Heidelberg,23,female,"supratentorial, intraventricular, ventricle II;  right;",initial operation ,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",48%,Not applicable,DNA_FFPE,1月18日,8942351007
LGG_SEGA_19,9553932123_R01C01,University Hospital of Frankfurt am Main,Subependymal giant cell astrocytoma  ,I,Central review Heidelberg,24,male,"supratentorial, intraventricular, ventricle III; ",initial operation ,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",43%,Not applicable,DNA_FFPE,2月28日,9553932123
LGG_SEGA_20,9407201030_R01C02,University Hospital of Bern,Subependymal giant cell astrocytoma  ,I,Central review Heidelberg,32,male,"supratentorial, intraventricular, ventricle II;  left;",not available,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",48%,Not applicable,DNA_FFPE,12月2日,9407201030
LGG_SEGA_21,9407201030_R02C02,University Hospital of Bern,Subependymal giant cell astrocytoma  ,I,Central review Heidelberg,39,female,not available,not available,LGG_SEGA,"methylation class low grade glioma, subependymal giant cell astrocytoma",54%,Not applicable,DNA_FFPE,12月2日,9407201030
LIPN_01,9305651037_R01C01,University Hospital of Heidelberg,Cerebellar liponeurocytoma  ,II,Central review Heidelberg,29,male,"posterior fossa, cerebellum; ",initial operation ,LIPN,methylation class cerebellar liponeurocytoma,75%,Not applicable,DNA_FFPE,6月28日,9305651037
LIPN_02,3998523002_R03C02,University Hospital of Heidelberg,Cerebellar liponeurocytoma  ,II,Central review Heidelberg,39,male,"posterior fossa, cerebellum;  left;",initial operation ,LIPN,methylation class cerebellar liponeurocytoma,72%,Not applicable,DNA_FFPE,7月24日,3998523002
LIPN_03,9376538149_R03C02,"Burdenko Neurosurgery Institute, Moscow",Cerebellar liponeurocytoma  ,II,Central review Heidelberg,41,male,"posterior fossa, cerebellum, ventricle IV; ",initial operation ,LIPN,methylation class cerebellar liponeurocytoma,72%,Not applicable,DNA_FFPE,10月25日,9376538149
LIPN_04,9379086132_R03C02,University Hospital of Heidelberg,Cerebellar liponeurocytoma  ,II,Central review Heidelberg,44,male,"posterior fossa, cerebellum; ",initial operation ,LIPN,methylation class cerebellar liponeurocytoma,73%,Not applicable,DNA_FFPE,10月4日,9379086132
LIPN_05,9553932053_R04C02,University Hospital of Erlangen,Cerebellar liponeurocytoma  ,II,Central review Heidelberg,47,female,"posterior fossa, cerebellum; ",not available,LIPN,methylation class cerebellar liponeurocytoma,70%,Not applicable,DNA_FFPE,2月21日,9553932053
LIPN_06,9553932123_R02C02,University Hospital of Erlangen,Cerebellar liponeurocytoma  ,II,Central review Heidelberg,47,female,"posterior fossa, cerebellum; ",not available,LIPN,methylation class cerebellar liponeurocytoma,72%,Not applicable,DNA_FFPE,2月28日,9553932123
LIPN_07,101231000014_R01C02,University Hospital of Duesseldorf ,Cerebellar liponeurocytoma  ,II,Central review Heidelberg,58,female,"posterior fossa, cerebellum; ",initial operation ,LIPN,methylation class cerebellar liponeurocytoma,77%,Not applicable,DNA_FFPE,9月18日,1.01231E+11
LIPN_08,3999078079_R04C01,University Hospital of Heidelberg,Cerebellar liponeurocytoma  ,II,Central review Heidelberg,62,female,posterior fossa; ,not available,LIPN,methylation class cerebellar liponeurocytoma,76%,Not applicable,DNA_FFPE,7月3日,3999078079
LIPN_09,9407201028_R02C02,University Hospital of Tuebingen,Cerebellar liponeurocytoma  ,II,Central review Heidelberg,64,female,"posterior fossa, cerebellum; ",initial operation ,LIPN,methylation class cerebellar liponeurocytoma,80%,Not applicable,DNA_FFPE,12月2日,9407201028
LIPN_10,9741950101_R02C01,Charite Universitaetsmedizin Berlin,Cerebellar liponeurocytoma  ,II,Central review Heidelberg,78,female,"posterior fossa, cerebellum; ",recurrence ,LIPN,methylation class cerebellar liponeurocytoma,69%,Not applicable,DNA_FFPE,5月16日,9741950101
LYMPHO_01,9878820122_R03C02,University Hospital of Heidelberg,Diffuse large B cell lymphoma (DLBCL),not available,Central review Heidelberg,28,male,"supratentorial, hemispheric, frontal;  right;",recurrence ,LYMPHO,methylation class lymphoma,65%,Not applicable,DNA_FFPE,10月31日,9878820122
LYMPHO_02,8942351007_R02C02,University Hospital of Heidelberg,Diffuse large B cell lymphoma (DLBCL),not available,Central review Heidelberg,42,female,"supratentorial, hemispheric, occipital;  right;",initial operation ,LYMPHO,methylation class lymphoma,65%,Not applicable,DNA_FFPE,1月18日,8942351007
LYMPHO_03,8942351007_R04C02,University Hospital of Heidelberg,Diffuse large B cell lymphoma (DLBCL),not available,Central review Heidelberg,43,male,not available,not available,LYMPHO,methylation class lymphoma,61%,Not applicable,DNA_FFPE,1月18日,8942351007
LYMPHO_04,8963311099_R06C02,University Hospital of Heidelberg,Diffuse large B cell lymphoma (DLBCL),not available,Central review Heidelberg,50,female,"posterior fossa, cerebellum;  right;",initial operation ,LYMPHO,methylation class lymphoma,65%,Not applicable,DNA_FFPE,1月28日,8963311099
LYMPHO_05,8942351007_R01C02,University Hospital of Heidelberg,Diffuse large B cell lymphoma (DLBCL),not available,Central review Heidelberg,51,male,"supratentorial, diencephalic, basal ganglia;  left;",initial operation ,LYMPHO,methylation class lymphoma,64%,Not applicable,DNA_FFPE,1月18日,8942351007
LYMPHO_06,9007217153_R01C01,University Hospital of Heidelberg,Diffuse large B cell lymphoma (DLBCL),not available,Central review Heidelberg,54,female,"supratentorial, hemispheric, frontal;  left;",initial operation ,LYMPHO,methylation class lymphoma,67%,Not applicable,DNA_FFPE,2月20日,9007217153
LYMPHO_07,9007217153_R02C01,University Hospital of Heidelberg,Diffuse large B cell lymphoma (DLBCL),not available,Central review Heidelberg,55,male,"posterior fossa, brain stem, medulla oblongata (craniocervical); ",initial operation ,LYMPHO,methylation class lymphoma,67%,Not applicable,DNA_FFPE,2月20日,9007217153
LYMPHO_08,9007217153_R04C01,University Hospital of Heidelberg,Diffuse large B cell lymphoma (DLBCL),not available,Central review Heidelberg,57,female,"supratentorial, hemispheric, temporal;  right;",initial operation ,LYMPHO,methylation class lymphoma,58%,Not applicable,DNA_FFPE,2月20日,9007217153
LYMPHO_09,9878820030_R04C01,University Hospital of Heidelberg,Diffuse large B cell lymphoma (DLBCL),not available,Central review Heidelberg,62,female,"supratentorial, hemispheric, temporal, diencephalic, basal ganglia;  left; right;",initial operation ,LYMPHO,methylation class lymphoma,68%,Not applicable,DNA_FFPE,10月17日,9878820030
LYMPHO_10,9406921039_R04C02,University Hospital of Heidelberg,Diffuse large B cell lymphoma (DLBCL),not available,Central review Heidelberg,65,male,"supratentorial, hemispheric, parietal;  left;",initial operation ,LYMPHO,methylation class lymphoma,64%,Not applicable,DNA_FFPE,11月18日,9406921039
LYMPHO_11,9376561042_R03C01,University Hospital of Heidelberg,Diffuse large B cell lymphoma (DLBCL),not available,Central review Heidelberg,67,not available,"supratentorial, hemispheric, frontal;  left;",initial operation ,LYMPHO,methylation class lymphoma,63%,Not applicable,DNA_FFPE,11月8日,9376561042
LYMPHO_12,3998567085_R06C02,University Hospital of Heidelberg,Diffuse large B cell lymphoma (DLBCL),not available,Central review Heidelberg,78,male,"supratentorial, hemispheric, frontal, temporal;  right;",initial operation ,LYMPHO,methylation class lymphoma,62%,Not applicable,DNA_FFPE,8月21日,3998567085
LYMPHO_13,6929718009_R05C01,International Cancer Genome Consortium ,Diffuse large B cell lymphoma (DLBCL),not available,Central review Heidelberg,not available ,not available,posterior fossa; ,not available,LYMPHO,methylation class lymphoma,65%,Not applicable,DNA_KRYO,12月23日,6929718009
MB_G3_01,7970376005_R01C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,1,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",67%,Not applicable,DNA_FFPE,7月19日,7970376005
MB_G3_02,7990908004_R05C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,1,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",66%,Not applicable,DNA_FFPE,7月30日,7990908004
MB_G3_03,6229017094_R01C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,1,male,posterior fossa; ,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",63%,Not applicable,DNA_KRYO,3月15日,6229017094
MB_G3_04,7970368167_R04C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,2,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",68%,Not applicable,DNA_FFPE,7月19日,7970368167
MB_G3_05,7970376029_R03C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,2,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",66%,Not applicable,DNA_FFPE,7月19日,7970376029
MB_G3_06,7990908004_R02C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,2,male,"posterior fossa, cerebellum, vermis; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",68%,Not applicable,DNA_FFPE,7月30日,7990908004
MB_G3_07,6929718049_R04C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,2,male,"posterior fossa, cerebellum; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",76%,Not applicable,DNA_KRYO,12月23日,6929718049
MB_G3_08,8622007029_R01C01,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,2,female,"posterior fossa, cerebellum; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",70%,Not applicable,DNA_KRYO,10月23日,8622007029
MB_G3_09,9829119124_R02C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,2,male,posterior fossa; ,initial operation ,MB_G3,"methylation class medulloblastoma, subclass group 3",73%,Not applicable,DNA_FFPE,5月23日,9829119124
MB_G3_10,9533774033_R02C01,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,3,male,"posterior fossa, ventricle IV; ",initial operation ,MB_G3,"methylation class medulloblastoma, subclass group 3",65%,Not applicable,DNA_FFPE,6月7日,9533774033
MB_G3_11,10003886253_R05C02,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,3,male,posterior fossa; ,initial operation ,MB_G3,"methylation class medulloblastoma, subclass group 3",69%,Not applicable,DNA_FFPE,1月23日,10003886253
MB_G3_12,7970368167_R05C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,3,male,"posterior fossa, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",66%,Not applicable,DNA_FFPE,7月19日,7970368167
MB_G3_13,7970376055_R01C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,3,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",62%,Not applicable,DNA_FFPE,7月19日,7970376055
MB_G3_14,7970376055_R01C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,3,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",68%,Not applicable,DNA_FFPE,7月19日,7970376055
MB_G3_15,7990895120_R03C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,3,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",66%,Not applicable,DNA_FFPE,7月30日,7990895120
MB_G3_16,7990895093_R02C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,3,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",71%,Not applicable,DNA_FFPE,7月30日,7990895093
MB_G3_17,6752625054_R05C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,3,male,posterior fossa; ,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",74%,Not applicable,DNA_KRYO,6月18日,6752625054
MB_G3_18,8622007026_R01C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,3,not available,posterior fossa; ,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",64%,Not applicable,DNA_KRYO,10月23日,8622007026
MB_G3_19,8622007026_R06C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,3,male,posterior fossa; ,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",70%,Not applicable,DNA_KRYO,10月23日,8622007026
MB_G3_20,6929793061_R01C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,3,male,posterior fossa; ,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",67%,Not applicable,DNA_KRYO,1月27日,6929793061
MB_G3_21,6929689136_R03C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,3,not available,posterior fossa; ,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",74%,Not applicable,DNA_KRYO,11月23日,6929689136
MB_G3_22,6247004027_R05C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,3,male,posterior fossa; ,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",70%,Not applicable,DNA_KRYO,4月13日,6247004027
MB_G3_23,6229017094_R04C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,3,male,posterior fossa; ,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",68%,Not applicable,DNA_KRYO,3月15日,6229017094
MB_G3_24,8622007028_R03C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,3,female,"posterior fossa, cerebellum; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",65%,Not applicable,DNA_KRYO,10月23日,8622007028
MB_G3_25,9969477017_R01C02,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,4,male,"posterior fossa, cerebellum, vermis; ",initial operation ,MB_G3,"methylation class medulloblastoma, subclass group 3",66%,Not applicable,DNA_FFPE,7月25日,9969477017
MB_G3_26,3999002043_R06C02,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,4,male,"posterior fossa, brain stem, medulla oblongata (craniocervical); ",initial operation ,MB_G3,"methylation class medulloblastoma, subclass group 3",66%,Not applicable,DNA_FFPE,6月26日,3999002043
MB_G3_27,7970376026_R05C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,4,male,"posterior fossa, cerebellum, vermis; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",65%,Not applicable,DNA_FFPE,7月19日,7970376026
MB_G3_28,7990895142_R04C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,4,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",67%,Not applicable,DNA_FFPE,7月30日,7990895142
MB_G3_29,7990908004_R03C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,4,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",66%,Not applicable,DNA_FFPE,7月30日,7990908004
MB_G3_30,7990895127_R01C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,4,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",60%,Not applicable,DNA_FFPE,7月30日,7990895127
MB_G3_31,8622007026_R04C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,4,not available,posterior fossa; ,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",76%,Not applicable,DNA_KRYO,10月23日,8622007026
MB_G3_32,6969568004_R06C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,4,male,posterior fossa; ,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",80%,Not applicable,DNA_KRYO,11月23日,6969568004
MB_G3_33,6929689136_R01C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,4,male,posterior fossa; ,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",70%,Not applicable,DNA_KRYO,11月23日,6929689136
MB_G3_34,6229017094_R06C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,4,not available,posterior fossa; ,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",73%,Not applicable,DNA_KRYO,3月15日,6229017094
MB_G3_35,9829119072_R04C02,University Hospital of Magdeburg,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,4,male,posterior fossa; ,initial operation ,MB_G3,"methylation class medulloblastoma, subclass group 3",66%,Not applicable,DNA_FFPE,5月23日,9829119072
MB_G3_36,6929718049_R01C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,4,female,"posterior fossa, cerebellum; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",62%,Not applicable,DNA_KRYO,12月23日,6929718049
MB_G3_37,6929718049_R02C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,4,female,"posterior fossa, cerebellum; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",67%,Not applicable,DNA_KRYO,12月23日,6929718049
MB_G3_38,9407201029_R06C02,University Hospital of Tuebingen,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,4,male,"posterior fossa, cerebellum; ",initial operation ,MB_G3,"methylation class medulloblastoma, subclass group 3",73%,Not applicable,DNA_FFPE,12月2日,9407201029
MB_G3_39,9721366150_R04C01,University Hospital of Tuebingen,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,4,male,"posterior fossa, ventricle IV; ",initial operation ,MB_G3,"methylation class medulloblastoma, subclass group 3",65%,Not applicable,DNA_FFPE,5月9日,9721366150
MB_G3_40,8622007028_R02C01,Amsterdam Academic Medical Center,"Medulloblastoma, genetically defined, group 3 ",IV,Local review,5,male,not available,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",70%,Not applicable,DNA_KRYO,10月23日,8622007028
MB_G3_41,9305651055_R02C02,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,5,female,not available,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",70%,Not applicable,DNA_FFPE,7月19日,9305651055
MB_G3_42,9340996003_R06C02,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,5,male,posterior fossa; ,initial operation ,MB_G3,"methylation class medulloblastoma, subclass group 3",71%,Not applicable,DNA_FFPE,8月6日,9340996003
MB_G3_43,7970376026_R03C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,5,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",68%,Not applicable,DNA_FFPE,7月19日,7970376026
MB_G3_44,7970376005_R05C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,5,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",65%,Not applicable,DNA_FFPE,7月19日,7970376005
MB_G3_45,7970376055_R03C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,5,male,"posterior fossa, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",66%,Not applicable,DNA_FFPE,7月19日,7970376055
MB_G3_46,7970376055_R04C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,5,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",58%,Not applicable,DNA_FFPE,7月19日,7970376055
MB_G3_47,7990895120_R02C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,5,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",64%,Not applicable,DNA_FFPE,7月30日,7990895120
MB_G3_48,7990895120_R02C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,5,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",70%,Not applicable,DNA_FFPE,7月30日,7990895120
MB_G3_49,8622007025_R04C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,5,male,posterior fossa; ,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",69%,Not applicable,DNA_KRYO,10月23日,8622007025
MB_G3_50,7970368167_R06C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,6,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",69%,Not applicable,DNA_FFPE,7月19日,7970368167
MB_G3_51,7970376067_R02C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,6,male,"posterior fossa, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",66%,Not applicable,DNA_FFPE,7月19日,7970376067
MB_G3_52,7990895159_R02C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,6,male,"posterior fossa, cerebellum, vermis; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",66%,Not applicable,DNA_FFPE,7月30日,7990895159
MB_G3_53,7990895127_R04C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,6,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",64%,Not applicable,DNA_FFPE,7月30日,7990895127
MB_G3_54,7990895142_R01C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,6,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",67%,Not applicable,DNA_FFPE,7月30日,7990895142
MB_G3_55,6929793052_R03C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,6,not available,posterior fossa; ,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",62%,Not applicable,DNA_KRYO,1月27日,6929793052
MB_G3_56,6969568004_R04C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,6,male,posterior fossa; ,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",72%,Not applicable,DNA_KRYO,11月23日,6969568004
MB_G3_57,9533774024_R03C02,University Hospital of Magdeburg,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,6,male,posterior fossa; ,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",67%,Not applicable,DNA_FFPE,6月7日,9533774024
MB_G3_58,7990895159_R05C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,7,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",59%,Not applicable,DNA_FFPE,7月30日,7990895159
MB_G3_59,7990895093_R05C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,7,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",67%,Not applicable,DNA_FFPE,7月30日,7990895093
MB_G3_60,8622007027_R03C02,Amsterdam Academic Medical Center,"Medulloblastoma, genetically defined, group 3 ",IV,Local review,8,male,not available,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",72%,Not applicable,DNA_KRYO,10月23日,8622007027
MB_G3_61,7990895142_R01C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,8,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",63%,Not applicable,DNA_FFPE,7月30日,7990895142
MB_G3_62,7990895095_R03C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,8,male,"posterior fossa, cerebellum, vermis; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",66%,Not applicable,DNA_FFPE,7月30日,7990895095
MB_G3_63,6229017094_R05C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,8,not available,posterior fossa; ,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",62%,Not applicable,DNA_KRYO,3月15日,6229017094
MB_G3_64,6929718049_R03C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,8,male,"posterior fossa, cerebellum; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",76%,Not applicable,DNA_KRYO,12月23日,6929718049
MB_G3_65,6929718049_R05C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,8,male,"posterior fossa, cerebellum; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",67%,Not applicable,DNA_KRYO,12月23日,6929718049
MB_G3_66,9407201030_R03C01,University Hospital of Tuebingen,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,8,female,"posterior fossa, ventricle IV; ",initial operation ,MB_G3,"methylation class medulloblastoma, subclass group 3",67%,Not applicable,DNA_FFPE,12月2日,9407201030
MB_G3_67,7990895159_R01C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,9,female,not available,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",64%,Not applicable,DNA_FFPE,7月30日,7990895159
MB_G3_68,7970368141_R01C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,10,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",67%,Not applicable,DNA_FFPE,7月19日,7970368141
MB_G3_69,6929689136_R06C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,10,female,posterior fossa; ,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",68%,Not applicable,DNA_KRYO,11月23日,6929689136
MB_G3_70,7970376026_R02C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,11,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",69%,Not applicable,DNA_FFPE,7月19日,7970376026
MB_G3_71,7970376067_R05C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,11,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",67%,Not applicable,DNA_FFPE,7月19日,7970376067
MB_G3_72,7990895093_R02C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,11,male,"posterior fossa, cerebellum, vermis; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",71%,Not applicable,DNA_FFPE,7月30日,7990895093
MB_G3_73,7990895046_R03C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,11,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",67%,Not applicable,DNA_FFPE,7月30日,7990895046
MB_G3_74,7990895046_R06C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,11,male,"posterior fossa, cerebellum, hemispheric (cerebellum), vermis; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",67%,Not applicable,DNA_FFPE,7月30日,7990895046
MB_G3_75,6929793061_R02C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Heidelberg,13,not available,posterior fossa; ,not available,MB_G3,"methylation class medulloblastoma, subclass group 3",77%,Not applicable,DNA_KRYO,1月27日,6929793061
MB_G3_76,7970368141_R04C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,14,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",66%,Not applicable,DNA_FFPE,7月19日,7970368141
MB_G3_77,7970376005_R02C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 3 ",IV,Central review Bonn,17,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G3,"methylation class medulloblastoma, subclass group 3",62%,Not applicable,DNA_FFPE,7月19日,7970376005
MB_G4_01,7970376026_R04C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,2,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",67%,Not applicable,DNA_FFPE,7月19日,7970376026
MB_G4_02,7990895142_R04C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,3,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",65%,Not applicable,DNA_FFPE,7月30日,7990895142
MB_G4_03,7990895120_R04C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,3,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",66%,Not applicable,DNA_FFPE,7月30日,7990895120
MB_G4_04,7990895127_R01C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,3,male,not available,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",63%,Not applicable,DNA_FFPE,7月30日,7990895127
MB_G4_05,6929689136_R02C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,3,not available,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_KRYO,11月23日,6929689136
MB_G4_06,9533774018_R01C02,University Hospital of Tuebingen,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,3,male,"posterior fossa, cerebellum; ",initial operation ,MB_G4,"methylation class medulloblastoma, subclass group 4",63%,Not applicable,DNA_FFPE,5月30日,9533774018
MB_G4_07,7970368141_R06C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,4,male,"posterior fossa, ventricle IV;  left;",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",65%,Not applicable,DNA_FFPE,7月19日,7970368141
MB_G4_08,7970368168_R04C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,4,male,"supratentorial, intraventricular, ventricle III; posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",67%,Not applicable,DNA_FFPE,7月19日,7970368168
MB_G4_09,7970376029_R02C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,4,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",65%,Not applicable,DNA_FFPE,7月19日,7970376029
MB_G4_10,7970376055_R02C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,4,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_FFPE,7月19日,7970376055
MB_G4_100,9878820017_R04C01,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,14,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",66%,Not applicable,DNA_FFPE,10月17日,9878820017
MB_G4_101,7970368168_R01C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,14,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",66%,Not applicable,DNA_FFPE,7月19日,7970368168
MB_G4_102,7990895095_R03C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,14,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",64%,Not applicable,DNA_FFPE,7月30日,7990895095
MB_G4_103,7990895093_R01C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,14,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",69%,Not applicable,DNA_FFPE,7月30日,7990895093
MB_G4_104,7990895095_R02C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,14,male,"posterior fossa, cerebellum, vermis; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",67%,Not applicable,DNA_FFPE,7月30日,7990895095
MB_G4_105,6929793052_R04C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,14,not available,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",69%,Not applicable,DNA_KRYO,1月27日,6929793052
MB_G4_106,6229017094_R01C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,14,female,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",67%,Not applicable,DNA_KRYO,3月15日,6229017094
MB_G4_107,3999834093_R01C01,University Hospital of Duesseldorf ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,15,male,"posterior fossa, cerebellum; ",initial operation ,MB_G4,"methylation class medulloblastoma, subclass group 4",71%,Not applicable,DNA_FFPE,2月20日,3999834093
MB_G4_108,7970368167_R01C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,15,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_FFPE,7月19日,7970368167
MB_G4_109,7990895159_R05C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,15,female,"posterior fossa, cerebellum, vermis; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_FFPE,7月30日,7990895159
MB_G4_11,7990908004_R01C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,4,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",65%,Not applicable,DNA_FFPE,7月30日,7990908004
MB_G4_110,6229017094_R02C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,15,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",70%,Not applicable,DNA_KRYO,3月15日,6229017094
MB_G4_111,6247004027_R04C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,15,not available,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",73%,Not applicable,DNA_KRYO,4月13日,6247004027
MB_G4_112,7970376005_R04C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,16,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_FFPE,7月19日,7970376005
MB_G4_113,7990895159_R04C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,16,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_FFPE,7月30日,7990895159
MB_G4_114,7990895095_R02C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,16,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",64%,Not applicable,DNA_FFPE,7月30日,7990895095
MB_G4_115,6752625054_R06C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,16,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",70%,Not applicable,DNA_KRYO,6月18日,6752625054
MB_G4_116,8622007025_R02C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,16,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",71%,Not applicable,DNA_KRYO,10月23日,8622007025
MB_G4_117,7970376005_R05C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,17,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_FFPE,7月19日,7970376005
MB_G4_118,6929793052_R06C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,17,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",73%,Not applicable,DNA_KRYO,1月27日,6929793052
MB_G4_119,7970376026_R04C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,18,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",69%,Not applicable,DNA_FFPE,7月19日,7970376026
MB_G4_12,7990895046_R05C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,4,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",59%,Not applicable,DNA_FFPE,7月30日,7990895046
MB_G4_120,6929718020_R01C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,18,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_KRYO,12月23日,6929718020
MB_G4_121,6929718020_R02C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,18,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",71%,Not applicable,DNA_KRYO,12月23日,6929718020
MB_G4_122,6929718050_R01C01,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,18,male,"posterior fossa, cerebellum; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",69%,Not applicable,DNA_KRYO,12月23日,6929718050
MB_G4_123,6929718009_R02C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,19,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",72%,Not applicable,DNA_KRYO,12月23日,6929718009
MB_G4_124,9855358027_R05C01,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,19,male,"posterior fossa, cerebellum; ",initial operation ,MB_G4,"methylation class medulloblastoma, subclass group 4",71%,Not applicable,DNA_FFPE,9月26日,9855358027
MB_G4_125,6929718020_R02C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,20,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",74%,Not applicable,DNA_KRYO,12月23日,6929718020
MB_G4_126,8622007028_R06C01,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,22,female,"posterior fossa, cerebellum; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_KRYO,10月23日,8622007028
MB_G4_127,6929718009_R01C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,23,female,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",74%,Not applicable,DNA_KRYO,12月23日,6929718009
MB_G4_128,8622007029_R02C01,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,23,male,"posterior fossa, cerebellum; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",72%,Not applicable,DNA_KRYO,10月23日,8622007029
MB_G4_129,8622007029_R02C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,25,male,"posterior fossa, cerebellum; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",70%,Not applicable,DNA_KRYO,10月23日,8622007029
MB_G4_13,10006823143_R03C02,INFORM (INdividualized Therapy FOr Relapsed Malignancies in Childhood) Registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,4,male,"posterior fossa, ventricle IV; ",recurrence ,MB_G4,"methylation class medulloblastoma, subclass group 4",73%,Not applicable,DNA_KRYO,1月12日,10006823143
MB_G4_130,9373550131_R06C01,University Hospital of Tuebingen,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,25,male,"posterior fossa, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",71%,Not applicable,DNA_FFPE,8月21日,9373550131
MB_G4_131,8622007029_R03C01,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,27,male,"posterior fossa, cerebellum; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",69%,Not applicable,DNA_KRYO,10月23日,8622007029
MB_G4_132,10006823132_R06C02,University Hospital of Hannover,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,28,male,"posterior fossa, cerebellum, ventricle IV; ",initial operation ,MB_G4,"methylation class medulloblastoma, subclass group 4",70%,Not applicable,DNA_FFPE,1月30日,10006823132
MB_G4_133,6929718020_R01C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,28,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",71%,Not applicable,DNA_KRYO,12月23日,6929718020
MB_G4_134,9855358058_R06C01,University Hospital of Tuebingen,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,49,male,"posterior fossa, ventricle IV; ",initial operation ,MB_G4,"methylation class medulloblastoma, subclass group 4",74%,Not applicable,DNA_FFPE,10月6日,9855358058
MB_G4_135,8622007132_R05C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,not available ,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",73%,Not applicable,DNA_KRYO,1月16日,8622007132
MB_G4_136,9305651054_R01C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,not available ,male,not available,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",72%,Not applicable,DNA_KRYO,7月19日,9305651054
MB_G4_137,8622007028_R04C01,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,not available ,not available,not available,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",70%,Not applicable,DNA_KRYO,10月23日,8622007028
MB_G4_138,8622007066_R01C02,University Hospital of Zurich,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,not available ,male,not available,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",70%,Not applicable,DNA_FFPE,11月26日,8622007066
MB_G4_14,8622007026_R06C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,4,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",69%,Not applicable,DNA_KRYO,10月23日,8622007026
MB_G4_15,6229017094_R04C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,4,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",67%,Not applicable,DNA_KRYO,3月15日,6229017094
MB_G4_16,9878827240_R03C01,University Hospital of Essen,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,5,male,"posterior fossa, ventricle IV; ",initial operation ,MB_G4,"methylation class medulloblastoma, subclass group 4",67%,Not applicable,DNA_FFPE,12月5日,9878827240
MB_G4_17,7970368167_R04C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,5,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",64%,Not applicable,DNA_FFPE,7月19日,7970368167
MB_G4_18,7970376026_R05C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,5,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",64%,Not applicable,DNA_FFPE,7月19日,7970376026
MB_G4_19,7970376029_R04C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,5,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",67%,Not applicable,DNA_FFPE,7月19日,7970376029
MB_G4_20,7990895046_R02C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,5,female,"posterior fossa, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",69%,Not applicable,DNA_FFPE,7月30日,7990895046
MB_G4_21,7990895120_R05C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,5,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_FFPE,7月30日,7990895120
MB_G4_22,7990895127_R02C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,5,male,"posterior fossa, cerebellum, vermis; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",69%,Not applicable,DNA_FFPE,7月30日,7990895127
MB_G4_23,7990895093_R06C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,5,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",67%,Not applicable,DNA_FFPE,7月30日,7990895093
MB_G4_24,6752625079_R01C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,5,female,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",69%,Not applicable,DNA_KRYO,6月22日,6752625079
MB_G4_25,6229017094_R03C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,5,female,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",67%,Not applicable,DNA_KRYO,3月15日,6229017094
MB_G4_26,6929793089_R03C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,5,female,"posterior fossa, cerebellum; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",78%,Not applicable,DNA_KRYO,1月27日,6929793089
MB_G4_27,8622007028_R05C01,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,5,male,"posterior fossa, cerebellum; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_KRYO,10月23日,8622007028
MB_G4_28,9611519030_R03C01,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,6,male,"posterior fossa, brain stem, ventricle IV; ",initial operation ,MB_G4,"methylation class medulloblastoma, subclass group 4",73%,Not applicable,DNA_FFPE,3月10日,9611519030
MB_G4_29,7970368141_R03C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,6,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",67%,Not applicable,DNA_FFPE,7月19日,7970368141
MB_G4_30,7970376026_R01C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,6,male,"posterior fossa, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_FFPE,7月19日,7970376026
MB_G4_31,7970376029_R02C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,6,male,"posterior fossa, cerebellum; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",71%,Not applicable,DNA_FFPE,7月19日,7970376029
MB_G4_32,7970368168_R05C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,6,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",69%,Not applicable,DNA_FFPE,7月19日,7970368168
MB_G4_33,7970368168_R02C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,6,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",70%,Not applicable,DNA_FFPE,7月19日,7970368168
MB_G4_34,7970376005_R01C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,6,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",66%,Not applicable,DNA_FFPE,7月19日,7970376005
MB_G4_35,7990895120_R06C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,6,male,"posterior fossa, cerebellum, vermis; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",72%,Not applicable,DNA_FFPE,7月30日,7990895120
MB_G4_36,7990895093_R03C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,6,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",67%,Not applicable,DNA_FFPE,7月30日,7990895093
MB_G4_37,7990895093_R03C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,6,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",66%,Not applicable,DNA_FFPE,7月30日,7990895093
MB_G4_38,8622007026_R05C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,6,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",74%,Not applicable,DNA_KRYO,10月23日,8622007026
MB_G4_39,6929793061_R05C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,6,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",67%,Not applicable,DNA_KRYO,1月27日,6929793061
MB_G4_40,6929718009_R02C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,6,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",70%,Not applicable,DNA_KRYO,12月23日,6929718009
MB_G4_41,9340996008_R01C01,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,7,male,"posterior fossa, cerebellum; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",74%,Not applicable,DNA_FFPE,8月6日,9340996008
MB_G4_42,9878820127_R02C01,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,7,male,"posterior fossa, ventricle IV; ",initial operation ,MB_G4,"methylation class medulloblastoma, subclass group 4",66%,Not applicable,DNA_FFPE,10月31日,9878820127
MB_G4_43,7970376067_R01C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,7,male,"posterior fossa, cerebellum, vermis; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",64%,Not applicable,DNA_FFPE,7月19日,7970376067
MB_G4_44,7970376067_R03C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,7,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",67%,Not applicable,DNA_FFPE,7月19日,7970376067
MB_G4_45,7970368141_R05C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,7,male,not available,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_FFPE,7月19日,7970368141
MB_G4_46,7970368167_R03C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,7,female,"posterior fossa, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_FFPE,7月19日,7970368167
MB_G4_47,7970368167_R05C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,7,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",66%,Not applicable,DNA_FFPE,7月19日,7970368167
MB_G4_48,7970376029_R03C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,7,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",67%,Not applicable,DNA_FFPE,7月19日,7970376029
MB_G4_49,7990895159_R02C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,7,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_FFPE,7月30日,7990895159
MB_G4_50,7990895095_R01C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,7,male,not available,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_FFPE,7月30日,7990895095
MB_G4_51,7990895093_R06C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,7,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",66%,Not applicable,DNA_FFPE,7月30日,7990895093
MB_G4_52,6929793052_R02C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,7,not available,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",65%,Not applicable,DNA_KRYO,1月27日,6929793052
MB_G4_53,6969568004_R06C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,7,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_KRYO,11月23日,6969568004
MB_G4_54,6929689136_R01C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,7,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_KRYO,11月23日,6929689136
MB_G4_55,6929793089_R04C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,7,male,"posterior fossa, cerebellum; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",79%,Not applicable,DNA_KRYO,1月27日,6929793089
MB_G4_56,7970376067_R02C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,8,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",67%,Not applicable,DNA_FFPE,7月19日,7970376067
MB_G4_57,7970368141_R02C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,8,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_FFPE,7月19日,7970368141
MB_G4_58,7970376026_R01C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,8,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",70%,Not applicable,DNA_FFPE,7月19日,7970376026
MB_G4_59,7970376029_R04C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,8,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",70%,Not applicable,DNA_FFPE,7月19日,7970376029
MB_G4_60,7970376055_R06C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,8,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",65%,Not applicable,DNA_FFPE,7月19日,7970376055
MB_G4_61,7990895159_R01C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,8,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",69%,Not applicable,DNA_FFPE,7月30日,7990895159
MB_G4_62,7990895046_R02C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,8,male,not available,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",65%,Not applicable,DNA_FFPE,7月30日,7990895046
MB_G4_63,7990895120_R05C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,8,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",63%,Not applicable,DNA_FFPE,7月30日,7990895120
MB_G4_64,7990895142_R05C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,8,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",69%,Not applicable,DNA_FFPE,7月30日,7990895142
MB_G4_65,7990895046_R05C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,8,male,"posterior fossa, cerebellum, vermis; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",61%,Not applicable,DNA_FFPE,7月30日,7990895046
MB_G4_66,7990895127_R04C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,8,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",61%,Not applicable,DNA_FFPE,7月30日,7990895127
MB_G4_67,6752625054_R05C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,8,not available,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",69%,Not applicable,DNA_KRYO,6月18日,6752625054
MB_G4_68,6752625079_R02C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,8,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",70%,Not applicable,DNA_KRYO,6月22日,6752625079
MB_G4_69,6969568004_R01C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,8,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",70%,Not applicable,DNA_KRYO,11月23日,6969568004
MB_G4_70,6229017094_R06C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,8,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",72%,Not applicable,DNA_KRYO,3月15日,6229017094
MB_G4_71,8622007028_R01C01,Amsterdam Academic Medical Center,"Medulloblastoma, genetically defined, group 4",IV,Local review,9,male,not available,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",69%,Not applicable,DNA_KRYO,10月23日,8622007028
MB_G4_72,7970368168_R03C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,9,male,not available,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",66%,Not applicable,DNA_FFPE,7月19日,7970368168
MB_G4_73,7970368168_R06C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,9,female,"posterior fossa, brain stem, medulla oblongata (craniocervical), ventricle IV, cerebello-pontine angle;  left;",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",65%,Not applicable,DNA_FFPE,7月19日,7970368168
MB_G4_74,7970376029_R06C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,9,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_FFPE,7月19日,7970376029
MB_G4_75,7990895095_R05C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,9,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",67%,Not applicable,DNA_FFPE,7月30日,7990895095
MB_G4_76,8622007025_R06C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,9,not available,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",71%,Not applicable,DNA_KRYO,10月23日,8622007025
MB_G4_77,6969568004_R03C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,9,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",72%,Not applicable,DNA_KRYO,11月23日,6969568004
MB_G4_78,8622007027_R05C02,Amsterdam Academic Medical Center,"Medulloblastoma, genetically defined, group 4",IV,Local review,10,male,not available,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",67%,Not applicable,DNA_KRYO,10月23日,8622007027
MB_G4_79,7970368168_R04C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,10,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",60%,Not applicable,DNA_FFPE,7月19日,7970368168
MB_G4_80,7990895120_R01C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,10,male,"posterior fossa, cerebellum, vermis; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",63%,Not applicable,DNA_FFPE,7月30日,7990895120
MB_G4_81,7990895095_R01C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,10,male,not available,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",64%,Not applicable,DNA_FFPE,7月30日,7990895095
MB_G4_82,7990895142_R02C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,10,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",59%,Not applicable,DNA_FFPE,7月30日,7990895142
MB_G4_83,6752625054_R01C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,10,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",75%,Not applicable,DNA_KRYO,6月18日,6752625054
MB_G4_84,6752625054_R02C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,10,not available,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",72%,Not applicable,DNA_KRYO,6月18日,6752625054
MB_G4_85,6929689136_R05C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,10,not available,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",72%,Not applicable,DNA_KRYO,11月23日,6929689136
MB_G4_86,6229017094_R03C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,10,not available,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",70%,Not applicable,DNA_KRYO,3月15日,6229017094
MB_G4_87,10003886258_R05C02,University Hospital of Melbourne,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,10,female,"posterior fossa, ventricle IV; spinal; ",initial operation ,MB_G4,"methylation class medulloblastoma, subclass group 4",70%,Not applicable,DNA_FFPE,1月23日,10003886258
MB_G4_88,7970376067_R04C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,11,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",69%,Not applicable,DNA_FFPE,7月19日,7970376067
MB_G4_89,7970368168_R03C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,11,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",62%,Not applicable,DNA_FFPE,7月19日,7970368168
MB_G4_90,7970376005_R02C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,11,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",70%,Not applicable,DNA_FFPE,7月19日,7970376005
MB_G4_91,7990895120_R06C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,11,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",64%,Not applicable,DNA_FFPE,7月30日,7990895120
MB_G4_92,7990895120_R01C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,11,female,"posterior fossa, cerebellum, vermis; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",67%,Not applicable,DNA_FFPE,7月30日,7990895120
MB_G4_93,6752625079_R06C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,11,male,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_KRYO,6月22日,6752625079
MB_G4_94,6929718001_R06C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,11,not available,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",72%,Not applicable,DNA_KRYO,12月23日,6929718001
MB_G4_95,7970376005_R03C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, group 4",IV,Central review Bonn,12,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_G4,"methylation class medulloblastoma, subclass group 4",65%,Not applicable,DNA_FFPE,7月19日,7970376005
MB_G4_96,6229017094_R02C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,12,not available,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_KRYO,3月15日,6229017094
MB_G4_97,6929793061_R03C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,13,female,posterior fossa; ,not available,MB_G4,"methylation class medulloblastoma, subclass group 4",68%,Not applicable,DNA_KRYO,1月27日,6929793061
MB_G4_98,9444375150_R03C01,University Hospital of Tuebingen,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,13,male,posterior fossa; ,initial operation ,MB_G4,"methylation class medulloblastoma, subclass group 4",59%,Not applicable,DNA_FFPE,2月10日,9444375150
MB_G4_99,9305651037_R02C01,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, group 4",IV,Central review Heidelberg,14,male,"supratentorial, sellar region, suprasellar; posterior fossa, cerebellum; ",initial operation ,MB_G4,"methylation class medulloblastoma, subclass group 4",69%,Not applicable,DNA_FFPE,6月28日,9305651037
MB_SHH_CHL_AD_01,9305651146_R02C01,University Hospital of Tuebingen,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,3,female,"posterior fossa, cerebellum;  left;",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",74%,Not applicable,DNA_FFPE,7月30日,9305651146
MB_SHH_CHL_AD_02,6929793061_R04C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,4,female,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",78%,Not applicable,DNA_KRYO,1月27日,6929793061
MB_SHH_CHL_AD_03,6929793061_R06C01,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,5,male,"posterior fossa, cerebellum; ",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",69%,Not applicable,DNA_KRYO,1月27日,6929793061
MB_SHH_CHL_AD_04,7990895127_R05C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,6,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",74%,Not applicable,DNA_FFPE,7月30日,7990895127
MB_SHH_CHL_AD_05,6929718001_R04C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,6,female,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",80%,Not applicable,DNA_KRYO,12月23日,6929718001
MB_SHH_CHL_AD_06,8622007027_R06C02,Amsterdam Academic Medical Center,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Local review,7,male,not available,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",79%,Not applicable,DNA_KRYO,10月23日,8622007027
MB_SHH_CHL_AD_07,9379086089_R02C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,7,male,not available,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",80%,Not applicable,DNA_KRYO,11月18日,9379086089
MB_SHH_CHL_AD_08,6929793061_R02C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,7,male,"posterior fossa, cerebellum; ",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",74%,Not applicable,DNA_KRYO,1月27日,6929793061
MB_SHH_CHL_AD_09,6929718050_R04C01,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,9,female,"posterior fossa, cerebellum; ",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",76%,Not applicable,DNA_KRYO,12月23日,6929718050
MB_SHH_CHL_AD_10,7990895046_R03C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,10,female,"posterior fossa, cerebellum, hemispheric (cerebellum);  left;",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",66%,Not applicable,DNA_FFPE,7月30日,7990895046
MB_SHH_CHL_AD_11,9379086089_R06C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,10,not available,not available,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",82%,Not applicable,DNA_KRYO,11月18日,9379086089
MB_SHH_CHL_AD_12,8622007026_R04C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,10,not available,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",78%,Not applicable,DNA_KRYO,10月23日,8622007026
MB_SHH_CHL_AD_13,8622007025_R01C01,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,11,female,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",77%,Not applicable,DNA_KRYO,10月23日,8622007025
MB_SHH_CHL_AD_14,7970376055_R02C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,11,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",73%,Not applicable,DNA_FFPE,7月19日,7970376055
MB_SHH_CHL_AD_15,9297949033_R05C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,11,female,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",80%,Not applicable,DNA_KRYO,6月10日,9297949033
MB_SHH_CHL_AD_16,8622007058_R05C01,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,12,male,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",75%,Not applicable,DNA_KRYO,11月12日,8622007058
MB_SHH_CHL_AD_17,7970376055_R04C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,12,male,"posterior fossa, cerebellum, hemispheric (cerebellum);  right;",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",69%,Not applicable,DNA_FFPE,7月19日,7970376055
MB_SHH_CHL_AD_18,8622007027_R02C02,Amsterdam Academic Medical Center,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Local review,13,male,not available,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",72%,Not applicable,DNA_KRYO,10月23日,8622007027
MB_SHH_CHL_AD_19,7990895159_R04C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,13,female,"posterior fossa, cerebellum, hemispheric (cerebellum);  left;",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",64%,Not applicable,DNA_FFPE,7月30日,7990895159
MB_SHH_CHL_AD_20,8622007132_R03C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,13,male,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",81%,Not applicable,DNA_KRYO,1月16日,8622007132
MB_SHH_CHL_AD_21,6969568004_R04C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,13,female,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",79%,Not applicable,DNA_KRYO,11月23日,6969568004
MB_SHH_CHL_AD_22,7970376067_R05C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,14,male,"posterior fossa, cerebellum, hemispheric (cerebellum);  left;",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",73%,Not applicable,DNA_FFPE,7月19日,7970376067
MB_SHH_CHL_AD_23,7990895120_R04C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,14,male,not available,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",74%,Not applicable,DNA_FFPE,7月30日,7990895120
MB_SHH_CHL_AD_24,7970376055_R05C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,15,male,"posterior fossa, cerebellum, hemispheric (cerebellum);  right;",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",77%,Not applicable,DNA_FFPE,7月19日,7970376055
MB_SHH_CHL_AD_25,7970368168_R06C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,15,male,"posterior fossa, cerebellum, hemispheric (cerebellum), vermis;  right;",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",77%,Not applicable,DNA_FFPE,7月19日,7970368168
MB_SHH_CHL_AD_26,7990895120_R03C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,15,male,"posterior fossa, cerebellum, hemispheric (cerebellum);  right;",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",70%,Not applicable,DNA_FFPE,7月30日,7990895120
MB_SHH_CHL_AD_27,7990908004_R04C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,15,male,"posterior fossa, cerebellum, hemispheric (cerebellum), vermis; ",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",74%,Not applicable,DNA_FFPE,7月30日,7990908004
MB_SHH_CHL_AD_28,10006823141_R03C02,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,16,female,"posterior fossa, cerebellum, hemispheric (cerebellum);  right;",initial operation ,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",70%,Not applicable,DNA_FFPE,1月12日,10006823141
MB_SHH_CHL_AD_29,7990895159_R03C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,16,male,"posterior fossa, cerebellum, hemispheric (cerebellum);  left;",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",72%,Not applicable,DNA_FFPE,7月30日,7990895159
MB_SHH_CHL_AD_30,7990895142_R02C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,16,male,"posterior fossa, cerebellum, hemispheric (cerebellum);  right;",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",73%,Not applicable,DNA_FFPE,7月30日,7990895142
MB_SHH_CHL_AD_31,6929718001_R05C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,16,female,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",83%,Not applicable,DNA_KRYO,12月23日,6929718001
MB_SHH_CHL_AD_32,7970376029_R05C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,17,male,"posterior fossa, cerebellum, hemispheric (cerebellum), cerebello-pontine angle;  right;",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",68%,Not applicable,DNA_FFPE,7月19日,7970376029
MB_SHH_CHL_AD_33,8622007028_R02C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,19,male,"posterior fossa, cerebellum; ",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",73%,Not applicable,DNA_KRYO,10月23日,8622007028
MB_SHH_CHL_AD_34,8622007029_R03C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,19,male,"posterior fossa, cerebellum; ",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",76%,Not applicable,DNA_KRYO,10月23日,8622007029
MB_SHH_CHL_AD_35,9305216163_R05C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,20,female,not available,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",81%,Not applicable,DNA_KRYO,6月14日,9305216163
MB_SHH_CHL_AD_36,6929718009_R03C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,20,male,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",80%,Not applicable,DNA_KRYO,12月23日,6929718009
MB_SHH_CHL_AD_37,9297949037_R02C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,22,female,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",84%,Not applicable,DNA_KRYO,6月10日,9297949037
MB_SHH_CHL_AD_38,6929718020_R04C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,22,male,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",83%,Not applicable,DNA_KRYO,12月23日,6929718020
MB_SHH_CHL_AD_39,6929718020_R05C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,22,female,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",80%,Not applicable,DNA_KRYO,12月23日,6929718020
MB_SHH_CHL_AD_40,6929718009_R04C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,23,male,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",87%,Not applicable,DNA_KRYO,12月23日,6929718009
MB_SHH_CHL_AD_41,6247004027_R02C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,23,male,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",82%,Not applicable,DNA_KRYO,4月13日,6247004027
MB_SHH_CHL_AD_42,8622007029_R05C01,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,23,male,"posterior fossa, cerebellum; ",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",82%,Not applicable,DNA_KRYO,10月23日,8622007029
MB_SHH_CHL_AD_43,9297949033_R06C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,24,female,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",77%,Not applicable,DNA_KRYO,6月10日,9297949033
MB_SHH_CHL_AD_44,8622007029_R04C01,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,24,female,"posterior fossa, cerebellum; ",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",82%,Not applicable,DNA_KRYO,10月23日,8622007029
MB_SHH_CHL_AD_45,9379086095_R02C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,25,male,not available,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",82%,Not applicable,DNA_KRYO,11月18日,9379086095
MB_SHH_CHL_AD_46,6929718020_R03C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,25,male,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",80%,Not applicable,DNA_KRYO,12月23日,6929718020
MB_SHH_CHL_AD_47,6929718050_R02C01,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,26,male,"posterior fossa, cerebellum; ",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",84%,Not applicable,DNA_KRYO,12月23日,6929718050
MB_SHH_CHL_AD_48,9297949033_R05C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,27,male,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",75%,Not applicable,DNA_KRYO,6月10日,9297949033
MB_SHH_CHL_AD_49,9379086088_R06C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,27,female,not available,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",83%,Not applicable,DNA_KRYO,11月18日,9379086088
MB_SHH_CHL_AD_50,6929718009_R06C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,27,male,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",83%,Not applicable,DNA_KRYO,12月23日,6929718009
MB_SHH_CHL_AD_51,9379086095_R04C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,28,male,not available,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",83%,Not applicable,DNA_KRYO,11月18日,9379086095
MB_SHH_CHL_AD_52,6929718009_R05C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,28,male,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",83%,Not applicable,DNA_KRYO,12月23日,6929718009
MB_SHH_CHL_AD_53,9305216163_R04C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,31,male,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",82%,Not applicable,DNA_KRYO,6月14日,9305216163
MB_SHH_CHL_AD_54,6247004027_R06C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,31,male,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",84%,Not applicable,DNA_KRYO,4月13日,6247004027
MB_SHH_CHL_AD_55,6929718009_R03C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,32,female,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",86%,Not applicable,DNA_KRYO,12月23日,6929718009
MB_SHH_CHL_AD_56,6247004027_R03C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,32,male,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",84%,Not applicable,DNA_KRYO,4月13日,6247004027
MB_SHH_CHL_AD_57,9374342010_R03C02,University Hospital of Tuebingen,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,32,male,"posterior fossa, cerebellum;  right;",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",81%,Not applicable,DNA_FFPE,9月11日,9374342010
MB_SHH_CHL_AD_58,6929718050_R03C01,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,33,male,"posterior fossa, cerebellum; ",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",84%,Not applicable,DNA_KRYO,12月23日,6929718050
MB_SHH_CHL_AD_59,8622007029_R04C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,34,female,"posterior fossa, cerebellum; ",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",76%,Not applicable,DNA_KRYO,10月23日,8622007029
MB_SHH_CHL_AD_60,6752625054_R04C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,35,male,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",83%,Not applicable,DNA_KRYO,6月18日,6752625054
MB_SHH_CHL_AD_61,6247004027_R01C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,35,male,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",80%,Not applicable,DNA_KRYO,4月13日,6247004027
MB_SHH_CHL_AD_62,8622007028_R06C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,36,female,"posterior fossa, cerebellum; ",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",71%,Not applicable,DNA_KRYO,10月23日,8622007028
MB_SHH_CHL_AD_63,9422493151_R03C02,University Hospital of Tuebingen,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,36,female,"posterior fossa, cerebellum; ",initial operation ,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",73%,Not applicable,DNA_FFPE,12月13日,9422493151
MB_SHH_CHL_AD_64,8622007028_R01C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,38,male,"posterior fossa, cerebellum; ",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",61%,Not applicable,DNA_KRYO,10月23日,8622007028
MB_SHH_CHL_AD_65,6752625054_R01C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,39,female,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",82%,Not applicable,DNA_KRYO,6月18日,6752625054
MB_SHH_CHL_AD_66,3999875057_R06C01,University Hospital of Frankfurt am Main,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,40,male,"posterior fossa, brain stem; ",initial operation ,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",74%,Not applicable,DNA_FFPE,1月16日,3999875057
MB_SHH_CHL_AD_67,6929718009_R06C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,42,female,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",75%,Not applicable,DNA_KRYO,12月23日,6929718009
MB_SHH_CHL_AD_68,8622007028_R04C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,46,male,"posterior fossa, cerebellum; ",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",79%,Not applicable,DNA_KRYO,10月23日,8622007028
MB_SHH_CHL_AD_69,8622007029_R06C01,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,46,male,"posterior fossa, cerebellum; ",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",83%,Not applicable,DNA_KRYO,10月23日,8622007029
MB_SHH_CHL_AD_70,8622007029_R05C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,48,male,"posterior fossa, cerebellum; ",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",74%,Not applicable,DNA_KRYO,10月23日,8622007029
MB_SHH_CHL_AD_71,6247004027_R05C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,49,female,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",84%,Not applicable,DNA_KRYO,4月13日,6247004027
MB_SHH_CHL_AD_72,3999875056_R05C01,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,51,male,"posterior fossa, brain stem, medulla oblongata (craniocervical); ",not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",73%,Not applicable,DNA_FFPE,1月16日,3999875056
MB_SHH_CHL_AD_73,8622007084_R05C02,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,female,not available,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",70%,Not applicable,DNA_FFPE,12月7日,8622007084
MB_SHH_CHL_AD_74,8622007025_R03C01,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,female,not available,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",76%,Not applicable,DNA_KRYO,10月23日,8622007025
MB_SHH_CHL_AD_75,8622007025_R04C01,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,male,not available,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",76%,Not applicable,DNA_KRYO,10月23日,8622007025
MB_SHH_CHL_AD_76,8622007025_R05C01,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,male,not available,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",77%,Not applicable,DNA_KRYO,10月23日,8622007025
MB_SHH_CHL_AD_77,9297949147_R05C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,not available,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",71%,Not applicable,DNA_KRYO,6月28日,9297949147
MB_SHH_CHL_AD_78,9305216199_R02C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,male,posterior fossa; ,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",73%,Not applicable,DNA_KRYO,7月5日,9305216199
MB_SHH_CHL_AD_79,9305216199_R03C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,male,not available,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",73%,Not applicable,DNA_KRYO,7月5日,9305216199
MB_SHH_CHL_AD_80,9761749012_R06C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,male,not available,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",77%,Not applicable,DNA_KRYO,5月16日,9761749012
MB_SHH_CHL_AD_81,9761749088_R03C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,male,not available,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",82%,Not applicable,DNA_KRYO,5月16日,9761749088
MB_SHH_CHL_AD_82,8622007119_R05C02,"La Sapienza Hospital, Rome ","Medulloblastoma, genetically defined, SHH-activated       ",IV,Local review,not available ,male,not available,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",74%,Not applicable,DNA_FFPE,1月16日,8622007119
MB_SHH_CHL_AD_83,8622007119_R06C02,"La Sapienza Hospital, Rome ","Medulloblastoma, genetically defined, SHH-activated       ",IV,Local review,not available ,male,not available,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",82%,Not applicable,DNA_FFPE,1月16日,8622007119
MB_SHH_CHL_AD_84,8622007120_R04C02,University Hospital of Zurich,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,male,not available,not available,MB_SHH_CHL_AD,"methylation class medulloblastoma, subclass SHH A (children and adult)",79%,Not applicable,DNA_FFPE,1月16日,8622007120
MB_SHH_INF_01,7970376026_R02C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,0,male,"posterior fossa, cerebellum, vermis; ",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",66%,Not applicable,DNA_FFPE,7月19日,7970376026
MB_SHH_INF_02,7970376067_R04C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,0,male,not available,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",66%,Not applicable,DNA_FFPE,7月19日,7970376067
MB_SHH_INF_03,7970376005_R06C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,0,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",65%,Not applicable,DNA_FFPE,7月19日,7970376005
MB_SHH_INF_04,7990895046_R06C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,0,male,not available,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",64%,Not applicable,DNA_FFPE,7月30日,7990895046
MB_SHH_INF_05,9007217016_R03C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,0,female,posterior fossa; ,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",70%,Not applicable,DNA_KRYO,2月19日,9007217016
MB_SHH_INF_06,8622007066_R06C01,University Hospital of Basel ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,0,female,not available,initial operation ,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",67%,Not applicable,DNA_FFPE,11月26日,8622007066
MB_SHH_INF_07,3999834063_R04C01,"Beaumont Hospital, Dublin","Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,1,male,posterior fossa; ,initial operation ,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",65%,Not applicable,DNA_FFPE,2月13日,3999834063
MB_SHH_INF_08,7970368141_R02C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,1,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",66%,Not applicable,DNA_FFPE,7月19日,7970368141
MB_SHH_INF_09,7970368167_R03C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,1,female,"posterior fossa, cerebellum, hemispheric (cerebellum);  left;",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",66%,Not applicable,DNA_FFPE,7月19日,7970368167
MB_SHH_INF_10,7970376067_R06C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,1,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",65%,Not applicable,DNA_FFPE,7月19日,7970376067
MB_SHH_INF_11,7990895046_R01C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,1,male,not available,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",65%,Not applicable,DNA_FFPE,7月30日,7990895046
MB_SHH_INF_12,7990895093_R01C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,1,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",66%,Not applicable,DNA_FFPE,7月30日,7990895093
MB_SHH_INF_13,7990908004_R02C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,1,male,"posterior fossa, cerebellum, hemispheric (cerebellum);  left;",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",66%,Not applicable,DNA_FFPE,7月30日,7990908004
MB_SHH_INF_14,7990895127_R03C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,1,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",67%,Not applicable,DNA_FFPE,7月30日,7990895127
MB_SHH_INF_15,7990895093_R04C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,1,female,"posterior fossa, ventricle IV; ",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",68%,Not applicable,DNA_FFPE,7月30日,7990895093
MB_SHH_INF_16,8622007026_R03C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,1,male,posterior fossa; ,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",73%,Not applicable,DNA_KRYO,10月23日,8622007026
MB_SHH_INF_17,6969568004_R02C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,1,male,posterior fossa; ,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",71%,Not applicable,DNA_KRYO,11月23日,6969568004
MB_SHH_INF_18,6929718009_R01C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,1,female,posterior fossa; ,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",70%,Not applicable,DNA_KRYO,12月23日,6929718009
MB_SHH_INF_19,9444374157_R04C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,1,female,not available,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",71%,Not applicable,DNA_FFPE,2月10日,9444374157
MB_SHH_INF_20,9374342010_R05C02,University Hospital of Tuebingen,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,1,female,"posterior fossa, cerebellum; ",initial operation ,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",67%,Not applicable,DNA_FFPE,9月11日,9374342010
MB_SHH_INF_21,7970368141_R03C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,2,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",63%,Not applicable,DNA_FFPE,7月19日,7970368141
MB_SHH_INF_22,7970376067_R03C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,2,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",69%,Not applicable,DNA_FFPE,7月19日,7970376067
MB_SHH_INF_23,7990895095_R04C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,2,male,"posterior fossa, cerebellum, hemispheric (cerebellum);  right;",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",63%,Not applicable,DNA_FFPE,7月30日,7990895095
MB_SHH_INF_24,7990895127_R05C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,2,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",63%,Not applicable,DNA_FFPE,7月30日,7990895127
MB_SHH_INF_25,6229017094_R05C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,2,male,posterior fossa; ,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",74%,Not applicable,DNA_KRYO,3月15日,6229017094
MB_SHH_INF_26,6929793061_R03C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,2,female,"posterior fossa, cerebellum; ",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",73%,Not applicable,DNA_KRYO,1月27日,6929793061
MB_SHH_INF_27,9007217108_R06C01,"Hospital for Sick Children, Toronto  ","Medulloblastoma, genetically defined, SHH-activated       ",IV,Local review,2,female,posterior fossa; ,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",75%,Not applicable,DNA_KRYO,2月19日,9007217108
MB_SHH_INF_28,7970376026_R06C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,3,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",68%,Not applicable,DNA_FFPE,7月19日,7970376026
MB_SHH_INF_29,7970376026_R06C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,3,female,"posterior fossa, cerebellum, hemispheric (cerebellum);  left;",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",71%,Not applicable,DNA_FFPE,7月19日,7970376026
MB_SHH_INF_30,7970368168_R05C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,3,female,"supratentorial, diencephalic, pineal region; posterior fossa, cerebellum, vermis; ",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",65%,Not applicable,DNA_FFPE,7月19日,7970368168
MB_SHH_INF_31,7990895095_R06C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,3,female,"posterior fossa, cerebellum, hemispheric (cerebellum); ",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",64%,Not applicable,DNA_FFPE,7月30日,7990895095
MB_SHH_INF_32,9379086089_R05C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,3,male,not available,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",77%,Not applicable,DNA_KRYO,11月18日,9379086089
MB_SHH_INF_33,6929793061_R01C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,3,male,"posterior fossa, cerebellum; ",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",72%,Not applicable,DNA_KRYO,1月27日,6929793061
MB_SHH_INF_34,7970376055_R05C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,4,female,"posterior fossa, cerebellum, hemispheric (cerebellum), ventricle IV;  right;",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",75%,Not applicable,DNA_FFPE,7月19日,7970376055
MB_SHH_INF_35,6969568004_R05C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,4,female,posterior fossa; ,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",73%,Not applicable,DNA_KRYO,11月23日,6969568004
MB_SHH_INF_36,7990895095_R06C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,5,female,"posterior fossa, ventricle IV; ",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",67%,Not applicable,DNA_FFPE,7月30日,7990895095
MB_SHH_INF_37,9305216168_R01C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,5,female,not available,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",75%,Not applicable,DNA_KRYO,6月14日,9305216168
MB_SHH_INF_38,8622007025_R05C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,5,female,posterior fossa; ,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",72%,Not applicable,DNA_KRYO,10月23日,8622007025
MB_SHH_INF_39,9007217016_R06C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,5,female,posterior fossa; ,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",79%,Not applicable,DNA_KRYO,2月19日,9007217016
MB_SHH_INF_40,7970368167_R02C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Bonn,6,female,"posterior fossa, cerebellum, hemispheric (cerebellum);  left;",not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",69%,Not applicable,DNA_FFPE,7月19日,7970368167
MB_SHH_INF_41,9297949147_R01C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,female,posterior fossa; ,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",65%,Not applicable,DNA_KRYO,6月28日,9297949147
MB_SHH_INF_42,9305216199_R04C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,male,posterior fossa; ,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",72%,Not applicable,DNA_KRYO,7月5日,9305216199
MB_SHH_INF_43,9374341006_R02C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,male,not available,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",74%,Not applicable,DNA_KRYO,8月23日,9374341006
MB_SHH_INF_44,9374341006_R04C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,female,not available,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",71%,Not applicable,DNA_KRYO,8月23日,9374341006
MB_SHH_INF_45,9374341006_R05C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,female,not available,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",69%,Not applicable,DNA_KRYO,8月23日,9374341006
MB_SHH_INF_46,9533774072_R01C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,female,not available,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",69%,Not applicable,DNA_KRYO,6月16日,9533774072
MB_SHH_INF_47,9741950152_R02C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,female,not available,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",71%,Not applicable,DNA_KRYO,5月16日,9741950152
MB_SHH_INF_48,9741950152_R06C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,female,not available,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",69%,Not applicable,DNA_KRYO,5月16日,9741950152
MB_SHH_INF_49,9761749012_R05C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,male,not available,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",71%,Not applicable,DNA_KRYO,5月16日,9761749012
MB_SHH_INF_50,9761749088_R06C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,female,not available,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",76%,Not applicable,DNA_KRYO,5月16日,9761749088
MB_SHH_INF_51,9969477090_R02C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,male,not available,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",72%,Not applicable,DNA_KRYO,8月22日,9969477090
MB_SHH_INF_52,9969477099_R02C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, SHH-activated       ",IV,Central review Heidelberg,not available ,male,not available,not available,MB_SHH_INF,"methylation class medulloblastoma, subclass SHH B (infant)",72%,Not applicable,DNA_KRYO,8月22日,9969477099
MB_WNT_01,7990895095_R04C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Bonn,6,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",71%,Not applicable,DNA_FFPE,7月30日,7990895095
MB_WNT_02,6929689136_R04C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,6,female,posterior fossa; ,not available,MB_WNT,"methylation class medulloblastoma, WNT",66%,Not applicable,DNA_KRYO,11月23日,6929689136
MB_WNT_03,9374342010_R04C02,University Hospital of Tuebingen,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,6,female,"posterior fossa, cerebellum, hemispheric (cerebellum);  right;",not available,MB_WNT,"methylation class medulloblastoma, WNT",71%,Not applicable,DNA_FFPE,9月11日,9374342010
MB_WNT_04,7970376026_R03C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Bonn,7,female,"posterior fossa, cerebellum, vermis; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",72%,Not applicable,DNA_FFPE,7月19日,7970376026
MB_WNT_05,7970376067_R06C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Bonn,7,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",70%,Not applicable,DNA_FFPE,7月19日,7970376067
MB_WNT_06,6752625054_R03C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,7,male,posterior fossa; ,not available,MB_WNT,"methylation class medulloblastoma, WNT",73%,Not applicable,DNA_KRYO,6月18日,6752625054
MB_WNT_07,8622007025_R03C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,7,female,posterior fossa; ,not available,MB_WNT,"methylation class medulloblastoma, WNT",82%,Not applicable,DNA_KRYO,10月23日,8622007025
MB_WNT_08,6929689161_R03C02,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,8,female,"posterior fossa, cerebellum; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",73%,Not applicable,DNA_KRYO,11月23日,6929689161
MB_WNT_09,7990895142_R05C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Bonn,8,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",67%,Not applicable,DNA_FFPE,7月30日,7990895142
MB_WNT_10,6929689152_R06C02,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,8,male,"posterior fossa, cerebellum; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",77%,Not applicable,DNA_KRYO,11月23日,6929689152
MB_WNT_11,9741950149_R02C02,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,9,female,"posterior fossa, brain stem, cerebellar peduncles, ventricle IV; ",initial operation ,MB_WNT,"methylation class medulloblastoma, WNT",70%,Not applicable,DNA_FFPE,4月14日,9741950149
MB_WNT_12,6929689161_R04C02,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,10,male,"posterior fossa, cerebellum; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",74%,Not applicable,DNA_KRYO,11月23日,6929689161
MB_WNT_13,7970376029_R01C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Bonn,10,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",72%,Not applicable,DNA_FFPE,7月19日,7970376029
MB_WNT_14,7970376005_R04C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Bonn,10,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",70%,Not applicable,DNA_FFPE,7月19日,7970376005
MB_WNT_15,6929689161_R06C02,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,11,male,"posterior fossa, cerebellum; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",75%,Not applicable,DNA_KRYO,11月23日,6929689161
MB_WNT_16,7970376005_R03C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Bonn,11,female,"posterior fossa, cerebellum, vermis; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",62%,Not applicable,DNA_FFPE,7月19日,7970376005
MB_WNT_17,6752625079_R03C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,11,male,posterior fossa; ,not available,MB_WNT,"methylation class medulloblastoma, WNT",72%,Not applicable,DNA_KRYO,6月22日,6752625079
MB_WNT_18,6929689161_R05C02,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,12,male,"posterior fossa, cerebellum; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",78%,Not applicable,DNA_KRYO,11月23日,6929689161
MB_WNT_19,6929689149_R06C02,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,12,male,"posterior fossa, cerebellum; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",72%,Not applicable,DNA_KRYO,12月23日,6929689149
MB_WNT_20,6929689161_R02C02,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,12,female,"posterior fossa, cerebellum; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",79%,Not applicable,DNA_KRYO,11月23日,6929689161
MB_WNT_21,7990895095_R05C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Bonn,13,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",66%,Not applicable,DNA_FFPE,7月30日,7990895095
MB_WNT_22,6752625079_R05C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,13,female,posterior fossa; ,not available,MB_WNT,"methylation class medulloblastoma, WNT",72%,Not applicable,DNA_KRYO,6月22日,6752625079
MB_WNT_23,10003886258_R02C01,University Hospital of Heidelberg,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,14,female,posterior fossa; ,not available,MB_WNT,"methylation class medulloblastoma, WNT",72%,Not applicable,DNA_FFPE,1月23日,10003886258
MB_WNT_24,7990908004_R01C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Bonn,14,male,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",65%,Not applicable,DNA_FFPE,7月30日,7990908004
MB_WNT_25,7990908004_R03C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Bonn,14,female,"posterior fossa, cerebellum, vermis; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",70%,Not applicable,DNA_FFPE,7月30日,7990908004
MB_WNT_26,6752625054_R04C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,14,female,posterior fossa; ,not available,MB_WNT,"methylation class medulloblastoma, WNT",79%,Not applicable,DNA_KRYO,6月18日,6752625054
MB_WNT_27,7970376005_R06C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Bonn,15,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",66%,Not applicable,DNA_FFPE,7月19日,7970376005
MB_WNT_28,7970376055_R06C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Bonn,15,female,"posterior fossa, cerebellum, cerebello-pontine angle;  left;",not available,MB_WNT,"methylation class medulloblastoma, WNT",68%,Not applicable,DNA_FFPE,7月19日,7970376055
MB_WNT_29,7990895159_R03C02,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Bonn,15,female,"posterior fossa, cerebellum, vermis, ventricle IV; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",68%,Not applicable,DNA_FFPE,7月30日,7990895159
MB_WNT_30,6752625054_R06C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,15,male,posterior fossa; ,not available,MB_WNT,"methylation class medulloblastoma, WNT",72%,Not applicable,DNA_KRYO,6月18日,6752625054
MB_WNT_31,6929689168_R01C01,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,15,male,"posterior fossa, cerebellum; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",75%,Not applicable,DNA_KRYO,11月23日,6929689168
MB_WNT_32,7990895046_R04C01,HIT2000 trial / HIT2000 registry,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Bonn,16,male,"posterior fossa, cerebellum, hemispheric (cerebellum), vermis;  right;",not available,MB_WNT,"methylation class medulloblastoma, WNT",67%,Not applicable,DNA_FFPE,7月30日,7990895046
MB_WNT_33,6752625079_R04C02,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,17,female,posterior fossa; ,not available,MB_WNT,"methylation class medulloblastoma, WNT",68%,Not applicable,DNA_KRYO,6月22日,6752625079
MB_WNT_34,9968646167_R05C01,University Hospital of Tuebingen,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,17,male,"posterior fossa, ventricle IV; ",initial operation ,MB_WNT,"methylation class medulloblastoma, WNT",67%,Not applicable,DNA_FFPE,7月11日,9968646167
MB_WNT_35,6929689168_R03C01,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,18,female,"posterior fossa, cerebellum; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",82%,Not applicable,DNA_KRYO,11月23日,6929689168
MB_WNT_36,9422493151_R01C02,University Hospital of Tuebingen,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,19,female,"posterior fossa, brain stem, cerebellum;  left;",initial operation ,MB_WNT,"methylation class medulloblastoma, WNT",70%,Not applicable,DNA_FFPE,12月13日,9422493151
MB_WNT_37,6929689168_R02C01,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,20,female,"posterior fossa, cerebellum; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",70%,Not applicable,DNA_KRYO,11月23日,6929689168
MB_WNT_38,6929689168_R05C01,"Burdenko Neurosurgery Institute, Moscow","Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,27,male,"posterior fossa, cerebellum; ",not available,MB_WNT,"methylation class medulloblastoma, WNT",76%,Not applicable,DNA_KRYO,11月23日,6929689168
MB_WNT_39,6929718009_R04C01,International Cancer Genome Consortium ,"Medulloblastoma, genetically defined, WNT-activated ",IV,Central review Heidelberg,not available ,female,posterior fossa; ,not available,MB_WNT,"methylation class medulloblastoma, WNT",74%,Not applicable,DNA_KRYO,12月23日,6929718009
MELAN_01,9406921038_R04C01,University Hospital of Heidelberg,Malignant melanoma,not available,Central review Heidelberg,46,male,"supratentorial, hemispheric, parietal;  right;",metastasis,MELAN,methylation class melanoma,66%,Not applicable,DNA_FFPE,11月18日,9406921038
MELAN_02,9647455233_R06C01,University Hospital of Heidelberg,Malignant melanoma,not available,Central review Heidelberg,49,female,"peripheral nerve, cranial nerve, I; ",metastasis,MELAN,methylation class melanoma,57%,Not applicable,DNA_FFPE,4月11日,9647455233
MELAN_03,9406921039_R02C01,University Hospital of Heidelberg,Malignant melanoma,not available,Central review Heidelberg,51,male,"posterior fossa, cerebellum, hemispheric (cerebellum), meningeal (posterior fossa);  right;",metastasis,MELAN,methylation class melanoma,59%,Not applicable,DNA_FFPE,11月18日,9406921039
MELAN_04,9406921038_R03C01,University Hospital of Heidelberg,Malignant melanoma,not available,Central review Heidelberg,60,male,"supratentorial, hemispheric, frontal, temporal;  left;",metastasis,MELAN,methylation class melanoma,61%,Not applicable,DNA_FFPE,11月18日,9406921038
MELAN_05,9406921038_R06C01,University Hospital of Heidelberg,Malignant melanoma,not available,Central review Heidelberg,60,female,"supratentorial, hemispheric, frontal;  left;",metastasis,MELAN,methylation class melanoma,65%,Not applicable,DNA_FFPE,11月18日,9406921038
MELAN_06,9969477101_R02C01,University Hospital of Heidelberg,Malignant melanoma,not available,Central review Heidelberg,60,female,"supratentorial, hemispheric, frontal;  left;",metastasis,MELAN,methylation class melanoma,66%,Not applicable,DNA_FFPE,8月22日,9969477101
MELAN_07,9420867053_R06C01,University Hospital of Heidelberg,Malignant melanoma,not available,Central review Heidelberg,68,female,"supratentorial, hemispheric, parietal, occipital; ",metastasis,MELAN,methylation class melanoma,63%,Not applicable,DNA_FFPE,1月14日,9420867053
MELAN_08,9420867053_R01C02,University Hospital of Heidelberg,Malignant melanoma,not available,Central review Heidelberg,68,female,not available,metastasis,MELAN,methylation class melanoma,64%,Not applicable,DNA_FFPE,1月14日,9420867053
MELAN_09,3998568167_R05C01,University Hospital of Heidelberg,Malignant melanoma,not available,Central review Heidelberg,74,male,"supratentorial, hemispheric, temporal;  right;",metastasis,MELAN,methylation class melanoma,63%,Not applicable,DNA_FFPE,8月28日,3998568167
MELAN_10,9406921038_R05C02,University Hospital of Heidelberg,Malignant melanoma,not available,Central review Heidelberg,74,female,"supratentorial, hemispheric, parietal, occipital;  right;",metastasis,MELAN,methylation class melanoma,58%,Not applicable,DNA_FFPE,11月18日,9406921038
MELAN_11,9406921038_R04C02,University Hospital of Heidelberg,Malignant melanoma,not available,Central review Heidelberg,87,male,"supratentorial, hemispheric, parietal;  left;",metastasis,MELAN,methylation class melanoma,62%,Not applicable,DNA_FFPE,11月18日,9406921038
MELAN_12,9296930016_R05C01,University Hospital of Vienna,Malignant melanoma,not available,Central review Heidelberg,not available ,female,not available,metastasis,MELAN,methylation class melanoma,53%,Not applicable,DNA_FFPE,5月21日,9296930016
MELCYT_01,9340996058_R03C01,University Hospital of Heidelberg,Melanocytoma  ,not available,Central review Heidelberg,15,male,supratentorial; posterior fossa; ,initial operation ,MELCYT,methylation class melanocytoma,53%,Not applicable,DNA_FFPE,8月9日,9340996058
MELCYT_02,9533774024_R04C01,University Hospital of Freiburg ,Melanocytoma  ,not available,Central review Heidelberg,23,female,"spinal, intramedullary, meningeal (spinal), thoracic, T9, T10; ",recurrence ,MELCYT,methylation class melanocytoma,57%,Not applicable,DNA_FFPE,6月7日,9533774024
MELCYT_03,9406921149_R03C02,University Hospital of Tuebingen,Melanocytoma  ,not available,Central review Heidelberg,33,female,not available,initial operation ,MELCYT,methylation class melanocytoma,60%,Not applicable,DNA_FFPE,11月18日,9406921149
MELCYT_04,9406921149_R01C02,University Hospital of Heidelberg,Melanocytoma  ,not available,Central review Heidelberg,38,male,"posterior fossa, cerebello-pontine angle;  right;",initial operation ,MELCYT,methylation class melanocytoma,62%,Not applicable,DNA_FFPE,11月18日,9406921149
MELCYT_05,9553932029_R01C02,University Hospital of Frankfurt am Main,Melanocytoma  ,not available,Central review Heidelberg,41,male,"posterior fossa, meningeal (posterior fossa); spinal, meningeal (spinal); ",not available,MELCYT,methylation class melanocytoma,61%,Not applicable,DNA_FFPE,2月21日,9553932029
MELCYT_06,9741950008_R03C02,University Hospital of Frankfurt am Main,Melanocytoma  ,not available,Central review Heidelberg,43,female,"spinal, meningeal (spinal), thoracic, T8, T9; ",initial operation ,MELCYT,methylation class melanocytoma,60%,Not applicable,DNA_FFPE,3月24日,9741950008
MELCYT_07,9420867053_R02C02,University Hospital of Heidelberg,Melanocytoma  ,not available,Central review Heidelberg,43,male,"spinal, intramedullary, thoracic, T10, T11; ",initial operation ,MELCYT,methylation class melanocytoma,54%,Not applicable,DNA_FFPE,1月14日,9420867053
MELCYT_08,9406921149_R06C01,University Hospital of Heidelberg,Melanocytoma  ,not available,Central review Heidelberg,46,female,not available,recurrence ,MELCYT,methylation class melanocytoma,58%,Not applicable,DNA_FFPE,11月18日,9406921149
MELCYT_09,9553932029_R03C01,University Hospital of Heidelberg,Melanocytoma  ,not available,Central review Heidelberg,53,male,"spinal, extramedullary intradural, thoracic, T1, T2; ",initial operation ,MELCYT,methylation class melanocytoma,61%,Not applicable,DNA_FFPE,2月21日,9553932029
MELCYT_10,9406921149_R05C02,University Hospital of Hannover,Melanocytoma  ,not available,Central review Heidelberg,54,male,not available,not available,MELCYT,methylation class melanocytoma,62%,Not applicable,DNA_FFPE,11月18日,9406921149
MELCYT_11,9406921149_R02C02,University Hospital of Tuebingen,Melanocytoma  ,not available,Central review Heidelberg,54,male,"posterior fossa, meningeal (posterior fossa); ",recurrence ,MELCYT,methylation class melanocytoma,60%,Not applicable,DNA_FFPE,11月18日,9406921149
MELCYT_12,9406921149_R04C01,University Hospital of Heidelberg,Melanocytoma  ,not available,Central review Heidelberg,65,male,"spinal, meningeal (spinal), thoracic, T1, T2; ",initial operation ,MELCYT,methylation class melanocytoma,60%,Not applicable,DNA_FFPE,11月18日,9406921149
MELCYT_13,9647455131_R04C02,University Hospital of Hannover,Melanocytoma  ,not available,Central review Heidelberg,67,male,"peripheral nerve, plexus, plexus brachialis; ",not available,MELCYT,methylation class melanocytoma,54%,Not applicable,DNA_FFPE,4月11日,9647455131
MELCYT_14,9553932029_R04C01,University Hospital of Heidelberg,Melanocytoma  ,not available,Central review Heidelberg,67,female,"supratentorial, meningeal (supratentorial); ",initial operation ,MELCYT,methylation class melanocytoma,63%,Not applicable,DNA_FFPE,2月21日,9553932029
MELCYT_15,9533774023_R04C01,University Hospital of Freiburg ,Melanocytoma  ,not available,Central review Heidelberg,86,female,"spinal, intramedullary, thoracic, T9, T10; ",initial operation ,MELCYT,methylation class melanocytoma,59%,Not applicable,DNA_FFPE,5月30日,9533774023
MNG_01,3999834036_R06C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,29,male,"posterior fossa, cerebello-pontine angle; ",not available,MNG,methylation class meningioma,61%,Not applicable,DNA_FFPE,2月13日,3999834036
MNG_02,8622007072_R03C02,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,34,female,"supratentorial, hemispheric, frontal;  left;",not available,MNG,methylation class meningioma,54%,Not applicable,DNA_KRYO,12月6日,8622007072
MNG_03,9297949046_R06C02,University Hospital of Heidelberg,Atypical meningioma  ,II,Central review Heidelberg,34,female,"supratentorial, intraventricular, ventricle II;  left;",recurrence ,MNG,methylation class meningioma,54%,Not applicable,DNA_FFPE,6月7日,9297949046
MNG_04,9376561043_R02C02,University Hospital of Muenster,Anaplastic (malignant) meningioma  ,III,Central review Heidelberg,34,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,59%,Not applicable,DNA_FFPE,9月11日,9376561043
MNG_05,8622007073_R03C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,35,female,"supratentorial, intraventricular;  right;",not available,MNG,methylation class meningioma,50%,Not applicable,DNA_KRYO,12月6日,8622007073
MNG_06,8622007073_R06C01,University Hospital of Heidelberg,Atypical meningioma  ,II,Central review Heidelberg,39,female,"supratentorial, meningeal (supratentorial), frontal;  right;",not available,MNG,methylation class meningioma,50%,Not applicable,DNA_KRYO,12月6日,8622007073
MNG_07,3999834036_R04C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,42,female,"supratentorial, meningeal (supratentorial);  left;",not available,MNG,methylation class meningioma,53%,Not applicable,DNA_FFPE,2月13日,3999834036
MNG_08,3999834045_R05C02,University Hospital of Cambridge,Meningioma,I,Central review Heidelberg,43,female,"supratentorial, meningeal (supratentorial), falx, anterior; ",not available,MNG,methylation class meningioma,49%,Not applicable,DNA_KRYO,2月13日,3999834045
MNG_09,8622007073_R02C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,43,female,"supratentorial, meningeal (supratentorial), frontal;  right;",not available,MNG,methylation class meningioma,56%,Not applicable,DNA_KRYO,12月6日,8622007073
MNG_10,8622007072_R06C02,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,43,female,"supratentorial, hemispheric, temporal;  right;",not available,MNG,methylation class meningioma,50%,Not applicable,DNA_KRYO,12月6日,8622007072
MNG_11,8622007106_R04C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,44,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,56%,Not applicable,DNA_KRYO,1月16日,8622007106
MNG_12,8622007072_R03C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,44,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,53%,Not applicable,DNA_KRYO,12月6日,8622007072
MNG_13,9376561057_R06C01,University Hospital of Hannover,Atypical meningioma  ,II,Central review Heidelberg,46,female,"supratentorial, intraventricular, ventricle II; ",not available,MNG,methylation class meningioma,58%,Not applicable,DNA_FFPE,9月11日,9376561057
MNG_14,3999834036_R02C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,47,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,52%,Not applicable,DNA_FFPE,2月13日,3999834036
MNG_15,9376561057_R02C02,University Hospital of Heidelberg,Atypical meningioma  ,II,Central review Heidelberg,47,male,"supratentorial, meningeal (supratentorial), frontal;  left;",not available,MNG,methylation class meningioma,52%,Not applicable,DNA_FFPE,9月11日,9376561057
MNG_16,8622007071_R01C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,48,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,54%,Not applicable,DNA_KRYO,12月6日,8622007071
MNG_17,8622007072_R05C02,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,49,female,not available,not available,MNG,methylation class meningioma,45%,Not applicable,DNA_KRYO,12月6日,8622007072
MNG_18,8622007073_R04C01,University Hospital of Heidelberg,Atypical meningioma  ,II,Central review Heidelberg,49,male,"supratentorial, meningeal (supratentorial), frontal; ",not available,MNG,methylation class meningioma,43%,Not applicable,DNA_KRYO,12月6日,8622007073
MNG_19,3999834045_R03C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,52,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,49%,Not applicable,DNA_KRYO,2月13日,3999834045
MNG_20,9376561057_R03C02,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,52,female,"supratentorial, meningeal (supratentorial), falx, anterior;  right;",not available,MNG,methylation class meningioma,49%,Not applicable,DNA_FFPE,9月11日,9376561057
MNG_21,9376561057_R05C02,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,52,female,"supratentorial, meningeal (supratentorial), falx, anterior;  left;",not available,MNG,methylation class meningioma,50%,Not applicable,DNA_FFPE,9月11日,9376561057
MNG_22,8622007072_R02C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,53,female,"supratentorial, hemispheric, parietal; peripheral nerve, cranial nerve;  left;",not available,MNG,methylation class meningioma,49%,Not applicable,DNA_KRYO,12月6日,8622007072
MNG_23,9376561057_R05C01,University Hospital of Heidelberg,Atypical meningioma  ,II,Central review Heidelberg,53,female,"posterior fossa, meningeal (posterior fossa), tentorium cerebelli;  left;",not available,MNG,methylation class meningioma,57%,Not applicable,DNA_FFPE,9月11日,9376561057
MNG_24,8622007073_R03C02,University Hospital of Heidelberg,Atypical meningioma  ,II,Central review Heidelberg,54,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,65%,Not applicable,DNA_KRYO,12月6日,8622007073
MNG_25,3999834045_R06C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,54,male,meningeal unspecified; ,not available,MNG,methylation class meningioma,54%,Not applicable,DNA_KRYO,2月13日,3999834045
MNG_26,9297949040_R05C01,University Hospital of Cambridge,Meningioma,I,Central review Heidelberg,55,female,"supratentorial, meningeal (supratentorial), falx; ",not available,MNG,methylation class meningioma,50%,Not applicable,DNA_KRYO,6月10日,9297949040
MNG_27,9305651051_R04C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,55,female,"posterior fossa, cerebellum, meningeal (posterior fossa);  left;",not available,MNG,methylation class meningioma,49%,Not applicable,DNA_FFPE,7月12日,9305651051
MNG_28,9376561057_R04C01,University Hospital of Heidelberg,Atypical meningioma  ,II,Central review Heidelberg,56,female,"supratentorial, meningeal (supratentorial), temporal;  right;",not available,MNG,methylation class meningioma,53%,Not applicable,DNA_FFPE,9月11日,9376561057
MNG_29,9297949040_R06C01,University Hospital of Cambridge,Meningioma,I,Central review Heidelberg,57,female,"supratentorial, meningeal (supratentorial), temporal, parietal; ",not available,MNG,methylation class meningioma,51%,Not applicable,DNA_KRYO,6月10日,9297949040
MNG_30,8622007072_R06C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,57,female,"supratentorial, meningeal (supratentorial), temporal, parietal; ",not available,MNG,methylation class meningioma,49%,Not applicable,DNA_KRYO,12月6日,8622007072
MNG_31,9444374132_R03C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,57,female,"supratentorial, meningeal (supratentorial), frontal;  right;",not available,MNG,methylation class meningioma,59%,Not applicable,DNA_FFPE,1月27日,9444374132
MNG_32,9376561057_R02C01,University Hospital of Heidelberg,Atypical meningioma  ,II,Central review Heidelberg,57,male,"supratentorial, meningeal (supratentorial), falx; ",not available,MNG,methylation class meningioma,59%,Not applicable,DNA_FFPE,9月11日,9376561057
MNG_33,8622007072_R02C02,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,58,female,"supratentorial, meningeal (supratentorial), parietal;  right;",not available,MNG,methylation class meningioma,45%,Not applicable,DNA_KRYO,12月6日,8622007072
MNG_34,8622007071_R06C01,University Hospital of Homburg/Saar,Meningioma,I,Central review Heidelberg,58,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,51%,Not applicable,DNA_KRYO,12月6日,8622007071
MNG_35,8622007072_R04C02,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,59,female,"posterior fossa, meningeal (posterior fossa);  left;",recurrence ,MNG,methylation class meningioma,45%,Not applicable,DNA_KRYO,12月6日,8622007072
MNG_36,9444374132_R01C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,59,male,"supratentorial, meningeal (supratentorial), frontal; ",not available,MNG,methylation class meningioma,51%,Not applicable,DNA_FFPE,1月27日,9444374132
MNG_37,3999834045_R03C02,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,59,female,supratentorial; ,not available,MNG,methylation class meningioma,44%,Not applicable,DNA_KRYO,2月13日,3999834045
MNG_38,8622007106_R01C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,60,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,47%,Not applicable,DNA_KRYO,1月16日,8622007106
MNG_39,3999834036_R03C02,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,60,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,52%,Not applicable,DNA_FFPE,2月13日,3999834036
MNG_40,8622007073_R02C02,University Hospital of Heidelberg,Atypical meningioma  ,II,Central review Heidelberg,62,male,"supratentorial, meningeal (supratentorial), parietal; ",not available,MNG,methylation class meningioma,56%,Not applicable,DNA_KRYO,12月6日,8622007073
MNG_41,3999834045_R02C02,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,62,male,meningeal unspecified; ,not available,MNG,methylation class meningioma,47%,Not applicable,DNA_KRYO,2月13日,3999834045
MNG_42,9376561043_R03C02,University Hospital of Muenster,Anaplastic (malignant) meningioma  ,III,Central review Heidelberg,62,female,"supratentorial, meningeal (supratentorial), parietal; ",not available,MNG,methylation class meningioma,66%,Not applicable,DNA_FFPE,9月11日,9376561043
MNG_43,8622007072_R04C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,63,female,"supratentorial, meningeal (supratentorial), frontal; ",not available,MNG,methylation class meningioma,54%,Not applicable,DNA_KRYO,12月6日,8622007072
MNG_44,8622007071_R01C02,University Hospital of Homburg/Saar,Meningioma,I,Central review Heidelberg,63,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,58%,Not applicable,DNA_KRYO,12月6日,8622007071
MNG_45,3999834045_R04C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,64,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,55%,Not applicable,DNA_KRYO,2月13日,3999834045
MNG_46,9444374132_R06C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,64,male,"supratentorial, meningeal (supratentorial), frontal; ",not available,MNG,methylation class meningioma,59%,Not applicable,DNA_FFPE,1月27日,9444374132
MNG_47,9376561043_R06C02,University Hospital of Heidelberg,Atypical meningioma  ,II,Central review Heidelberg,64,male,"supratentorial, meningeal (supratentorial), falx;  left; right;",not available,MNG,methylation class meningioma,59%,Not applicable,DNA_FFPE,9月11日,9376561043
MNG_48,9376561057_R06C02,University Hospital of Heidelberg,Atypical meningioma  ,II,Central review Heidelberg,64,female,"supratentorial, meningeal (supratentorial), frontal;  left;",not available,MNG,methylation class meningioma,54%,Not applicable,DNA_FFPE,9月11日,9376561057
MNG_49,8622007072_R05C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,65,female,not available,not available,MNG,methylation class meningioma,61%,Not applicable,DNA_KRYO,12月6日,8622007072
MNG_50,8622007071_R02C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,65,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,49%,Not applicable,DNA_KRYO,12月6日,8622007071
MNG_51,8622007106_R02C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,65,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,56%,Not applicable,DNA_KRYO,1月16日,8622007106
MNG_52,3999834045_R05C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,66,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,50%,Not applicable,DNA_KRYO,2月13日,3999834045
MNG_53,9444374132_R02C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,66,female,"supratentorial, meningeal (supratentorial), temporal;  right;",not available,MNG,methylation class meningioma,58%,Not applicable,DNA_FFPE,1月27日,9444374132
MNG_54,3999834036_R02C02,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,66,male,"supratentorial, meningeal (supratentorial);  left;",not available,MNG,methylation class meningioma,49%,Not applicable,DNA_FFPE,2月13日,3999834036
MNG_55,9444374132_R02C02,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,66,male,"supratentorial, meningeal (supratentorial), frontal; ",not available,MNG,methylation class meningioma,61%,Not applicable,DNA_FFPE,1月27日,9444374132
MNG_56,8622007071_R03C02,University Hospital of Homburg/Saar,Meningioma,I,Central review Heidelberg,67,male,"peripheral nerve, peripheral nerve, N. femoralis; meningeal unspecified; ",not available,MNG,methylation class meningioma,55%,Not applicable,DNA_KRYO,12月6日,8622007071
MNG_57,9376561057_R04C02,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,68,female,"supratentorial, meningeal (supratentorial), falx; ",not available,MNG,methylation class meningioma,54%,Not applicable,DNA_FFPE,9月11日,9376561057
MNG_58,3999834045_R01C02,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,69,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,53%,Not applicable,DNA_KRYO,2月13日,3999834045
MNG_59,3999834036_R01C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,69,female,"spinal, meningeal (spinal), cervical; ",not available,MNG,methylation class meningioma,54%,Not applicable,DNA_FFPE,2月13日,3999834036
MNG_60,8622007073_R01C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,70,female,"supratentorial, meningeal (supratentorial), frontal, temporal; ",not available,MNG,methylation class meningioma,50%,Not applicable,DNA_KRYO,12月6日,8622007073
MNG_61,8622007071_R05C01,University Hospital of Homburg/Saar,Meningioma,I,Central review Heidelberg,70,male,meningeal unspecified; ,not available,MNG,methylation class meningioma,67%,Not applicable,DNA_KRYO,12月6日,8622007071
MNG_62,9376561043_R05C01,University Hospital of Muenster,Anaplastic (malignant) meningioma  ,III,Central review Heidelberg,70,female,"supratentorial, meningeal (supratentorial), frontal;  right;",not available,MNG,methylation class meningioma,60%,Not applicable,DNA_FFPE,9月11日,9376561043
MNG_63,9376561043_R06C01,University Hospital of Muenster,Anaplastic (malignant) meningioma  ,III,Central review Heidelberg,70,female,"supratentorial, hemispheric, frontal;  left;",not available,MNG,methylation class meningioma,66%,Not applicable,DNA_FFPE,9月11日,9376561043
MNG_64,3999834036_R05C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,71,female,"supratentorial, meningeal (supratentorial);  right;",not available,MNG,methylation class meningioma,54%,Not applicable,DNA_FFPE,2月13日,3999834036
MNG_65,3999834045_R02C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,72,female,"supratentorial, meningeal (supratentorial), falx; ",not available,MNG,methylation class meningioma,50%,Not applicable,DNA_KRYO,2月13日,3999834045
MNG_66,3999834036_R03C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,72,female,"supratentorial, meningeal (supratentorial), frontal; ",not available,MNG,methylation class meningioma,57%,Not applicable,DNA_FFPE,2月13日,3999834036
MNG_67,8622007071_R03C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,73,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,47%,Not applicable,DNA_KRYO,12月6日,8622007071
MNG_68,8622007071_R04C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,73,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,56%,Not applicable,DNA_KRYO,12月6日,8622007071
MNG_69,8622007073_R01C02,University Hospital of Heidelberg,Atypical meningioma  ,II,Central review Heidelberg,73,female,"supratentorial, meningeal (supratentorial), parietal;  left;",not available,MNG,methylation class meningioma,50%,Not applicable,DNA_KRYO,12月6日,8622007073
MNG_70,9444374132_R05C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,73,female,"supratentorial, meningeal (supratentorial), frontal; ",not available,MNG,methylation class meningioma,56%,Not applicable,DNA_FFPE,1月27日,9444374132
MNG_71,9305651051_R01C02,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,73,female,"supratentorial, meningeal (supratentorial), frontal; ",not available,MNG,methylation class meningioma,52%,Not applicable,DNA_FFPE,7月12日,9305651051
MNG_72,3999834036_R01C02,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,73,female,"spinal, meningeal (spinal); ",not available,MNG,methylation class meningioma,48%,Not applicable,DNA_FFPE,2月13日,3999834036
MNG_73,8622007071_R02C02,University Hospital of Homburg/Saar,Meningioma,I,Central review Heidelberg,74,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,62%,Not applicable,DNA_KRYO,12月6日,8622007071
MNG_74,9376561043_R05C02,University Hospital of Heidelberg,Atypical meningioma  ,II,Central review Heidelberg,75,male,"supratentorial, meningeal (supratentorial), frontal; ",not available,MNG,methylation class meningioma,54%,Not applicable,DNA_FFPE,9月11日,9376561043
MNG_75,3999834045_R04C02,University Hospital of Cambridge,Meningioma,I,Central review Heidelberg,76,female,"supratentorial, meningeal (supratentorial), falx; ",not available,MNG,methylation class meningioma,54%,Not applicable,DNA_KRYO,2月13日,3999834045
MNG_76,8622007073_R05C01,University Hospital of Heidelberg,Atypical meningioma  ,II,Central review Heidelberg,76,male,"supratentorial, meningeal (supratentorial), frontal; ",not available,MNG,methylation class meningioma,56%,Not applicable,DNA_KRYO,12月6日,8622007073
MNG_77,3999834003_R05C01,University Hospital of Heidelberg,Atypical meningioma  ,II,Central review Heidelberg,76,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,MNG,methylation class meningioma,49%,Not applicable,DNA_FFPE,2月6日,3999834003
MNG_78,9376561043_R04C01,University Hospital of Muenster,Rhabdoid meningioma  ,III,Central review Heidelberg,77,male,"supratentorial, meningeal (supratentorial), frontal;  left;",not available,MNG,methylation class meningioma,57%,Not applicable,DNA_FFPE,9月11日,9376561043
MNG_79,9444374132_R04C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,82,male,"supratentorial, meningeal (supratentorial), frontal; ",not available,MNG,methylation class meningioma,56%,Not applicable,DNA_FFPE,1月27日,9444374132
MNG_80,9376561057_R01C01,University Hospital of Heidelberg,Atypical meningioma  ,II,Central review Heidelberg,83,male,"supratentorial, meningeal (supratentorial), parietal, occipital;  right;",not available,MNG,methylation class meningioma,55%,Not applicable,DNA_FFPE,9月11日,9376561057
MNG_81,9376561057_R03C01,University Hospital of Heidelberg,Atypical meningioma  ,II,Central review Heidelberg,84,female,"spinal, meningeal (spinal); ",not available,MNG,methylation class meningioma,59%,Not applicable,DNA_FFPE,9月11日,9376561057
MNG_82,8622007106_R05C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,86,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,52%,Not applicable,DNA_KRYO,1月16日,8622007106
MNG_83,8622007106_R03C01,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,88,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,54%,Not applicable,DNA_KRYO,1月16日,8622007106
MNG_84,9376561043_R04C02,University Hospital of Muenster,Anaplastic (malignant) meningioma  ,III,Central review Heidelberg,93,female,"supratentorial, meningeal (supratentorial), temporal; ",not available,MNG,methylation class meningioma,60%,Not applicable,DNA_FFPE,9月11日,9376561043
MNG_85,8622007071_R04C02,University Hospital of Cambridge,Meningioma,I,Central review Heidelberg,not available ,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,52%,Not applicable,DNA_KRYO,12月6日,8622007071
MNG_86,8622007071_R05C02,University Hospital of Cambridge,Meningioma,I,Central review Heidelberg,not available ,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,60%,Not applicable,DNA_KRYO,12月6日,8622007071
MNG_87,8622007071_R06C02,University Hospital of Cambridge,Meningioma,I,Central review Heidelberg,not available ,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,50%,Not applicable,DNA_KRYO,12月6日,8622007071
MNG_88,8622007072_R01C01,University Hospital of Cambridge,Meningioma,I,Central review Heidelberg,not available ,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,56%,Not applicable,DNA_KRYO,12月6日,8622007072
MNG_89,3999834036_R05C02,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,not available ,male,meningeal unspecified; ,not available,MNG,methylation class meningioma,50%,Not applicable,DNA_FFPE,2月13日,3999834036
MNG_90,3999834036_R06C02,University Hospital of Heidelberg,Meningioma,I,Central review Heidelberg,not available ,female,meningeal unspecified; ,not available,MNG,methylation class meningioma,50%,Not applicable,DNA_FFPE,2月13日,3999834036
O_IDH_01,8622007067_R03C02,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,18,male,not available,not available,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",63%,LGm2,DNA_FFPE,11月26日,8622007067
O_IDH_02,9420867053_R06C02,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,19,female,"supratentorial, hemispheric, frontal;  right;",not available,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",54%,LGm2,DNA_KRYO,1月14日,9420867053
O_IDH_03,9968646164_R04C02,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,28,male,"supratentorial, hemispheric, frontal;  left;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",77%,LGm2,DNA_FFPE,7月11日,9968646164
O_IDH_04,3999834003_R06C01,University Hospital of Frankfurt am Main,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,30,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",78%,LGm2,DNA_FFPE,2月6日,3999834003
O_IDH_05,9373551039_R01C01,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,30,male,"supratentorial, hemispheric, frontal;  left;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",72%,LGm2,DNA_FFPE,8月23日,9373551039
O_IDH_06,9534104010_R03C02,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,31,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",67%,LGm2,DNA_FFPE,6月27日,9534104010
O_IDH_07,9969477123_R03C01,University Hospital of Tuebingen,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,31,male,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",70%,LGm2,DNA_FFPE,9月6日,9969477123
O_IDH_08,9420867051_R05C02,University Hospital of Hannover,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,32,male,"supratentorial, hemispheric, frontal;  right;",not available,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",73%,LGm3,DNA_FFPE,1月14日,9420867051
O_IDH_09,9968646113_R02C02,University Hospital of Heidelberg,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,32,male,not available,not available,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",70%,LGm3,DNA_FFPE,7月8日,9968646113
O_IDH_10,9379082039_R03C01,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,32,male,"supratentorial, hemispheric, temporal, parietal;  left;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",73%,LGm3,DNA_FFPE,9月19日,9379082039
O_IDH_11,9379086163_R04C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,32,male,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",72%,LGm3,DNA_FFPE,11月14日,9379086163
O_IDH_12,9829119119_R01C01,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,33,female,"supratentorial, hemispheric, frontal;  right;",not available,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",69%,LGm3,DNA_FFPE,5月23日,9829119119
O_IDH_13,9406922108_R06C01,University Hospital of Tuebingen,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,34,female,"supratentorial, hemispheric, parietal;  right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",65%,LGm2,DNA_FFPE,11月14日,9406922108
O_IDH_14,9878820123_R06C01,University Hospital of Frankfurt am Main,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,35,female,"supratentorial, hemispheric, temporal; ",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",74%,LGm3,DNA_FFPE,10月31日,9878820123
O_IDH_15,9379086138_R06C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,35,female,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",75%,LGm3,DNA_FFPE,11月14日,9379086138
O_IDH_16,9379086164_R06C02,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,35,male,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",66%,LGm3,DNA_FFPE,11月14日,9379086164
O_IDH_17,9968646163_R06C02,University Hospital of Bern,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,36,male,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",76%,LGm3,DNA_FFPE,7月11日,9968646163
O_IDH_18,9855358018_R02C01,German Glioma Network ,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Duesseldorf,36,male,"supratentorial, hemispheric, corpus callosum; ",not available,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",72%,LGm3,DNA_KRYO,9月12日,9855358018
O_IDH_19,9379086163_R05C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,36,male,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",60%,LGm2,DNA_FFPE,11月14日,9379086163
O_IDH_20,9969477122_R02C01,University Hospital of Frankfurt am Main,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,37,male,"supratentorial, hemispheric, temporal;  left;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",66%,LGm3,DNA_FFPE,9月6日,9969477122
O_IDH_21,9878820066_R06C02,German Glioma Network ,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Duesseldorf,37,male,not available,not available,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",79%,LGm2,DNA_KRYO,10月17日,9878820066
O_IDH_22,9769100024_R02C02,German Glioma Network ,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Duesseldorf,37,male,not available,not available,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",66%,LGm3,DNA_KRYO,5月23日,9769100024
O_IDH_23,8622007084_R04C01,University Hospital of Heidelberg,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,37,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",70%,LGm3,DNA_FFPE,12月7日,8622007084
O_IDH_24,9968646165_R05C02,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,38,female,"supratentorial, hemispheric, frontal;  right;",not available,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",67%,LGm3,DNA_FFPE,7月11日,9968646165
O_IDH_25,9379086138_R04C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,38,male,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",79%,LGm3,DNA_FFPE,11月14日,9379086138
O_IDH_26,9379086163_R03C02,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,39,female,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",80%,LGm3,DNA_FFPE,11月14日,9379086163
O_IDH_27,9406922107_R02C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,39,male,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",70%,LGm3,DNA_FFPE,11月14日,9406922107
O_IDH_28,9969477014_R01C02,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,40,male,"supratentorial, hemispheric, frontal, temporal;  right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",67%,LGm2,DNA_FFPE,7月18日,9969477014
O_IDH_29,8622007130_R01C02,University Hospital of Heidelberg,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,40,male,"supratentorial, hemispheric, frontal;  left;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",63%,LGm3,DNA_FFPE,1月16日,8622007130
O_IDH_30,9305651060_R05C02,University Hospital of Heidelberg,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,40,male,"supratentorial, hemispheric, frontal;  left;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",66%,LGm3,DNA_FFPE,7月19日,9305651060
O_IDH_31,9878820113_R06C02,University Hospital of Heidelberg,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,41,female,supratentorial; ,not available,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",74%,LGm3,DNA_KRYO,10月27日,9878820113
O_IDH_32,9221197132_R03C01,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,41,male,"supratentorial, hemispheric, parietal;  right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",65%,LGm2,DNA_FFPE,3月28日,9221197132
O_IDH_33,9379086167_R02C02,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,41,female,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",74%,LGm3,DNA_FFPE,11月14日,9379086167
O_IDH_34,9406922107_R06C02,University Hospital of Tuebingen,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,41,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",75%,LGm3,DNA_FFPE,11月14日,9406922107
O_IDH_35,9968646113_R06C01,University Hospital of Heidelberg,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,42,male,"supratentorial, hemispheric, temporal, occipital;  right;",not available,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",67%,LGm3,DNA_FFPE,7月8日,9968646113
O_IDH_36,9379086138_R06C02,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,42,female,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",67%,LGm3,DNA_FFPE,11月14日,9379086138
O_IDH_37,9379086166_R06C02,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,42,male,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",65%,LGm3,DNA_FFPE,11月14日,9379086166
O_IDH_38,8622007130_R06C01,University Hospital of Heidelberg,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,43,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",73%,LGm3,DNA_FFPE,1月16日,8622007130
O_IDH_39,9968646164_R03C01,University Hospital of Bern,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,44,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",73%,LGm3,DNA_FFPE,7月11日,9968646164
O_IDH_40,10006823141_R02C02,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,44,female,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",70%,LGm3,DNA_FFPE,1月12日,10006823141
O_IDH_41,9379086163_R05C02,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,44,male,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",75%,LGm3,DNA_FFPE,11月14日,9379086163
O_IDH_42,8622007083_R03C01,University Hospital of Heidelberg,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,45,female,"supratentorial, hemispheric, frontal;  left; right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",68%,LGm3,DNA_FFPE,12月7日,8622007083
O_IDH_43,9969477064_R02C02,University Hospital of Heidelberg,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,45,male,"supratentorial, hemispheric, frontal;  left; right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",72%,LGm3,DNA_FFPE,8月8日,9969477064
O_IDH_44,10006823141_R01C01,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,46,male,"supratentorial, hemispheric, frontal, parietal;  left;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",75%,LGm3,DNA_FFPE,1月12日,10006823141
O_IDH_45,10006823155_R02C02,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,47,female,"supratentorial, hemispheric, temporal;  right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",72%,LGm3,DNA_FFPE,1月30日,10006823155
O_IDH_46,9878820021_R05C02,University Hospital of Frankfurt am Main,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,48,female,"supratentorial, hemispheric, frontal, temporal;  right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",68%,LGm3,DNA_FFPE,10月17日,9878820021
O_IDH_47,9407201028_R04C01,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,48,male,"supratentorial, hemispheric, parietal;  left;",not available,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",59%,LGm3,DNA_FFPE,12月2日,9407201028
O_IDH_48,9878820107_R06C01,German Glioma Network ,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Duesseldorf,49,female,supratentorial;  left;,not available,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",80%,LGm2,DNA_KRYO,10月27日,9878820107
O_IDH_49,9741950087_R02C01,University Hospital of Hannover,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,49,male,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",77%,LGm3,DNA_FFPE,4月7日,9741950087
O_IDH_50,9373551042_R06C02,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,49,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",75%,LGm3,DNA_FFPE,8月23日,9373551042
O_IDH_51,9533774023_R01C02,University Hospital of Frankfurt am Main,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,50,female,"supratentorial, hemispheric, frontal;  left; right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",69%,LGm2,DNA_FFPE,5月30日,9533774023
O_IDH_52,3998909013_R05C01,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,50,female,"supratentorial, hemispheric, frontal, temporal;  left;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",71%,LGm3,DNA_FFPE,4月24日,3998909013
O_IDH_53,9878827225_R02C02,University Hospital of Frankfurt am Main,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,51,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",57%,LGm2,DNA_FFPE,11月28日,9878827225
O_IDH_54,9379086155_R02C02,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,52,male,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",67%,LGm3,DNA_FFPE,11月14日,9379086155
O_IDH_55,9855358001_R03C01,University Hospital of Frankfurt am Main,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,54,female,"supratentorial, hemispheric, frontal;  left;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",80%,LGm3,DNA_FFPE,9月12日,9855358001
O_IDH_56,9855358026_R03C02,University Hospital of Frankfurt am Main,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,54,male,"supratentorial, hemispheric, temporal, parietal;  left;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",77%,LGm3,DNA_FFPE,9月26日,9855358026
O_IDH_57,9878820068_R03C01,German Glioma Network ,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Duesseldorf,54,male,not available,not available,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",81%,LGm3,DNA_KRYO,10月17日,9878820068
O_IDH_58,9444375037_R01C02,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,54,male,not available,not available,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",67%,LGm3,DNA_FFPE,1月31日,9444375037
O_IDH_59,9406922161_R02C01,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,54,female,"supratentorial, hemispheric; ",not available,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",64%,LGm3,DNA_FFPE,10月18日,9406922161
O_IDH_60,9741950085_R01C01,University Hospital of Heidelberg,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,54,male,"supratentorial, hemispheric, frontal;  left;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",72%,LGm3,DNA_FFPE,4月7日,9741950085
O_IDH_61,10006823123_R05C01,University Hospital of Bergen,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,55,male,"supratentorial, hemispheric, frontal;  left;",not available,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",74%,LGm3,DNA_FFPE,1月12日,10006823123
O_IDH_62,9647455112_R01C02,University Hospital of Hannover,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,55,male,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",80%,LGm3,DNA_FFPE,4月11日,9647455112
O_IDH_63,9379086155_R06C01,University Hospital of Tuebingen,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,55,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",82%,LGm3,DNA_FFPE,11月14日,9379086155
O_IDH_64,3999875055_R04C02,University Hospital of Frankfurt am Main,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,56,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",67%,LGm3,DNA_FFPE,1月16日,3999875055
O_IDH_65,9379086163_R04C02,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,56,male,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",77%,LGm3,DNA_FFPE,11月14日,9379086163
O_IDH_66,9878820121_R02C01,University Hospital of Heidelberg,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,57,female,supratentorial; ,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",84%,LGm3,DNA_FFPE,10月31日,9878820121
O_IDH_67,9379086138_R04C02,University Hospital of Tuebingen,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,57,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",68%,LGm3,DNA_FFPE,11月14日,9379086138
O_IDH_68,3999543047_R01C02,University Hospital of Frankfurt am Main,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,58,male,"supratentorial, hemispheric, temporal;  right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",77%,LGm3,DNA_FFPE,4月10日,3999543047
O_IDH_69,9406922107_R01C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,59,male,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",72%,LGm3,DNA_FFPE,11月14日,9406922107
O_IDH_70,9553932088_R02C02,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,60,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",73%,LGm3,DNA_FFPE,2月28日,9553932088
O_IDH_71,9969477086_R06C02,University Hospital of Heidelberg,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,60,female,"supratentorial, hemispheric, frontal;  left;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",79%,LGm3,DNA_FFPE,8月22日,9969477086
O_IDH_72,9878820021_R06C01,University Hospital of Heidelberg,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,60,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",80%,LGm3,DNA_FFPE,10月17日,9878820021
O_IDH_73,9878820030_R06C01,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,60,female,supratentorial; ,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",70%,LGm3,DNA_FFPE,10月17日,9878820030
O_IDH_74,8622007084_R01C01,University Hospital of Heidelberg,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,61,male,"supratentorial, hemispheric, frontal;  right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",76%,LGm3,DNA_FFPE,12月7日,8622007084
O_IDH_75,9379086138_R03C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,61,female,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",74%,LGm3,DNA_FFPE,11月14日,9379086138
O_IDH_76,9878820068_R06C01,German Glioma Network ,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Duesseldorf,63,female,not available,not available,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",63%,LGm3,DNA_KRYO,10月17日,9878820068
O_IDH_77,9406922104_R02C01,Neuroonkologische Arbeitsgemeinschaft (NOA) trial cohort,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,64,female,not available,initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",68%,LGm3,DNA_FFPE,11月14日,9406922104
O_IDH_78,9969477013_R06C02,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,66,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",68%,LGm3,DNA_FFPE,7月18日,9969477013
O_IDH_79,8622007084_R01C02,University Hospital of Heidelberg,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted",III,Central review Heidelberg,71,female,"supratentorial, hemispheric, temporal;  right;",not available,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",67%,LGm3,DNA_FFPE,12月7日,8622007084
O_IDH_80,9969477079_R01C02,University Hospital of Heidelberg,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted ",II,Central review Heidelberg,78,male,"supratentorial, hemispheric, frontal; ",initial operation ,O_IDH,"methylation class IDH glioma, subclass 1p/19q codeleted oligodendroglioma",66%,LGm3,DNA_FFPE,8月15日,9969477079
PGG_nC_01,9379082039_R05C01,University Hospital of Heidelberg,Paraganglioma  ,I,Central review Heidelberg,18,male,"spinal, lumbar, L3; ",initial operation ,PGG_nC,"methylation class paraganglioma, spinal non-CIMP",61%,Not applicable,DNA_FFPE,9月19日,9379082039
PGG_nC_02,9305651146_R05C02,University Hospital of Heidelberg,Paraganglioma  ,I,Central review Heidelberg,27,male,"spinal, lumbar, L1, L2; ",initial operation ,PGG_nC,"methylation class paraganglioma, spinal non-CIMP",62%,Not applicable,DNA_FFPE,7月30日,9305651146
PGG_nC_03,9406922158_R01C02,University Hospital of Heidelberg,Paraganglioma  ,I,Central review Heidelberg,28,female,"spinal, extramedullary intradural; ",initial operation ,PGG_nC,"methylation class paraganglioma, spinal non-CIMP",53%,Not applicable,DNA_FFPE,10月18日,9406922158
PGG_nC_04,9422491130_R01C01,University Hospital of Heidelberg,Paraganglioma  ,I,Central review Heidelberg,30,male,"spinal, lumbar, L2, L3; ",initial operation ,PGG_nC,"methylation class paraganglioma, spinal non-CIMP",63%,Not applicable,DNA_FFPE,11月18日,9422491130
PGG_nC_05,9305651146_R03C02,University Hospital of Heidelberg,Paraganglioma  ,I,Central review Heidelberg,34,female,"spinal, extramedullary intradural, cauda equina region; ",initial operation ,PGG_nC,"methylation class paraganglioma, spinal non-CIMP",56%,Not applicable,DNA_FFPE,7月30日,9305651146
PGG_nC_06,9305651089_R06C02,University Hospital of Heidelberg,Paraganglioma  ,I,Central review Heidelberg,38,female,"spinal, lumbar, L5, sacral, S1, conus region; ",recurrence ,PGG_nC,"methylation class paraganglioma, spinal non-CIMP",63%,Not applicable,DNA_FFPE,7月30日,9305651089
PGG_nC_07,9422491130_R02C01,University Hospital of Heidelberg,Paraganglioma  ,I,Central review Heidelberg,41,male,"spinal, extramedullary intradural, lumbar, L2, L3; ",initial operation ,PGG_nC,"methylation class paraganglioma, spinal non-CIMP",65%,Not applicable,DNA_FFPE,11月18日,9422491130
PGG_nC_08,9305651146_R01C02,University Hospital of Heidelberg,Paraganglioma  ,I,Central review Heidelberg,41,male,"spinal, cauda equina region; ",initial operation ,PGG_nC,"methylation class paraganglioma, spinal non-CIMP",60%,Not applicable,DNA_FFPE,7月30日,9305651146
PGG_nC_09,9305651089_R03C02,University Hospital of Heidelberg,Paraganglioma  ,I,Central review Heidelberg,42,female,"spinal, lumbar, L5; ",initial operation ,PGG_nC,"methylation class paraganglioma, spinal non-CIMP",64%,Not applicable,DNA_FFPE,7月30日,9305651089
PGG_nC_10,9422491130_R01C02,University Hospital of Heidelberg,Paraganglioma  ,I,Central review Heidelberg,42,female,"spinal, lumbar, L3; ",initial operation ,PGG_nC,"methylation class paraganglioma, spinal non-CIMP",63%,Not applicable,DNA_FFPE,11月18日,9422491130
PGG_nC_11,9007225086_R04C01,University Hospital of Heidelberg,Paraganglioma  ,I,Central review Heidelberg,43,female,"spinal, lumbar, L3; ",initial operation ,PGG_nC,"methylation class paraganglioma, spinal non-CIMP",66%,Not applicable,DNA_FFPE,3月28日,9007225086
PGG_nC_12,9305651089_R01C02,University Hospital of Heidelberg,Paraganglioma  ,I,Central review Heidelberg,44,male,"spinal, thoracic, lumbar, cauda equina region; ",initial operation ,PGG_nC,"methylation class paraganglioma, spinal non-CIMP",62%,Not applicable,DNA_FFPE,7月30日,9305651089
PGG_nC_13,9305651095_R02C01,University Hospital of Heidelberg,Paraganglioma  ,I,Central review Heidelberg,45,male,"spinal, lumbar, L3; ",initial operation ,PGG_nC,"methylation class paraganglioma, spinal non-CIMP",63%,Not applicable,DNA_FFPE,7月30日,9305651095
PGG_nC_14,9305651095_R01C01,University Hospital of Heidelberg,Paraganglioma  ,I,Central review Heidelberg,46,female,"spinal, cauda equina region; ",initial operation ,PGG_nC,"methylation class paraganglioma, spinal non-CIMP",64%,Not applicable,DNA_FFPE,7月30日,9305651095
PGG_nC_15,9305651089_R04C02,University Hospital of Heidelberg,Paraganglioma  ,I,Central review Heidelberg,50,male,"spinal, lumbar, L5; ",initial operation ,PGG_nC,"methylation class paraganglioma, spinal non-CIMP",62%,Not applicable,DNA_FFPE,7月30日,9305651089
PGG_nC_16,9305651146_R02C02,University Hospital of Heidelberg,Paraganglioma  ,I,Central review Heidelberg,55,male,"spinal, cauda equina region; ",initial operation ,PGG_nC,"methylation class paraganglioma, spinal non-CIMP",61%,Not applicable,DNA_FFPE,7月30日,9305651146
PGG_nC_17,9007225086_R05C02,University Hospital of Heidelberg,Paraganglioma  ,I,Central review Heidelberg,57,female,"spinal, lumbar, L3; ",initial operation ,PGG_nC,"methylation class paraganglioma, spinal non-CIMP",64%,Not applicable,DNA_FFPE,3月28日,9007225086
PGG_nC_18,9305651089_R05C02,University Hospital of Heidelberg,Paraganglioma  ,I,Central review Heidelberg,68,female,"spinal, lumbar, L5; ",initial operation ,PGG_nC,"methylation class paraganglioma, spinal non-CIMP",62%,Not applicable,DNA_FFPE,7月30日,9305651089
PGG_nC_19,9305651146_R05C01,University Hospital of Heidelberg,Paraganglioma  ,I,Central review Heidelberg,73,male,"spinal, extramedullary intradural, lumbar, L3, L4; ",initial operation ,PGG_nC,"methylation class paraganglioma, spinal non-CIMP",61%,Not applicable,DNA_FFPE,7月30日,9305651146
PIN_T_PB_A_01,200078650174_R03C01,University Hospital of Heidelberg,Retinoblastoma,not available,Central review Heidelberg,0,male,"supratentorial, sellar region, suprasellar; peripheral nerve, cranial nerve, II; ",initial operation ,PIN_T_PB_A,methylation class pineoblastoma group A / intracranial retinoblastoma,53%,Not applicable,DNA_FFPE,11月27日,2.00079E+11
PIN_T_PB_A_02,9611519030_R06C01,University Hospital of Hannover,Pineoblastoma  ,IV,Central review Heidelberg,2,male,"supratentorial, diencephalic, pineal region, intraventricular, ventricle III; ",not available,PIN_T_PB_A,methylation class pineoblastoma group A / intracranial retinoblastoma,66%,Not applicable,DNA_FFPE,3月10日,9611519030
PIN_T_PB_A_03,9553932053_R01C02,University Hospital of Erlangen,Pineoblastoma  ,IV,Central review Heidelberg,3,male,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PB_A,methylation class pineoblastoma group A / intracranial retinoblastoma,60%,Not applicable,DNA_FFPE,2月21日,9553932053
PIN_T_PB_A_04,9993943074_R03C01,New York University Langone,Pineoblastoma  ,IV,Local review,3,female,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PB_A,methylation class pineoblastoma group A / intracranial retinoblastoma,65%,Not applicable,DNA_FFPE,7月16日,9993943074
PIN_T_PB_A_05,6929718027_R05C02,University Hospital of Heidelberg,Pineoblastoma  ,IV,Central review Heidelberg,4,male,not available,not available,PIN_T_PB_A,methylation class pineoblastoma group A / intracranial retinoblastoma,67%,Not applicable,DNA_KRYO,12月2日,6929718027
PIN_T_PB_A_06,9855358027_R03C01,University Hospital of Essen,Retinoblastoma,not available,Central review Heidelberg,not available ,female,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PB_A,methylation class pineoblastoma group A / intracranial retinoblastoma,62%,Not applicable,DNA_FFPE,9月26日,9855358027
PIN_T_PB_A_07,9878820123_R06C02,University Hospital of Essen,Retinoblastoma,not available,Central review Heidelberg,not available ,male,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PB_A,methylation class pineoblastoma group A / intracranial retinoblastoma,64%,Not applicable,DNA_FFPE,10月31日,9878820123
PIN_T_PB_A_08,9407210157_R04C01,"St. Jude Childrens Research Hospital, Memphis",Pineoblastoma  ,IV,Local review,not available ,female,not available,not available,PIN_T_PB_A,methylation class pineoblastoma group A / intracranial retinoblastoma,59%,Not applicable,DNA_FFPE,2月24日,9407210157
PIN_T_PB_A_09,9741950159_R01C01,"St. Jude Childrens Research Hospital, Memphis",Pineoblastoma  ,IV,Local review,not available ,female,not available,not available,PIN_T_PB_A,methylation class pineoblastoma group A / intracranial retinoblastoma,62%,Not applicable,DNA_FFPE,2月24日,9741950159
PIN_T_PB_B_01,3999100033_R02C02,"Teleton Kids Institute, Perth ",Pineoblastoma  ,IV,Central review Heidelberg,4,male,not available,not available,PIN_T_PB_B,methylation class pineoblastoma group B,66%,Not applicable,DNA_FFPE,3月20日,3999100033
PIN_T_PB_B_02,101178130118_R06C01,University Hospital of Basel ,Pineoblastoma  ,IV,Central review Heidelberg,5,female,"supratentorial, diencephalic, pineal region; ",initial operation ,PIN_T_PB_B,methylation class pineoblastoma group B,63%,Not applicable,DNA_FFPE,10月9日,1.01178E+11
PIN_T_PB_B_03,9993943074_R05C01,New York University Langone,Pineoblastoma  ,IV,Local review,9,female,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PB_B,methylation class pineoblastoma group B,60%,Not applicable,DNA_FFPE,7月16日,9993943074
PIN_T_PB_B_04,9993943074_R04C02,New York University Langone,Pineoblastoma  ,IV,Local review,11,female,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PB_B,methylation class pineoblastoma group B,62%,Not applicable,DNA_FFPE,7月16日,9993943074
PIN_T_PB_B_05,9993943074_R02C02,New York University Langone,Pineoblastoma  ,IV,Local review,15,female,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PB_B,methylation class pineoblastoma group B,64%,Not applicable,DNA_FFPE,7月16日,9993943074
PIN_T_PB_B_06,3999078120_R02C01,University Hospital of Goettingen,Pineoblastoma  ,IV,Central review Heidelberg,16,female,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PB_B,methylation class pineoblastoma group B,62%,Not applicable,DNA_FFPE,7月10日,3999078120
PIN_T_PB_B_07,9420867122_R05C02,"MD Anderson Cancer Center, Houston",Pineoblastoma  ,IV,Central review Heidelberg,16,female,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PB_B,methylation class pineoblastoma group B,64%,Not applicable,DNA_FFPE,1月17日,9420867122
PIN_T_PB_B_08,9420867122_R06C02,"MD Anderson Cancer Center, Houston",Pineoblastoma  ,IV,Central review Heidelberg,17,female,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PB_B,methylation class pineoblastoma group B,65%,Not applicable,DNA_FFPE,1月17日,9420867122
PIN_T_PB_B_09,9993943074_R01C01,New York University Langone,Pineoblastoma  ,IV,Local review,21,female,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PB_B,methylation class pineoblastoma group B,63%,Not applicable,DNA_FFPE,7月16日,9993943074
PIN_T_PB_B_10,8942351007_R03C02,University Hospital of Heidelberg,Pineoblastoma  ,IV,Central review Heidelberg,22,female,"supratentorial, diencephalic, pineal region; ",initial operation ,PIN_T_PB_B,methylation class pineoblastoma group B,65%,Not applicable,DNA_FFPE,1月18日,8942351007
PIN_T_PB_B_11,9340996008_R02C02,University Hospital of Muenster,Pineoblastoma  ,IV,Central review Heidelberg,23,female,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PB_B,methylation class pineoblastoma group B,65%,Not applicable,DNA_FFPE,8月6日,9340996008
PIN_T_PB_B_12,3999078080_R04C01,University Hospital of Heidelberg,Pineoblastoma  ,IV,Central review Heidelberg,not available ,female,not available,initial operation ,PIN_T_PB_B,methylation class pineoblastoma group B,64%,Not applicable,DNA_FFPE,7月3日,3999078080
PIN_T_PB_B_13,3999078080_R02C02,University Hospital of Heidelberg,Pineoblastoma  ,IV,Central review Heidelberg,not available ,male,not available,initial operation ,PIN_T_PB_B,methylation class pineoblastoma group B,60%,Not applicable,DNA_FFPE,7月3日,3999078080
PIN_T_PB_B_14,9553932010_R03C01,"MD Anderson Cancer Center, Houston",Pineal parenchymal tumour of intermediate differentiation  ,II or III,Central review Heidelberg,not available ,male,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PB_B,methylation class pineoblastoma group B,62%,Not applicable,DNA_FFPE,2月14日,9553932010
PIN_T_PB_B_15,9741950038_R06C01,"St. Jude Childrens Research Hospital, Memphis",Pineoblastoma  ,IV,Local review,not available ,female,not available,not available,PIN_T_PB_B,methylation class pineoblastoma group B,64%,Not applicable,DNA_FFPE,2月24日,9741950038
PIN_T_PB_B_16,9741950074_R05C02,"St. Jude Childrens Research Hospital, Memphis",Pineoblastoma  ,IV,Local review,not available ,female,not available,not available,PIN_T_PB_B,methylation class pineoblastoma group B,63%,Not applicable,DNA_FFPE,2月24日,9741950074
PIN_T_PB_B_17,9741950159_R05C01,"St. Jude Childrens Research Hospital, Memphis",Pineoblastoma  ,IV,Local review,not available ,male,not available,not available,PIN_T_PB_B,methylation class pineoblastoma group B,62%,Not applicable,DNA_FFPE,2月24日,9741950159
PIN_T_PB_B_18,9741950159_R06C01,"St. Jude Childrens Research Hospital, Memphis",Pineoblastoma  ,IV,Local review,not available ,male,not available,not available,PIN_T_PB_B,methylation class pineoblastoma group B,62%,Not applicable,DNA_FFPE,2月24日,9741950159
PIN_T_PB_B_19,9741950159_R01C02,"St. Jude Childrens Research Hospital, Memphis",Pineoblastoma  ,IV,Local review,not available ,female,not available,not available,PIN_T_PB_B,methylation class pineoblastoma group B,62%,Not applicable,DNA_FFPE,2月24日,9741950159
PIN_T_PB_B_20,9741950159_R03C02,"St. Jude Childrens Research Hospital, Memphis",Pineoblastoma  ,IV,Local review,not available ,female,not available,not available,PIN_T_PB_B,methylation class pineoblastoma group B,62%,Not applicable,DNA_FFPE,2月24日,9741950159
PIN_T_PB_B_21,9741950158_R06C01,"St. Jude Childrens Research Hospital, Memphis",Pineoblastoma  ,IV,Local review,not available ,not available,not available,not available,PIN_T_PB_B,methylation class pineoblastoma group B,62%,Not applicable,DNA_FFPE,2月24日,9741950158
PIN_T_PB_B_22,9878820078_R03C01,New York University Langone,Pineoblastoma  ,IV,Local review,not available ,not available,not available,not available,PIN_T_PB_B,methylation class pineoblastoma group B,67%,Not applicable,DNA_KRYO,10月17日,9878820078
PIN_T_PPT_01,9553932053_R02C02,University Hospital of Erlangen,Pineoblastoma  ,IV,Central review Heidelberg,9,male,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PPT,methylation class pineal parenchymal tumor ,59%,Not applicable,DNA_FFPE,2月21日,9553932053
PIN_T_PPT_02,9553932029_R06C02,University Hospital of Frankfurt am Main,Pineoblastoma  ,IV,Central review Heidelberg,11,male,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PPT,methylation class pineal parenchymal tumor ,66%,Not applicable,DNA_FFPE,2月21日,9553932029
PIN_T_PPT_03,9969477079_R01C01,"University of California, San Francisco ",Pineal parenchymal tumour of intermediate differentiation  ,II or III,Central review Heidelberg,13,male,"supratentorial, diencephalic, pineal region; ",initial operation ,PIN_T_PPT,methylation class pineal parenchymal tumor ,64%,Not applicable,DNA_FFPE,8月15日,9969477079
PIN_T_PPT_04,9007225003_R03C01,University Hospital of Heidelberg,Pineal parenchymal tumour of intermediate differentiation  ,II or III,Central review Heidelberg,33,female,"supratentorial, diencephalic, pineal region; ",initial operation ,PIN_T_PPT,methylation class pineal parenchymal tumor ,66%,Not applicable,DNA_FFPE,2月20日,9007225003
PIN_T_PPT_05,9007225144_R04C02,University Hospital of Hannover,Pineal parenchymal tumour of intermediate differentiation  ,II or III,Central review Heidelberg,38,male,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PPT,methylation class pineal parenchymal tumor ,62%,Not applicable,DNA_FFPE,4月19日,9007225144
PIN_T_PPT_06,9007225144_R01C01,University Hospital of Hannover,Pineal parenchymal tumour of intermediate differentiation  ,II or III,Central review Heidelberg,40,male,"supratentorial, hemispheric, occipital, diencephalic, pineal region;  left; right;",not available,PIN_T_PPT,methylation class pineal parenchymal tumor ,68%,Not applicable,DNA_FFPE,4月19日,9007225144
PIN_T_PPT_07,9969477106_R05C02,University Hospital of Heidelberg,Pineal parenchymal tumour of intermediate differentiation  ,II or III,Central review Heidelberg,40,female,"supratentorial, hemispheric, temporal;  left;",initial operation ,PIN_T_PPT,methylation class pineal parenchymal tumor ,64%,Not applicable,DNA_FFPE,9月4日,9969477106
PIN_T_PPT_08,3999834055_R06C02,University College London Hospitals,Pineal parenchymal tumour of intermediate differentiation  ,II or III,Central review Heidelberg,41,female,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PPT,methylation class pineal parenchymal tumor ,66%,Not applicable,DNA_FFPE,2月13日,3999834055
PIN_T_PPT_09,9007225163_R04C01,University Hospital of Heidelberg,Pineal parenchymal tumour of intermediate differentiation  ,II or III,Central review Heidelberg,42,female,"supratentorial, diencephalic, pineal region; ",recurrence ,PIN_T_PPT,methylation class pineal parenchymal tumor ,60%,Not applicable,DNA_FFPE,4月19日,9007225163
PIN_T_PPT_10,9533774013_R03C02,"MD Anderson Cancer Center, Houston",Pineal parenchymal tumour of intermediate differentiation  ,II or III,Central review Heidelberg,44,male,"supratentorial, hemispheric, parietal, diencephalic, pineal region; ",not available,PIN_T_PPT,methylation class pineal parenchymal tumor ,65%,Not applicable,DNA_FFPE,5月30日,9533774013
PIN_T_PPT_11,9993943074_R06C01,New York University Langone,Pineoblastoma  ,IV,Local review,45,male,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PPT,methylation class pineal parenchymal tumor ,63%,Not applicable,DNA_FFPE,7月16日,9993943074
PIN_T_PPT_12,9420867122_R04C02,"MD Anderson Cancer Center, Houston",Pineoblastoma  ,IV,Central review Heidelberg,46,male,"spinal, thoracic, T5; ",metastasis,PIN_T_PPT,methylation class pineal parenchymal tumor ,66%,Not applicable,DNA_FFPE,1月17日,9420867122
PIN_T_PPT_13,9007225003_R02C01,University Hospital of Heidelberg,Pineal parenchymal tumour of intermediate differentiation  ,II or III,Central review Heidelberg,51,female,"supratentorial, diencephalic, pineal region; posterior fossa; ",initial operation ,PIN_T_PPT,methylation class pineal parenchymal tumor ,62%,Not applicable,DNA_FFPE,2月20日,9007225003
PIN_T_PPT_14,9340996008_R01C02,University Hospital of Muenster,Pineoblastoma  ,IV,Central review Heidelberg,56,male,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PPT,methylation class pineal parenchymal tumor ,64%,Not applicable,DNA_FFPE,8月6日,9340996008
PIN_T_PPT_15,3999834062_R03C01,University College London Hospitals,Pineal parenchymal tumour of intermediate differentiation  ,II or III,Central review Heidelberg,57,female,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PPT,methylation class pineal parenchymal tumor ,64%,Not applicable,DNA_FFPE,2月13日,3999834062
PIN_T_PPT_16,9340996008_R05C01,University Hospital of Muenster,Pineal parenchymal tumour of intermediate differentiation  ,II or III,Central review Heidelberg,58,female,"supratentorial, diencephalic, pineal region; ",not available,PIN_T_PPT,methylation class pineal parenchymal tumor ,65%,Not applicable,DNA_FFPE,8月6日,9340996008
PIN_T_PPT_17,9741950085_R06C01,University Hospital of Bern,Pineoblastoma  ,IV,Central review Heidelberg,61,female,"supratentorial, diencephalic, pineal region; ",recurrence ,PIN_T_PPT,methylation class pineal parenchymal tumor ,68%,Not applicable,DNA_FFPE,4月7日,9741950085
PIN_T_PPT_18,9420867122_R02C01,University Hospital of Muenster,Pineal parenchymal tumour of intermediate differentiation  ,II or III,Central review Heidelberg,61,female,"supratentorial, diencephalic, pineal region, intraventricular, ventricle III; ",not available,PIN_T_PPT,methylation class pineal parenchymal tumor ,70%,Not applicable,DNA_FFPE,1月17日,9420867122
PIN_T_PPT_19,9878820062_R06C02,New York University Langone,Pineoblastoma  ,IV,Local review,not available ,female,not available,not available,PIN_T_PPT,methylation class pineal parenchymal tumor ,61%,Not applicable,DNA_FFPE,10月17日,9878820062
PITAD_ACTH_01,3998920095_R03C02,University Hospital of Erlangen,Pituitary adenoma ACTH producing,not available,Central review Heidelberg,19,female,"supratentorial, sellar region; ",initial operation ,PITAD_ACTH,"methylation class pituitary adenoma, ACTH",64%,Not applicable,DNA_FFPE,6月5日,3998920095
PITAD_ACTH_02,3998920095_R01C02,University Hospital of Erlangen,Pituitary adenoma ACTH producing,not available,Central review Heidelberg,20,female,"supratentorial, sellar region; ",initial operation ,PITAD_ACTH,"methylation class pituitary adenoma, ACTH",64%,Not applicable,DNA_FFPE,6月5日,3998920095
PITAD_ACTH_03,3998920096_R05C01,University Hospital of Erlangen,Pituitary adenoma ACTH producing,not available,Central review Heidelberg,28,male,"supratentorial, sellar region; ",initial operation ,PITAD_ACTH,"methylation class pituitary adenoma, ACTH",67%,Not applicable,DNA_FFPE,6月5日,3998920096
PITAD_ACTH_04,9379082039_R01C01,University Hospital of Heidelberg,Pituitary adenoma ACTH producing,not available,Central review Heidelberg,32,female,"supratentorial, sellar region; ",initial operation ,PITAD_ACTH,"methylation class pituitary adenoma, ACTH",64%,Not applicable,DNA_FFPE,9月19日,9379082039
PITAD_ACTH_05,3998920095_R05C01,University Hospital of Erlangen,Pituitary adenoma ACTH producing,not available,Central review Heidelberg,34,female,"supratentorial, sellar region; ",recurrence ,PITAD_ACTH,"methylation class pituitary adenoma, ACTH",63%,Not applicable,DNA_FFPE,6月5日,3998920095
PITAD_ACTH_06,3998998187_R04C02,University Hospital of Erlangen,Pituitary adenoma ACTH producing,not available,Central review Heidelberg,35,male,"supratentorial, sellar region; ",initial operation ,PITAD_ACTH,"methylation class pituitary adenoma, ACTH",61%,Not applicable,DNA_FFPE,6月19日,3998998187
PITAD_ACTH_07,9406922158_R05C02,University Hospital of Heidelberg,Pituitary adenoma ACTH producing,not available,Central review Heidelberg,40,female,"supratentorial, sellar region; ",initial operation ,PITAD_ACTH,"methylation class pituitary adenoma, ACTH",64%,Not applicable,DNA_FFPE,10月18日,9406922158
PITAD_ACTH_08,3998998187_R06C02,University Hospital of Erlangen,Pituitary adenoma ACTH producing,not available,Central review Heidelberg,41,female,"supratentorial, sellar region; ",initial operation ,PITAD_ACTH,"methylation class pituitary adenoma, ACTH",63%,Not applicable,DNA_FFPE,6月19日,3998998187
PITAD_ACTH_09,3998920095_R01C01,University Hospital of Erlangen,Pituitary adenoma ACTH producing,not available,Central review Heidelberg,42,male,"supratentorial, sellar region; ",initial operation ,PITAD_ACTH,"methylation class pituitary adenoma, ACTH",64%,Not applicable,DNA_FFPE,6月5日,3998920095
PITAD_ACTH_10,3998998187_R01C02,University Hospital of Erlangen,Pituitary adenoma ACTH producing,not available,Central review Heidelberg,50,female,"supratentorial, sellar region; ",recurrence ,PITAD_ACTH,"methylation class pituitary adenoma, ACTH",65%,Not applicable,DNA_FFPE,6月19日,3998998187
PITAD_ACTH_11,3998920096_R01C01,University Hospital of Erlangen,Pituitary adenoma ACTH producing,not available,Central review Heidelberg,51,female,"supratentorial, sellar region; ",initial operation ,PITAD_ACTH,"methylation class pituitary adenoma, ACTH",66%,Not applicable,DNA_FFPE,6月5日,3998920096
PITAD_ACTH_12,9376561062_R04C02,University Hospital of Heidelberg,Pituitary adenoma ACTH producing,not available,Central review Heidelberg,51,female,"supratentorial, sellar region; ",initial operation ,PITAD_ACTH,"methylation class pituitary adenoma, ACTH",61%,Not applicable,DNA_FFPE,9月27日,9376561062
PITAD_ACTH_13,9426021162_R04C02,University Hospital of Erlangen,Pituitary adenoma ACTH producing,not available,Central review Heidelberg,54,female,"supratentorial, sellar region; ",not available,PITAD_ACTH,"methylation class pituitary adenoma, ACTH",62%,Not applicable,DNA_FFPE,12月20日,9426021162
PITAD_ACTH_14,3998920095_R03C01,University Hospital of Erlangen,Pituitary adenoma ACTH producing,not available,Central review Heidelberg,55,male,"supratentorial, sellar region, suprasellar, intrasellar; ",recurrence ,PITAD_ACTH,"methylation class pituitary adenoma, ACTH",67%,Not applicable,DNA_FFPE,6月5日,3998920095
PITAD_ACTH_15,9426021103_R04C02,University Hospital of Erlangen,Pituitary adenoma ACTH producing,not available,Central review Heidelberg,56,female,"supratentorial, sellar region; ",not available,PITAD_ACTH,"methylation class pituitary adenoma, ACTH",64%,Not applicable,DNA_FFPE,12月20日,9426021103
PITAD_ACTH_16,3998920095_R05C02,University Hospital of Erlangen,Pituitary adenoma ACTH producing,not available,Central review Heidelberg,56,female,"supratentorial, sellar region, intrasellar; ",initial operation ,PITAD_ACTH,"methylation class pituitary adenoma, ACTH",60%,Not applicable,DNA_FFPE,6月5日,3998920095
PITAD_ACTH_17,9426021162_R05C02,University Hospital of Erlangen,Pituitary adenoma ACTH producing,not available,Central review Heidelberg,61,female,"supratentorial, sellar region; ",not available,PITAD_ACTH,"methylation class pituitary adenoma, ACTH",60%,Not applicable,DNA_FFPE,12月20日,9426021162
PITAD_ACTH_18,3998920096_R03C01,University Hospital of Erlangen,Pituitary adenoma ACTH producing,not available,Central review Heidelberg,67,male,"supratentorial, sellar region; ",initial operation ,PITAD_ACTH,"methylation class pituitary adenoma, ACTH",66%,Not applicable,DNA_FFPE,6月5日,3998920096
PITAD_FSH_LH_01,3999078088_R01C02,University Hospital of Erlangen,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,18,male,"supratentorial, sellar region; ",initial operation ,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",65%,Not applicable,DNA_FFPE,7月3日,3999078088
PITAD_FSH_LH_02,3999078084_R05C02,University Hospital of Erlangen,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,39,male,"supratentorial, sellar region; ",initial operation ,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",62%,Not applicable,DNA_FFPE,7月3日,3999078084
PITAD_FSH_LH_03,9426021103_R06C01,University Hospital of Erlangen,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,43,male,"supratentorial, sellar region; ",not available,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",66%,Not applicable,DNA_FFPE,12月20日,9426021103
PITAD_FSH_LH_04,9426021086_R03C01,University Hospital of Erlangen,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,47,male,"supratentorial, sellar region; ",not available,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",65%,Not applicable,DNA_FFPE,12月20日,9426021086
PITAD_FSH_LH_05,9426021103_R04C01,University Hospital of Erlangen,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,47,female,"supratentorial, sellar region; ",not available,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",64%,Not applicable,DNA_FFPE,12月20日,9426021103
PITAD_FSH_LH_06,9426021103_R03C02,University Hospital of Erlangen,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,48,male,"supratentorial, sellar region; ",not available,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",65%,Not applicable,DNA_FFPE,12月20日,9426021103
PITAD_FSH_LH_07,9426021086_R04C01,University Hospital of Erlangen,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,57,male,"supratentorial, sellar region; ",not available,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",64%,Not applicable,DNA_FFPE,12月20日,9426021086
PITAD_FSH_LH_08,9426021103_R01C02,University Hospital of Erlangen,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,57,male,"supratentorial, sellar region; ",not available,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",64%,Not applicable,DNA_FFPE,12月20日,9426021103
PITAD_FSH_LH_09,9406922158_R03C02,University Hospital of Heidelberg,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,64,male,"supratentorial, sellar region; ",initial operation ,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",62%,Not applicable,DNA_FFPE,10月18日,9406922158
PITAD_FSH_LH_10,9426021103_R02C01,University Hospital of Erlangen,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,65,male,"supratentorial, sellar region; ",not available,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",65%,Not applicable,DNA_FFPE,12月20日,9426021103
PITAD_FSH_LH_11,9426021103_R03C01,University Hospital of Erlangen,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,65,female,"supratentorial, sellar region; ",not available,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",63%,Not applicable,DNA_FFPE,12月20日,9426021103
PITAD_FSH_LH_12,9426021086_R02C01,University Hospital of Erlangen,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,66,male,"supratentorial, sellar region; ",not available,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",68%,Not applicable,DNA_FFPE,12月20日,9426021086
PITAD_FSH_LH_13,9426021103_R05C01,University Hospital of Erlangen,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,66,female,"supratentorial, sellar region; ",not available,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",64%,Not applicable,DNA_FFPE,12月20日,9426021103
PITAD_FSH_LH_14,9422493151_R04C01,University Hospital of Erlangen,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,67,female,"supratentorial, sellar region; ",not available,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",65%,Not applicable,DNA_FFPE,12月13日,9422493151
PITAD_FSH_LH_15,9426021086_R05C01,University Hospital of Erlangen,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,68,female,"supratentorial, sellar region; ",not available,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",64%,Not applicable,DNA_FFPE,12月20日,9426021086
PITAD_FSH_LH_16,3999078088_R01C01,University Hospital of Erlangen,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,68,male,"supratentorial, sellar region, suprasellar, intrasellar; ",initial operation ,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",60%,Not applicable,DNA_FFPE,7月3日,3999078088
PITAD_FSH_LH_17,3999078088_R03C01,University Hospital of Erlangen,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,69,male,"supratentorial, sellar region; ",initial operation ,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",62%,Not applicable,DNA_FFPE,7月3日,3999078088
PITAD_FSH_LH_18,9426021103_R01C01,University Hospital of Erlangen,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,74,male,"supratentorial, sellar region; ",not available,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",63%,Not applicable,DNA_FFPE,12月20日,9426021103
PITAD_FSH_LH_19,9426021103_R02C02,University Hospital of Erlangen,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,75,male,"supratentorial, sellar region; ",not available,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",63%,Not applicable,DNA_FFPE,12月20日,9426021103
PITAD_FSH_LH_20,3999078088_R05C01,University Hospital of Erlangen,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,78,male,"supratentorial, sellar region; ",initial operation ,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",64%,Not applicable,DNA_FFPE,7月3日,3999078088
PITAD_FSH_LH_21,9406922161_R04C01,University Hospital of Heidelberg,Pituitary adenoma gonadotropin producing,not available,Central review Heidelberg,79,male,"supratentorial, sellar region; ",initial operation ,PITAD_FSH_LH,"methylation class pituitary adenoma, FSH/LH",61%,Not applicable,DNA_FFPE,10月18日,9406922161
PITAD_PRL_01,9444374133_R06C02,University Hospital of Tuebingen,Pituitary adenoma prolactin producing,not available,Central review Heidelberg,12,male,"supratentorial, sellar region; ",initial operation ,PITAD_PRL,"methylation class pituitary adenoma, prolactin",66%,Not applicable,DNA_FFPE,1月27日,9444374133
PITAD_PRL_02,9426021103_R05C02,University Hospital of Erlangen,Pituitary adenoma prolactin producing,not available,Central review Heidelberg,40,male,"supratentorial, sellar region; ",not available,PITAD_PRL,"methylation class pituitary adenoma, prolactin",61%,Not applicable,DNA_FFPE,12月20日,9426021103
PITAD_PRL_03,3999834115_R04C01,University Hospital of Heidelberg,Pituitary adenoma prolactin producing,not available,Central review Heidelberg,51,male,"supratentorial, sellar region, suprasellar; ",initial operation ,PITAD_PRL,"methylation class pituitary adenoma, prolactin",65%,Not applicable,DNA_FFPE,2月27日,3999834115
PITAD_PRL_04,9426021162_R05C01,University Hospital of Erlangen,Pituitary adenoma prolactin producing,not available,Central review Heidelberg,56,female,"supratentorial, sellar region; ",not available,PITAD_PRL,"methylation class pituitary adenoma, prolactin",64%,Not applicable,DNA_FFPE,12月20日,9426021162
PITAD_PRL_05,9426021162_R03C02,University Hospital of Erlangen,Pituitary adenoma prolactin producing,not available,Central review Heidelberg,58,female,"supratentorial, sellar region; ",not available,PITAD_PRL,"methylation class pituitary adenoma, prolactin",67%,Not applicable,DNA_FFPE,12月20日,9426021162
PITAD_PRL_06,9426021162_R06C02,University Hospital of Erlangen,Pituitary adenoma prolactin producing,not available,Central review Heidelberg,59,female,"supratentorial, sellar region; ",not available,PITAD_PRL,"methylation class pituitary adenoma, prolactin",64%,Not applicable,DNA_FFPE,12月20日,9426021162
PITAD_PRL_07,9406921039_R06C01,"Ludwig-Maximilians University Hospital, Munich ",Pituitary adenoma prolactin producing,not available,Central review Heidelberg,75,male,"mesenchyme, cranium, nasal cavity; ",not available,PITAD_PRL,"methylation class pituitary adenoma, prolactin",67%,Not applicable,DNA_FFPE,11月18日,9406921039
PITAD_PRL_08,9406922158_R06C02,University Hospital of Heidelberg,Pituitary adenoma prolactin producing,not available,Central review Heidelberg,78,female,"supratentorial, hemispheric, frontal, sellar region; ",initial operation ,PITAD_PRL,"methylation class pituitary adenoma, prolactin",65%,Not applicable,DNA_FFPE,10月18日,9406922158
PITAD_STH_DNS_A_01,9407210069_R06C02,University Hospital of Erlangen,Pituitary adenoma densely granulated GH/STH producing,not available,Central review Heidelberg,37,female,"supratentorial, sellar region; ",not available,PITAD_STH_DNS_A,"methylation class pituitary adenoma, STH densely granulated, group A",70%,Not applicable,DNA_FFPE,12月6日,9407210069
PITAD_STH_DNS_A_02,9407210090_R02C01,University Hospital of Erlangen,Pituitary adenoma densely granulated GH/STH producing,not available,Central review Heidelberg,37,female,"supratentorial, sellar region; ",not available,PITAD_STH_DNS_A,"methylation class pituitary adenoma, STH densely granulated, group A",66%,Not applicable,DNA_FFPE,12月6日,9407210090
PITAD_STH_DNS_A_03,9407210090_R05C01,University Hospital of Erlangen,Pituitary adenoma densely granulated GH/STH producing,not available,Central review Heidelberg,43,male,"supratentorial, sellar region; ",initial operation ,PITAD_STH_DNS_A,"methylation class pituitary adenoma, STH densely granulated, group A",69%,Not applicable,DNA_FFPE,12月6日,9407210090
PITAD_STH_DNS_A_04,9407210069_R05C02,University Hospital of Erlangen,Pituitary adenoma densely granulated GH/STH producing,not available,Central review Heidelberg,44,female,"supratentorial, sellar region; ",not available,PITAD_STH_DNS_A,"methylation class pituitary adenoma, STH densely granulated, group A",64%,Not applicable,DNA_FFPE,12月6日,9407210069
PITAD_STH_DNS_A_05,9407210090_R04C01,University Hospital of Erlangen,Pituitary adenoma densely granulated GH/STH producing,not available,Central review Heidelberg,45,male,"supratentorial, sellar region; ",not available,PITAD_STH_DNS_A,"methylation class pituitary adenoma, STH densely granulated, group A",68%,Not applicable,DNA_FFPE,12月6日,9407210090
PITAD_STH_DNS_A_06,9422493146_R06C02,University Hospital of Erlangen,Pituitary adenoma densely granulated GH/STH producing,not available,Central review Heidelberg,48,female,"supratentorial, sellar region; ",not available,PITAD_STH_DNS_A,"methylation class pituitary adenoma, STH densely granulated, group A",65%,Not applicable,DNA_FFPE,12月13日,9422493146
PITAD_STH_DNS_A_07,3998998189_R04C01,University Hospital of Erlangen,Pituitary adenoma densely granulated GH/STH producing,not available,Central review Heidelberg,49,male,"supratentorial, sellar region; ",initial operation ,PITAD_STH_DNS_A,"methylation class pituitary adenoma, STH densely granulated, group A",70%,Not applicable,DNA_FFPE,6月19日,3998998189
PITAD_STH_DNS_A_08,3998998189_R01C02,University Hospital of Erlangen,Pituitary adenoma densely granulated GH/STH producing,not available,Central review Heidelberg,52,female,"supratentorial, sellar region; ",initial operation ,PITAD_STH_DNS_A,"methylation class pituitary adenoma, STH densely granulated, group A",64%,Not applicable,DNA_FFPE,6月19日,3998998189
PITAD_STH_DNS_A_09,9422493146_R02C02,University Hospital of Erlangen,Pituitary adenoma densely granulated GH/STH producing,not available,Central review Heidelberg,59,male,"supratentorial, sellar region; ",not available,PITAD_STH_DNS_A,"methylation class pituitary adenoma, STH densely granulated, group A",67%,Not applicable,DNA_FFPE,12月13日,9422493146
PITAD_STH_DNS_B_01,9376561024_R06C01,University Hospital of Heidelberg,Pituitary adenoma densely granulated GH/STH producing,not available,Central review Heidelberg,18,male,"supratentorial, sellar region; ",initial operation ,PITAD_STH_DNS_B,"methylation class pituitary adenoma, STH densely granulated, group B",69%,Not applicable,DNA_FFPE,11月4日,9376561024
PITAD_STH_DNS_B_02,9426021162_R02C01,University Hospital of Erlangen,Pituitary adenoma densely granulated GH/STH producing,not available,Central review Heidelberg,28,male,"supratentorial, sellar region; ",not available,PITAD_STH_DNS_B,"methylation class pituitary adenoma, STH densely granulated, group B",68%,Not applicable,DNA_FFPE,12月20日,9426021162
PITAD_STH_DNS_B_03,9379082039_R02C01,University Hospital of Heidelberg,Pituitary adenoma densely granulated GH/STH producing,not available,Central review Heidelberg,29,female,"supratentorial, sellar region; ",initial operation ,PITAD_STH_DNS_B,"methylation class pituitary adenoma, STH densely granulated, group B",66%,Not applicable,DNA_FFPE,9月19日,9379082039
PITAD_STH_DNS_B_04,3998998189_R02C01,University Hospital of Erlangen,Pituitary adenoma densely granulated GH/STH producing,not available,Central review Heidelberg,40,female,"supratentorial, sellar region; ",initial operation ,PITAD_STH_DNS_B,"methylation class pituitary adenoma, STH densely granulated, group B",67%,Not applicable,DNA_FFPE,6月19日,3998998189
PITAD_STH_DNS_B_05,9422493146_R01C02,University Hospital of Erlangen,Pituitary adenoma densely granulated GH/STH producing,not available,Central review Heidelberg,44,male,"supratentorial, sellar region; ",not available,PITAD_STH_DNS_B,"methylation class pituitary adenoma, STH densely granulated, group B",68%,Not applicable,DNA_FFPE,12月13日,9422493146
PITAD_STH_DNS_B_06,9422493146_R04C02,University Hospital of Erlangen,Pituitary adenoma densely granulated GH/STH producing,not available,Central review Heidelberg,47,male,"supratentorial, sellar region; ",not available,PITAD_STH_DNS_B,"methylation class pituitary adenoma, STH densely granulated, group B",64%,Not applicable,DNA_FFPE,12月13日,9422493146
PITAD_STH_DNS_B_07,9407210069_R01C02,University Hospital of Erlangen,Pituitary adenoma sparsely granulated GH/STH producing,not available,Central review Heidelberg,48,male,"supratentorial, sellar region; ",not available,PITAD_STH_DNS_B,"methylation class pituitary adenoma, STH densely granulated, group B",71%,Not applicable,DNA_FFPE,12月6日,9407210069
PITAD_STH_DNS_B_08,9422493146_R05C02,University Hospital of Erlangen,Pituitary adenoma densely granulated GH/STH producing,not available,Central review Heidelberg,49,male,"supratentorial, sellar region; ",not available,PITAD_STH_DNS_B,"methylation class pituitary adenoma, STH densely granulated, group B",66%,Not applicable,DNA_FFPE,12月13日,9422493146
PITAD_STH_DNS_B_09,3998998189_R06C01,University Hospital of Erlangen,Pituitary adenoma densely granulated GH/STH producing,not available,Central review Heidelberg,52,male,"supratentorial, sellar region; ",initial operation ,PITAD_STH_DNS_B,"methylation class pituitary adenoma, STH densely granulated, group B",70%,Not applicable,DNA_FFPE,6月19日,3998998189
PITAD_STH_DNS_B_10,9426021086_R01C01,University Hospital of Erlangen,Pituitary adenoma densely granulated GH/STH producing,not available,Central review Heidelberg,54,female,"supratentorial, sellar region; ",not available,PITAD_STH_DNS_B,"methylation class pituitary adenoma, STH densely granulated, group B",70%,Not applicable,DNA_FFPE,12月20日,9426021086
PITAD_STH_DNS_B_11,9422493146_R03C02,University Hospital of Erlangen,Pituitary adenoma densely granulated GH/STH producing,not available,Central review Heidelberg,62,female,"supratentorial, sellar region; ",not available,PITAD_STH_DNS_B,"methylation class pituitary adenoma, STH densely granulated, group B",67%,Not applicable,DNA_FFPE,12月13日,9422493146
PITAD_STH_DNS_B_12,3998998189_R03C01,University Hospital of Erlangen,Pituitary adenoma densely granulated GH/STH producing,not available,Central review Heidelberg,75,female,"supratentorial, sellar region; ",initial operation ,PITAD_STH_DNS_B,"methylation class pituitary adenoma, STH densely granulated, group B",70%,Not applicable,DNA_FFPE,6月19日,3998998189
PITAD_STH_SPA_01,9407210003_R05C02,University Hospital of Erlangen,Pituitary adenoma sparsely granulated GH/STH producing,not available,Central review Heidelberg,30,female,"supratentorial, sellar region; ",not available,PITAD_STH_SPA,"methylation class pituitary adenoma, STH sparsely granulated",61%,Not applicable,DNA_FFPE,12月6日,9407210003
PITAD_STH_SPA_02,3998909200_R06C01,University Hospital of Erlangen,Pituitary adenoma sparsely granulated GH/STH producing,not available,Central review Heidelberg,30,female,"supratentorial, sellar region; ",initial operation ,PITAD_STH_SPA,"methylation class pituitary adenoma, STH sparsely granulated",62%,Not applicable,DNA_FFPE,5月29日,3998909200
PITAD_STH_SPA_03,9407210069_R04C02,University Hospital of Erlangen,Pituitary adenoma sparsely granulated GH/STH producing,not available,Central review Heidelberg,31,male,"supratentorial, sellar region; ",not available,PITAD_STH_SPA,"methylation class pituitary adenoma, STH sparsely granulated",67%,Not applicable,DNA_FFPE,12月6日,9407210069
PITAD_STH_SPA_04,9426021162_R01C02,University Hospital of Erlangen,Pituitary adenoma sparsely granulated GH/STH producing,not available,Central review Heidelberg,32,female,"supratentorial, sellar region; ",not available,PITAD_STH_SPA,"methylation class pituitary adenoma, STH sparsely granulated",68%,Not applicable,DNA_FFPE,12月20日,9426021162
PITAD_STH_SPA_05,9426021162_R03C01,University Hospital of Erlangen,Pituitary adenoma sparsely granulated GH/STH producing,not available,Central review Heidelberg,33,male,"supratentorial, sellar region; ",not available,PITAD_STH_SPA,"methylation class pituitary adenoma, STH sparsely granulated",64%,Not applicable,DNA_FFPE,12月20日,9426021162
PITAD_STH_SPA_06,9407210069_R05C01,University Hospital of Erlangen,Pituitary adenoma sparsely granulated GH/STH producing,not available,Central review Heidelberg,34,male,"supratentorial, sellar region; ",not available,PITAD_STH_SPA,"methylation class pituitary adenoma, STH sparsely granulated",65%,Not applicable,DNA_FFPE,12月6日,9407210069
PITAD_STH_SPA_07,9407210003_R03C02,University Hospital of Erlangen,Pituitary adenoma sparsely granulated GH/STH producing,not available,Central review Heidelberg,35,female,"supratentorial, sellar region; ",not available,PITAD_STH_SPA,"methylation class pituitary adenoma, STH sparsely granulated",66%,Not applicable,DNA_FFPE,12月6日,9407210003
PITAD_STH_SPA_08,9407210069_R03C02,University Hospital of Erlangen,Pituitary adenoma sparsely granulated GH/STH producing,not available,Central review Heidelberg,38,male,"supratentorial, sellar region; ",not available,PITAD_STH_SPA,"methylation class pituitary adenoma, STH sparsely granulated",64%,Not applicable,DNA_FFPE,12月6日,9407210069
PITAD_STH_SPA_09,9407210069_R02C02,University Hospital of Erlangen,Pituitary adenoma sparsely granulated GH/STH producing,not available,Central review Heidelberg,48,female,"supratentorial, sellar region; ",not available,PITAD_STH_SPA,"methylation class pituitary adenoma, STH sparsely granulated",65%,Not applicable,DNA_FFPE,12月6日,9407210069
PITAD_STH_SPA_10,9407210069_R02C01,University Hospital of Erlangen,Pituitary adenoma sparsely granulated GH/STH producing,not available,Central review Heidelberg,49,male,"supratentorial, sellar region; ",not available,PITAD_STH_SPA,"methylation class pituitary adenoma, STH sparsely granulated",68%,Not applicable,DNA_FFPE,12月6日,9407210069
PITAD_STH_SPA_11,9407210069_R04C01,University Hospital of Erlangen,Pituitary adenoma sparsely granulated GH/STH producing,not available,Central review Heidelberg,50,female,"supratentorial, sellar region; ",not available,PITAD_STH_SPA,"methylation class pituitary adenoma, STH sparsely granulated",64%,Not applicable,DNA_FFPE,12月6日,9407210069
PITAD_STH_SPA_12,9407210003_R02C02,University Hospital of Erlangen,Pituitary adenoma sparsely granulated GH/STH producing,not available,Central review Heidelberg,51,female,"supratentorial, sellar region; ",not available,PITAD_STH_SPA,"methylation class pituitary adenoma, STH sparsely granulated",65%,Not applicable,DNA_FFPE,12月6日,9407210003
PITAD_STH_SPA_13,9407210069_R03C01,University Hospital of Erlangen,Pituitary adenoma sparsely granulated GH/STH producing,not available,Central review Heidelberg,51,male,"supratentorial, sellar region; ",not available,PITAD_STH_SPA,"methylation class pituitary adenoma, STH sparsely granulated",67%,Not applicable,DNA_FFPE,12月6日,9407210069
PITAD_STH_SPA_14,9407210003_R06C02,University Hospital of Erlangen,Pituitary adenoma sparsely granulated GH/STH producing,not available,Central review Heidelberg,53,female,"supratentorial, sellar region; ",not available,PITAD_STH_SPA,"methylation class pituitary adenoma, STH sparsely granulated",63%,Not applicable,DNA_FFPE,12月6日,9407210003
PITAD_STH_SPA_15,9407210069_R01C01,University Hospital of Erlangen,Pituitary adenoma sparsely granulated GH/STH producing,not available,Central review Heidelberg,54,female,"supratentorial, sellar region; ",not available,PITAD_STH_SPA,"methylation class pituitary adenoma, STH sparsely granulated",66%,Not applicable,DNA_FFPE,12月6日,9407210069
PITAD_STH_SPA_16,9407210069_R06C01,University Hospital of Erlangen,Pituitary adenoma sparsely granulated GH/STH producing,not available,Central review Heidelberg,66,female,"supratentorial, sellar region; ",not available,PITAD_STH_SPA,"methylation class pituitary adenoma, STH sparsely granulated",66%,Not applicable,DNA_FFPE,12月6日,9407210069
PITAD_STH_SPA_17,9407210003_R04C02,University Hospital of Erlangen,Pituitary adenoma sparsely granulated GH/STH producing,not available,Central review Heidelberg,71,male,"supratentorial, sellar region; ",not available,PITAD_STH_SPA,"methylation class pituitary adenoma, STH sparsely granulated",67%,Not applicable,DNA_FFPE,12月6日,9407210003
PITAD_TSH_01,3998523019_R05C02,University Hospital of Erlangen,Pituitary adenoma TSH producing,not available,Central review Heidelberg,23,female,"supratentorial, sellar region, suprasellar, intrasellar; ",initial operation ,PITAD_TSH,"methylation class pituitary adenoma, TSH",65%,Not applicable,DNA_FFPE,7月31日,3998523019
PITAD_TSH_02,3998523022_R01C01,University Hospital of Erlangen,Pituitary adenoma TSH producing,not available,Central review Heidelberg,30,female,"supratentorial, sellar region, suprasellar, intrasellar; ",initial operation ,PITAD_TSH,"methylation class pituitary adenoma, TSH",67%,Not applicable,DNA_FFPE,7月31日,3998523022
PITAD_TSH_03,3998523019_R04C02,University Hospital of Erlangen,Pituitary adenoma TSH producing,not available,Central review Heidelberg,32,male,"supratentorial, sellar region, suprasellar;  right;",recurrence ,PITAD_TSH,"methylation class pituitary adenoma, TSH",67%,Not applicable,DNA_FFPE,7月31日,3998523019
PITAD_TSH_04,3998523022_R01C02,University Hospital of Erlangen,Pituitary adenoma TSH producing,not available,Central review Heidelberg,37,female,"supratentorial, sellar region; ",initial operation ,PITAD_TSH,"methylation class pituitary adenoma, TSH",65%,Not applicable,DNA_FFPE,7月31日,3998523022
PITAD_TSH_05,3998523022_R03C01,University Hospital of Erlangen,Pituitary adenoma TSH producing,not available,Central review Heidelberg,43,female,"supratentorial, sellar region; ",initial operation ,PITAD_TSH,"methylation class pituitary adenoma, TSH",63%,Not applicable,DNA_FFPE,7月31日,3998523022
PITAD_TSH_06,3998523022_R04C01,University Hospital of Erlangen,Pituitary adenoma TSH producing,not available,Central review Heidelberg,43,male,"supratentorial, sellar region; ",initial operation ,PITAD_TSH,"methylation class pituitary adenoma, TSH",65%,Not applicable,DNA_FFPE,7月31日,3998523022
PITAD_TSH_07,3998523022_R05C01,University Hospital of Erlangen,Pituitary adenoma TSH producing,not available,Central review Heidelberg,45,male,"supratentorial, sellar region, intrasellar; ",initial operation ,PITAD_TSH,"methylation class pituitary adenoma, TSH",67%,Not applicable,DNA_FFPE,7月31日,3998523022
PITAD_TSH_08,3998523019_R06C02,University Hospital of Erlangen,Pituitary adenoma TSH producing,not available,Central review Heidelberg,51,female,"supratentorial, sellar region, suprasellar, intrasellar; ",initial operation ,PITAD_TSH,"methylation class pituitary adenoma, TSH",65%,Not applicable,DNA_FFPE,7月31日,3998523019
PITAD_TSH_09,3998523022_R02C01,University Hospital of Erlangen,Pituitary adenoma TSH producing,not available,Central review Heidelberg,69,female,"supratentorial, sellar region, intrasellar; ",initial operation ,PITAD_TSH,"methylation class pituitary adenoma, TSH",63%,Not applicable,DNA_FFPE,7月31日,3998523022
PITAD_TSH_10,3998523022_R06C01,University Hospital of Erlangen,Pituitary adenoma TSH producing,not available,Central review Heidelberg,69,male,"supratentorial, sellar region; ",initial operation ,PITAD_TSH,"methylation class pituitary adenoma, TSH",64%,Not applicable,DNA_FFPE,7月31日,3998523022
PITUI_01,3998920147_R03C01,University of Virginia,Granular cell tumour,I,Central review Heidelberg,27,female,supratentorial; ,initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,55%,Not applicable,DNA_FFPE,6月12日,3998920147
PITUI_02,3999834115_R01C02,"University of California, San Francisco ",Spindle cell oncocytoma,I,Central review Heidelberg,31,female,"supratentorial, sellar region, intrasellar; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,60%,Not applicable,DNA_FFPE,2月27日,3999834115
PITUI_03,3998909051_R02C02,University of Virginia,Granular cell tumour,I,Central review Heidelberg,34,male,"supratentorial, sellar region; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,58%,Not applicable,DNA_FFPE,5月8日,3998909051
PITUI_04,3998909182_R04C01,University Hospital of Frankfurt am Main,Spindle cell oncocytoma,I,Central review Heidelberg,35,female,"supratentorial, sellar region; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,50%,Not applicable,DNA_FFPE,5月29日,3998909182
PITUI_05,3998909051_R03C02,University of Virginia,Granular cell tumour,I,Central review Heidelberg,37,female,"supratentorial, sellar region; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,54%,Not applicable,DNA_FFPE,5月8日,3998909051
PITUI_06,3998920147_R01C01,University of Virginia,Granular cell tumour,I,Central review Heidelberg,38,female,supratentorial; ,not available,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,54%,Not applicable,DNA_FFPE,6月12日,3998920147
PITUI_07,9373550164_R02C02,University Hospital of Muenster,Granular cell tumour,I,Central review Heidelberg,40,male,"supratentorial, sellar region; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,50%,Not applicable,DNA_FFPE,8月21日,9373550164
PITUI_08,9420867087_R02C01,University Hospital of Erlangen,Granular cell tumour,I,Central review Heidelberg,43,male,"supratentorial, sellar region, suprasellar; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,58%,Not applicable,DNA_FFPE,1月17日,9420867087
PITUI_09,9969477057_R02C01,University Hospital of Frankfurt am Main,Spindle cell oncocytoma,I,Central review Heidelberg,43,female,"supratentorial, sellar region; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,62%,Not applicable,DNA_FFPE,8月4日,9969477057
PITUI_10,3999308203_R02C01,University of Virginia,Pituicytoma  ,I,Central review Heidelberg,47,male,"supratentorial, sellar region, suprasellar; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,53%,Not applicable,DNA_FFPE,4月6日,3999308203
PITUI_11,9420867053_R03C02,University Hospital of Tuebingen,Pituicytoma  ,I,Central review Heidelberg,48,male,"supratentorial, sellar region; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,61%,Not applicable,DNA_FFPE,1月14日,9420867053
PITUI_12,3999002043_R05C02,University Hospital of Heidelberg,Granular cell tumour,I,Central review Heidelberg,50,female,"supratentorial, sellar region, suprasellar; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,57%,Not applicable,DNA_FFPE,6月26日,3999002043
PITUI_13,3999308203_R03C01,University of Virginia,Pituicytoma  ,I,Central review Heidelberg,51,male,"supratentorial, sellar region, suprasellar; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,59%,Not applicable,DNA_FFPE,4月6日,3999308203
PITUI_14,9420867087_R01C01,University Hospital of Erlangen,Spindle cell oncocytoma,I,Central review Heidelberg,53,male,"supratentorial, sellar region, infundibulum; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,63%,Not applicable,DNA_FFPE,1月17日,9420867087
PITUI_15,9420867097_R03C01,University Hospital of Erlangen,Pituicytoma  ,I,Central review Heidelberg,54,male,"supratentorial, sellar region; ",not available,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,62%,Not applicable,DNA_FFPE,1月17日,9420867097
PITUI_16,9305651095_R04C01,University Hospital of Heidelberg,Pituicytoma  ,I,Central review Heidelberg,58,female,"supratentorial, sellar region, intrasellar; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,60%,Not applicable,DNA_FFPE,7月30日,9305651095
PITUI_17,3999308203_R04C01,University of Virginia,Spindle cell oncocytoma,I,Central review Heidelberg,61,male,"supratentorial, sellar region, suprasellar, intrasellar; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,65%,Not applicable,DNA_FFPE,4月6日,3999308203
PITUI_18,3999308203_R05C01,University of Virginia,Pituicytoma  ,I,Central review Heidelberg,61,male,"supratentorial, sellar region, suprasellar; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,60%,Not applicable,DNA_FFPE,4月6日,3999308203
PITUI_19,9373550164_R03C02,University Hospital of Muenster,Granular cell tumour,I,Central review Heidelberg,63,female,"supratentorial, sellar region; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,59%,Not applicable,DNA_FFPE,8月21日,9373550164
PITUI_20,3998920094_R03C01,University Hospital of Heidelberg,Pituicytoma  ,I,Central review Heidelberg,65,male,"supratentorial, intraventricular, ventricle III, sellar region, suprasellar; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,59%,Not applicable,DNA_FFPE,6月5日,3998920094
PITUI_21,3999112131_R06C02,University Hospital of Zurich,Pituicytoma  ,I,Central review Heidelberg,67,female,"supratentorial, sellar region; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,58%,Not applicable,DNA_FFPE,3月27日,3999112131
PITUI_22,9420867097_R02C01,University Hospital of Erlangen,Pituicytoma  ,I,Central review Heidelberg,68,male,"supratentorial, sellar region, suprasellar, intrasellar; mesenchyme, cranium, clivus; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,61%,Not applicable,DNA_FFPE,1月17日,9420867097
PITUI_23,3998920147_R05C01,University of Virginia,Spindle cell oncocytoma,I,Central review Heidelberg,69,male,supratentorial; ,initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,59%,Not applicable,DNA_FFPE,6月12日,3998920147
PITUI_24,9305651037_R01C02,University Hospital of Heidelberg,Pituicytoma  ,I,Central review Heidelberg,69,male,"supratentorial, sellar region, suprasellar; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,61%,Not applicable,DNA_FFPE,6月28日,9305651037
PITUI_25,3999834115_R02C02,"University of California, San Francisco ",Granular cell tumour,I,Central review Heidelberg,69,male,"supratentorial, sellar region, intrasellar; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,53%,Not applicable,DNA_FFPE,2月27日,3999834115
PITUI_26,3998920147_R06C01,University of Virginia,Granular cell tumour,I,Central review Heidelberg,71,female,supratentorial; ,initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,55%,Not applicable,DNA_FFPE,6月12日,3998920147
PITUI_27,3999834115_R06C01,"University of California, San Francisco ",Spindle cell oncocytoma,I,Central review Heidelberg,74,female,"supratentorial, sellar region, intrasellar; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,62%,Not applicable,DNA_FFPE,2月27日,3999834115
PITUI_28,9221197132_R01C02,University Hospital of Heidelberg,Pituicytoma  ,I,Central review Heidelberg,76,female,"supratentorial, sellar region, suprasellar; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,55%,Not applicable,DNA_FFPE,3月28日,9221197132
PITUI_29,3999112130_R04C01,University of Virginia,Spindle cell oncocytoma,I,Central review Heidelberg,77,male,"supratentorial, sellar region, suprasellar, intrasellar; ",initial operation ,PITUI,methylation class pituicytoma / granular cell tumor / spindle cell oncocytoma,48%,Not applicable,DNA_FFPE,3月27日,3999112130
PLASMA_01,9878820105_R03C01,University Hospital of Heidelberg,Plasmacytoma,not available,Central review Heidelberg,44,male,"mesenchyme, cranium; ",initial operation ,PLASMA,methylation class plasmacytoma,62%,Not applicable,DNA_FFPE,10月27日,9878820105
PLASMA_02,9420867121_R04C02,University Hospital of Heidelberg,Plasmacytoma,not available,Central review Heidelberg,53,female,"mesenchyme, cranium; ",not available,PLASMA,methylation class plasmacytoma,69%,Not applicable,DNA_FFPE,1月17日,9420867121
PLASMA_03,9969477123_R02C02,University Hospital of Heidelberg,Plasmacytoma,not available,Central review Heidelberg,53,female,"spinal, extradural, thoracic, T5;  left;",initial operation ,PLASMA,methylation class plasmacytoma,63%,Not applicable,DNA_FFPE,9月6日,9969477123
PLASMA_04,9878820021_R06C02,University Hospital of Heidelberg,Plasmacytoma,not available,Central review Heidelberg,56,female,posterior fossa; ,initial operation ,PLASMA,methylation class plasmacytoma,66%,Not applicable,DNA_FFPE,10月17日,9878820021
PLASMA_05,9878820105_R02C01,University Hospital of Heidelberg,Plasmacytoma,not available,Central review Heidelberg,66,male,"spinal, thoracic, T4, T5; ",not available,PLASMA,methylation class plasmacytoma,66%,Not applicable,DNA_FFPE,10月27日,9878820105
PLASMA_06,9855358026_R05C01,University Hospital of Heidelberg,Plasmacytoma,not available,Central review Heidelberg,69,male,"spinal, thoracic, T5; ",initial operation ,PLASMA,methylation class plasmacytoma,63%,Not applicable,DNA_FFPE,9月26日,9855358026
PLASMA_07,9741950027_R05C01,University Hospital of Heidelberg,Plasmacytoma,not available,Central review Heidelberg,72,male,"supratentorial, sellar region, suprasellar; ",initial operation ,PLASMA,methylation class plasmacytoma,67%,Not applicable,DNA_FFPE,3月28日,9741950027
PLASMA_08,9855358003_R05C01,University Hospital of Heidelberg,Plasmacytoma,not available,Central review Heidelberg,79,male,"spinal, thoracic, T4, T5, T6, T7; ",initial operation ,PLASMA,methylation class plasmacytoma,71%,Not applicable,DNA_FFPE,9月12日,9855358003
PLEX_AD_01,9704031008_R05C01,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Muenster,12,female,"posterior fossa, ventricle IV; ",not available,PLEX_AD,"methylation class plexus tumor, subclass adult",65%,Not applicable,DNA_FFPE,7月23日,9704031008
PLEX_AD_02,9704031014_R03C02,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Muenster,15,male,"posterior fossa, ventricle IV; ",not available,PLEX_AD,"methylation class plexus tumor, subclass adult",62%,Not applicable,DNA_FFPE,7月23日,9704031014
PLEX_AD_03,9376538153_R03C02,"Burdenko Neurosurgery Institute, Moscow",Atypical choroid plexus papilloma  ,II,Central review Heidelberg,20,male,"posterior fossa, ventricle IV; ",not available,PLEX_AD,"methylation class plexus tumor, subclass adult",62%,Not applicable,DNA_FFPE,10月25日,9376538153
PLEX_AD_04,9340996058_R02C02,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Heidelberg,22,female,"posterior fossa, cerebello-pontine angle; ",initial operation ,PLEX_AD,"methylation class plexus tumor, subclass adult",63%,Not applicable,DNA_FFPE,8月9日,9340996058
PLEX_AD_05,9741950023_R04C02,University Hospital of Tuebingen,Atypical choroid plexus papilloma  ,II,Central review Heidelberg,23,female,"posterior fossa, ventricle IV; ",initial operation ,PLEX_AD,"methylation class plexus tumor, subclass adult",68%,Not applicable,DNA_FFPE,3月24日,9741950023
PLEX_AD_06,9769100123_R01C02,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Muenster,26,male,"posterior fossa, ventricle IV; ",not available,PLEX_AD,"methylation class plexus tumor, subclass adult",60%,Not applicable,DNA_FFPE,7月23日,9769100123
PLEX_AD_07,9704031075_R01C01,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Muenster,31,female,"posterior fossa, ventricle IV; ",not available,PLEX_AD,"methylation class plexus tumor, subclass adult",63%,Not applicable,DNA_FFPE,7月23日,9704031075
PLEX_AD_08,9704031019_R05C01,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Muenster,34,male,"posterior fossa, ventricle IV; ",not available,PLEX_AD,"methylation class plexus tumor, subclass adult",63%,Not applicable,DNA_FFPE,7月23日,9704031019
PLEX_AD_09,9704031014_R01C01,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Muenster,35,female,"posterior fossa, ventricle IV; ",not available,PLEX_AD,"methylation class plexus tumor, subclass adult",64%,Not applicable,DNA_FFPE,7月23日,9704031014
PLEX_AD_10,9741950023_R02C01,University Hospital of Tuebingen,Choroid plexus papilloma,I,Central review Heidelberg,37,male,"posterior fossa, ventricle IV; ",initial operation ,PLEX_AD,"methylation class plexus tumor, subclass adult",68%,Not applicable,DNA_FFPE,3月24日,9741950023
PLEX_AD_11,9704031075_R02C01,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Muenster,38,female,"posterior fossa, ventricle IV; ",not available,PLEX_AD,"methylation class plexus tumor, subclass adult",67%,Not applicable,DNA_FFPE,7月23日,9704031075
PLEX_AD_12,9741950023_R05C02,University Hospital of Tuebingen,Atypical choroid plexus papilloma  ,II,Central review Heidelberg,38,female,"posterior fossa, ventricle IV; ",initial operation ,PLEX_AD,"methylation class plexus tumor, subclass adult",69%,Not applicable,DNA_FFPE,3月24日,9741950023
PLEX_AD_13,9296930016_R06C02,University Hospital of Heidelberg,Choroid plexus papilloma,I,Central review Heidelberg,44,male,"posterior fossa, ventricle IV; ",initial operation ,PLEX_AD,"methylation class plexus tumor, subclass adult",64%,Not applicable,DNA_FFPE,5月21日,9296930016
PLEX_AD_14,9406921070_R03C02,University Hospital of Heidelberg,Atypical choroid plexus papilloma  ,II,Central review Heidelberg,45,male,posterior fossa; ,not available,PLEX_AD,"methylation class plexus tumor, subclass adult",69%,Not applicable,DNA_FFPE,10月11日,9406921070
PLEX_AD_15,9741950023_R06C01,University Hospital of Tuebingen,Atypical choroid plexus papilloma  ,II,Central review Heidelberg,47,female,"supratentorial, intraventricular, ventricle III; posterior fossa, ventricle IV; ",recurrence ,PLEX_AD,"methylation class plexus tumor, subclass adult",69%,Not applicable,DNA_FFPE,3月24日,9741950023
PLEX_AD_16,9741950023_R01C02,University Hospital of Tuebingen,Atypical choroid plexus papilloma  ,II,Central review Heidelberg,51,male,"posterior fossa, ventricle IV; ",recurrence ,PLEX_AD,"methylation class plexus tumor, subclass adult",64%,Not applicable,DNA_FFPE,3月24日,9741950023
PLEX_AD_17,9340996058_R01C02,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Heidelberg,53,female,"posterior fossa, ventricle IV; ",initial operation ,PLEX_AD,"methylation class plexus tumor, subclass adult",67%,Not applicable,DNA_FFPE,8月9日,9340996058
PLEX_AD_18,9704031075_R01C02,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Muenster,54,male,"posterior fossa, ventricle IV; ",not available,PLEX_AD,"methylation class plexus tumor, subclass adult",63%,Not applicable,DNA_FFPE,7月23日,9704031075
PLEX_AD_19,9704031014_R05C02,University Hospital of Muenster,Atypical choroid plexus papilloma  ,II,Central review Muenster,59,female,"posterior fossa, cerebello-pontine angle; ",not available,PLEX_AD,"methylation class plexus tumor, subclass adult",63%,Not applicable,DNA_FFPE,7月23日,9704031014
PLEX_AD_20,9741950023_R02C02,University Hospital of Tuebingen,Atypical choroid plexus papilloma  ,II,Central review Heidelberg,70,male,"posterior fossa, ventricle IV; ",initial operation ,PLEX_AD,"methylation class plexus tumor, subclass adult",69%,Not applicable,DNA_FFPE,3月24日,9741950023
PLEX_AD_21,9340996008_R04C02,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Heidelberg,71,female,"posterior fossa, cerebello-pontine angle; ",initial operation ,PLEX_AD,"methylation class plexus tumor, subclass adult",60%,Not applicable,DNA_FFPE,8月6日,9340996008
PLEX_AD_22,9444375033_R01C01,"MD Anderson Cancer Center, Houston",Atypical choroid plexus papilloma  ,II,Central review Heidelberg,not available ,female,"supratentorial, intraventricular, ventricle III, sellar region, suprasellar; ",not available,PLEX_AD,"methylation class plexus tumor, subclass adult",57%,Not applicable,DNA_FFPE,1月31日,9444375033
PLEX_PED_A_01,9553932030_R01C01,University Hospital of Frankfurt am Main,Atypical choroid plexus papilloma  ,II,Central review Heidelberg,0,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_A,"methylation class plexus tumor, subclass paediatric A",71%,Not applicable,DNA_FFPE,2月21日,9553932030
PLEX_PED_A_02,9444374134_R05C02,University Hospital of Heidelberg,Atypical choroid plexus papilloma  ,II,Central review Heidelberg,0,female,"supratentorial, intraventricular, ventricle III; ",initial operation ,PLEX_PED_A,"methylation class plexus tumor, subclass paediatric A",64%,Not applicable,DNA_FFPE,1月27日,9444374134
PLEX_PED_A_03,9704031075_R03C01,University Hospital of Muenster,Atypical choroid plexus papilloma  ,II,Central review Muenster,0,female,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_A,"methylation class plexus tumor, subclass paediatric A",69%,Not applicable,DNA_FFPE,7月23日,9704031075
PLEX_PED_A_04,9704031014_R04C01,University Hospital of Muenster,Atypical choroid plexus papilloma  ,II,Central review Muenster,0,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_A,"methylation class plexus tumor, subclass paediatric A",66%,Not applicable,DNA_FFPE,7月23日,9704031014
PLEX_PED_A_05,9704031008_R06C01,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Muenster,0,male,"supratentorial, intraventricular, ventricle III; ",not available,PLEX_PED_A,"methylation class plexus tumor, subclass paediatric A",63%,Not applicable,DNA_FFPE,7月23日,9704031008
PLEX_PED_A_06,9704031075_R03C02,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Muenster,0,female,not available,not available,PLEX_PED_A,"methylation class plexus tumor, subclass paediatric A",59%,Not applicable,DNA_FFPE,7月23日,9704031075
PLEX_PED_A_07,9704031014_R06C02,University Hospital of Muenster,Atypical choroid plexus papilloma  ,II,Central review Muenster,0,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_A,"methylation class plexus tumor, subclass paediatric A",62%,Not applicable,DNA_FFPE,7月23日,9704031014
PLEX_PED_A_08,9704031078_R01C02,University Hospital of Muenster,Atypical choroid plexus papilloma  ,II,Central review Muenster,0,female,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_A,"methylation class plexus tumor, subclass paediatric A",66%,Not applicable,DNA_FFPE,7月23日,9704031078
PLEX_PED_A_09,9704031019_R01C02,University Hospital of Muenster,Atypical choroid plexus papilloma  ,II,Central review Muenster,1,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_A,"methylation class plexus tumor, subclass paediatric A",66%,Not applicable,DNA_FFPE,7月23日,9704031019
PLEX_PED_A_10,9704031019_R06C01,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Muenster,1,female,"posterior fossa, cerebello-pontine angle; ",not available,PLEX_PED_A,"methylation class plexus tumor, subclass paediatric A",68%,Not applicable,DNA_FFPE,7月23日,9704031019
PLEX_PED_A_11,9769100123_R02C01,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Muenster,2,male,"posterior fossa, cerebello-pontine angle; ",not available,PLEX_PED_A,"methylation class plexus tumor, subclass paediatric A",62%,Not applicable,DNA_KRYO,7月23日,9769100123
PLEX_PED_A_12,9704031014_R04C02,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Muenster,3,male,"supratentorial, intraventricular, ventricle III; ",not available,PLEX_PED_A,"methylation class plexus tumor, subclass paediatric A",65%,Not applicable,DNA_FFPE,7月23日,9704031014
PLEX_PED_A_13,9704031014_R02C01,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Muenster,4,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_A,"methylation class plexus tumor, subclass paediatric A",67%,Not applicable,DNA_FFPE,7月23日,9704031014
PLEX_PED_A_14,9340996003_R04C02,University Hospital of Heidelberg,Choroid plexus papilloma,I,Central review Heidelberg,8,male,"supratentorial, hemispheric, temporal;  right;",initial operation ,PLEX_PED_A,"methylation class plexus tumor, subclass paediatric A",66%,Not applicable,DNA_FFPE,8月6日,9340996003
PLEX_PED_A_15,9376538153_R02C02,"Burdenko Neurosurgery Institute, Moscow",Atypical choroid plexus papilloma  ,II,Central review Heidelberg,9,female,"posterior fossa, ventricle IV; ",not available,PLEX_PED_A,"methylation class plexus tumor, subclass paediatric A",63%,Not applicable,DNA_FFPE,10月25日,9376538153
PLEX_PED_B_01,9704031078_R02C02,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,0,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",64%,Not applicable,DNA_FFPE,7月23日,9704031078
PLEX_PED_B_02,9704031075_R06C01,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,0,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",62%,Not applicable,DNA_FFPE,7月23日,9704031075
PLEX_PED_B_03,9704031078_R03C01,University Hospital of Muenster,Atypical choroid plexus papilloma  ,II,Central review Muenster,0,female,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",65%,Not applicable,DNA_FFPE,7月23日,9704031078
PLEX_PED_B_04,9704031075_R05C01,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,0,female,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",62%,Not applicable,DNA_FFPE,7月23日,9704031075
PLEX_PED_B_05,9704031008_R02C02,University Hospital of Muenster,Atypical choroid plexus papilloma  ,II,Central review Muenster,0,female,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",62%,Not applicable,DNA_FFPE,7月23日,9704031008
PLEX_PED_B_06,9704031014_R03C01,University Hospital of Muenster,Atypical choroid plexus papilloma  ,II,Central review Muenster,0,male,not available,not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",63%,Not applicable,DNA_FFPE,7月23日,9704031014
PLEX_PED_B_07,9769100123_R06C02,University Hospital of Muenster,Atypical choroid plexus papilloma  ,II,Central review Muenster,0,female,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",62%,Not applicable,DNA_FFPE,7月23日,9769100123
PLEX_PED_B_08,9769100123_R03C01,University Hospital of Muenster,Atypical choroid plexus papilloma  ,II,Central review Muenster,0,female,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",58%,Not applicable,DNA_FFPE,7月23日,9769100123
PLEX_PED_B_09,9704031019_R02C02,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,0,female,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",67%,Not applicable,DNA_FFPE,7月23日,9704031019
PLEX_PED_B_10,9769100123_R05C02,University Hospital of Muenster,Atypical choroid plexus papilloma  ,II,Central review Muenster,0,male,not available,not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",63%,Not applicable,DNA_FFPE,7月23日,9769100123
PLEX_PED_B_11,9704031014_R01C02,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,0,male,not available,not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",65%,Not applicable,DNA_FFPE,7月23日,9704031014
PLEX_PED_B_12,9704031008_R01C02,University Hospital of Muenster,Atypical choroid plexus papilloma  ,II,Central review Muenster,0,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",65%,Not applicable,DNA_FFPE,7月23日,9704031008
PLEX_PED_B_13,9769100123_R06C01,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,0,female,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",64%,Not applicable,DNA_FFPE,7月23日,9769100123
PLEX_PED_B_14,9376561024_R02C02,University Hospital of Heidelberg,Choroid plexus carcinoma  ,III,Central review Heidelberg,1,male,"supratentorial, hemispheric; ",initial operation ,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",67%,Not applicable,DNA_FFPE,11月4日,9376561024
PLEX_PED_B_15,9704031019_R01C01,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,1,female,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",62%,Not applicable,DNA_FFPE,7月23日,9704031019
PLEX_PED_B_16,9704031078_R04C02,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,1,female,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",63%,Not applicable,DNA_FFPE,7月23日,9704031078
PLEX_PED_B_17,9704031008_R01C01,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,1,female,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",59%,Not applicable,DNA_FFPE,7月23日,9704031008
PLEX_PED_B_18,9704031008_R05C02,University Hospital of Muenster,Atypical choroid plexus papilloma  ,II,Central review Muenster,1,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",58%,Not applicable,DNA_FFPE,7月23日,9704031008
PLEX_PED_B_19,9704031008_R04C01,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,1,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",64%,Not applicable,DNA_FFPE,7月23日,9704031008
PLEX_PED_B_20,9704031014_R02C02,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Muenster,1,female,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",67%,Not applicable,DNA_FFPE,7月23日,9704031014
PLEX_PED_B_21,9704031078_R04C01,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,1,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",56%,Not applicable,DNA_FFPE,7月23日,9704031078
PLEX_PED_B_22,9769100123_R05C01,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,1,not available,not available,not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",61%,Not applicable,DNA_FFPE,7月23日,9769100123
PLEX_PED_B_23,9741950023_R03C02,University Hospital of Tuebingen,Atypical choroid plexus papilloma  ,II,Central review Heidelberg,1,female,"supratentorial, intraventricular, ventricle II; ",initial operation ,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",65%,Not applicable,DNA_FFPE,3月24日,9741950023
PLEX_PED_B_24,9376538153_R01C02,"Burdenko Neurosurgery Institute, Moscow",Choroid plexus carcinoma  ,III,Central review Heidelberg,2,male,"supratentorial, intraventricular, ventricle II; ",initial operation ,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",61%,Not applicable,DNA_FFPE,10月25日,9376538153
PLEX_PED_B_25,9704031019_R03C02,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,2,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",61%,Not applicable,DNA_FFPE,7月23日,9704031019
PLEX_PED_B_26,9704031078_R02C01,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,2,female,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",60%,Not applicable,DNA_FFPE,7月23日,9704031078
PLEX_PED_B_27,9704031014_R05C01,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,2,female,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",60%,Not applicable,DNA_FFPE,7月23日,9704031014
PLEX_PED_B_28,9376538153_R06C01,"Burdenko Neurosurgery Institute, Moscow",Choroid plexus carcinoma  ,III,Central review Heidelberg,4,male,"supratentorial, intraventricular, ventricle II; ",initial operation ,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",63%,Not applicable,DNA_FFPE,10月25日,9376538153
PLEX_PED_B_29,9704031019_R03C01,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,4,female,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",69%,Not applicable,DNA_FFPE,7月23日,9704031019
PLEX_PED_B_30,9704031008_R03C01,University Hospital of Muenster,Atypical choroid plexus papilloma  ,II,Central review Muenster,5,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",59%,Not applicable,DNA_FFPE,7月23日,9704031008
PLEX_PED_B_31,9704031019_R02C01,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,5,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",60%,Not applicable,DNA_FFPE,7月23日,9704031019
PLEX_PED_B_32,9704031019_R04C02,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,5,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",63%,Not applicable,DNA_FFPE,7月23日,9704031019
PLEX_PED_B_33,9704031008_R03C02,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,6,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",65%,Not applicable,DNA_FFPE,7月23日,9704031008
PLEX_PED_B_34,9704031008_R04C02,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,6,female,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",62%,Not applicable,DNA_FFPE,7月23日,9704031008
PLEX_PED_B_35,9769100123_R04C01,University Hospital of Muenster,Atypical choroid plexus papilloma  ,II,Central review Muenster,6,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",62%,Not applicable,DNA_FFPE,7月23日,9769100123
PLEX_PED_B_36,9704031075_R05C02,University Hospital of Muenster,Atypical choroid plexus papilloma  ,II,Central review Muenster,7,female,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",65%,Not applicable,DNA_FFPE,7月23日,9704031075
PLEX_PED_B_37,9704031019_R04C01,University Hospital of Muenster,Atypical choroid plexus papilloma  ,II,Central review Muenster,7,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",64%,Not applicable,DNA_FFPE,7月23日,9704031019
PLEX_PED_B_38,9704031075_R04C02,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Muenster,10,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",58%,Not applicable,DNA_FFPE,7月23日,9704031075
PLEX_PED_B_39,9704031075_R06C02,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,11,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",71%,Not applicable,DNA_FFPE,7月23日,9704031075
PLEX_PED_B_40,9704031078_R05C01,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Muenster,12,female,"posterior fossa, ventricle IV; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",59%,Not applicable,DNA_FFPE,7月23日,9704031078
PLEX_PED_B_41,9704031078_R06C01,University Hospital of Muenster,Choroid plexus papilloma,I,Central review Muenster,14,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",58%,Not applicable,DNA_FFPE,7月23日,9704031078
PLEX_PED_B_42,9704031078_R05C02,University Hospital of Muenster,Atypical choroid plexus papilloma  ,II,Central review Muenster,14,male,not available,not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",69%,Not applicable,DNA_FFPE,7月23日,9704031078
PLEX_PED_B_43,9704031008_R02C01,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,16,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",59%,Not applicable,DNA_FFPE,7月23日,9704031008
PLEX_PED_B_44,9704031075_R02C02,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,30,male,"supratentorial, intraventricular, ventricle II; ",not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",66%,Not applicable,DNA_FFPE,7月23日,9704031075
PLEX_PED_B_45,9704031078_R01C01,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,not available ,female,not available,not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",67%,Not applicable,DNA_FFPE,7月23日,9704031078
PLEX_PED_B_46,9704031075_R04C01,University Hospital of Muenster,Choroid plexus carcinoma  ,III,Central review Muenster,not available ,male,not available,not available,PLEX_PED_B,"methylation class plexus tumor, subclass paediatric B",63%,Not applicable,DNA_FFPE,7月23日,9704031075
PTPR_A_01,9305651046_R05C01,University Hospital of Muenster,Papillary tumour of the pineal region  ,II or III,Local review,10,female,"supratentorial, diencephalic, pineal region; ",not available,PTPR_A,methylation class papillary tumor of the pineal region group A,61%,Not applicable,DNA_FFPE,7月12日,9305651046
PTPR_A_02,3998909063_R03C02,University Hospital of Heidelberg,Papillary tumour of the pineal region  ,II or III,Central review Heidelberg,14,female,"supratentorial, diencephalic, pineal region; ",initial operation ,PTPR_A,methylation class papillary tumor of the pineal region group A,64%,Not applicable,DNA_FFPE,5月8日,3998909063
PTPR_A_03,9829119072_R05C02,University Hospital of Heidelberg,Papillary tumour of the pineal region  ,II or III,Central review Heidelberg,29,female,"supratentorial, diencephalic, pineal region; ",not available,PTPR_A,methylation class papillary tumor of the pineal region group A,66%,Not applicable,DNA_FFPE,5月23日,9829119072
PTPR_A_04,9305651046_R03C01,University Hospital of Muenster,Papillary tumour of the pineal region  ,II or III,Local review,35,male,"supratentorial, diencephalic, pineal region; ",not available,PTPR_A,methylation class papillary tumor of the pineal region group A,63%,Not applicable,DNA_FFPE,7月12日,9305651046
PTPR_A_05,9305651046_R04C02,University Hospital of Muenster,Papillary tumour of the pineal region  ,II or III,Local review,36,female,"supratentorial, diencephalic, pineal region; ",not available,PTPR_A,methylation class papillary tumor of the pineal region group A,68%,Not applicable,DNA_FFPE,7月12日,9305651046
PTPR_A_06,9305651050_R02C01,University Hospital of Muenster,Papillary tumour of the pineal region  ,II or III,Local review,46,female,"supratentorial, diencephalic, pineal region; ",not available,PTPR_A,methylation class papillary tumor of the pineal region group A,59%,Not applicable,DNA_FFPE,7月12日,9305651050
PTPR_A_07,9420867051_R03C02,University Hospital of Heidelberg,Papillary tumour of the pineal region  ,II or III,Central review Heidelberg,48,female,"supratentorial, diencephalic, pineal region; ",initial operation ,PTPR_A,methylation class papillary tumor of the pineal region group A,63%,Not applicable,DNA_FFPE,1月14日,9420867051
PTPR_A_08,9305651050_R05C01,University Hospital of Muenster,Papillary tumour of the pineal region  ,II or III,Local review,63,male,"supratentorial, diencephalic, pineal region; ",not available,PTPR_A,methylation class papillary tumor of the pineal region group A,63%,Not applicable,DNA_FFPE,7月12日,9305651050
PTPR_B_01,6929806038_R05C02,"Burdenko Neurosurgery Institute, Moscow",Papillary tumour of the pineal region  ,II or III,Central review Heidelberg,5,male,"supratentorial, diencephalic, pineal region; ",not available,PTPR_B,methylation class papillary tumor of the pineal region group B,63%,Not applicable,DNA_KRYO,7月2日,6929806038
PTPR_B_02,9969477061_R01C02,"Burdenko Neurosurgery Institute, Moscow",Papillary tumour of the pineal region  ,II or III,Central review Heidelberg,8,male,"supratentorial, diencephalic, pineal region; ",initial operation ,PTPR_B,methylation class papillary tumor of the pineal region group B,68%,Not applicable,DNA_FFPE,8月4日,9969477061
PTPR_B_03,9969477063_R06C01,"Burdenko Neurosurgery Institute, Moscow",Papillary tumour of the pineal region  ,II or III,Central review Heidelberg,10,male,"supratentorial, diencephalic, pineal region; ",initial operation ,PTPR_B,methylation class papillary tumor of the pineal region group B,67%,Not applicable,DNA_FFPE,8月4日,9969477063
PTPR_B_04,9969477063_R02C01,"Burdenko Neurosurgery Institute, Moscow",Papillary tumour of the pineal region  ,II or III,Central review Heidelberg,11,male,"supratentorial, diencephalic, pineal region; posterior fossa; ",initial operation ,PTPR_B,methylation class papillary tumor of the pineal region group B,64%,Not applicable,DNA_FFPE,8月4日,9969477063
PTPR_B_05,6929689149_R01C02,"Burdenko Neurosurgery Institute, Moscow",Papillary tumour of the pineal region  ,II or III,Central review Heidelberg,12,female,"supratentorial, diencephalic, pineal region; ",not available,PTPR_B,methylation class papillary tumor of the pineal region group B,66%,Not applicable,DNA_KRYO,12月23日,6929689149
PTPR_B_06,9340996008_R04C01,University Hospital of Muenster,Papillary tumour of the pineal region  ,II or III,Local review,12,female,"supratentorial, diencephalic, pineal region; ",not available,PTPR_B,methylation class papillary tumor of the pineal region group B,64%,Not applicable,DNA_FFPE,8月6日,9340996008
PTPR_B_07,9741950023_R06C02,University Hospital of Muenster,Papillary tumour of the pineal region  ,II or III,Local review,15,female,"supratentorial, diencephalic, pineal region; ",initial operation ,PTPR_B,methylation class papillary tumor of the pineal region group B,66%,Not applicable,DNA_FFPE,3月24日,9741950023
PTPR_B_08,9305651046_R04C01,University Hospital of Muenster,Papillary tumour of the pineal region  ,II or III,Local review,18,female,"supratentorial, diencephalic, pineal region; ",not available,PTPR_B,methylation class papillary tumor of the pineal region group B,60%,Not applicable,DNA_FFPE,7月12日,9305651046
PTPR_B_09,3999834062_R06C01,University College London Hospitals,Papillary tumour of the pineal region  ,II or III,Central review Heidelberg,19,female,"supratentorial, diencephalic, pineal region; ",not available,PTPR_B,methylation class papillary tumor of the pineal region group B,65%,Not applicable,DNA_FFPE,2月13日,3999834062
PTPR_B_10,9305651050_R03C01,University Hospital of Muenster,Papillary tumour of the pineal region  ,II or III,Local review,19,female,"supratentorial, diencephalic, pineal region; ",not available,PTPR_B,methylation class papillary tumor of the pineal region group B,69%,Not applicable,DNA_FFPE,7月12日,9305651050
PTPR_B_11,9969477111_R01C01,University Hospital of Freiburg ,Papillary tumour of the pineal region  ,II or III,Central review Heidelberg,20,male,"supratentorial, diencephalic, pineal region; ",initial operation ,PTPR_B,methylation class papillary tumor of the pineal region group B,73%,Not applicable,DNA_KRYO,9月4日,9969477111
PTPR_B_12,9305651046_R06C02,University Hospital of Muenster,Papillary tumour of the pineal region  ,II or III,Local review,28,female,"supratentorial, diencephalic, pineal region; ",not available,PTPR_B,methylation class papillary tumor of the pineal region group B,61%,Not applicable,DNA_FFPE,7月12日,9305651046
PTPR_B_13,9305651050_R02C02,University Hospital of Muenster,Papillary tumour of the pineal region  ,II or III,Local review,36,female,"supratentorial, diencephalic, pineal region; ",not available,PTPR_B,methylation class papillary tumor of the pineal region group B,65%,Not applicable,DNA_FFPE,7月12日,9305651050
PTPR_B_14,9305651050_R06C01,University Hospital of Muenster,Papillary tumour of the pineal region  ,II or III,Local review,36,female,"supratentorial, diencephalic, pineal region; ",not available,PTPR_B,methylation class papillary tumor of the pineal region group B,68%,Not applicable,DNA_FFPE,7月12日,9305651050
PTPR_B_15,9007225003_R04C01,University Hospital of Heidelberg,Papillary tumour of the pineal region  ,II or III,Central review Heidelberg,37,male,"supratentorial, diencephalic, pineal region; ",not available,PTPR_B,methylation class papillary tumor of the pineal region group B,60%,Not applicable,DNA_FFPE,2月20日,9007225003
PTPR_B_16,9444375114_R03C01,"MD Anderson Cancer Center, Houston",Papillary tumour of the pineal region  ,II or III,Central review Heidelberg,39,male,"supratentorial, intraventricular, ventricle III; ",not available,PTPR_B,methylation class papillary tumor of the pineal region group B,68%,Not applicable,DNA_FFPE,2月10日,9444375114
PTPR_B_17,9305651046_R02C02,University Hospital of Muenster,Papillary tumour of the pineal region  ,II or III,Local review,44,male,"supratentorial, diencephalic, pineal region; ",not available,PTPR_B,methylation class papillary tumor of the pineal region group B,62%,Not applicable,DNA_FFPE,7月12日,9305651046
PTPR_B_18,9305651046_R06C01,University Hospital of Muenster,Papillary tumour of the pineal region  ,II or III,Local review,45,female,"supratentorial, diencephalic, pineal region; ",not available,PTPR_B,methylation class papillary tumor of the pineal region group B,68%,Not applicable,DNA_FFPE,7月12日,9305651046
PTPR_B_19,9305651050_R01C02,University Hospital of Muenster,Papillary tumour of the pineal region  ,II or III,Local review,46,male,not available,not available,PTPR_B,methylation class papillary tumor of the pineal region group B,63%,Not applicable,DNA_FFPE,7月12日,9305651050
PTPR_B_20,9305651046_R03C02,University Hospital of Muenster,Papillary tumour of the pineal region  ,II or III,Local review,52,male,"supratentorial, diencephalic, pineal region; ",not available,PTPR_B,methylation class papillary tumor of the pineal region group B,68%,Not applicable,DNA_FFPE,7月12日,9305651046
PTPR_B_21,3999834062_R05C01,University College London Hospitals,Papillary tumour of the pineal region  ,II or III,Central review Heidelberg,56,male,"supratentorial, diencephalic, pineal region; ",not available,PTPR_B,methylation class papillary tumor of the pineal region group B,68%,Not applicable,DNA_FFPE,2月13日,3999834062
PTPR_B_22,9305651050_R01C01,University Hospital of Muenster,Papillary tumour of the pineal region  ,II or III,Local review,not available ,female,not available,not available,PTPR_B,methylation class papillary tumor of the pineal region group B,70%,Not applicable,DNA_FFPE,7月12日,9305651050
PXA_01,3999834003_R01C01,University Hospital of Heidelberg,Pleomorphic xanthoastrocytoma  ,II,Central review Heidelberg,7,male,"supratentorial, hemispheric, temporal;  left;",initial operation ,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,69%,Not applicable,DNA_FFPE,2月6日,3999834003
PXA_02,3999834003_R02C01,University Hospital of Heidelberg,Pleomorphic xanthoastrocytoma  ,II,Central review Heidelberg,7,male,"supratentorial, hemispheric, temporal;  right;",initial operation ,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,72%,Not applicable,DNA_FFPE,2月6日,3999834003
PXA_03,8963311099_R05C01,University Hospital of Heidelberg,Anaplastic pleomorphic xanthoastrocytoma  ,III,Central review Heidelberg,8,female,not available,not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,64%,Not applicable,DNA_FFPE,1月28日,8963311099
PXA_04,9721365197_R03C02,"MD Anderson Cancer Center, Houston",Pleomorphic xanthoastrocytoma  ,II,Central review Heidelberg,11,not available,"supratentorial, hemispheric, temporal, parietal;  right;",not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,61%,Not applicable,DNA_FFPE,4月14日,9721365197
PXA_05,8963311099_R02C02,University Hospital of Vienna,Pleomorphic xanthoastrocytoma  ,II,Central review Heidelberg,11,female,"supratentorial, hemispheric, parietal;  right;",not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,57%,Not applicable,DNA_FFPE,1月28日,8963311099
PXA_06,9420867087_R04C01,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,12,female,"supratentorial, hemispheric, temporal;  right;",not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,67%,Not applicable,DNA_FFPE,1月17日,9420867087
PXA_07,9553932123_R01C02,University Hospital of Frankfurt am Main,"Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,12,female,"supratentorial, hemispheric, temporal;  left;",not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,49%,Not applicable,DNA_FFPE,2月28日,9553932123
PXA_08,9533774018_R04C02,University Hospital of Heidelberg,Anaplastic pleomorphic xanthoastrocytoma  ,III,Central review Heidelberg,12,female,"supratentorial, hemispheric, frontal; mesenchyme, cranium;  right;",initial operation ,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,67%,Not applicable,DNA_FFPE,5月30日,9533774018
PXA_09,9741950100_R05C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,12,male,"supratentorial, hemispheric, frontal; ",not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,63%,Not applicable,DNA_FFPE,4月7日,9741950100
PXA_10,9878820021_R03C02,University Hospital of Heidelberg,Pleomorphic xanthoastrocytoma  ,II,Central review Heidelberg,16,female,supratentorial; ,recurrence ,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,55%,Not applicable,DNA_FFPE,10月17日,9878820021
PXA_11,9721366135_R06C01,"MD Anderson Cancer Center, Houston",Anaplastic pleomorphic xanthoastrocytoma  ,III,Central review Heidelberg,16,female,"supratentorial, hemispheric, parietal;  right;",not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,56%,Not applicable,DNA_FFPE,5月9日,9721366135
PXA_12,8963311099_R02C01,University Hospital of Muenster,Pleomorphic xanthoastrocytoma  ,II,Local review,17,female,"supratentorial, hemispheric, temporal, parietal;  left;",not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,58%,Not applicable,DNA_FFPE,1月28日,8963311099
PXA_13,9305651095_R01C02,University Hospital of Tuebingen,Pleomorphic xanthoastrocytoma  ,II,Central review Heidelberg,17,female,"supratentorial, hemispheric, frontal, parietal;  left;",not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,62%,Not applicable,DNA_FFPE,7月30日,9305651095
PXA_14,8963311099_R06C01,University Hospital of Heidelberg,Pleomorphic xanthoastrocytoma  ,II,Central review Heidelberg,19,female,"supratentorial, hemispheric, frontal;  left;",not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,66%,Not applicable,DNA_FFPE,1月28日,8963311099
PXA_15,9721365197_R06C02,"MD Anderson Cancer Center, Houston",Pleomorphic xanthoastrocytoma  ,II,Central review Heidelberg,19,female,"supratentorial, hemispheric, occipital;  left;",not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,48%,Not applicable,DNA_FFPE,4月14日,9721365197
PXA_16,9721366135_R01C02,"MD Anderson Cancer Center, Houston",Pleomorphic xanthoastrocytoma  ,II,Central review Heidelberg,19,female,"supratentorial, hemispheric, temporal;  left;",not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,63%,Not applicable,DNA_FFPE,5月9日,9721366135
PXA_17,9721365197_R04C02,"MD Anderson Cancer Center, Houston",Pleomorphic xanthoastrocytoma  ,II,Central review Heidelberg,20,male,"supratentorial, hemispheric, frontal;  left;",not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,63%,Not applicable,DNA_FFPE,4月14日,9721365197
PXA_18,8963311099_R04C01,University Hospital of Muenster,Pleomorphic xanthoastrocytoma  ,II,Local review,21,male,"supratentorial, hemispheric, temporal; posterior fossa, cerebello-pontine angle;  left;",not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,49%,Not applicable,DNA_FFPE,1月28日,8963311099
PXA_19,9422492035_R03C01,Amsterdam Academic Medical Center,Anaplastic ganglioglioma  ,III,Local review,23,female,"supratentorial, hemispheric, temporal; ",not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,66%,Not applicable,DNA_FFPE,12月6日,9422492035
PXA_20,9969477065_R02C01,University Hospital of Frankfurt am Main,Anaplastic pleomorphic xanthoastrocytoma  ,III,Central review Heidelberg,24,male,"supratentorial, hemispheric, temporal;  right;",initial operation ,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,63%,Not applicable,DNA_FFPE,8月8日,9969477065
PXA_21,9533774023_R05C02,"MD Anderson Cancer Center, Houston",Pleomorphic xanthoastrocytoma  ,II,Central review Heidelberg,24,female,"supratentorial, hemispheric, temporal;  left;",not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,57%,Not applicable,DNA_FFPE,5月30日,9533774023
PXA_22,9968646167_R04C02,University Hospital of Heidelberg,Anaplastic pleomorphic xanthoastrocytoma  ,III,Central review Heidelberg,25,female,not available,initial operation ,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,67%,Not applicable,DNA_FFPE,7月11日,9968646167
PXA_23,9553932010_R05C01,"MD Anderson Cancer Center, Houston",Anaplastic ganglioglioma  ,III,Central review Heidelberg,25,female,"supratentorial, hemispheric, temporal;  left;",not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,66%,Not applicable,DNA_FFPE,2月14日,9553932010
PXA_24,9969477089_R05C02,"Ludwig-Maximilians University Hospital, Munich ",Anaplastic pleomorphic xanthoastrocytoma  ,III,Central review Heidelberg,25,female,not available,not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,56%,Not applicable,DNA_FFPE,8月22日,9969477089
PXA_25,9878820127_R02C02,University Hospital of Magdeburg,Anaplastic pleomorphic xanthoastrocytoma  ,III,Central review Heidelberg,26,male,meningeal unspecified; ,not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,59%,Not applicable,DNA_FFPE,10月31日,9878820127
PXA_26,8963311099_R01C02,University Hospital of Vienna,Pleomorphic xanthoastrocytoma  ,II,Central review Heidelberg,36,male,"supratentorial, hemispheric, temporal;  left;",not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,59%,Not applicable,DNA_FFPE,1月28日,8963311099
PXA_27,8963311099_R01C01,University Hospital of Heidelberg,Anaplastic pleomorphic xanthoastrocytoma  ,III,Central review Heidelberg,39,male,"supratentorial, hemispheric, temporal;  left;",initial operation ,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,64%,Not applicable,DNA_FFPE,1月28日,8963311099
PXA_28,9969477080_R06C01,University Hospital of Heidelberg,Anaplastic pleomorphic xanthoastrocytoma  ,III,Central review Heidelberg,40,male,"supratentorial, hemispheric, frontal, temporal;  right;",initial operation ,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,63%,Not applicable,DNA_FFPE,8月15日,9969477080
PXA_29,9969477102_R01C01,University Hospital of Frankfurt am Main,Pleomorphic xanthoastrocytoma  ,II,Central review Heidelberg,42,female,"supratentorial, hemispheric, temporal;  right;",initial operation ,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,59%,Not applicable,DNA_FFPE,8月22日,9969477102
PXA_30,9969477080_R01C02,University Hospital of Frankfurt am Main,Anaplastic pleomorphic xanthoastrocytoma  ,III,Central review Heidelberg,51,male,"supratentorial, hemispheric, parietal; ",not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,58%,Not applicable,DNA_FFPE,8月15日,9969477080
PXA_31,3999112147_R06C02,University Hospital of Bonn,Pleomorphic xanthoastrocytoma  ,II,Central review Bonn ,not available ,male,not available,not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,63%,Not applicable,DNA_FFPE,4月6日,3999112147
PXA_32,3999112155_R01C01,University Hospital of Bonn,Pleomorphic xanthoastrocytoma  ,II,Central review Bonn ,not available ,male,not available,not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,57%,Not applicable,DNA_FFPE,4月6日,3999112155
PXA_33,3999112155_R04C01,University Hospital of Bonn,Pleomorphic xanthoastrocytoma  ,II,Central review Bonn ,not available ,not available,not available,not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,67%,Not applicable,DNA_FFPE,4月6日,3999112155
PXA_34,3999112155_R05C01,University Hospital of Bonn,Pleomorphic xanthoastrocytoma  ,II,Central review Bonn ,not available ,female,not available,not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,62%,Not applicable,DNA_FFPE,4月6日,3999112155
PXA_35,3999112155_R06C01,University Hospital of Bonn,Pleomorphic xanthoastrocytoma  ,II,Central review Bonn ,not available ,male,not available,not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,59%,Not applicable,DNA_FFPE,4月6日,3999112155
PXA_36,3999112155_R02C02,University Hospital of Bonn,Pleomorphic xanthoastrocytoma  ,II,Central review Bonn ,not available ,female,not available,not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,63%,Not applicable,DNA_FFPE,4月6日,3999112155
PXA_37,3999112155_R03C02,University Hospital of Bonn,Pleomorphic xanthoastrocytoma  ,II,Central review Bonn ,not available ,male,not available,not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,66%,Not applicable,DNA_FFPE,4月6日,3999112155
PXA_38,9340996032_R02C01,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,66%,Not applicable,DNA_FFPE,8月9日,9340996032
PXA_39,9444375004_R06C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,61%,Not applicable,DNA_FFPE,1月31日,9444375004
PXA_40,9444375014_R05C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,50%,Not applicable,DNA_FFPE,1月31日,9444375014
PXA_41,9444375017_R03C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,51%,Not applicable,DNA_FFPE,1月31日,9444375017
PXA_42,9444375017_R04C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,female,not available,not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,64%,Not applicable,DNA_FFPE,1月31日,9444375017
PXA_43,9305651054_R03C02,"Burdenko Neurosurgery Institute, Moscow","Glioblastoma, IDH-wildtype ",IV,Central review Heidelberg,not available ,male,not available,not available,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,63%,Not applicable,DNA_KRYO,7月19日,9305651054
PXA_44,3999834067_R06C02,University Hospital of Odense,Pleomorphic xanthoastrocytoma  ,II,Central review Heidelberg,not available ,female,not available,initial operation ,PXA,methylation class (anaplastic) pleomorphic xanthoastrocytoma,61%,Not applicable,DNA_FFPE,2月13日,3999834067
RETB_01,9878827214_R06C01,University Hospital of Essen,Retinoblastoma,not available,Local review,0,female,"mesenchyme, cranium, intraocular; ",not available,RETB,methylation class retinoblastoma,54%,Not applicable,DNA_KRYO,11月21日,9878827214
RETB_02,9878827214_R02C02,University Hospital of Essen,Retinoblastoma,not available,Local review,0,female,"mesenchyme, cranium, intraocular; ",not available,RETB,methylation class retinoblastoma,57%,Not applicable,DNA_KRYO,11月21日,9878827214
RETB_03,9878827214_R04C02,University Hospital of Essen,Retinoblastoma,not available,Local review,0,male,"mesenchyme, cranium, intraocular; ",not available,RETB,methylation class retinoblastoma,59%,Not applicable,DNA_KRYO,11月21日,9878827214
RETB_04,10006823005_R01C01,University Hospital of Essen,Retinoblastoma,not available,Local review,0,female,"mesenchyme, cranium, intraocular; ",not available,RETB,methylation class retinoblastoma,60%,Not applicable,DNA_KRYO,12月5日,10006823005
RETB_05,10006823005_R02C01,University Hospital of Essen,Retinoblastoma,not available,Local review,0,male,"mesenchyme, cranium, intraocular; ",not available,RETB,methylation class retinoblastoma,57%,Not applicable,DNA_KRYO,12月5日,10006823005
RETB_06,10006823005_R05C01,University Hospital of Essen,Retinoblastoma,not available,Local review,0,male,"mesenchyme, cranium, intraocular; ",not available,RETB,methylation class retinoblastoma,56%,Not applicable,DNA_KRYO,12月5日,10006823005
RETB_07,9980102125_R01C02,University Hospital of Essen,Retinoblastoma,not available,Local review,0,female,"mesenchyme, cranium, intraocular; ",not available,RETB,methylation class retinoblastoma,51%,Not applicable,DNA_KRYO,11月14日,9980102125
RETB_08,9878827214_R03C02,University Hospital of Essen,Retinoblastoma,not available,Local review,1,male,"mesenchyme, cranium, intraocular; ",not available,RETB,methylation class retinoblastoma,60%,Not applicable,DNA_KRYO,11月21日,9878827214
RETB_09,9878827214_R05C02,University Hospital of Essen,Retinoblastoma,not available,Local review,1,female,"mesenchyme, cranium, intraocular; ",not available,RETB,methylation class retinoblastoma,61%,Not applicable,DNA_KRYO,11月21日,9878827214
RETB_10,9878827214_R06C02,University Hospital of Essen,Retinoblastoma,not available,Local review,1,female,"mesenchyme, cranium, intraocular; ",not available,RETB,methylation class retinoblastoma,49%,Not applicable,DNA_KRYO,11月21日,9878827214
RETB_11,10006823005_R03C01,University Hospital of Essen,Retinoblastoma,not available,Local review,1,female,"mesenchyme, cranium, intraocular; ",not available,RETB,methylation class retinoblastoma,60%,Not applicable,DNA_KRYO,12月5日,10006823005
RETB_12,10006823005_R04C01,University Hospital of Essen,Retinoblastoma,not available,Local review,1,female,"mesenchyme, cranium, intraocular; ",not available,RETB,methylation class retinoblastoma,62%,Not applicable,DNA_KRYO,12月5日,10006823005
RETB_13,9980102125_R02C02,University Hospital of Essen,Retinoblastoma,not available,Local review,1,female,"mesenchyme, cranium, intraocular; ",not available,RETB,methylation class retinoblastoma,60%,Not applicable,DNA_KRYO,11月14日,9980102125
RETB_14,9980102125_R03C02,University Hospital of Essen,Retinoblastoma,not available,Local review,1,male,"mesenchyme, cranium, intraocular; ",not available,RETB,methylation class retinoblastoma,59%,Not applicable,DNA_KRYO,11月14日,9980102125
RETB_15,9878827214_R02C01,University Hospital of Essen,Retinoblastoma,not available,Local review,1,male,"mesenchyme, cranium, intraocular; ",not available,RETB,methylation class retinoblastoma,58%,Not applicable,DNA_KRYO,11月21日,9878827214
RETB_16,9878827214_R03C01,University Hospital of Essen,Retinoblastoma,not available,Local review,1,female,"mesenchyme, cranium, intraocular; ",not available,RETB,methylation class retinoblastoma,55%,Not applicable,DNA_KRYO,11月21日,9878827214
RETB_17,9878827214_R05C01,University Hospital of Essen,Retinoblastoma,not available,Local review,2,female,"mesenchyme, cranium, intraocular; ",not available,RETB,methylation class retinoblastoma,58%,Not applicable,DNA_KRYO,11月21日,9878827214
RETB_18,9878827214_R01C02,University Hospital of Essen,Retinoblastoma,not available,Local review,2,female,"mesenchyme, cranium, intraocular; ",not available,RETB,methylation class retinoblastoma,65%,Not applicable,DNA_KRYO,11月21日,9878827214
RETB_19,9878827214_R04C01,University Hospital of Essen,Retinoblastoma,not available,Local review,3,female,"mesenchyme, cranium, intraocular; ",not available,RETB,methylation class retinoblastoma,70%,Not applicable,DNA_KRYO,11月21日,9878827214
SCHW_01,8622007069_R01C01,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,12,male,"posterior fossa, cerebello-pontine angle; peripheral nerve, cranial nerve, VIII; ",initial operation ,SCHW,methylation class schwannoma,46%,Not applicable,DNA_FFPE,11月26日,8622007069
SCHW_02,9305651060_R02C02,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,12,male,"posterior fossa, cerebello-pontine angle; peripheral nerve, cranial nerve, VIII; ",initial operation ,SCHW,methylation class schwannoma,58%,Not applicable,DNA_FFPE,7月19日,9305651060
SCHW_03,9305651060_R01C02,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,14,male,"posterior fossa, cerebello-pontine angle; peripheral nerve, cranial nerve, VIII;  right;",initial operation ,SCHW,methylation class schwannoma,57%,Not applicable,DNA_FFPE,7月19日,9305651060
SCHW_04,9305651060_R05C01,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,15,female,"posterior fossa, cerebello-pontine angle; peripheral nerve, cranial nerve, VIII;  left; right;",initial operation ,SCHW,methylation class schwannoma,53%,Not applicable,DNA_FFPE,7月19日,9305651060
SCHW_05,9305651053_R06C02,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,16,male,"posterior fossa, cerebello-pontine angle; peripheral nerve, cranial nerve; ",initial operation ,SCHW,methylation class schwannoma,53%,Not applicable,DNA_FFPE,7月12日,9305651053
SCHW_06,8622007067_R04C02,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,17,male,"supratentorial, intraventricular;  right;",initial operation ,SCHW,methylation class schwannoma,53%,Not applicable,DNA_FFPE,11月26日,8622007067
SCHW_07,9305651055_R05C02,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,17,female,"posterior fossa, cerebello-pontine angle; peripheral nerve, cranial nerve, VIII;  left;",initial operation ,SCHW,methylation class schwannoma,65%,Not applicable,DNA_FFPE,7月19日,9305651055
SCHW_08,9305651060_R04C01,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,17,male,"spinal, cervical, C5, C6, C7, thoracic, T1; ",initial operation ,SCHW,methylation class schwannoma,57%,Not applicable,DNA_FFPE,7月19日,9305651060
SCHW_09,8622007069_R06C01,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,18,male,"spinal, sacral; ",initial operation ,SCHW,methylation class schwannoma,46%,Not applicable,DNA_FFPE,11月26日,8622007069
SCHW_10,9305216209_R03C01,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,18,female,"peripheral nerve, cranial nerve, V; ",initial operation ,SCHW,methylation class schwannoma,49%,Not applicable,DNA_FFPE,7月5日,9305216209
SCHW_11,9305651060_R06C01,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,18,male,"peripheral nerve, spinal root, thoracic; ",initial operation ,SCHW,methylation class schwannoma,58%,Not applicable,DNA_FFPE,7月19日,9305651060
SCHW_12,9305651055_R06C02,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,21,female,"posterior fossa, cerebello-pontine angle; peripheral nerve, cranial nerve, VIII; ",initial operation ,SCHW,methylation class schwannoma,53%,Not applicable,DNA_FFPE,7月19日,9305651055
SCHW_13,9305651060_R01C01,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,21,male,"peripheral nerve, cranial nerve, VIII, dermal, head;  left;",initial operation ,SCHW,methylation class schwannoma,51%,Not applicable,DNA_FFPE,7月19日,9305651060
SCHW_14,9305651060_R02C01,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,22,female,"posterior fossa, cerebello-pontine angle; peripheral nerve, cranial nerve, VIII; ",initial operation ,SCHW,methylation class schwannoma,53%,Not applicable,DNA_FFPE,7月19日,9305651060
SCHW_15,9305651060_R03C01,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,24,female,"posterior fossa, cerebello-pontine angle; peripheral nerve, cranial nerve, VIII; ",initial operation ,SCHW,methylation class schwannoma,54%,Not applicable,DNA_FFPE,7月19日,9305651060
SCHW_16,9305651037_R06C02,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,29,male,"spinal, extramedullary intradural, cervical, C4, C5; ",initial operation ,SCHW,methylation class schwannoma,48%,Not applicable,DNA_FFPE,6月28日,9305651037
SCHW_17,9373551039_R05C01,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,33,male,"peripheral nerve, plexus, plexus brachialis;  right;",initial operation ,SCHW,methylation class schwannoma,46%,Not applicable,DNA_FFPE,8月23日,9373551039
SCHW_18,9420867087_R02C02,University Hospital of Frankfurt am Main,Schwannoma  ,I,Central review Heidelberg,41,male,"spinal, extramedullary intradural, thoracic, T3; ",not available,SCHW,methylation class schwannoma,55%,Not applicable,DNA_FFPE,1月17日,9420867087
SCHW_19,3999834002_R02C02,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,49,male,"peripheral nerve, peripheral nerve, other;  left;",recurrence ,SCHW,methylation class schwannoma,49%,Not applicable,DNA_FFPE,2月6日,3999834002
SCHW_20,9444374132_R03C02,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,64,male,"posterior fossa, cerebello-pontine angle; peripheral nerve, cranial nerve, VIII; ",initial operation ,SCHW,methylation class schwannoma,53%,Not applicable,DNA_FFPE,1月27日,9444374132
SCHW_21,9444374132_R06C02,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,65,male,"spinal, thoracic, T11, T12; ",initial operation ,SCHW,methylation class schwannoma,56%,Not applicable,DNA_FFPE,1月27日,9444374132
SCHW_22,9444374133_R03C01,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,66,male,"spinal, cervical, C3, C4; ",initial operation ,SCHW,methylation class schwannoma,57%,Not applicable,DNA_FFPE,1月27日,9444374133
SCHW_23,9444374133_R02C01,University Hospital of Heidelberg,Schwannoma  ,I,Central review Heidelberg,68,male,"spinal, lumbar, L2, L3; ",initial operation ,SCHW,methylation class schwannoma,66%,Not applicable,DNA_FFPE,1月27日,9444374133
SCHW_MEL_01,9379086120_R01C01,University Hospital of Heidelberg,Melanotic schwannoma,not available,Central review Heidelberg,11,female,not available,not available,SCHW_MEL,methylation class melanotic schwannoma,45%,Not applicable,DNA_KRYO,12月2日,9379086120
SCHW_MEL_02,9406921148_R05C02,University Hospital of Bern,Melanotic schwannoma,not available,Central review Heidelberg,18,female,"peripheral nerve, dermal, neck; ",not available,SCHW_MEL,methylation class melanotic schwannoma,45%,Not applicable,DNA_FFPE,11月18日,9406921148
SCHW_MEL_03,9406921038_R02C02,University Hospital of Hannover,Melanotic schwannoma,not available,Central review Heidelberg,21,female,meningeal unspecified; ,initial operation ,SCHW_MEL,methylation class melanotic schwannoma,49%,Not applicable,DNA_FFPE,11月18日,9406921038
SCHW_MEL_04,9553932029_R02C02,University Hospital of Frankfurt am Main,Melanotic schwannoma,not available,Central review Heidelberg,32,male,spinal; ,initial operation ,SCHW_MEL,methylation class melanotic schwannoma,50%,Not applicable,DNA_FFPE,2月21日,9553932029
SCHW_MEL_05,9406921039_R01C01,University Hospital of Heidelberg,Melanotic schwannoma,not available,Central review Heidelberg,44,male,"spinal, sacral; ",initial operation ,SCHW_MEL,methylation class melanotic schwannoma,42%,Not applicable,DNA_FFPE,11月18日,9406921039
SCHW_MEL_06,9406921038_R01C02,University Hospital of Heidelberg,Melanotic schwannoma,not available,Central review Heidelberg,60,female,"spinal, cervical, C7;  right;",initial operation ,SCHW_MEL,methylation class melanotic schwannoma,54%,Not applicable,DNA_FFPE,11月18日,9406921038
SCHW_MEL_07,9553932029_R05C01,University Hospital of Heidelberg,Melanotic schwannoma,not available,Central review Heidelberg,64,female,"spinal, lumbar, L1, L2; ",not available,SCHW_MEL,methylation class melanotic schwannoma,49%,Not applicable,DNA_FFPE,2月21日,9553932029
SCHW_MEL_08,9406921038_R06C02,University Hospital of Heidelberg,Melanotic schwannoma,not available,Central review Heidelberg,64,female,"spinal, cervical; ",initial operation ,SCHW_MEL,methylation class melanotic schwannoma,56%,Not applicable,DNA_FFPE,11月18日,9406921038
SFT_HMPC_01,9376561062_R02C01,University Hospital of Heidelberg,Solitary fibrous tumour / haemangiopericytoma  ,"I, II or III",Central review Heidelberg,22,female,supratentorial; posterior fossa;  right;,initial operation ,SFT_HMPC,methylation class solitary fibrous tumor / hemangiopericytoma,61%,Not applicable,DNA_FFPE,9月27日,9376561062
SFT_HMPC_02,9340996003_R01C02,University Hospital of Heidelberg,Solitary fibrous tumour / haemangiopericytoma  ,"I, II or III",Central review Heidelberg,41,male,"supratentorial, hemispheric, temporal;  left;",recurrence ,SFT_HMPC,methylation class solitary fibrous tumor / hemangiopericytoma,64%,Not applicable,DNA_FFPE,8月6日,9340996003
SFT_HMPC_03,9969477006_R02C02,University Hospital of Heidelberg,Solitary fibrous tumour / haemangiopericytoma  ,"I, II or III",Central review Heidelberg,45,female,"posterior fossa, meningeal (posterior fossa), tentorium cerebelli; ",initial operation ,SFT_HMPC,methylation class solitary fibrous tumor / hemangiopericytoma,60%,Not applicable,DNA_KRYO,7月18日,9969477006
SFT_HMPC_04,9878820156_R04C01,University Hospital of Heidelberg,Solitary fibrous tumour / haemangiopericytoma  ,"I, II or III",Central review Heidelberg,56,female,"supratentorial, meningeal (supratentorial); posterior fossa, meningeal (posterior fossa); ",initial operation ,SFT_HMPC,methylation class solitary fibrous tumor / hemangiopericytoma,69%,Not applicable,DNA_FFPE,11月7日,9878820156
SFT_HMPC_05,9305651055_R01C01,University Hospital of Heidelberg,Solitary fibrous tumour / haemangiopericytoma  ,"I, II or III",Central review Heidelberg,60,female,"spinal, thoracic, T4; ",initial operation ,SFT_HMPC,methylation class solitary fibrous tumor / hemangiopericytoma,66%,Not applicable,DNA_FFPE,7月19日,9305651055
SFT_HMPC_06,9969477124_R04C01,University Hospital of Heidelberg,Solitary fibrous tumour / haemangiopericytoma  ,"I, II or III",Central review Heidelberg,60,male,"posterior fossa, cerebello-pontine angle, meningeal (posterior fossa); ",initial operation ,SFT_HMPC,methylation class solitary fibrous tumor / hemangiopericytoma,65%,Not applicable,DNA_FFPE,9月6日,9969477124
SFT_HMPC_07,9305651055_R02C01,University Hospital of Heidelberg,Solitary fibrous tumour / haemangiopericytoma  ,"I, II or III",Central review Heidelberg,62,female,"supratentorial, hemispheric, frontal;  right;",initial operation ,SFT_HMPC,methylation class solitary fibrous tumor / hemangiopericytoma,56%,Not applicable,DNA_FFPE,7月19日,9305651055
SFT_HMPC_08,9533774097_R02C02,University Hospital of Heidelberg,Solitary fibrous tumour / haemangiopericytoma  ,"I, II or III",Central review Heidelberg,62,male,"supratentorial, intraventricular, ventricle II;  left;",initial operation ,SFT_HMPC,methylation class solitary fibrous tumor / hemangiopericytoma,72%,Not applicable,DNA_FFPE,6月16日,9533774097
SFT_HMPC_09,9340996003_R02C01,University Hospital of Heidelberg,Solitary fibrous tumour / haemangiopericytoma  ,"I, II or III",Central review Heidelberg,65,female,"supratentorial, hemispheric, occipital;  right;",initial operation ,SFT_HMPC,methylation class solitary fibrous tumor / hemangiopericytoma,63%,Not applicable,DNA_FFPE,8月6日,9340996003
SFT_HMPC_10,9305651055_R06C01,University Hospital of Heidelberg,Solitary fibrous tumour / haemangiopericytoma  ,"I, II or III",Central review Heidelberg,70,male,"posterior fossa, cerebello-pontine angle;  left;",initial operation ,SFT_HMPC,methylation class solitary fibrous tumor / hemangiopericytoma,64%,Not applicable,DNA_FFPE,7月19日,9305651055
SFT_HMPC_11,3999875056_R06C02,University Hospital of Heidelberg,Solitary fibrous tumour / haemangiopericytoma  ,"I, II or III",Central review Heidelberg,70,female,"supratentorial, meningeal (supratentorial); ",initial operation ,SFT_HMPC,methylation class solitary fibrous tumor / hemangiopericytoma,65%,Not applicable,DNA_FFPE,1月16日,3999875056
SFT_HMPC_12,10003886253_R03C01,University Hospital of Heidelberg,Solitary fibrous tumour / haemangiopericytoma  ,"I, II or III",Central review Heidelberg,71,male,"spinal, thoracic; ",initial operation ,SFT_HMPC,methylation class solitary fibrous tumor / hemangiopericytoma,68%,Not applicable,DNA_FFPE,1月23日,10003886253
SFT_HMPC_13,9340996050_R06C02,University Hospital of Heidelberg,Solitary fibrous tumour / haemangiopericytoma  ,"I, II or III",Central review Heidelberg,73,male,"supratentorial, hemispheric, parietal, occipital;  left;",recurrence ,SFT_HMPC,methylation class solitary fibrous tumor / hemangiopericytoma,65%,Not applicable,DNA_FFPE,8月9日,9340996050
SFT_HMPC_14,9340996003_R04C01,University Hospital of Heidelberg,Solitary fibrous tumour / haemangiopericytoma  ,"I, II or III",Central review Heidelberg,74,female,"supratentorial, hemispheric, frontal;  left;",initial operation ,SFT_HMPC,methylation class solitary fibrous tumor / hemangiopericytoma,67%,Not applicable,DNA_FFPE,8月6日,9340996003
SFT_HMPC_15,9376561024_R02C01,University Hospital of Heidelberg,Solitary fibrous tumour / haemangiopericytoma  ,"I, II or III",Central review Heidelberg,75,male,"supratentorial, meningeal (supratentorial), occipital, falx, posterior; ",initial operation ,SFT_HMPC,methylation class solitary fibrous tumor / hemangiopericytoma,58%,Not applicable,DNA_FFPE,11月4日,9376561024
SFT_HMPC_16,9741950027_R02C01,University Hospital of Frankfurt am Main,Solitary fibrous tumour / haemangiopericytoma  ,"I, II or III",Central review Heidelberg,83,female,"spinal, thoracic, T8; ",initial operation ,SFT_HMPC,methylation class solitary fibrous tumor / hemangiopericytoma,69%,Not applicable,DNA_FFPE,3月28日,9741950027
SUBEPN_PF_01,9376538149_R06C01,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,33,male,"posterior fossa, ventricle IV; ",initial operation ,SUBEPN_PF,"methylation class subependymoma, posterior fossa",67%,Not applicable,DNA_FFPE,10月25日,9376538149
SUBEPN_PF_02,9533774018_R06C02,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,33,male,"posterior fossa, ventricle IV; ",initial operation ,SUBEPN_PF,"methylation class subependymoma, posterior fossa",66%,Not applicable,DNA_FFPE,5月30日,9533774018
SUBEPN_PF_03,9406921148_R02C02,University Hospital of Bern,Subependymoma  ,I,Central review Heidelberg,35,male,"posterior fossa, ventricle IV; ",not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",64%,Not applicable,DNA_FFPE,11月18日,9406921148
SUBEPN_PF_04,9406921148_R06C01,University Hospital of Bern,Subependymoma  ,I,Central review Heidelberg,39,male,"posterior fossa, ventricle IV; ",not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",65%,Not applicable,DNA_FFPE,11月18日,9406921148
SUBEPN_PF_05,9533774106_R04C01,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,39,male,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",67%,Not applicable,DNA_FFPE,6月27日,9533774106
SUBEPN_PF_06,9968646156_R05C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,39,male,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",66%,Not applicable,DNA_KRYO,7月11日,9968646156
SUBEPN_PF_07,9406922161_R06C02,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,40,male,"posterior fossa, ventricle IV; ",initial operation ,SUBEPN_PF,"methylation class subependymoma, posterior fossa",67%,Not applicable,DNA_FFPE,10月18日,9406922161
SUBEPN_PF_08,9406922161_R02C02,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,46,male,"posterior fossa, ventricle IV; ",initial operation ,SUBEPN_PF,"methylation class subependymoma, posterior fossa",66%,Not applicable,DNA_FFPE,10月18日,9406922161
SUBEPN_PF_09,9406922161_R03C02,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,51,male,"posterior fossa, ventricle IV; ",initial operation ,SUBEPN_PF,"methylation class subependymoma, posterior fossa",66%,Not applicable,DNA_FFPE,10月18日,9406922161
SUBEPN_PF_10,9533774066_R02C02,University Hospital of Cambridge,Subependymoma  ,I,Local review,52,male,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",65%,Not applicable,DNA_KRYO,6月7日,9533774066
SUBEPN_PF_11,9533774066_R02C01,University Hospital of Cambridge,Subependymoma  ,I,Local review,52,male,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",66%,Not applicable,DNA_KRYO,6月7日,9533774066
SUBEPN_PF_12,9426020065_R05C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,52,male,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",66%,Not applicable,DNA_KRYO,12月20日,9426020065
SUBEPN_PF_13,9426020064_R01C02,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,52,female,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",70%,Not applicable,DNA_KRYO,12月20日,9426020064
SUBEPN_PF_14,9376538149_R03C01,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,53,male,"posterior fossa, ventricle IV; ",initial operation ,SUBEPN_PF,"methylation class subependymoma, posterior fossa",69%,Not applicable,DNA_FFPE,10月25日,9376538149
SUBEPN_PF_15,9376538149_R05C01,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,54,male,"posterior fossa, ventricle IV; ",initial operation ,SUBEPN_PF,"methylation class subependymoma, posterior fossa",67%,Not applicable,DNA_FFPE,10月25日,9376538149
SUBEPN_PF_16,9611519051_R03C01,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,54,male,"posterior fossa, ventricle IV; ",initial operation ,SUBEPN_PF,"methylation class subependymoma, posterior fossa",65%,Not applicable,DNA_FFPE,3月15日,9611519051
SUBEPN_PF_17,9533774066_R04C01,University Hospital of Cambridge,Subependymoma  ,I,Local review,56,male,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",67%,Not applicable,DNA_KRYO,6月7日,9533774066
SUBEPN_PF_18,9533774057_R06C02,University Hospital of Cambridge,Subependymoma  ,I,Local review,56,male,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",69%,Not applicable,DNA_KRYO,6月7日,9533774057
SUBEPN_PF_19,9305651060_R03C02,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,56,male,"posterior fossa, ventricle IV; ",initial operation ,SUBEPN_PF,"methylation class subependymoma, posterior fossa",63%,Not applicable,DNA_FFPE,7月19日,9305651060
SUBEPN_PF_20,9533774033_R01C02,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,58,male,"posterior fossa, ventricle IV; ",initial operation ,SUBEPN_PF,"methylation class subependymoma, posterior fossa",65%,Not applicable,DNA_FFPE,6月7日,9533774033
SUBEPN_PF_21,9534104006_R03C02,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,59,female,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",66%,Not applicable,DNA_FFPE,6月27日,9534104006
SUBEPN_PF_22,9406921148_R03C02,University Hospital of Bern,Subependymoma  ,I,Central review Heidelberg,61,male,"posterior fossa, ventricle IV; ",not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",63%,Not applicable,DNA_FFPE,11月18日,9406921148
SUBEPN_PF_23,9533774106_R01C01,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,61,female,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",66%,Not applicable,DNA_FFPE,6月27日,9533774106
SUBEPN_PF_24,9426020064_R04C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,62,male,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",67%,Not applicable,DNA_KRYO,12月20日,9426020064
SUBEPN_PF_25,9376538149_R02C01,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,63,male,"posterior fossa, ventricle IV; ",initial operation ,SUBEPN_PF,"methylation class subependymoma, posterior fossa",63%,Not applicable,DNA_FFPE,10月25日,9376538149
SUBEPN_PF_26,9533774101_R05C02,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,63,male,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",66%,Not applicable,DNA_FFPE,6月27日,9533774101
SUBEPN_PF_27,6929689149_R06C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,63,female,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",64%,Not applicable,DNA_KRYO,12月23日,6929689149
SUBEPN_PF_28,9533774066_R06C01,University Hospital of Cambridge,Subependymoma  ,I,Local review,68,male,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",64%,Not applicable,DNA_KRYO,6月7日,9533774066
SUBEPN_PF_29,9533774066_R04C02,University Hospital of Cambridge,Subependymoma  ,I,Local review,69,male,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",65%,Not applicable,DNA_KRYO,6月7日,9533774066
SUBEPN_PF_30,9406921148_R01C02,University Hospital of Bern,Subependymoma  ,I,Central review Heidelberg,73,male,"posterior fossa, ventricle IV; ",not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",70%,Not applicable,DNA_FFPE,11月18日,9406921148
SUBEPN_PF_31,9403904071_R03C01,University Hospital of Heidelberg,Ependymoma  ,II,Central review Heidelberg,75,female,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",65%,Not applicable,DNA_KRYO,12月3日,9403904071
SUBEPN_PF_32,9533774066_R06C02,University Hospital of Cambridge,Subependymoma  ,I,Local review,76,male,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",65%,Not applicable,DNA_KRYO,6月7日,9533774066
SUBEPN_PF_33,9373551023_R06C02,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,76,female,"posterior fossa, brain stem, medulla oblongata (craniocervical); ",initial operation ,SUBEPN_PF,"methylation class subependymoma, posterior fossa",66%,Not applicable,DNA_FFPE,8月23日,9373551023
SUBEPN_PF_34,9407201032_R02C01,"MD Anderson Cancer Center, Houston",Ependymoma  ,II,Local review,not available ,male,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",70%,Not applicable,DNA_FFPE,10月25日,9407201032
SUBEPN_PF_35,9407201032_R01C01,"MD Anderson Cancer Center, Houston",Subependymoma  ,I,Local review,not available ,male,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",66%,Not applicable,DNA_FFPE,10月25日,9407201032
SUBEPN_PF_36,9407201032_R05C01,"MD Anderson Cancer Center, Houston",Subependymoma  ,I,Local review,not available ,female,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",67%,Not applicable,DNA_FFPE,10月25日,9407201032
SUBEPN_PF_37,9407201032_R06C01,"MD Anderson Cancer Center, Houston",Subependymoma  ,I,Local review,not available ,male,posterior fossa; ,not available,SUBEPN_PF,"methylation class subependymoma, posterior fossa",62%,Not applicable,DNA_FFPE,10月25日,9407201032
SUBEPN_SPINE_01,8622007203_R06C02,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,22,female,"spinal, intramedullary, thoracic, T10, T11, T12, lumbar, L1, L2; ",initial operation ,SUBEPN_SPINE,"methylation class subependymoma, spinal",65%,Not applicable,DNA_FFPE,1月17日,8622007203
SUBEPN_SPINE_02,9406922161_R05C02,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,33,female,"spinal, cervical, C2, C3, C4, C5, C6, C7, thoracic, T1; ",initial operation ,SUBEPN_SPINE,"methylation class subependymoma, spinal",59%,Not applicable,DNA_FFPE,10月18日,9406922161
SUBEPN_SPINE_03,9376561024_R05C02,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,38,male,"spinal, intramedullary, extramedullary intradural, thoracic, T10; ",initial operation ,SUBEPN_SPINE,"methylation class subependymoma, spinal",66%,Not applicable,DNA_FFPE,11月4日,9376561024
SUBEPN_SPINE_04,9968646165_R01C02,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,43,female,"spinal, thoracic, T4, T5; ",initial operation ,SUBEPN_SPINE,"methylation class subependymoma, spinal",64%,Not applicable,DNA_FFPE,7月11日,9968646165
SUBEPN_SPINE_05,9533774097_R03C01,German Glioma Network ,Ependymoma  ,II,Central review Duesseldorf,46,male,"spinal, intramedullary, cervical, C2, C3, C4, C5, C6; ",recurrence ,SUBEPN_SPINE,"methylation class subependymoma, spinal",65%,Not applicable,DNA_FFPE,6月16日,9533774097
SUBEPN_SPINE_06,9533774057_R02C02,University Hospital of Cambridge,Subependymoma  ,I,Local review,49,female,spinal; ,not available,SUBEPN_SPINE,"methylation class subependymoma, spinal",67%,Not applicable,DNA_KRYO,6月7日,9533774057
SUBEPN_SPINE_07,9373550164_R06C02,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,52,male,"spinal, intramedullary, cervical, C7, thoracic, T1, T2; ",initial operation ,SUBEPN_SPINE,"methylation class subependymoma, spinal",67%,Not applicable,DNA_FFPE,8月21日,9373550164
SUBEPN_SPINE_08,9373550164_R01C01,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,59,male,"spinal, intramedullary, thoracic, T10, T11; ",initial operation ,SUBEPN_SPINE,"methylation class subependymoma, spinal",64%,Not applicable,DNA_FFPE,8月21日,9373550164
SUBEPN_SPINE_09,9422491130_R04C02,University Hospital of Tuebingen,Ependymoma  ,II,Central review Heidelberg,68,female,"spinal, intramedullary, cervical, C3, C4, C5, C6; ",initial operation ,SUBEPN_SPINE,"methylation class subependymoma, spinal",65%,Not applicable,DNA_FFPE,11月18日,9422491130
SUBEPN_ST_01,9533774066_R01C01,University Hospital of Cambridge,Subependymoma  ,I,Local review,25,male,not available,not available,SUBEPN_ST,"methylation class subependymoma, supratentorial",68%,Not applicable,DNA_KRYO,6月7日,9533774066
SUBEPN_ST_02,6929806038_R04C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,31,male,supratentorial; ,not available,SUBEPN_ST,"methylation class subependymoma, supratentorial",63%,Not applicable,DNA_KRYO,7月2日,6929806038
SUBEPN_ST_03,6929806024_R01C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,37,male,supratentorial; ,not available,SUBEPN_ST,"methylation class subependymoma, supratentorial",65%,Not applicable,DNA_KRYO,7月2日,6929806024
SUBEPN_ST_04,6929806038_R04C02,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,38,male,supratentorial; ,not available,SUBEPN_ST,"methylation class subependymoma, supratentorial",64%,Not applicable,DNA_KRYO,7月2日,6929806038
SUBEPN_ST_05,9533774066_R03C02,University Hospital of Cambridge,Subependymoma  ,I,Local review,39,female,supratentorial; ,not available,SUBEPN_ST,"methylation class subependymoma, supratentorial",69%,Not applicable,DNA_KRYO,6月7日,9533774066
SUBEPN_ST_06,8622007203_R03C02,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,40,male,"supratentorial, intraventricular, ventricle II; ",initial operation ,SUBEPN_ST,"methylation class subependymoma, supratentorial",62%,Not applicable,DNA_FFPE,1月17日,8622007203
SUBEPN_ST_07,6929806046_R06C01,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,41,male,supratentorial; ,not available,SUBEPN_ST,"methylation class subependymoma, supratentorial",65%,Not applicable,DNA_KRYO,7月2日,6929806046
SUBEPN_ST_08,8622007203_R04C02,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,42,male,"supratentorial, intraventricular, ventricle II;  left;",initial operation ,SUBEPN_ST,"methylation class subependymoma, supratentorial",66%,Not applicable,DNA_FFPE,1月17日,8622007203
SUBEPN_ST_09,8622007189_R06C01,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,45,male,"supratentorial, intraventricular, ventricle II;  left;",initial operation ,SUBEPN_ST,"methylation class subependymoma, supratentorial",71%,Not applicable,DNA_FFPE,1月17日,8622007189
SUBEPN_ST_10,9533774066_R01C02,University Hospital of Cambridge,Subependymoma  ,I,Local review,48,female,supratentorial; ,not available,SUBEPN_ST,"methylation class subependymoma, supratentorial",68%,Not applicable,DNA_KRYO,6月7日,9533774066
SUBEPN_ST_11,6929689149_R02C02,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,48,male,supratentorial; ,not available,SUBEPN_ST,"methylation class subependymoma, supratentorial",62%,Not applicable,DNA_KRYO,12月23日,6929689149
SUBEPN_ST_12,9370847051_R05C02,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,53,female,"supratentorial, intraventricular, ventricle II;  left; right;",initial operation ,SUBEPN_ST,"methylation class subependymoma, supratentorial",67%,Not applicable,DNA_FFPE,9月19日,9370847051
SUBEPN_ST_13,9376561024_R06C02,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,56,male,"supratentorial, intraventricular, ventricle II;  left;",initial operation ,SUBEPN_ST,"methylation class subependymoma, supratentorial",68%,Not applicable,DNA_FFPE,11月4日,9376561024
SUBEPN_ST_14,9370847051_R05C01,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,58,male,"supratentorial, intraventricular, ventricle II;  left;",initial operation ,SUBEPN_ST,"methylation class subependymoma, supratentorial",65%,Not applicable,DNA_FFPE,9月19日,9370847051
SUBEPN_ST_15,8622007203_R05C02,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,59,male,not available,initial operation ,SUBEPN_ST,"methylation class subependymoma, supratentorial",65%,Not applicable,DNA_FFPE,1月17日,8622007203
SUBEPN_ST_16,9370847051_R06C01,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,64,female,"supratentorial, intraventricular, ventricle II;  left;",initial operation ,SUBEPN_ST,"methylation class subependymoma, supratentorial",68%,Not applicable,DNA_FFPE,9月19日,9370847051
SUBEPN_ST_17,8622007189_R01C01,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,69,female,"supratentorial, intraventricular, ventricle II;  left;",initial operation ,SUBEPN_ST,"methylation class subependymoma, supratentorial",68%,Not applicable,DNA_FFPE,1月17日,8622007189
SUBEPN_ST_18,6929806046_R04C02,"Burdenko Neurosurgery Institute, Moscow",Ependymoma  ,II,Central review Heidelberg,70,female,supratentorial; ,not available,SUBEPN_ST,"methylation class subependymoma, supratentorial",66%,Not applicable,DNA_KRYO,7月2日,6929806046
SUBEPN_ST_19,8622007189_R03C01,University Hospital of Heidelberg,Subependymoma  ,I,Central review Heidelberg,72,male,"supratentorial, intraventricular, ventricle II;  left;",initial operation ,SUBEPN_ST,"methylation class subependymoma, supratentorial",66%,Not applicable,DNA_FFPE,1月17日,8622007189
